LOGO

 

LOGO

 

2023 Annual Report

RiverSource of New York Account 8

 

This wrapper contains financial statements provided for owners of:

 

 

RiverSource Succession Select® Variable Life Insurance

 

 

RiverSource® Variable Second-To-Die Life Insurance

 

 

RiverSource® Variable Universal Life Insurance

 

 

RiverSource® Variable Universal Life Insurance III

 

 

RiverSource® Variable Universal Life IV

 

 

RiverSource® Variable Universal Life IV – Estate Series

 

 

RiverSource® Variable Universal Life 5

 

 

RiverSource® Variable Universal Life 5 – Estate Series

This Annual Report contains financial information for all the subaccounts of RiverSource of New York Account 8. Not all subaccounts of RiverSource of New York Account 8 apply to your specific contract.

 

LOGO

 

ANN9126_12_C01_(05/24)     

Issued by: RiverSource Life Insurance Co. of New York

 


 

 

 

This page left blank intentionally

 

 

 

 


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

TO THE BOARD OF DIRECTORS OF RIVERSOURCE LIFE INSURANCE CO. OF NEW YORK

AND THE POLICY OWNERS OF RIVERSOURCE OF NEW YORK ACCOUNT 8

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities of each of the divisions of RiverSource of New York Account 8, as indicated in Note 1, as of December 31, 2023, and the related statements of operations and of changes in net assets for each of the periods indicated in Note 1, including the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the divisions of RiverSource of New York Account 8 as of December 31, 2023, and the results of each of their operations and the changes in each of their net assets for each of the periods indicated in Note 1 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

These financial statements are the responsibility of the RiverSource Life Insurance Co. of New York management. Our responsibility is to express an opinion on the financial statements of each of the divisions of the RiverSource of New York Account 8 based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to each of the divisions of the RiverSource of New York Account 8 in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of investments owned as of December 31, 2023 by correspondence with the transfer agents of the investee mutual funds. We believe that our audits provide a reasonable basis for our opinions.

/s/ PricewaterhouseCoopers LLP

Minneapolis, Minnesota

April 22, 2024

We have served as the auditor of one or more of the divisions of RiverSource of New York Account 8 since 2010.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      1  


Statement of Assets and Liabilities

 

December 31, 2023    AB VPS Dyn
Asset Alloc,
Cl B
    AB VPS
Intl Val,
Cl B
    AB VPS
Lg Cap Gro,
Cl A
    AB VPS
Lg Cap Gro,
Cl B
    AB VPS
Relative Val,
Cl B
 
Assets           

Investments, at fair value(1),(2)

   $ 482     $ 2,702,634     $ 349,453     $ 2,799,308     $ 2,515,292  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

           1,164             2,773       102  

Receivable for share redemptions

           1,001             772       902  

Total assets

     482       2,704,799       349,453       2,802,853       2,516,296  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           1,001             772       902  

Contract terminations

                              

Payable for investments purchased

           1,164             2,773       102  

Total liabilities

           2,165             3,545       1,004  

Net assets applicable to Variable Life contracts in accumulation period

           2,702,531       349,453       2,798,989       2,515,138  

Net assets applicable to seed money

     482       103             319       154  

Total net assets

   $ 482     $ 2,702,634     $ 349,453     $ 2,799,308     $ 2,515,292  

(1)  Investment shares

     54       183,728       4,691       41,806       87,397  

(2)  Investments, at cost

   $ 590     $ 2,600,809     $ 333,631     $ 2,525,264     $ 2,514,522  
December 31, 2023 (continued)    Allspg VT
Index Asset Alloc,
Cl 2
    Allspg VT
Intl Eq,
Cl 2
    Allspg VT
Opp,
Cl 1
    Allspg VT
Opp,
Cl 2
    Allspg VT
Sm Cap Gro,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 536,098     $ 1,026,163     $ 20,536     $ 1,367,078     $ 279,900  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

           592             169       29  

Receivable for share redemptions

     172       511             422        

Total assets

     536,270       1,027,266       20,536       1,367,669       279,929  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     172       511             422        

Contract terminations

                              

Payable for investments purchased

           592             169       29  

Total liabilities

     172       1,103             591       29  

Net assets applicable to Variable Life contracts in accumulation period

     535,992       1,026,061       20,536       1,366,942       279,900  

Net assets applicable to seed money

     106       102             136        

Total net assets

   $ 536,098     $ 1,026,163     $ 20,536     $ 1,367,078     $ 279,900  

(1)  Investment shares

     28,699       523,553       791       52,600       33,361  

(2)  Investments, at cost

   $ 557,463     $ 1,423,491     $ 20,131     $ 1,325,857     $ 321,338  

See accompanying notes to financial statements.

 

2    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Allspg VT
Sm Cap Gro,
Cl 2
    ALPS Alerian
Engy Infr,
Class I
    ALPS Alerian
Engy Infr,
Class III
    AC VP
Intl,
Cl I
    AC VP
Intl,
Cl II
 
Assets           

Investments, at fair value(1),(2)

   $ 1,311,216     $ 49,847     $ 514,470     $ 701,441     $ 786,190  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     763       840       225             31  

Receivable for share redemptions

     323             234       563       246  

Total assets

     1,312,302       50,687       514,929       702,004       786,467  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     323             234       390       246  

Contract terminations

                       173        

Payable for investments purchased

     763       840       225             31  

Total liabilities

     1,086       840       459       563       277  

Net assets applicable to Variable Life contracts in accumulation period

     1,311,136       49,847       514,307       701,441       786,108  

Net assets applicable to seed money

     80             163             82  

Total net assets

   $ 1,311,216     $ 49,847     $ 514,470     $ 701,441     $ 786,190  

(1)  Investment shares

     166,821       4,603       47,548       66,299       74,450  

(2)  Investments, at cost

   $ 1,661,750     $ 47,674     $ 413,255     $ 641,388     $ 816,280  
December 31, 2023 (continued)    AC VP
Val,
Cl I
    AC VP
Val,
Cl II
    BlackRock
Global Alloc,
Cl I
    BlackRock
Global Alloc,
Cl III
    Calvert VP
EAFE Intl Index,
Cl F
 
Assets           

Investments, at fair value(1),(2)

   $ 4,042,517     $ 2,352,619     $ 189,307     $ 514,457     $ 1,966  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     67       134       12,580              

Receivable for share redemptions

     2,176       713             418        

Total assets

     4,044,760       2,353,466       201,887       514,875       1,966  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     2,163       713             201        

Contract terminations

     13                   217        

Payable for investments purchased

     67       134       12,580              

Total liabilities

     2,243       847       12,580       418        

Net assets applicable to Variable Life contracts in accumulation period

     4,042,517       2,352,443       189,307       514,346       1,570  

Net assets applicable to seed money

           176             111       396  

Total net assets

   $ 4,042,517     $ 2,352,619     $ 189,307     $ 514,457     $ 1,966  

(1)  Investment shares

     331,626       192,680       11,607       39,483       21  

(2)  Investments, at cost

   $ 3,052,429     $ 2,052,458     $ 198,031     $ 553,558     $ 1,847  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      3  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Calvert VP
EAFE Intl Index,
Cl I
    Calvert VP
Nasdaq
100 Index,
Cl F
    Calvert VP
Nasdaq
100 Index,
Cl I
    Calv VP
Russ 2000
Sm Cap Ind,
Cl F
    Calv VP
Russ 2000
Sm Cap Ind,
Cl I
 
Assets           

Investments, at fair value(1),(2)

   $ 102,156     $ 19,111     $ 109,164     $ 371     $ 21,811  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                 17              

Receivable for share redemptions

                              

Total assets

     102,156       19,111       109,181       371       21,811  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                              

Contract terminations

                              

Payable for investments purchased

                 17              

Total liabilities

                 17              

Net assets applicable to Variable Life contracts in accumulation period

     102,156       19,111       109,164             21,811  

Net assets applicable to seed money

                       371        

Total net assets

   $ 102,156     $ 19,111     $ 109,164     $ 371     $ 21,811  

(1)  Investment shares

     1,071       137       762       5       273  

(2)  Investments, at cost

   $ 94,185     $ 16,601     $ 100,560     $ 391     $ 20,000  
December 31, 2023 (continued)   

Calvert VP

SRI Bal,

Cl I

    Col VP
Bal,
Cl 1
    Col VP
Bal,
Cl 3
    Col VP
Commodity
Strategy,
Cl 1
    Col VP
Commodity
Strategy,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 2,776,355     $ 1,561,171     $ 17,115,084     $ 59,443     $ 35,719  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

           12,222             1,360        

Receivable for share redemptions

     1,060             10,423              

Total assets

     2,777,415       1,573,393       17,125,507       60,803       35,719  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     1,060             10,406              

Contract terminations

                 17              

Payable for investments purchased

           12,222             1,360        

Total liabilities

     1,060       12,222       10,423       1,360        

Net assets applicable to Variable Life contracts in accumulation period

     2,776,263       1,561,171       17,114,894       59,443       35,719  

Net assets applicable to seed money

     92             190              

Total net assets

   $ 2,776,355     $ 1,561,171     $ 17,115,084     $ 59,443     $ 35,719  

(1)  Investment shares

     1,171,458       36,587       405,571       15,809       9,733  

(2)  Investments, at cost

   $ 2,794,483     $ 1,411,710     $ 8,319,297     $ 74,981     $ 47,274  

See accompanying notes to financial statements.

 

4    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Col VP
Contrarian
Core,
Cl 1
    Col VP
Contrarian
Core,
Cl 2
    Col VP
Disciplined
Core,
Cl 1
    Col VP
Disciplined
Core,
Cl 2
    Col VP
Disciplined
Core,
Cl 3
 
Assets           

Investments, at fair value(1),(2)

   $ 298,501     $ 201,452     $ 164,764     $ 464,570     $ 28,607,416  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     1,842                   17       5  

Receivable for share redemptions

                             23,288  

Total assets

     300,343       201,452       164,764       464,587       28,630,709  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                             18,576  

Contract terminations

                             4,712  

Payable for investments purchased

     1,842                   17       5  

Total liabilities

     1,842                   17       23,293  

Net assets applicable to Variable Life contracts in accumulation period

     298,501       201,452       164,764       464,570       28,607,023  

Net assets applicable to seed money

                             393  

Total net assets

   $ 298,501     $ 201,452     $ 164,764     $ 464,570     $ 28,607,416  

(1)  Investment shares

     6,821       4,738       1,839       5,363       324,937  

(2)  Investments, at cost

   $ 246,481     $ 132,721     $ 144,808     $ 268,543     $ 8,183,091  
December 31, 2023 (continued)    Col VP
Divd Opp,
Cl 1
    Col VP
Divd Opp,
Cl 2
    Col VP
Divd Opp,
Cl 3
    Col VP
Emerg
Mkts Bond,
Cl 1
    Col VP
Emerg
Mkts Bond,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 131,296     $ 236,403     $ 12,144,207     $ 31,360     $ 15,252  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     29             8,632              

Receivable for share redemptions

                 5,395              

Total assets

     131,325       236,403       12,158,234       31,360       15,252  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                 5,395              

Contract terminations

                              

Payable for investments purchased

     29             8,632              

Total liabilities

     29             14,027              

Net assets applicable to Variable Life contracts in accumulation period

     131,296       236,403       12,144,030       31,360       15,252  

Net assets applicable to seed money

                 177              

Total net assets

   $ 131,296     $ 236,403     $ 12,144,207     $ 31,360     $ 15,252  

(1)  Investment shares

     3,346       6,238       314,943       3,990       1,943  

(2)  Investments, at cost

   $ 119,570     $ 197,915     $ 6,364,587     $ 31,249     $ 17,805  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      5  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Col VP
Emer Mkts,
Cl 1
    Col VP
Emer Mkts,
Cl 2
    Col VP
Emer Mkts,
Cl 3
    Col VP Global
Strategic Inc,
Cl 2
    Col VP Global
Strategic Inc,
Cl 3
 
Assets           

Investments, at fair value(1),(2)

   $ 211,450     $ 349,799     $ 1,916,622     $ 88,721     $ 1,264,754  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     344       392       135             28  

Receivable for share redemptions

                 827             609  

Total assets

     211,794       350,191       1,917,584       88,721       1,265,391  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                 827             529  

Contract terminations

                             80  

Payable for investments purchased

     344       392       135             28  

Total liabilities

     344       392       962             637  

Net assets applicable to Variable Life contracts in accumulation period

     211,450       349,799       1,916,533       88,721       1,264,669  

Net assets applicable to seed money

                 89             85  

Total net assets

   $ 211,450     $ 349,799     $ 1,916,622     $ 88,721     $ 1,264,754  

(1)  Investment shares

     21,489       36,362       196,577       11,598       163,405  

(2)  Investments, at cost

   $ 280,150     $ 512,683     $ 2,782,580     $ 98,830     $ 1,508,922  
December 31, 2023 (continued)    Col VP Govt
Money Mkt,
Cl 1
    Col VP Govt
Money Mkt,
Cl 2
    Col VP Govt
Money Mkt,
Cl 3
    Col VP
Hi Yield Bond,
Cl 1
    Col VP
Hi Yield Bond,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 561,626     $ 404,171     $ 2,635,135     $ 122,128     $ 318,522  

Dividends receivable

     77       54       355              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                 1,265       324       317  

Receivable for share redemptions

           7,492       1,509              

Total assets

     561,703       411,717       2,638,264       122,452       318,839  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                 1,068              

Contract terminations

           7,492       441              

Payable for investments purchased

                 1,265       324       317  

Total liabilities

           7,492       2,774       324       317  

Net assets applicable to Variable Life contracts in accumulation period

     561,703       404,225       2,633,321       122,128       318,522  

Net assets applicable to seed money

                 2,169              

Total net assets

   $ 561,703     $ 404,225     $ 2,635,490     $ 122,128     $ 318,522  

(1)  Investment shares

     561,626       404,171       2,635,135       19,988       52,823  

(2)  Investments, at cost

   $ 561,626     $ 404,170     $ 2,635,132     $ 121,575     $ 341,450  

See accompanying notes to financial statements.

 

6    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Col VP
Hi Yield Bond,
Cl 3
    Col VP
Inc Opp,
Cl 1
    Col VP
Inc Opp,
Cl 2
    Col VP
Inc Opp,
Cl 3
    Col VP
Inter Bond,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 2,638,118     $ 22,053     $ 79,753     $ 1,082,634     $ 87,090  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     28                   42       728  

Receivable for share redemptions

     1,112                   567        

Total assets

     2,639,258       22,053       79,753       1,083,243       87,818  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     1,105                   452        

Contract terminations

     7                   115        

Payable for investments purchased

     28                   42       728  

Total liabilities

     1,140                   609       728  

Net assets applicable to Variable Life contracts in accumulation period

     2,638,118       22,053       79,753       1,082,634       87,090  

Net assets applicable to seed money

                              

Total net assets

   $ 2,638,118     $ 22,053     $ 79,753     $ 1,082,634     $ 87,090  

(1)  Investment shares

     433,188       3,473       12,659       169,161       10,139  

(2)  Investments, at cost

   $ 2,862,764     $ 24,269     $ 82,714     $ 1,250,235     $ 97,090  
December 31, 2023 (continued)    Col VP
Inter Bond,
Cl 2
    Col VP
Inter Bond,
Cl 3
    Col VP
Lg Cap Gro,
Cl 1
    Col VP
Lg Cap Gro,
Cl 2
    Col VP
Lg Cap Gro,
Cl 3
 
Assets           

Investments, at fair value(1),(2)

   $ 54,558     $ 5,536,137     $ 1,690,340     $ 470,350     $ 3,401,791  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

           3,593       20,036             84  

Receivable for share redemptions

     125       2,632                   10,560  

Total assets

     54,683       5,542,362       1,710,376       470,350       3,412,435  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           2,632                   1,488  

Contract terminations

     125                         9,072  

Payable for investments purchased

           3,593       20,036             84  

Total liabilities

     125       6,225       20,036             10,644  

Net assets applicable to Variable Life contracts in accumulation period

     54,558       5,536,056       1,690,340       470,350       3,401,606  

Net assets applicable to seed money

           81                   185  

Total net assets

   $ 54,558     $ 5,536,137     $ 1,690,340     $ 470,350     $ 3,401,791  

(1)  Investment shares

     6,381       643,737       45,342       13,058       92,742  

(2)  Investments, at cost

   $ 61,896     $ 6,630,373     $ 1,395,185     $ 310,964     $ 1,497,978  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      7  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)   Col VP
Lg Cap Index,
Cl 1
    Col VP
Lg Cap Index,
Cl 3
    Col VP Limited
Duration Cr,
Cl 1
    Col VP Limited
Duration Cr,
Cl 2
    Col VP
Long Govt/
Cr Bond,
Cl 1
 
Assets          

Investments, at fair value(1),(2)

  $ 5,146,295     $ 14,291,500     $ 22,154     $ 874,816     $ 10,295  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

    18,049       925                    

Receivable for share redemptions

          6,092             374        

Total assets

    5,164,344       14,298,517       22,154       875,190       10,295  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

          5,461             364        

Contract terminations

          631             10        

Payable for investments purchased

    18,049       925                    

Total liabilities

    18,049       7,017             374        

Net assets applicable to Variable Life contracts in accumulation period

    5,146,295       14,291,332       22,154       874,730       10,295  

Net assets applicable to seed money

          168             86        

Total net assets

  $ 5,146,295     $ 14,291,500     $ 22,154     $ 874,816     $ 10,295  

(1)  Investment shares

    127,478       359,354       2,337       92,769       1,303  

(2)  Investments, at cost

  $ 4,387,609     $ 7,166,188     $ 21,807     $ 876,690     $ 11,705  
December 31, 2023 (continued)   Col VP
Long Govt/Cr
Bond,
Cl 2
    Col VP
Overseas Core,
Cl 1
    Col VP
Overseas Core,
Cl 2
    Col VP
Overseas Core,
Cl 3
    Col VP Select
Lg Cap Val,
Cl 1
 
Assets          

Investments, at fair value(1),(2)

  $ 8,689     $ 225,445     $ 182,815     $ 4,687,997     $ 659,264  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

          435       976       810       1,166  

Receivable for share redemptions

                      3,075        

Total assets

    8,689       225,880       183,791       4,691,882       660,430  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

                      3,075        

Contract terminations

                             

Payable for investments purchased

          435       976       810       1,166  

Total liabilities

          435       976       3,885       1,166  

Net assets applicable to Variable Life contracts in accumulation period

    8,689       225,445       182,815       4,687,897       659,264  

Net assets applicable to seed money

                      100        

Total net assets

  $ 8,689     $ 225,445     $ 182,815     $ 4,687,997     $ 659,264  

(1)  Investment shares

    1,103       16,887       13,829       352,481       17,031  

(2)  Investments, at cost

  $ 12,067     $ 217,661     $ 180,922     $ 4,002,782     $ 618,552  

See accompanying notes to financial statements.

 

8    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Col VP Select
Lg Cap Val,
Cl 2
    Col VP Select
Lg Cap Val,
Cl 3
    Col VP Select
Mid Cap Gro,
Cl 1
    Col VP Select
Mid Cap Gro,
Cl 2
    Col VP Select
Mid Cap Gro,
Cl 3
 
Assets           

Investments, at fair value(1),(2)

   $ 145,583     $ 911,236     $ 313,355     $ 95,372     $ 1,030,424  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     864       1,577       11,980       167        

Receivable for share redemptions

           374                   412  

Total assets

     146,447       913,187       325,335       95,539       1,030,836  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           370                   412  

Contract terminations

           4                    

Payable for investments purchased

     864       1,577       11,980       167        

Total liabilities

     864       1,951       11,980       167       412  

Net assets applicable to Variable Life contracts in accumulation period

     145,583       911,058       313,355       95,372       1,030,424  

Net assets applicable to seed money

           178                    

Total net assets

   $ 145,583     $ 911,236     $ 313,355     $ 95,372     $ 1,030,424  

(1)  Investment shares

     3,888       23,961       6,902       2,172       23,088  

(2)  Investments, at cost

   $ 113,362     $ 655,739     $ 265,864     $ 65,675     $ 691,395  
December 31, 2023 (continued)    Col VP Select
Mid Cap Val,
Cl 1
    Col VP Select
Mid Cap Val,
Cl 2
    Col VP Select
Mid Cap Val,
Cl 3
    Col VP Select
Sm Cap Val,
Cl 1
    Col VP Select
Sm Cap Val,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 290,223     $ 157,860     $ 905,717     $ 99,284     $ 150,492  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                 1       5,990        

Receivable for share redemptions

           1,791       303             49  

Total assets

     290,223       159,651       906,021       105,274       150,541  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                 303              

Contract terminations

           1,791                   49  

Payable for investments purchased

                 1       5,990        

Total liabilities

           1,791       304       5,990       49  

Net assets applicable to Variable Life contracts in accumulation period

     290,223       157,860       905,717       99,284       150,492  

Net assets applicable to seed money

                              

Total net assets

   $ 290,223     $ 157,860     $ 905,717     $ 99,284     $ 150,492  

(1)  Investment shares

     7,878       4,422       24,978       2,876       4,508  

(2)  Investments, at cost

   $ 262,289     $ 113,274     $ 580,050     $ 89,967     $ 118,296  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      9  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Col VP Select
Sm Cap Val,
Cl 3
    Col VP Sel
Gbl Tech,
Cl 1
    Col VP Sel
Gbl Tech,
Cl 2
    Col VP
Strategic Inc,
Cl 1
    Col VP
Strategic Inc,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 1,118,237     $ 184,277     $ 40,654     $ 145,094     $ 179,736  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     15       11,980             6,434       1,018  

Receivable for share redemptions

     496                          

Total assets

     1,118,748       196,257       40,654       151,528       180,754  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     468                          

Contract terminations

     28                          

Payable for investments purchased

     15       11,980             6,434       1,018  

Total liabilities

     511       11,980             6,434       1,018  

Net assets applicable to Variable Life contracts in accumulation period

     1,118,088       184,277       40,654       145,094       179,736  

Net assets applicable to seed money

     149                          

Total net assets

   $ 1,118,237     $ 184,277     $ 40,654     $ 145,094     $ 179,736  

(1)  Investment shares

     32,928       6,405       1,681       39,215       49,243  

(2)  Investments, at cost

   $ 713,122     $ 152,832     $ 34,934     $ 149,460     $ 186,202  
December 31, 2023 (continued)    Col VP US
Govt Mtge,
Cl 1
    Col VP US
Govt Mtge,
Cl 2
    Col VP US
Govt Mtge,
Cl 3
    CS Commodity
Return,
Cl 1
    CTIVP AC
Div Bond,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 17,377     $ 18,754     $ 1,185,996     $ 406,360     $ 31,124  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                 243       4       302  

Receivable for share redemptions

                 538       171        

Total assets

     17,377       18,754       1,186,777       406,535       31,426  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                 538       171        

Contract terminations

                              

Payable for investments purchased

                 243       4       302  

Total liabilities

                 781       175       302  

Net assets applicable to Variable Life contracts in accumulation period

     17,377       18,754       1,185,915       406,248       31,124  

Net assets applicable to seed money

                 81       112        

Total net assets

   $ 17,377     $ 18,754     $ 1,185,996     $ 406,360     $ 31,124  

(1)  Investment shares

     1,946       2,105       132,810       22,997       3,390  

(2)  Investments, at cost

   $ 18,348     $ 19,883     $ 1,352,665     $ 546,928     $ 34,216  

See accompanying notes to financial statements.

 

10    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    CTIVP AC
Div Bond,
Cl 2
    CTIVP BR
Gl Infl
Prot Sec,
Cl 1
    CTIVP BR
Gl Infl
Prot Sec,
Cl 2
    CTIVP BR
Gl Infl
Prot Sec,
Cl 3
    CTIVP
CenterSquare
Real Est,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 18,473     $ 37,778     $ 17,057     $ 554,871     $ 63,938  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

           342             62        

Receivable for share redemptions

                       226        

Total assets

     18,473       38,120       17,057       555,159       63,938  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                       226        

Contract terminations

                              

Payable for investments purchased

           342             62        

Total liabilities

           342             288        

Net assets applicable to Variable Life contracts in accumulation period

     18,473       37,778       17,057       554,871       63,938  

Net assets applicable to seed money

                              

Total net assets

   $ 18,473     $ 37,778     $ 17,057     $ 554,871     $ 63,938  

(1)  Investment shares

     2,021       8,395       3,894       124,132       10,085  

(2)  Investments, at cost

   $ 21,982     $ 46,494     $ 20,689     $ 701,398     $ 72,491  
December 31, 2023 (continued)    CTIVP
CenterSquare
Real Est,
Cl 2
    CTIVP
MFS Val,
Cl 1
    CTIVP
MFS Val,
Cl 2
    CTIVP
MS Adv,
Cl 1
    CTIVP
MS Adv,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 213,304     $ 207,794     $ 252,418     $ 151,030     $ 70,545  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     8             1,425       6,178        

Receivable for share redemptions

                              

Total assets

     213,312       207,794       253,843       157,208       70,545  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                              

Contract terminations

                              

Payable for investments purchased

     8             1,425       6,178        

Total liabilities

     8             1,425       6,178        

Net assets applicable to Variable Life contracts in accumulation period

     213,304       207,794       252,418       151,030       70,545  

Net assets applicable to seed money

                              

Total net assets

   $ 213,304     $ 207,794     $ 252,418     $ 151,030     $ 70,545  

(1)  Investment shares

     33,966       5,407       6,793       3,261       1,576  

(2)  Investments, at cost

   $ 269,461     $ 184,950     $ 185,460     $ 138,603     $ 73,795  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      11  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    CTIVP
Prin Blue
Chip Gro,
Cl 1
    CTIVP
Prin Blue
Chip Gro,
Cl 2
    CTIVP
T Rowe Price
LgCap Val,
Cl 1
    CTIVP
T Rowe Price
LgCap Val,
Cl 2
    CTIVP
TCW Core
Plus Bond,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 118,899     $ 77,895     $ 187,324     $ 131,380     $ 87,087  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     1,003             1,003              

Receivable for share redemptions

                              

Total assets

     119,902       77,895       188,327       131,380       87,087  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                              

Contract terminations

                              

Payable for investments purchased

     1,003             1,003              

Total liabilities

     1,003             1,003              

Net assets applicable to Variable Life contracts in accumulation period

     118,899       77,895       187,324       131,380       87,087  

Net assets applicable to seed money

                              

Total net assets

   $ 118,899     $ 77,895     $ 187,324     $ 131,380     $ 87,087  

(1)  Investment shares

     2,015       1,365       5,338       3,874       9,255  

(2)  Investments, at cost

   $ 104,239     $ 44,041     $ 168,864     $ 99,959     $ 94,273  
December 31, 2023 (continued)    CTIVP
TCW Core
Plus Bond,
Cl 2
    CTIVP Vty
Sycamore
Estb Val,
Cl 1
    CTIVP Vty
Sycamore
Estb Val,
Cl 2
    CTIVP Vty
Sycamore
Estb Val,
Cl 3
    CTIVP
Westfield
Mid Cap Gro,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 41,165     $ 554,052     $ 534,583     $ 1,247,572     $ 82,165  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     750       6,638       1,063       268        

Receivable for share redemptions

                       517        

Total assets

     41,915       560,690       535,646       1,248,357       82,165  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                       498        

Contract terminations

                       19        

Payable for investments purchased

     750       6,638       1,063       268        

Total liabilities

     750       6,638       1,063       785        

Net assets applicable to Variable Life contracts in accumulation period

     41,165       554,052       534,583       1,247,360       82,165  

Net assets applicable to seed money

                       212        

Total net assets

   $ 41,165     $ 554,052     $ 534,583     $ 1,247,572     $ 82,165  

(1)  Investment shares

     4,393       11,995       11,967       27,449       1,838  

(2)  Investments, at cost

   $ 43,413     $ 495,758     $ 346,701     $ 809,995     $ 71,396  

See accompanying notes to financial statements.

 

12    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    CTIVP
Westfield
Mid Cap Gro,
Cl 2
    Del Ivy
VIP Asset
Strategy,
Cl II
    DWS
Alt Asset
Alloc VIP,
Cl A
    DWS
Alt Asset
Alloc VIP,
Cl B
    EV VT
Floating-Rate Inc,
Init Cl
 
Assets           

Investments, at fair value(1),(2)

   $ 69,959     $ 54,893     $ 27,043     $ 260,554     $ 1,426,202  

Dividends receivable

                             9,940  

Accounts receivable from RiverSource Life of NY for contract purchase payments

                             47  

Receivable for share redemptions

           9             19       662  

Total assets

     69,959       54,902       27,043       260,573       1,436,851  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           9             19       637  

Contract terminations

                             25  

Payable for investments purchased

                             9,987  

Total liabilities

           9             19       10,649  

Net assets applicable to Variable Life contracts in accumulation period

     69,959       54,686       27,043       260,464       1,423,959  

Net assets applicable to seed money

           207             90       2,243  

Total net assets

   $ 69,959     $ 54,893     $ 27,043     $ 260,554     $ 1,426,202  

(1)  Investment shares

     1,621       6,266       2,123       20,484       164,879  

(2)  Investments, at cost

   $ 54,651     $ 58,055     $ 27,178     $ 268,261     $ 1,488,110  
December 31, 2023 (continued)    Fid VIP
Contrafund,
Init Cl
    Fid VIP
Contrafund,
Serv Cl 2
    Fid VIP
Gro & Inc,
Serv Cl
    Fid VIP
Gro & Inc,
Serv Cl 2
    Fid VIP
Mid Cap,
Init Cl
 
Assets           

Investments, at fair value(1),(2)

   $ 702,527     $ 5,896,977     $ 4,579,195     $ 2,266,201     $ 433,660  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     9,487       1,171       70       29       300  

Receivable for share redemptions

           2,487       2,292       706        

Total assets

     712,014       5,900,635       4,581,557       2,266,936       433,960  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           2,313       2,292       706        

Contract terminations

           174                    

Payable for investments purchased

     9,487       1,171       70       29       300  

Total liabilities

     9,487       3,658       2,362       735       300  

Net assets applicable to Variable Life contracts in accumulation period

     702,527       5,896,733       4,579,195       2,266,062       433,660  

Net assets applicable to seed money

           244             139        

Total net assets

   $ 702,527     $ 5,896,977     $ 4,579,195     $ 2,266,201     $ 433,660  

(1)  Investment shares

     14,446       125,923       171,570       86,761       11,901  

(2)  Investments, at cost

   $ 651,455     $ 4,642,116     $ 3,146,708     $ 1,804,183     $ 431,797  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      13  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Fid VIP
Mid Cap,
Serv Cl
    Fid VIP
Mid Cap,
Serv Cl 2
    Fid VIP
Overseas,
Serv Cl
    Fid VIP
Overseas,
Serv Cl 2
    Fid VIP
Strategic Inc,
Init Cl
 
Assets           

Investments, at fair value(1),(2)

   $ 5,692,586     $ 5,571,907     $ 1,470,954     $ 1,224,179     $ 359,237  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

           41             11       828  

Receivable for share redemptions

     3,605       1,640       3,086       381        

Total assets

     5,696,191       5,573,588       1,474,040       1,224,571       360,065  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     3,066       1,640       795       381        

Contract terminations

     539             2,291              

Payable for investments purchased

           41             11       828  

Total liabilities

     3,605       1,681       3,086       392       828  

Net assets applicable to Variable Life contracts in accumulation period

     5,692,586       5,571,563       1,470,954       1,223,906       359,237  

Net assets applicable to seed money

           344             273        

Total net assets

   $ 5,692,586     $ 5,571,907     $ 1,470,954     $ 1,224,179     $ 359,237  

(1)  Investment shares

     158,524       160,620       57,280       47,988       34,278  

(2)  Investments, at cost

   $ 5,228,818     $ 5,481,747     $ 1,148,632     $ 1,060,473     $ 370,151  
December 31, 2023 (continued)    Fid VIP
Strategic Inc,
Serv Cl 2
    Frank Global
Real Est,
Cl 2
    Frank
Inc,
Cl 1
    Frank
Inc,
Cl 2
    Frank Mutual
Shares,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 23,424     $ 2,039,199     $ 46,630     $ 446,052     $ 25,391  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

           12       29              

Receivable for share redemptions

           843             631        

Total assets

     23,424       2,040,054       46,659       446,683       25,391  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           810             194        

Contract terminations

           33             437        

Payable for investments purchased

           12       29              

Total liabilities

           855       29       631        

Net assets applicable to Variable Life contracts in accumulation period

     23,424       2,039,199       46,630       445,943       25,391  

Net assets applicable to seed money

                       109        

Total net assets

   $ 23,424     $ 2,039,199     $ 46,630     $ 446,052     $ 25,391  

(1)  Investment shares

     2,263       162,486       3,127       31,412       1,613  

(2)  Investments, at cost

   $ 24,994     $ 2,354,462     $ 47,477     $ 466,280     $ 24,798  

See accompanying notes to financial statements.

 

14    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)   Frank Mutual
Shares,
Cl 2
    Frank Sm
Cap Val,
Cl 1
    Frank Sm
Cap Val,
Cl 2
    GS VIT
Mid Cap Val,
Inst
    GS VIT
Multi-Strategy Alt,
Advisor
 
Assets          

Investments, at fair value(1),(2)

  $ 1,692,719     $ 212,299     $ 2,855,602     $ 6,092,781     $ 35,698  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

    1,230       389       169       596        

Receivable for share redemptions

    611             1,503       2,558       13  

Total assets

    1,694,560       212,688       2,857,274       6,095,935       35,711  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

    611             1,087       2,558       13  

Contract terminations

                416              

Payable for investments purchased

    1,230       389       169       596        

Total liabilities

    1,841       389       1,672       3,154       13  

Net assets applicable to Variable Life contracts in accumulation period

    1,692,624       212,299       2,855,509       6,092,690       35,455  

Net assets applicable to seed money

    95             93       91       243  

Total net assets

  $ 1,692,719     $ 212,299     $ 2,855,602     $ 6,092,781     $ 35,698  

(1)  Investment shares

    110,419       14,993       215,192       380,561       4,038  

(2)  Investments, at cost

  $ 1,947,493     $ 214,475     $ 3,236,588     $ 6,177,070     $ 37,490  
December 31, 2023 (continued)   GS VIT Sm Cap
Eq Insights,
Inst
    GS VIT U.S.
Eq Insights,
Inst
    Invesco VI
Am Fran,
Ser I
    Invesco VI
Am Fran,
Ser II
    Invesco VI
Bal Risk Alloc,
Ser I
 
Assets          

Investments, at fair value(1),(2)

  $ 551,818     $ 2,923,675     $ 628,746     $ 994,889     $ 29,236  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

                             

Receivable for share redemptions

    300       1,661       439       332        

Total assets

    552,118       2,925,336       629,185       995,221       29,236  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

    285       1,154       323       332        

Contract terminations

    15       507       116              

Payable for investments purchased

                             

Total liabilities

    300       1,661       439       332        

Net assets applicable to Variable Life contracts in accumulation period

    551,818       2,923,577       628,746       994,641       29,236  

Net assets applicable to seed money

          98             248        

Total net assets

  $ 551,818     $ 2,923,675     $ 628,746     $ 994,889     $ 29,236  

(1)  Investment shares

    44,936       149,702       10,664       18,697       3,368  

(2)  Investments, at cost

  $ 560,684     $ 2,657,287     $ 589,862     $ 1,094,517     $ 32,274  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      15  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Invesco VI
Bal Risk Alloc,
Ser II
    Invesco VI
Comstock,
Ser II
    Invesco VI
Core Eq,
Ser I
    Invesco VI
Dis Mid Cap Gro,
Ser I
    Invesco VI
Div Divd,
Ser I
 
Assets           

Investments, at fair value(1),(2)

   $ 253,106     $ 390,796     $ 10,346,008     $ 881,494     $ 1,167,398  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     86       3                   58  

Receivable for share redemptions

     81       216       7,456       463       441  

Total assets

     253,273       391,015       10,353,464       881,957       1,167,897  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     81       216       6,987       375       441  

Contract terminations

                 469       88        

Payable for investments purchased

     86       3                   58  

Total liabilities

     167       219       7,456       463       499  

Net assets applicable to Variable Life contracts in accumulation period

     253,006       390,671       10,346,008       881,091       1,167,248  

Net assets applicable to seed money

     100       125             403       150  

Total net assets

   $ 253,106     $ 390,796     $ 10,346,008     $ 881,494     $ 1,167,398  

(1)  Investment shares

     29,847       19,959       353,227       14,034       48,160  

(2)  Investments, at cost

   $ 284,822     $ 342,374     $ 9,983,319     $ 1,033,213     $ 1,183,485  
December 31, 2023 (continued)    Invesco VI
EQV Intl Eq,
Ser II
    Invesco VI
Global,
Ser I
    Invesco VI
Global,
Ser II
    Invesco VI
Gbl Strat Inc,
Ser I
    Invesco VI
Gbl Strat Inc,
Ser II
 
Assets           

Investments, at fair value(1),(2)

   $ 1,110,101     $ 499,172     $ 1,823,314     $ 30,814     $ 1,624,807  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     55       972       1,092             4,915  

Receivable for share redemptions

     466             587             648  

Total assets

     1,110,622       500,144       1,824,993       30,814       1,630,370  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     466             587             623  

Contract terminations

                             25  

Payable for investments purchased

     55       972       1,092             4,915  

Total liabilities

     521       972       1,679             5,563  

Net assets applicable to Variable Life contracts in accumulation period

     1,109,933       499,172       1,823,091       30,814       1,624,719  

Net assets applicable to seed money

     168             223             88  

Total net assets

   $ 1,110,101     $ 499,172     $ 1,823,314     $ 30,814     $ 1,624,807  

(1)  Investment shares

     33,167       13,653       51,361       7,183       367,603  

(2)  Investments, at cost

   $ 1,112,229     $ 503,708     $ 1,958,783     $ 29,684     $ 1,836,213  

See accompanying notes to financial statements.

 

16    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)   Invesco VI
Mn St Sm Cap,
Ser I
    Invesco VI
Mn St Sm Cap,
Ser II
    Invesco VI
Tech,
Ser I
    Invesco VI
Tech,
Ser II
    Janus
Henderson
VIT Bal,
Inst
 
Assets          

Investments, at fair value(1),(2)

  $ 252,875     $ 1,802,594     $ 1,252,269     $ 6,355     $ 737,372  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

    761       167       32       225        

Receivable for share redemptions

          767       522              

Total assets

    253,636       1,803,528       1,252,823       6,580       737,372  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

          476       468              

Contract terminations

          291       54              

Payable for investments purchased

    761       167       32       225        

Total liabilities

    761       934       554       225        

Net assets applicable to Variable Life contracts in accumulation period

    252,875       1,802,594       1,252,120       6,213       737,372  

Net assets applicable to seed money

                149       142        

Total net assets

  $ 252,875     $ 1,802,594     $ 1,252,269     $ 6,355     $ 737,372  

(1)  Investment shares

    9,397       68,540       67,690       401       16,285  

(2)  Investments, at cost

  $ 250,192     $ 1,656,708     $ 1,385,574     $ 5,798     $ 697,276  
December 31, 2023 (continued)   Janus
Henderson
VIT Bal,
Serv
    Janus
Henderson
VIT Enter,
Serv
    Janus
Henderson
VIT Flex Bd,
Inst
    Janus
Henderson
VIT Flex Bd,
Serv
    Janus Hend
VIT Gbl Tech
Innov,
Srv
 
Assets          

Investments, at fair value(1),(2)

  $ 64,068     $ 800,241     $ 81,235     $ 26,124     $ 2,297,291  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

          45                   49  

Receivable for share redemptions

          337                   2,075  

Total assets

    64,068       800,623       81,235       26,124       2,299,415  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

          337                   952  

Contract terminations

                            1,123  

Payable for investments purchased

          45                   49  

Total liabilities

          382                   2,124  

Net assets applicable to Variable Life contracts in accumulation period

    64,068       800,241       81,235       26,124       2,297,086  

Net assets applicable to seed money

                            205  

Total net assets

  $ 64,068     $ 800,241     $ 81,235     $ 26,124     $ 2,297,291  

(1)  Investment shares

    1,333       11,705       8,083       2,341       143,044  

(2)  Investments, at cost

  $ 56,485     $ 686,878     $ 82,038     $ 27,044     $ 1,749,002  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      17  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)   Janus
Henderson
VIT Overseas,
Serv
    Janus
Henderson
VIT Res,
Inst
    Janus
Henderson
VIT Res,
Serv
    Lazard Ret
Global Dyn MA,
Inv
    Lazard Ret
Global Dyn MA,
Serv
 
Assets          

Investments, at fair value(1),(2)

  $ 1,822,478     $ 51,257     $ 618,403     $ 11,605     $ 17,069  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

    494                          

Receivable for share redemptions

    823             279             7  

Total assets

    1,823,795       51,257       618,682       11,605       17,076  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

    823             270             7  

Contract terminations

                9              

Payable for investments purchased

    494                          

Total liabilities

    1,317             279             7  

Net assets applicable to Variable Life contracts in accumulation period

    1,822,314       51,257       618,215       11,605       16,749  

Net assets applicable to seed money

    164             188             320  

Total net assets

  $ 1,822,478     $ 51,257     $ 618,403     $ 11,605     $ 17,069  

(1)  Investment shares

    45,471       1,135       14,361       965       1,425  

(2)  Investments, at cost

  $ 1,565,332     $ 40,097     $ 502,399     $ 11,654     $ 18,237  
December 31, 2023 (continued)   MFS Mass
Inv Gro Stock,
Serv Cl
    MFS
New Dis,
Serv Cl
    MFS
Utilities,
Init Cl
    MFS
Utilities,
Serv Cl
    MS
VIF Dis,
Cl I
 
Assets          

Investments, at fair value(1),(2)

  $ 3,106,178     $ 2,010,897     $ 75,089     $ 1,061,468     $ 362,442  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

          263             978       7,438  

Receivable for share redemptions

    1,444       803             380        

Total assets

    3,107,622       2,011,963       75,089       1,062,826       369,880  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

    1,357       772             380        

Contract terminations

    87       31                    

Payable for investments purchased

          263             978       7,438  

Total liabilities

    1,444       1,066             1,358       7,438  

Net assets applicable to Variable Life contracts in accumulation period

    3,106,077       2,010,806       75,089       1,061,304       362,442  

Net assets applicable to seed money

    101       91             164        

Total net assets

  $ 3,106,178     $ 2,010,897     $ 75,089     $ 1,061,468     $ 362,442  

(1)  Investment shares

    140,551       199,099       2,328       33,655       78,963  

(2)  Investments, at cost

  $ 2,819,944     $ 2,932,565     $ 81,212     $ 1,053,321     $ 417,220  

See accompanying notes to financial statements.

 

18    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)   MS
VIF Dis,
Cl II
    MS VIF
Global Real Est,
Cl II
    NB AMT
Sus Eq,
Cl I
    NB AMT
Sus Eq,
Cl S
    NB AMT
US Eq Index
PW Strat,
Cl S
 
Assets          

Investments, at fair value(1),(2)

  $ 791,586     $ 328,405     $ 32,618     $ 46,275     $ 28,509  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

    66       97                    

Receivable for share redemptions

    299       847                   6  

Total assets

    791,951       329,349       32,618       46,275       28,515  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

    299       131                   6  

Contract terminations

          716                    

Payable for investments purchased

    66       97                    

Total liabilities

    365       944                   6  

Net assets applicable to Variable Life contracts in accumulation period

    791,491       328,314       32,618       46,275       28,199  

Net assets applicable to seed money

    95       91                   310  

Total net assets

  $ 791,586     $ 328,405     $ 32,618     $ 46,275     $ 28,509  

(1)  Investment shares

    195,453       43,555       978       1,382       3,023  

(2)  Investments, at cost

  $ 1,633,747     $ 406,326     $ 29,872     $ 42,907     $ 29,411  
December 31, 2023 (continued)   PIMCO
VIT All Asset,
Advisor Cl
    PIMCO
VIT All Asset,
Inst Cl
    PIMCO VIT Glb
Man As Alloc,
Adv Cl
    PIMCO VIT
Tot Return,
Advisor Cl
    PIMCO VIT
Tot Return,
Inst Cl
 
Assets          

Investments, at fair value(1),(2)

  $ 616,253     $ 12,766     $ 5,540     $ 435,359     $ 115,433  

Dividends receivable

                      1,228       350  

Accounts receivable from RiverSource Life of NY for contract purchase payments

    24                         200  

Receivable for share redemptions

    276                   196        

Total assets

    616,553       12,766       5,540       436,783       115,983  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

    276                   189        

Contract terminations

                      7        

Payable for investments purchased

    24                   1,228       550  

Total liabilities

    300                   1,424       550  

Net assets applicable to Variable Life contracts in accumulation period

    616,167       12,766       5,540       433,127       115,433  

Net assets applicable to seed money

    86                   2,232        

Total net assets

  $ 616,253     $ 12,766     $ 5,540     $ 435,359     $ 115,433  

(1)  Investment shares

    66,984       1,388       589       47,425       12,574  

(2)  Investments, at cost

  $ 693,664     $ 13,324     $ 6,674     $ 493,998     $ 122,487  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      19  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    Put VT Global
Hlth Care,
Cl IA
    Put VT Global
Hlth Care,
Cl IB
    Put VT
Hi Yield,
Cl IB
    Put VT
Intl Eq,
Cl IB
    Put VT
Sus Leaders,
Cl IA
 
Assets           

Investments, at fair value(1),(2)

   $ 44,251     $ 1,404,360     $ 251,646     $ 162,490     $ 12,550,221  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     705       2             452        

Receivable for share redemptions

           561       162       62       8,909  

Total assets

     44,956       1,404,923       251,808       163,004       12,559,130  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           560       142       62       8,513  

Contract terminations

           1       20             396  

Payable for investments purchased

     705       2             452        

Total liabilities

     705       563       162       514       8,909  

Net assets applicable to Variable Life contracts in accumulation period

     44,251       1,404,360       251,646       162,386       12,550,221  

Net assets applicable to seed money

                       104        

Total net assets

   $ 44,251     $ 1,404,360     $ 251,646     $ 162,490     $ 12,550,221  

(1)  Investment shares

     2,588       86,582       45,342       10,641       303,365  

(2)  Investments, at cost

   $ 41,257     $ 1,349,056     $ 280,754     $ 152,119     $ 9,629,943  
December 31, 2023 (continued)    Put VT
Sus Leaders,
Cl IB
    Royce
Micro-Cap,
Invest Cl
    Temp
Global Bond,
Cl 1
    Temp
Global Bond,
Cl 2
    Third Ave
VST Third
Ave Value
 
Assets           

Investments, at fair value(1),(2)

   $ 150,338     $ 1,977,007     $ 27,102     $ 203,323     $ 2,465,879  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                       39        

Receivable for share redemptions

     51       2,099             62       1,861  

Total assets

     150,389       1,979,106       27,102       203,424       2,467,740  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     51       1,073             62       1,246  

Contract terminations

           1,026                   615  

Payable for investments purchased

                       39        

Total liabilities

     51       2,099             101       1,861  

Net assets applicable to Variable Life contracts in accumulation period

     149,945       1,977,007       27,102       203,256       2,465,879  

Net assets applicable to seed money

     393                   67        

Total net assets

   $ 150,338     $ 1,977,007     $ 27,102     $ 203,323     $ 2,465,879  

(1)  Investment shares

     3,796       215,595       1,997       15,835       105,968  

(2)  Investments, at cost

   $ 136,713     $ 2,085,456     $ 28,203     $ 226,443     $ 1,750,365  

See accompanying notes to financial statements.

 

20    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    VanEck VIP
Global Gold,
Cl S
    VP
Aggr,
Cl 1
    VP
Aggr,
Cl 2
    VP
Aggr,
Cl 4
    VP
Conserv,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 145,126     $ 1,669,346     $ 26,120,255     $ 23,650,778     $ 22  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     225       1,651       1,171       102        

Receivable for share redemptions

     43             5,076       22,116        

Total assets

     145,394       1,670,997       26,126,502       23,672,996       22  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     43             5,076       9,083        

Contract terminations

                       13,033        

Payable for investments purchased

     225       1,651       1,171       102        

Total liabilities

     268       1,651       6,247       22,218        

Net assets applicable to Variable Life contracts in accumulation period

     144,958       1,669,346       26,120,128       23,650,651        

Net assets applicable to seed money

     168             127       127       22  

Total net assets

   $ 145,126     $ 1,669,346     $ 26,120,255     $ 23,650,778     $ 22  

(1)  Investment shares

     17,318       58,800       929,216       840,170       1  

(2)  Investments, at cost

   $ 147,306     $ 1,544,319     $ 19,892,885     $ 15,111,992     $ 20  
December 31, 2023 (continued)    VP
Conserv,
Cl 2
    VP
Conserv,
Cl 4
    VP Man
Vol Conserv,
Cl 1
    VP Man
Vol Conserv,
Cl 2
    VP Man
Vol Conserv Gro,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 583,324     $ 431,816     $ 22     $ 93,993     $ 56,064  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                              

Receivable for share redemptions

     1,648       182             49        

Total assets

     584,972       431,998       22       94,042       56,064  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     285       182             49        

Contract terminations

     1,363                          

Payable for investments purchased

                              

Total liabilities

     1,648       182             49        

Net assets applicable to Variable Life contracts in accumulation period

     583,216       431,732             93,921       56,064  

Net assets applicable to seed money

     108       84       22       72        

Total net assets

   $ 583,324     $ 431,816     $ 22     $ 93,993     $ 56,064  

(1)  Investment shares

     37,927       28,095       2       7,372       3,929  

(2)  Investments, at cost

   $ 584,092     $ 385,725     $ 20     $ 95,818     $ 60,174  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      21  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    VP Man
Vol Conserv Gro,
Cl 2
    VP Man
Vol Gro,
Cl 1
    VP Man
Vol Gro,
Cl 2
    VP Man
Vol Mod Gro,
Cl 1
    VP Man
Vol Mod Gro,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 136,266     $ 944,431     $ 2,238,621     $ 295,544     $ 1,861,237  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                       16,416       322  

Receivable for share redemptions

     63             517             499  

Total assets

     136,329       944,431       2,239,138       311,960       1,862,058  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     63             517             499  

Contract terminations

                              

Payable for investments purchased

                       16,416       322  

Total liabilities

     63             517       16,416       821  

Net assets applicable to Variable Life contracts in accumulation period

     136,215       944,431       2,238,592       295,544       1,861,183  

Net assets applicable to seed money

     51             29             54  

Total net assets

   $ 136,266     $ 944,431     $ 2,238,621     $ 295,544     $ 1,861,237  

(1)  Investment shares

     9,657       54,340       130,152       17,093       108,781  

(2)  Investments, at cost

   $ 129,385     $ 900,409     $ 1,797,400     $ 282,698     $ 1,602,517  
December 31, 2023 (continued)    VP
Mod,
Cl 1
    VP
Mod,
Cl 2
    VP
Mod,
Cl 4
    VP Mod
Aggr,
Cl 1
    VP Mod
Aggr,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 3,786,147     $ 26,124,048     $ 33,732,420     $ 8,376,897     $ 40,433,107  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     86       1,592       3,028       5,123       21,382  

Receivable for share redemptions

           10,641       14,167             11,824  

Total assets

     3,786,233       26,136,281       33,749,615       8,382,020       40,466,313  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

           10,107       13,551             11,824  

Contract terminations

           534       616              

Payable for investments purchased

     86       1,592       3,028       5,123       21,382  

Total liabilities

     86       12,233       17,195       5,123       33,206  

Net assets applicable to Variable Life contracts in accumulation period

     3,786,147       26,123,958       33,732,330       8,376,897       40,432,984  

Net assets applicable to seed money

           90       90             123  

Total net assets

   $ 3,786,147     $ 26,124,048     $ 33,732,420     $ 8,376,897     $ 40,433,107  

(1)  Investment shares

     174,718       1,218,472       1,571,142       337,506       1,646,970  

(2)  Investments, at cost

   $ 3,681,376     $ 20,534,977     $ 23,865,163     $ 7,859,033     $ 31,205,572  

See accompanying notes to financial statements.

 

22    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    VP Mod
Aggr,
Cl 4
    VP Mod
Conserv,
Cl 1
    VP Mod
Conserv,
Cl 2
    VP Mod
Conserv,
Cl 4
    VP Ptnrs
Core Bond,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 55,836,994     $ 338,632     $ 2,193,073     $ 2,850,754     $ 24,343  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     2,151             13       299        

Receivable for share redemptions

     23,241             823       1,077        

Total assets

     55,862,386       338,632       2,193,909       2,852,130       24,343  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

     21,112             823       1,077        

Contract terminations

     2,129                          

Payable for investments purchased

     2,151             13       299        

Total liabilities

     25,392             836       1,376        

Net assets applicable to Variable Life contracts in accumulation period

     55,836,871       338,632       2,192,986       2,850,667       24,343  

Net assets applicable to seed money

     123             87       87        

Total net assets

   $ 55,836,994     $ 338,632     $ 2,193,073     $ 2,850,754     $ 24,343  

(1)  Investment shares

     2,270,720       18,504       121,164       157,240       2,502  

(2)  Investments, at cost

   $ 37,196,610     $ 314,686     $ 2,008,661     $ 2,374,913     $ 24,804  
December 31, 2023 (continued)    VP Ptnrs
Core Bond,
Cl 2
    VP Ptnrs
Core Eq,
Cl 1
    VP Ptnrs
Core Eq,
Cl 2
    VP Ptnrs
Core Eq,
Cl 3
    VP Ptnrs
Intl Core Eq,
Cl 1
 
Assets           

Investments, at fair value(1),(2)

   $ 13,393     $ 1,590     $ 31,536     $ 423,476     $ 63,609  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                 1,125       216        

Receivable for share redemptions

                       172        

Total assets

     13,393       1,590       32,661       423,864       63,609  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                       172        

Contract terminations

                              

Payable for investments purchased

                 1,125       216        

Total liabilities

                 1,125       388        

Net assets applicable to Variable Life contracts in accumulation period

     13,393       1,546       31,536       423,309       63,609  

Net assets applicable to seed money

           44             167        

Total net assets

   $ 13,393     $ 1,590     $ 31,536     $ 423,476     $ 63,609  

(1)  Investment shares

     1,384       43       875       11,561       6,230  

(2)  Investments, at cost

   $ 13,600     $ 1,336     $ 29,021     $ 243,326     $ 68,510  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      23  


Statement of Assets and Liabilities

 

December 31, 2023 (continued)    VP Ptnrs
Intl Core Eq,
Cl 2
    VP Ptnrs
Intl Gro,
Cl 1
    VP Ptnrs
Intl Gro,
Cl 2
    VP Ptnrs
Intl Val,
Cl 1
    VP Ptnrs
Intl Val,
Cl 2
 
Assets           

Investments, at fair value(1),(2)

   $ 55,681     $ 150,089     $ 198,015     $ 38,952     $ 67,130  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

     900             8              

Receivable for share redemptions

                              

Total assets

     56,581       150,089       198,023       38,952       67,130  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                              

Contract terminations

                              

Payable for investments purchased

     900             8              

Total liabilities

     900             8              

Net assets applicable to Variable Life contracts in accumulation period

     55,681       150,089       198,015       38,952       67,130  

Net assets applicable to seed money

                              

Total net assets

   $ 55,681     $ 150,089     $ 198,015     $ 38,952     $ 67,130  

(1)  Investment shares

     5,513       13,063       17,446       3,880       6,720  

(2)  Investments, at cost

   $ 55,990     $ 134,641     $ 203,365     $ 35,103     $ 64,416  
December 31, 2023 (continued)    VP Ptnrs
Sm Cap Gro,
Cl 1
    VP Ptnrs
Sm Cap Gro,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 1
    VP Ptnrs
Sm Cap Val,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 3
 
Assets           

Investments, at fair value(1),(2)

   $ 57,582     $ 28,644     $ 10,867     $ 6,172     $ 659,426  

Dividends receivable

                              

Accounts receivable from RiverSource Life of NY for contract purchase payments

                             30  

Receivable for share redemptions

                             251  

Total assets

     57,582       28,644       10,867       6,172       659,707  
          
Liabilities           

Payable to RiverSource Life of NY for:

          

Mortality and expense risk fee

                             251  

Contract terminations

                              

Payable for investments purchased

                             30  

Total liabilities

                             281  

Net assets applicable to Variable Life contracts in accumulation period

     57,582       28,644       10,867       6,172       659,275  

Net assets applicable to seed money

                             151  

Total net assets

   $ 57,582     $ 28,644     $ 10,867     $ 6,172     $ 659,426  

(1)  Investment shares

     1,983       1,020       298       175       18,435  

(2)  Investments, at cost

   $ 56,956     $ 26,553     $ 10,547     $ 4,857     $ 489,188  

See accompanying notes to financial statements.

 

24    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Assets and Liabilities

 

December 31, 2023 (continued)   VP US
Flex Conserv Gro,
Cl 1
    VP US
Flex Gro,
Cl 1
    VP US
Flex Mod Gro,
Cl 1
    Wanger
Acorn
    Wanger
Intl
 
Assets          

Investments, at fair value(1),(2)

  $ 5,846     $ 139,815     $ 10,130     $ 5,633,902     $ 4,275,604  

Dividends receivable

                             

Accounts receivable from RiverSource Life of NY for contract purchase payments

          672             823        

Receivable for share redemptions

                      2,405       4,328  

Total assets

    5,846       140,487       10,130       5,637,130       4,279,932  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

                      2,343       1,742  

Contract terminations

                      62       2,586  

Payable for investments purchased

          672             823        

Total liabilities

          672             3,228       4,328  

Net assets applicable to Variable Life contracts in accumulation period

    5,823       139,815       10,130       5,633,808       4,275,501  

Net assets applicable to seed money

    23                   94       103  

Total net assets

  $ 5,846     $ 139,815     $ 10,130     $ 5,633,902     $ 4,275,604  

(1)  Investment shares

    435       8,489       677       422,648       209,794  

(2)  Investments, at cost

  $ 5,547     $ 128,950     $ 9,072     $ 8,376,035     $ 5,247,533  
December 31, 2023 (continued)                     WA Var Global
Hi Yd Bond,
Cl I
    WA Var Global
Hi Yd Bond,
Cl II
 
Assets          

Investments, at fair value(1),(2)

        $ 17,530     $ 9,308  

Dividends receivable

                 

Accounts receivable from RiverSource Life of NY for contract purchase payments

          503        

Receivable for share redemptions

                                   

Total assets

                            18,033       9,308  
         
Liabilities          

Payable to RiverSource Life of NY for:

         

Mortality and expense risk fee

                 

Contract terminations

                 

Payable for investments purchased

                            503        

Total liabilities

                            503        

Net assets applicable to Variable Life contracts in accumulation period

          17,530       9,308  

Net assets applicable to seed money

                                   

Total net assets

                          $ 17,530     $ 9,308  

(1)  Investment shares

          2,912       1,487  

(2)  Investments, at cost

                          $ 18,915     $ 10,678  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      25  


Statement of Operations

 

Year ended December 31, 2023    AB VPS Dyn
Asset Alloc,
Cl B
    AB VPS
Intl Val,
Cl B
    AB VPS
Lg Cap Gro,
Cl A
    AB VPS
Lg Cap Gro,
Cl B
    AB VPS
Relative Val,
Cl B
 
Investment income           

Dividend income

   $ 3     $ 18,506     $     $     $ 33,407  

Variable account expenses

     1       12,467             8,313       11,380  

Investment income (loss) — net

     2       6,039             (8,313     22,027  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     2       333,601       10,874       180,501       434,987  

Cost of investments sold

     3       335,069       11,581       172,728       455,922  

Net realized gain (loss) on sales of investments

     (1     (1,468     (707     7,773       (20,935

Distributions from capital gains

                 17,653       181,316       211,019  

Net change in unrealized appreciation (depreciation) of investments

     55       336,369       60,499       504,944       54,176  

Net gain (loss) on investments

     54       334,901       77,445       694,033       244,260  

Net increase (decrease) in net assets resulting from operations

   $ 56     $ 340,940     $ 77,445     $ 685,720     $ 266,287  
Year ended December 31, 2023 (continued)    Allspg VT
Index Asset Alloc,
Cl 2
    Allspg VT
Intl Eq,
Cl 2
    Allspg VT
Opp,
Cl 1
    Allspg VT
Opp,
Cl 2
    Allspg VT
Sm Cap Gro,
Cl 1
 
Investment income           

Dividend income

   $ 4,860     $ 14,343     $     $     $  

Variable account expenses

     2,073       6,236             5,014        

Investment income (loss) — net

     2,787       8,107             (5,014      
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     70,863       119,300       2,410       168,042       4,525  

Cost of investments sold

     79,524       178,154       2,669       177,391       5,682  

Net realized gain (loss) on sales of investments

     (8,661     (58,854     (259     (9,349     (1,157

Distributions from capital gains

     15,863             1,269       108,986        

Net change in unrealized appreciation (depreciation) of investments

     66,871       186,585       2,659       201,628       11,188  

Net gain (loss) on investments

     74,073       127,731       3,669       301,265       10,031  

Net increase (decrease) in net assets resulting from operations

   $ 76,860     $ 135,838     $ 3,669     $ 296,251     $ 10,031  
Year ended December 31, 2023 (continued)    Allspg VT
Sm Cap Gro,
Cl 2
    ALPS Alerian
Engy Infr,
Class I
    ALPS Alerian
Engy Infr,
Class III
   

AC VP
Intl,

Cl I

    AC VP
Intl,
Cl II
 
Investment income           

Dividend income

   $     $ 1,626     $ 14,863     $ 9,761     $ 9,053  

Variable account expenses

     3,950             3,035       4,822       2,976  

Investment income (loss) — net

     (3,950     1,626       11,828       4,939       6,077  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     110,551       761       117,601       63,271       74,787  

Cost of investments sold

     141,202       734       94,313       58,948       84,410  

Net realized gain (loss) on sales of investments

     (30,651     27       23,288       4,323       (9,623

Distributions from capital gains

           511       5,324              

Net change in unrealized appreciation (depreciation) of investments

     82,993       2,293       26,009       68,645       88,007  

Net gain (loss) on investments

     52,342       2,831       54,621       72,968       78,384  

Net increase (decrease) in net assets resulting from operations

   $ 48,392     $ 4,457     $ 66,449     $ 77,907     $ 84,461  

See accompanying notes to financial statements.

 

26    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    AC VP
Val,
Cl I
    AC VP
Val,
Cl II
    BlackRock
Global Alloc,
Cl I
    BlackRock
Global Alloc,
Cl III
    Calvert VP
EAFE Intl Index,
Cl F
 
Investment income           

Dividend income

   $ 93,312     $ 51,853     $ 3,765     $ 12,457     $ 55  

Variable account expenses

     26,411       9,104             2,372        

Investment income (loss) — net

     66,901       42,749       3,765       10,085       55  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     400,707       487,242       38,216       103,390        

Cost of investments sold

     304,538       445,268       41,702       117,869        

Net realized gain (loss) on sales of investments

     96,169       41,974       (3,486     (14,479      

Distributions from capital gains

     307,231       189,836                    

Net change in unrealized appreciation (depreciation) of investments

     (150,373     (88,352     18,992       57,522       144  

Net gain (loss) on investments

     253,027       143,458       15,506       43,043       144  

Net increase (decrease) in net assets resulting from operations

   $ 319,928     $ 186,207     $ 19,271     $ 53,128     $ 199  
Year ended December 31, 2023 (continued)    Calvert VP
EAFE Intl Index,
Cl I
    Calvert VP
Nasdaq
100 Index,
Cl F
    Calvert VP
Nasdaq
100 Index,
Cl I
    Calv VP
Russ 2000
Sm Cap Ind,
Cl F
    Calv VP
Russ 2000
Sm Cap Ind,
Cl I
 
Investment income           

Dividend income

   $ 1,684     $ 56     $ 122     $ 3     $ 77  

Variable account expenses

                              

Investment income (loss) — net

     1,684       56       122       3       77  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     2,625       497       1,448             655  

Cost of investments sold

     2,463       486       1,386             686  

Net realized gain (loss) on sales of investments

     162       11       62             (31

Distributions from capital gains

                             5  

Net change in unrealized appreciation (depreciation) of investments

     7,926       2,617       9,758       49       1,880  

Net gain (loss) on investments

     8,088       2,628       9,820       49       1,854  

Net increase (decrease) in net assets resulting from operations

   $ 9,772     $ 2,684     $ 9,942     $ 52     $ 1,931  
Year ended December 31, 2023 (continued)    Calvert VP
SRI Bal,
Cl I
    Col VP
Bal,
Cl 1
    Col VP
Bal,
Cl 3
    Col VP
Commodity
Strategy,
Cl 1
    Col VP
Commodity
Strategy,
Cl 2
 
Investment income           

Dividend income

   $ 41,486     $     $     $ 14,935     $ 8,006  

Variable account expenses

     12,697             123,137              

Investment income (loss) — net

     28,789             (123,137     14,935       8,006  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     160,770       6,723       1,391,344       22,310       1,090  

Cost of investments sold

     169,702       6,826       693,697       27,898       1,277  

Net realized gain (loss) on sales of investments

     (8,932     (103     697,647       (5,588     (187

Distributions from capital gains

     9,938                          

Net change in unrealized appreciation (depreciation) of investments

     367,010       247,787       2,387,268       (13,443     (10,538

Net gain (loss) on investments

     368,016       247,684       3,084,915       (19,031     (10,725

Net increase (decrease) in net assets resulting from operations

   $ 396,805     $ 247,684     $ 2,961,778     $ (4,096   $ (2,719

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      27  


Statement of Operations

 

Year ended December 31, 2023 (continued)    Col VP
Contrarian
Core,
Cl 1
    Col VP
Contrarian
Core,
Cl 2
    Col VP
Disciplined
Core,
Cl 1
    Col VP
Disciplined
Core,
Cl 2
    Col VP
Disciplined
Core,
Cl 3
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

                             219,617  

Investment income (loss) — net

                             (219,617
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     10,879       9,456       6,600       35,424       2,660,186  

Cost of investments sold

     10,155       6,630       6,506       22,437       838,932  

Net realized gain (loss) on sales of investments

     724       2,826       94       12,987       1,821,254  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     61,611       42,445       28,025       75,399       3,975,337  

Net gain (loss) on investments

     62,335       45,271       28,119       88,386       5,796,591  

Net increase (decrease) in net assets resulting from operations

   $ 62,335     $ 45,271     $ 28,119     $ 88,386     $ 5,576,974  
Year ended December 31, 2023 (continued)    Col VP
Divd Opp,
Cl 1
    Col VP
Divd Opp,
Cl 2
    Col VP
Divd Opp,
Cl 3
    Col VP
Emerg
Mkts Bond,
Cl 1
    Col VP
Emerg
Mkts Bond,
Cl 2
 
Investment income           

Dividend income

   $     $     $     $ 1,445     $ 842  

Variable account expenses

                 66,945              

Investment income (loss) — net

                 (66,945     1,445       842  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     58,361       26,845       1,275,962       780       7,166  

Cost of investments sold

     57,125       24,108       711,380       815       8,808  

Net realized gain (loss) on sales of investments

     1,236       2,737       564,582       (35     (1,642

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,670       5,857       (2,724     1,311       2,301  

Net gain (loss) on investments

     4,906       8,594       561,858       1,276       659  

Net increase (decrease) in net assets resulting from operations

   $ 4,906     $ 8,594     $ 494,913     $ 2,721     $ 1,501  
Year ended December 31, 2023 (continued)    Col VP
Emer Mkts,
Cl 1
    Col VP
Emer Mkts,
Cl 2
    Col VP
Emer Mkts,
Cl 3
    Col VP Global
Strategic Inc,
Cl 2
    Col VP Global
Strategic Inc,
Cl 3
 
Investment income           

Dividend income

   $ 203     $     $     $ 2,584     $ 38,983  

Variable account expenses

                 10,211             6,453  

Investment income (loss) — net

     203             (10,211     2,584       32,530  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     8,547       19,292       265,353       4,091       125,153  

Cost of investments sold

     12,063       30,843       421,953       4,815       157,249  

Net realized gain (loss) on sales of investments

     (3,516     (11,551     (156,600     (724     (32,096

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     20,741       40,132       323,906       5,814       107,697  

Net gain (loss) on investments

     17,225       28,581       167,306       5,090       75,601  

Net increase (decrease) in net assets resulting from operations

   $ 17,428     $ 28,581     $ 157,095     $ 7,674     $ 108,131  

See accompanying notes to financial statements.

 

28    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    Col VP Govt
Money Mkt,
Cl 1
    Col VP Govt
Money Mkt,
Cl 2
    Col VP Govt
Money Mkt,
Cl 3
    Col VP
Hi Yield Bond,
Cl 1
    Col VP
Hi Yield Bond,
Cl 2
 
Investment income           

Dividend income

   $ 9,588     $ 22,177     $ 118,403     $ 4,524     $ 15,319  

Variable account expenses

                 13,692              

Investment income (loss) — net

     9,588       22,177       104,711       4,524       15,319  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     347,022       253,700       575,503       6,328       18,455  

Cost of investments sold

     347,022       253,700       575,502       6,692       20,726  

Net realized gain (loss) on sales of investments

                 1       (364     (2,271

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

                 (1     7,030       20,221  

Net gain (loss) on investments

                       6,666       17,950  

Net increase (decrease) in net assets resulting from operations

   $ 9,588     $ 22,177     $ 104,711     $ 11,190     $ 33,269  
Year ended December 31, 2023 (continued)    Col VP
Hi Yield Bond,
Cl 3
    Col VP
Inc Opp,
Cl 1
    Col VP
Inc Opp,
Cl 2
    Col VP
Inc Opp,
Cl 3
    Col VP
Inter Bond,
Cl 1
 
Investment income           

Dividend income

   $ 135,922     $ 1,027     $ 3,779     $ 52,050     $ 1,940  

Variable account expenses

     13,370                   5,580        

Investment income (loss) — net

     122,552       1,027       3,779       46,470       1,940  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     228,749       607       2,686       157,735       7,378  

Cost of investments sold

     259,075       703       2,969       195,032       8,713  

Net realized gain (loss) on sales of investments

     (30,326     (96     (283     (37,297     (1,335

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     182,268       1,287       3,746       98,404       3,600  

Net gain (loss) on investments

     151,942       1,191       3,463       61,107       2,265  

Net increase (decrease) in net assets resulting from operations

   $ 274,494     $ 2,218     $ 7,242     $ 107,577     $ 4,205  
Year ended December 31, 2023 (continued)    Col VP
Inter Bond,
Cl 2
    Col VP
Inter Bond,
Cl 3
    Col VP
Lg Cap Gro,
Cl 1
    Col VP
Lg Cap Gro,
Cl 2
    Col VP
Lg Cap Gro,
Cl 3
 
Investment income           

Dividend income

   $ 1,205     $ 118,149     $     $     $  

Variable account expenses

           32,451                   17,012  

Investment income (loss) — net

     1,205       85,698                   (17,012
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     12,080       628,371       42,725       3,950       442,228  

Cost of investments sold

     14,357       783,118       42,664       3,201       206,856  

Net realized gain (loss) on sales of investments

     (2,277     (154,747     61       749       235,372  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,786       366,259       417,351       133,359       826,201  

Net gain (loss) on investments

     1,509       211,512       417,412       134,108       1,061,573  

Net increase (decrease) in net assets resulting from operations

   $ 2,714     $ 297,210     $ 417,412     $ 134,108     $ 1,044,561  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      29  


Statement of Operations

 

Year ended December 31, 2023 (continued)    Col VP
Lg Cap Index,
Cl 1
   

Col VP

Lg Cap Index,
Cl 3

    Col VP Limited
Duration Cr,
Cl 1
    Col VP Limited
Duration Cr,
Cl 2
    Col VP
Long Govt/
Cr Bond,
Cl 1
 
Investment income           

Dividend income

   $     $     $ 664     $ 25,957     $ 335  

Variable account expenses

           63,052             4,475        

Investment income (loss) — net

           (63,052     664       21,482       335  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     283,508       1,071,965       8,231       946,346       2,754  

Cost of investments sold

     261,534       547,204       8,241       919,098       3,188  

Net realized gain (loss) on sales of investments

     21,974       524,761       (10     27,248       (434

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     803,456       2,442,787       646       16,001       800  

Net gain (loss) on investments

     825,430       2,967,548       636       43,249       366  

Net increase (decrease) in net assets resulting from operations

   $ 825,430     $ 2,904,496     $ 1,300     $ 64,731     $ 701  
Year ended December 31, 2023 (continued)   

Col VP

Long Govt/Cr

Bond,
Cl 2

    Col VP
Overseas Core,
Cl 1
    Col VP
Overseas Core,
Cl 2
    Col VP
Overseas Core,
Cl 3
    Col VP Select
Lg Cap Val,
Cl 1
 
Investment income           

Dividend income

   $ 254     $ 3,348     $ 2,866     $ 80,901     $  

Variable account expenses

                       36,959        

Investment income (loss) — net

     254       3,348       2,866       43,942        
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     23       5,442       20,116       429,509       15,952  

Cost of investments sold

     31       5,702       21,516       394,593       15,848  

Net realized gain (loss) on sales of investments

     (8     (260     (1,400     34,916       104  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     297       25,043       22,356       531,091       35,494  

Net gain (loss) on investments

     289       24,783       20,956       566,007       35,598  

Net increase (decrease) in net assets resulting from operations

   $ 543     $ 28,131     $ 23,822     $ 609,949     $ 35,598  
Year ended December 31, 2023 (continued)    Col VP Select
Lg Cap Val,
Cl 2
   

Col VP Select
Lg Cap Val,

Cl 3

    Col VP Select
Mid Cap Gro,
Cl 1
    Col VP Select
Mid Cap Gro,
Cl 2
    Col VP Select
Mid Cap Gro,
Cl 3
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

           4,751                   4,814  

Investment income (loss) — net

           (4,751                 (4,814
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     16,338       137,034       4,922       1,362       113,808  

Cost of investments sold

     12,728       101,358       4,477       1,014       86,289  

Net realized gain (loss) on sales of investments

     3,610       35,676       445       348       27,519  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,539       11,520       55,654       17,801       177,538  

Net gain (loss) on investments

     7,149       47,196       56,099       18,149       205,057  

Net increase (decrease) in net assets resulting from operations

   $ 7,149     $ 42,445     $ 56,099     $ 18,149     $ 200,243  

See accompanying notes to financial statements.

 

30    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    Col VP Select
Mid Cap Val,
Cl 1
    Col VP Select
Mid Cap Val,
Cl 2
    Col VP Select
Mid Cap Val,
Cl 3
   

Col VP Select
Sm Cap Val,

Cl 1

    Col VP Select
Sm Cap Val,
Cl 2
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

                 3,561              

Investment income (loss) — net

                 (3,561            
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     6,814       6,155       98,067       3,960       5,371  

Cost of investments sold

     6,581       4,579       68,787       3,801       4,480  

Net realized gain (loss) on sales of investments

     233       1,576       29,280       159       891  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     27,043       12,945       53,322       9,399       15,929  

Net gain (loss) on investments

     27,276       14,521       82,602       9,558       16,820  

Net increase (decrease) in net assets resulting from operations

   $ 27,276     $ 14,521     $ 79,041     $ 9,558     $ 16,820  
Year ended December 31, 2023 (continued)    Col VP Select
Sm Cap Val,
Cl 3
    Col VP Sel
Gbl Tech,
Cl 1
    Col VP Sel
Gbl Tech,
Cl 2
    Col VP
Strategic Inc,
Cl 1
    Col VP
Strategic Inc,
Cl 2
 
Investment income           

Dividend income

   $     $     $     $ 4,113     $ 4,724  

Variable account expenses

     5,734                          

Investment income (loss) — net

     (5,734                 4,113       4,724  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     151,807       13,780       140       6,867       46,339  

Cost of investments sold

     101,935       12,601       135       7,505       51,670  

Net realized gain (loss) on sales of investments

     49,872       1,179       5       (638     (5,331

Distributions from capital gains

           4,353       1,863              

Net change in unrealized appreciation (depreciation) of investments

     81,005       35,526       5,796       7,903       14,182  

Net gain (loss) on investments

     130,877       41,058       7,664       7,265       8,851  

Net increase (decrease) in net assets resulting from operations

   $ 125,143     $ 41,058     $ 7,664     $ 11,378     $ 13,575  
Year ended December 31, 2023 (continued)    Col VP US
Govt Mtge,
Cl 1
    Col VP US
Govt Mtge,
Cl 2
    Col VP US
Govt Mtge,
Cl 3
   

CS Commodity
Return,

Cl 1

    CTIVP AC
Div Bond,
Cl 1
 
Investment income           

Dividend income

   $ 476     $ 494     $ 30,450     $ 95,071     $ 1,010  

Variable account expenses

                 6,660       2,395        

Investment income (loss) — net

     476       494       23,790       92,676       1,010  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     1,882       2,143       130,848       95,353       4,678  

Cost of investments sold

     2,078       2,430       156,107       124,333       5,454  

Net realized gain (loss) on sales of investments

     (196     (287     (25,259     (28,980     (776

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     565       509       56,529       (111,889     1,392  

Net gain (loss) on investments

     369       222       31,270       (140,869     616  

Net increase (decrease) in net assets resulting from operations

   $ 845     $ 716     $ 55,060     $ (48,193   $ 1,626  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      31  


Statement of Operations

 

Year ended December 31, 2023 (continued)    CTIVP AC
Div Bond,
Cl 2
    CTIVP BR
Gl Infl
Prot Sec,
Cl 1
    CTIVP BR
Gl Infl
Prot Sec,
Cl 2
    CTIVP BR
Gl Infl
Prot Sec,
Cl 3
    CTIVP
CenterSquare
Real Est,
Cl 1
 
Investment income           

Dividend income

   $ 578     $ 5,767     $ 1,393     $ 47,979     $ 1,142  

Variable account expenses

                       2,872        

Investment income (loss) — net

     578       5,767       1,393       45,107       1,142  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     2,520       31,930       5,256       99,075       1,457  

Cost of investments sold

     3,028       40,748       6,168       126,143       1,774  

Net realized gain (loss) on sales of investments

     (508     (8,818     (912     (27,068     (317

Distributions from capital gains

                             3,747  

Net change in unrealized appreciation (depreciation) of investments

     940       4,592       250       1,195       2,690  

Net gain (loss) on investments

     432       (4,226     (662     (25,873     6,120  

Net increase (decrease) in net assets resulting from operations

   $ 1,010     $ 1,541     $ 731     $ 19,234     $ 7,262  
Year ended December 31, 2023 (continued)   

CTIVP
CenterSquare
Real Est,

Cl 2

    CTIVP
MFS Val,
Cl 1
    CTIVP
MFS Val,
Cl 2
    CTIVP
MS Adv,
Cl 1
    CTIVP
MS Adv,
Cl 2
 
Investment income           

Dividend income

   $ 3,580     $     $     $     $  

Variable account expenses

                              

Investment income (loss) — net

     3,580                          
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     17,719       14,969       2,677       3,975       9,411  

Cost of investments sold

     24,156       13,873       2,013       4,245       11,117  

Net realized gain (loss) on sales of investments

     (6,437     1,096       664       (270     (1,706

Distributions from capital gains

     13,800                          

Net change in unrealized appreciation (depreciation) of investments

     14,657       14,027       16,912       32,902       17,531  

Net gain (loss) on investments

     22,020       15,123       17,576       32,632       15,825  

Net increase (decrease) in net assets resulting from operations

   $ 25,600     $ 15,123     $ 17,576     $ 32,632     $ 15,825  
Year ended December 31, 2023 (continued)    CTIVP
Prin Blue
Chip Gro,
Cl 1
    CTIVP
Prin Blue
Chip Gro,
Cl 2
    CTIVP
T Rowe Price
LgCap Val,
Cl 1
    CTIVP
T Rowe Price
LgCap Val,
Cl 2
    CTIVP
TCW Core
Plus Bond,
Cl 1
 
Investment income           

Dividend income

   $     $     $     $     $ 1,470  

Variable account expenses

                              

Investment income (loss) — net

                             1,470  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     1,245       2,056       5,840       3,304       2,922  

Cost of investments sold

     1,287       1,369       5,662       2,589       3,417  

Net realized gain (loss) on sales of investments

     (42     687       178       715       (495

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     31,490       20,747       14,472       10,508       3,668  

Net gain (loss) on investments

     31,448       21,434       14,650       11,223       3,173  

Net increase (decrease) in net assets resulting from operations

   $ 31,448     $ 21,434     $ 14,650     $ 11,223     $ 4,643  

See accompanying notes to financial statements.

 

32    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    CTIVP
TCW Core
Plus Bond,
Cl 2
    CTIVP Vty
Sycamore
Estb Val,
Cl 1
    CTIVP Vty
Sycamore
Estb Val,
Cl 2
    CTIVP Vty
Sycamore
Estb Val,
Cl 3
    CTIVP
Westfield
Mid Cap Gro,
Cl 1
 
Investment income           

Dividend income

   $ 497     $     $     $     $  

Variable account expenses

                       5,955        

Investment income (loss) — net

     497                   (5,955      
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     2,012       54,800       15,609       111,797       1,381  

Cost of investments sold

     2,343       52,562       10,368       74,305       1,345  

Net realized gain (loss) on sales of investments

     (331     2,238       5,241       37,492       36  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     1,913       43,172       41,414       76,460       15,364  

Net gain (loss) on investments

     1,582       45,410       46,655       113,952       15,400  

Net increase (decrease) in net assets resulting from operations

   $ 2,079     $ 45,410     $ 46,655     $ 107,997     $ 15,400  
Year ended December 31, 2023 (continued)    CTIVP
Westfield
Mid Cap Gro,
Cl 2
    Del Ivy
VIP Asset
Strategy,
Cl II
    DWS
Alt Asset
Alloc VIP,
Cl A
    DWS
Alt Asset
Alloc VIP,
Cl B
    EV VT
Floating-Rate Inc,
Init Cl
 
Investment income           

Dividend income

   $     $ 1,116     $ 999     $ 16,022     $ 111,259  

Variable account expenses

           224             271       7,721  

Investment income (loss) — net

           892       999       15,751       103,538  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     2,265       18,062       1,786       23,268       101,073  

Cost of investments sold

     2,138       20,922       1,794       24,461       107,060  

Net realized gain (loss) on sales of investments

     127       (2,860     (8     (1,193     (5,987

Distributions from capital gains

                 133       2,271        

Net change in unrealized appreciation (depreciation) of investments

     13,772       9,146       191       (3,119     39,141  

Net gain (loss) on investments

     13,899       6,286       316       (2,041     33,154  

Net increase (decrease) in net assets resulting from operations

   $ 13,899     $ 7,178     $ 1,315     $ 13,710     $ 136,692  
Year ended December 31, 2023 (continued)    Fid VIP
Contrafund,
Init Cl
    Fid VIP
Contrafund,
Serv Cl 2
    Fid VIP
Gro & Inc,
Serv Cl
    Fid VIP
Gro & Inc,
Serv Cl 2
    Fid VIP
Mid Cap,
Init Cl
 
Investment income           

Dividend income

   $ 2,989     $ 13,928     $ 68,453     $ 31,559     $ 2,423  

Variable account expenses

           26,792       28,013       8,448        

Investment income (loss) — net

     2,989       (12,864     40,440       23,111       2,423  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     82,245       739,499       647,011       320,981       36,840  

Cost of investments sold

     77,215       615,799       453,071       258,838       38,674  

Net realized gain (loss) on sales of investments

     5,030       123,700       193,940       62,143       (1,834

Distributions from capital gains

     20,567       196,205       165,318       82,876       10,949  

Net change in unrealized appreciation (depreciation) of investments

     131,050       1,188,867       328,274       181,436       42,561  

Net gain (loss) on investments

     156,647       1,508,772       687,532       326,455       51,676  

Net increase (decrease) in net assets resulting from operations

   $ 159,636     $ 1,495,908     $ 727,972     $ 349,566     $ 54,099  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      33  


Statement of Operations

 

Year ended December 31, 2023 (continued)    Fid VIP
Mid Cap,
Serv Cl
    Fid VIP
Mid Cap,
Serv Cl 2
    Fid VIP
Overseas,
Serv Cl
    Fid VIP
Overseas,
Serv Cl 2
    Fid VIP
Strategic Inc,
Init Cl
 
Investment income           

Dividend income

   $ 27,620     $ 20,325     $ 13,137     $ 9,249     $ 15,158  

Variable account expenses

     37,171       20,139       9,617       4,419        

Investment income (loss) — net

     (9,551     186       3,520       4,830       15,158  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     578,374       773,183       133,547       62,336       70,621  

Cost of investments sold

     562,296       809,104       112,010       55,523       73,705  

Net realized gain (loss) on sales of investments

     16,078       (35,921     21,537       6,813       (3,084

Distributions from capital gains

     150,031       151,643       3,681       3,099        

Net change in unrealized appreciation (depreciation) of investments

     574,434       592,328       218,598       181,933       14,517  

Net gain (loss) on investments

     740,543       708,050       243,816       191,845       11,433  

Net increase (decrease) in net assets resulting from operations

   $ 730,992     $ 708,236     $ 247,336     $ 196,675     $ 26,591  
Year ended December 31, 2023 (continued)    Fid VIP
Strategic Inc,
Serv Cl 2
    Frank Global
Real Est,
Cl 2
    Frank
Inc,
Cl 1
    Frank
Inc,
Cl 2
    Frank Mutual
Shares,
Cl 1
 
Investment income           

Dividend income

   $ 977     $ 57,370     $ 1,597     $ 20,840     $ 395  

Variable account expenses

           9,907             2,290        

Investment income (loss) — net

     977       47,463       1,597       18,550       395  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     514       274,852       1,768       28,848       973  

Cost of investments sold

     562       346,508       1,890       31,303       967  

Net realized gain (loss) on sales of investments

     (48     (71,656     (122     (2,455     6  

Distributions from capital gains

                 1,839       25,265       1,582  

Net change in unrealized appreciation (depreciation) of investments

     973       226,762       (699     (9,481     877  

Net gain (loss) on investments

     925       155,106       1,018       13,329       2,465  

Net increase (decrease) in net assets resulting from operations

   $ 1,902     $ 202,569     $ 2,615     $ 31,879     $ 2,860  
Year ended December 31, 2023 (continued)    Frank Mutual
Shares,
Cl 2
    Frank Sm
Cap Val,
Cl 1
    Frank Sm
Cap Val,
Cl 2
    GS VIT
Mid Cap Val,
Inst
    GS VIT
Multi-Strategy Alt,
Advisor
 
Investment income           

Dividend income

   $ 29,920     $ 1,109     $ 13,774     $ 58,594     $ 2,236  

Variable account expenses

     7,372             12,979       30,859       183  

Investment income (loss) — net

     22,548       1,109       795       27,735       2,053  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     284,056       7,881       287,322       693,043       11,702  

Cost of investments sold

     335,513       8,789       351,279       748,136       12,012  

Net realized gain (loss) on sales of investments

     (51,457     (908     (63,957     (55,093     (310

Distributions from capital gains

     137,713       8,014       149,322       144,316        

Net change in unrealized appreciation (depreciation) of investments

     90,748       13,057       226,179       484,799       939  

Net gain (loss) on investments

     177,004       20,163       311,544       574,022       629  

Net increase (decrease) in net assets resulting from operations

   $ 199,552     $ 21,272     $ 312,339     $ 601,757     $ 2,682  

See accompanying notes to financial statements.

 

34    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    GS VIT Sm Cap
Eq Insights,
Inst
    GS VIT U.S.
Eq Insights,
Inst
    Invesco VI
Am Fran,
Ser I
    Invesco VI
Am Fran,
Ser II
    Invesco VI
Bal Risk Alloc,
Ser I
 
Investment income           

Dividend income

   $ 5,185     $ 18,604     $     $     $  

Variable account expenses

     3,298       13,547       3,729       3,843        

Investment income (loss) — net

     1,887       5,057       (3,729     (3,843      
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     24,877       409,322       80,807       176,049       902  

Cost of investments sold

     27,300       390,005       83,609       206,095       1,065  

Net realized gain (loss) on sales of investments

     (2,423     19,317       (2,802     (30,046     (163

Distributions from capital gains

                 12,469       22,543        

Net change in unrealized appreciation (depreciation) of investments

     86,830       534,488       186,516       305,445       1,765  

Net gain (loss) on investments

     84,407       553,805       196,183       297,942       1,602  

Net increase (decrease) in net assets resulting from operations

   $ 86,294     $ 558,862     $ 192,454     $ 294,099     $ 1,602  
Year ended December 31, 2023 (continued)    Invesco VI
Bal Risk Alloc,
Ser II
    Invesco VI
Comstock,
Ser II
    Invesco VI
Core Eq,
Ser I
    Invesco VI
Dis Mid Cap Gro,
Ser I
    Invesco VI
Div Divd,
Ser I
 
Investment income           

Dividend income

   $     $ 5,894     $ 71,104     $     $ 22,351  

Variable account expenses

     1,097       2,593       82,628       4,368       5,306  

Investment income (loss) — net

     (1,097     3,301       (11,524     (4,368     17,045  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     102,730       69,668       715,276       37,371       208,626  

Cost of investments sold

     127,604       61,844       737,067       46,678       215,129  

Net realized gain (loss) on sales of investments

     (24,874     7,824       (21,791     (9,307     (6,503

Distributions from capital gains

           42,448       229,456             92,049  

Net change in unrealized appreciation (depreciation) of investments

     40,812       (12,201     1,743,334       107,276       (11,058

Net gain (loss) on investments

     15,938       38,071       1,950,999       97,969       74,488  

Net increase (decrease) in net assets resulting from operations

   $ 14,841     $ 41,372     $ 1,939,475     $ 93,601     $ 91,533  
Year ended December 31, 2023 (continued)    Invesco VI
EQV Intl Eq,
Ser II
    Invesco VI
Global,
Ser I
    Invesco VI
Global,
Ser II
    Invesco VI
Gbl Strat Inc,
Ser I
    Invesco VI
Gbl Strat Inc,
Ser II
 
Investment income           

Dividend income

   $     $ 941     $     $     $  

Variable account expenses

     5,609             7,022             7,606  

Investment income (loss) — net

     (5,609     941       (7,022           (7,606
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     129,501       14,831       281,630       1,921       147,616  

Cost of investments sold

     139,797       15,858       312,502       1,957       175,275  

Net realized gain (loss) on sales of investments

     (10,296     (1,027     (30,872     (36     (27,659

Distributions from capital gains

     803       47,600       198,454              

Net change in unrealized appreciation (depreciation) of investments

     182,401       50,822       309,233       2,186       157,074  

Net gain (loss) on investments

     172,908       97,395       476,815       2,150       129,415  

Net increase (decrease) in net assets resulting from operations

   $ 167,299     $ 98,336     $ 469,793     $ 2,150     $ 121,809  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      35  


Statement of Operations

 

Year ended December 31, 2023 (continued)    Invesco VI
Mn St Sm Cap,
Ser I
    Invesco VI
Mn St Sm Cap,
Ser II
    Invesco VI
Tech,
Ser I
    Invesco VI
Tech,
Ser II
    Janus
Henderson
VIT Bal,
Inst
 
Investment income           

Dividend income

   $ 2,553     $ 15,450     $     $     $ 14,135  

Variable account expenses

           5,619       5,103              

Investment income (loss) — net

     2,553       9,831       (5,103           14,135  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     4,567       178,211       129,014             20,665  

Cost of investments sold

     5,044       183,595       159,061             20,742  

Net realized gain (loss) on sales of investments

     (477     (5,384     (30,047           (77

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     34,793       265,462       403,317       633       77,226  

Net gain (loss) on investments

     34,316       260,078       373,270       633       77,149  

Net increase (decrease) in net assets resulting from operations

   $ 36,869     $ 269,909     $ 368,167     $ 633     $ 91,284  
Year ended December 31, 2023 (continued)    Janus
Henderson
VIT Bal,
Serv
    Janus
Henderson
VIT Enter,
Serv
    Janus
Henderson
VIT Flex Bd,
Inst
    Janus
Henderson
VIT Flex Bd,
Serv
    Janus Hend
VIT Gbl Tech
Innov,
Srv
 
Investment income           

Dividend income

   $ 1,078     $ 696     $ 2,602     $ 790     $  

Variable account expenses

           4,032                   10,739  

Investment income (loss) — net

     1,078       (3,336     2,602       790       (10,739
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     21,817       42,892       1,745       8,053       349,779  

Cost of investments sold

     20,373       39,024       1,841       8,690       310,982  

Net realized gain (loss) on sales of investments

     1,444       3,868       (96     (637     38,797  

Distributions from capital gains

           57,592                    

Net change in unrealized appreciation (depreciation) of investments

     7,114       61,242       1,842       693       808,002  

Net gain (loss) on investments

     8,558       122,702       1,746       56       846,799  

Net increase (decrease) in net assets resulting from operations

   $ 9,636     $ 119,366     $ 4,348     $ 846     $ 836,060  
Year ended December 31, 2023 (continued)    Janus
Henderson
VIT Overseas,
Serv
    Janus
Henderson
VIT Res,
Inst
    Janus
Henderson
VIT Res,
Serv
    Lazard Ret
Global Dyn MA,
Inv
    Lazard Ret
Global Dyn MA,
Serv
 
Investment income           

Dividend income

   $ 25,513     $ 61     $ 327     $     $  

Variable account expenses

     10,208             2,996             89  

Investment income (loss) — net

     15,305       61       (2,669           (89
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     187,388       692       78,012       1,043       1,857  

Cost of investments sold

     165,962       715       74,666       1,126       2,051  

Net realized gain (loss) on sales of investments

     21,426       (23     3,346       (83     (194

Distributions from capital gains

                       508       908  

Net change in unrealized appreciation (depreciation) of investments

     132,311       14,764       184,947       383       1,005  

Net gain (loss) on investments

     153,737       14,741       188,293       808       1,719  

Net increase (decrease) in net assets resulting from operations

   $ 169,042     $ 14,802     $ 185,624     $ 808     $ 1,630  

See accompanying notes to financial statements.

 

36    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    MFS Mass
Inv Gro Stock,
Serv Cl
    MFS
New Dis,
Serv Cl
    MFS
Utilities,
Init Cl
    MFS
Utilities,
Serv Cl
    MS
VIF Dis,
Cl I
 
Investment income           

Dividend income

   $ 1,393     $     $ 2,214     $ 36,342     $  

Variable account expenses

     16,010       9,421             4,994        

Investment income (loss) — net

     (14,617     (9,421     2,214       31,348        
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     381,996       202,513       2,149       142,495       12,756  

Cost of investments sold

     373,220       321,978       2,210       139,766       20,480  

Net realized gain (loss) on sales of investments

     8,776       (119,465     (61     2,729       (7,724

Distributions from capital gains

     150,573             3,426       60,958        

Net change in unrealized appreciation (depreciation) of investments

     447,821       374,087       (6,195     (128,849     95,116  

Net gain (loss) on investments

     607,170       254,622       (2,830     (65,162     87,392  

Net increase (decrease) in net assets resulting from operations

   $ 592,553     $ 245,201     $ (616   $ (33,814   $ 87,392  
Year ended December 31, 2023 (continued)    MS
VIF Dis,
Cl II
    MS VIF
Global Real Est,
Cl II
    NB AMT
Sus Eq,
Cl I
    NB AMT
Sus Eq,
Cl S
    NB AMT
US Eq Index
PW Strat,
Cl S
 
Investment income           

Dividend income

   $     $ 5,865     $ 87     $ 32     $  

Variable account expenses

     3,308       1,541                   67  

Investment income (loss) — net

     (3,308     4,324       87       32       (67
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     109,171       18,215       200       764       6,230  

Cost of investments sold

     298,320       24,343       198       805       6,881  

Net realized gain (loss) on sales of investments

     (189,149     (6,128     2       (41     (651

Distributions from capital gains

                 412       668        

Net change in unrealized appreciation (depreciation) of investments

     430,216       31,645       4,720       8,967       4,625  

Net gain (loss) on investments

     241,067       25,517       5,134       9,594       3,974  

Net increase (decrease) in net assets resulting from operations

   $ 237,759     $ 29,841     $ 5,221     $ 9,626     $ 3,907  
Year ended December 31, 2023 (continued)    PIMCO
VIT All Asset,
Advisor Cl
    PIMCO
VIT All Asset,
Inst Cl
    PIMCO VIT Glb
Man As Alloc,
Adv Cl
    PIMCO VIT
Tot Return,
Advisor Cl
    PIMCO VIT
Tot Return,
Inst Cl
 
Investment income           

Dividend income

   $ 17,259     $ 321     $ 115     $ 14,104     $ 3,082  

Variable account expenses

     3,626                   2,265        

Investment income (loss) — net

     13,633       321       115       11,839       3,082  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     108,000       3,196       306       64,716       3,610  

Cost of investments sold

     129,089       3,575       390       74,716       4,066  

Net realized gain (loss) on sales of investments

     (21,089     (379     (84     (10,000     (456

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     50,815       945       614       19,354       3,493  

Net gain (loss) on investments

     29,726       566       530       9,354       3,037  

Net increase (decrease) in net assets resulting from operations

   $ 43,359     $ 887     $ 645     $ 21,193     $ 6,119  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      37  


Statement of Operations

 

Year ended December 31, 2023 (continued)    Put VT Global
Hlth Care,
Cl IA
    Put VT Global
Hlth Care,
Cl IB
    Put VT
Hi Yield,
Cl IB
    Put VT
Intl Eq,
Cl IB
    Put VT
Sus Leaders,
Cl IA
 
Investment income           

Dividend income

   $ 95     $ 3,999     $ 12,703     $ 54     $ 85,047  

Variable account expenses

           6,694       1,700       753       98,055  

Investment income (loss) — net

     95       (2,695     11,003       (699     (13,008
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     962       137,453       18,846       25,731       830,428  

Cost of investments sold

     957       140,566       22,223       24,730       714,600  

Net realized gain (loss) on sales of investments

     5       (3,113     (3,377     1,001       115,828  

Distributions from capital gains

     1,371       105,810                   348,173  

Net change in unrealized appreciation (depreciation) of investments

     2,048       12,438       18,379       24,655       2,149,947  

Net gain (loss) on investments

     3,424       115,135       15,002       25,656       2,613,948  

Net increase (decrease) in net assets resulting from operations

   $ 3,519     $ 112,440     $ 26,005     $ 24,957     $ 2,600,940  
Year ended December 31, 2023 (continued)    Put VT
Sus Leaders,
Cl IB
    Royce
Micro-Cap,
Invest Cl
    Temp
Global Bond,
Cl 1
    Temp
Global Bond,
Cl 2
    Third Ave
VST Third
Ave Value
 
Investment income           

Dividend income

   $ 559     $     $     $     $ 54,864  

Variable account expenses

     537       12,356             713       14,992  

Investment income (loss) — net

     22       (12,356           (713     39,872  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     13,364       152,941       105       18,089       254,213  

Cost of investments sold

     13,187       183,367       116       22,279       182,990  

Net realized gain (loss) on sales of investments

     177       (30,426     (11     (4,190     71,223  

Distributions from capital gains

     3,424                         152,640  

Net change in unrealized appreciation (depreciation) of investments

     24,459       344,645       824       9,500       164,972  

Net gain (loss) on investments

     28,060       314,219       813       5,310       388,835  

Net increase (decrease) in net assets resulting from operations

   $ 28,082     $ 301,863     $ 813     $ 4,597     $ 428,707  
Year ended December 31, 2023 (continued)    VanEck VIP
Global Gold,
Cl S
    VP
Aggr,
Cl 1
    VP
Aggr,
Cl 2
    VP
Aggr,
Cl 4
    VP
Conserv,
Cl 1
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

     508             58,740       108,554        

Investment income (loss) — net

     (508           (58,740     (108,554      
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     15,348       69,899       1,400,867       1,854,381        

Cost of investments sold

     15,572       68,026       1,173,077       1,239,650        

Net realized gain (loss) on sales of investments

     (224     1,873       227,790       614,731        

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     14,148       181,508       3,521,280       2,928,301       1  

Net gain (loss) on investments

     13,924       183,381       3,749,070       3,543,032       1  

Net increase (decrease) in net assets resulting from operations

   $ 13,416     $ 183,381     $ 3,690,330     $ 3,434,478     $ 1  

See accompanying notes to financial statements.

 

38    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    VP
Conserv,
Cl 2
    VP
Conserv,
Cl 4
    VP Man
Vol Conserv,
Cl 1
    VP Man
Vol Conserv,
Cl 2
    VP Man
Vol Conserv Gro,
Cl 1
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

     2,949       2,332             594        

Investment income (loss) — net

     (2,949     (2,332           (594      
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     455,591       93,416             3,248       1,712  

Cost of investments sold

     446,318       86,719             3,405       1,946  

Net realized gain (loss) on sales of investments

     9,273       6,697             (157     (234

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     46,933       28,231       2       7,100       5,444  

Net gain (loss) on investments

     56,206       34,928       2       6,943       5,210  

Net increase (decrease) in net assets resulting from operations

   $ 53,257     $ 32,596     $ 2     $ 6,349     $ 5,210  
Year ended December 31, 2023 (continued)    VP Man
Vol Conserv Gro,
Cl 2
    VP Man
Vol Gro,
Cl 1
    VP Man
Vol Gro,
Cl 2
    VP Man
Vol Mod Gro,
Cl 1
    VP Man
Vol Mod Gro,
Cl 2
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

     775             6,204             5,716  

Investment income (loss) — net

     (775           (6,204           (5,716
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     11,303       35,386       65,392       27,800       87,631  

Cost of investments sold

     11,523       36,887       60,683       28,633       79,871  

Net realized gain (loss) on sales of investments

     (220     (1,501     4,709       (833     7,760  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     12,946       104,673       280,793       24,517       191,382  

Net gain (loss) on investments

     12,726       103,172       285,502       23,684       199,142  

Net increase (decrease) in net assets resulting from operations

   $ 11,951     $ 103,172     $ 279,298     $ 23,684     $ 193,426  
Year ended December 31, 2023 (continued)    VP
Mod,
Cl 1
    VP
Mod,
Cl 2
    VP
Mod,
Cl 4
    VP Mod
Aggr,
Cl 1
    VP Mod
Aggr,
Cl 2
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

           124,477       165,801             144,158  

Investment income (loss) — net

           (124,477     (165,801           (144,158
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     125,686       2,362,656       2,712,745       214,844       5,062,060  

Cost of investments sold

     129,980       1,915,353       1,986,977       214,203       4,338,704  

Net realized gain (loss) on sales of investments

     (4,294     447,303       725,768       641       723,356  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     352,799       2,631,972       3,219,738       983,039       4,696,860  

Net gain (loss) on investments

     348,505       3,079,275       3,945,506       983,680       5,420,216  

Net increase (decrease) in net assets resulting from operations

   $ 348,505     $ 2,954,798     $ 3,779,705     $ 983,680     $ 5,276,058  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      39  


Statement of Operations

 

Year ended December 31, 2023 (continued)    VP Mod
Aggr,
Cl 4
    VP Mod
Conserv,
Cl 1
    VP Mod
Conserv,
Cl 2
    VP Mod
Conserv,
Cl 4
    VP Ptnrs
Core Bond,
Cl 1
 
Investment income           

Dividend income

   $     $     $     $     $ 599  

Variable account expenses

     258,484             10,004       13,422        

Investment income (loss) — net

     (258,484           (10,004     (13,422     599  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     6,835,917       8,589       377,801       409,741       1,548  

Cost of investments sold

     4,806,865       8,488       333,707       353,118       1,627  

Net realized gain (loss) on sales of investments

     2,029,052       101       44,094       56,623       (79

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     5,533,079       33,180       166,802       219,500       618  

Net gain (loss) on investments

     7,562,131       33,281       210,896       276,123       539  

Net increase (decrease) in net assets resulting from operations

   $ 7,303,647     $ 33,281     $ 200,892     $ 262,701     $ 1,138  
Year ended December 31, 2023 (continued)    VP Ptnrs
Core Bond,
Cl 2
    VP Ptnrs
Core Eq,
Cl 1
    VP Ptnrs
Core Eq,
Cl 2
    VP Ptnrs
Core Eq,
Cl 3
    VP Ptnrs
Intl Core Eq,
Cl 1
 
Investment income           

Dividend income

   $ 357     $     $     $     $ 693  

Variable account expenses

                       2,047        

Investment income (loss) — net

     357                   (2,047     693  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     2,624       896       37       62,476       12,725  

Cost of investments sold

     2,810       812       35       41,547       15,428  

Net realized gain (loss) on sales of investments

     (186     84       2       20,929       (2,703

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     358       287       2,312       66,073       11,616  

Net gain (loss) on investments

     172       371       2,314       87,002       8,913  

Net increase (decrease) in net assets resulting from operations

   $ 529     $ 371     $ 2,314     $ 84,955     $ 9,606  
Year ended December 31, 2023 (continued)    VP Ptnrs
Intl Core Eq,
Cl 2
    VP Ptnrs
Intl Gro,
Cl 1
    VP Ptnrs
Intl Gro,
Cl 2
    VP Ptnrs
Intl Val,
Cl 1
    VP Ptnrs
Intl Val,
Cl 2
 
Investment income           

Dividend income

   $ 354     $ 652     $ 448     $ 523     $ 1,189  

Variable account expenses

                              

Investment income (loss) — net

     354       652       448       523       1,189  
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     1,769       3,374       18,446       5,725       5,102  

Cost of investments sold

     1,991       3,240       20,102       5,679       5,113  

Net realized gain (loss) on sales of investments

     (222     134       (1,656     46       (11

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     6,215       17,960       26,772       3,750       8,562  

Net gain (loss) on investments

     5,993       18,094       25,116       3,796       8,551  

Net increase (decrease) in net assets resulting from operations

   $ 6,347     $ 18,746     $ 25,564     $ 4,319     $ 9,740  

See accompanying notes to financial statements.

 

40    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Operations

 

Year ended December 31, 2023 (continued)    VP Ptnrs
Sm Cap Gro,
Cl 1
    VP Ptnrs
Sm Cap Gro,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 1
    VP Ptnrs
Sm Cap Val,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 3
 
Investment income           

Dividend income

   $     $     $     $     $  

Variable account expenses

                             3,028  

Investment income (loss) — net

                             (3,028
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     954       575       204       698       92,128  

Cost of investments sold

     1,009       554       216       591       73,343  

Net realized gain (loss) on sales of investments

     (55     21       (12     107       18,785  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,685       1,786       1,072       516       46,962  

Net gain (loss) on investments

     3,630       1,807       1,060       623       65,747  

Net increase (decrease) in net assets resulting from operations

   $ 3,630     $ 1,807     $ 1,060     $ 623     $ 62,719  
Year ended December 31, 2023 (continued)    VP US
Flex Conserv Gro,
Cl 1
    VP US
Flex Gro,
Cl 1
    VP US
Flex Mod Gro,
Cl 1
    Wanger
Acorn
    Wanger
Intl
 
Investment income           

Dividend income

   $     $     $     $     $ 12,912  

Variable account expenses

                       28,217       21,075  

Investment income (loss) — net

                       (28,217     (8,163
          
Realized and unrealized gain (loss) on investments — net

 

       

Realized gain (loss) on sales of investments:

          

Proceeds from sales

     861       6,899       589       659,412       542,587  

Cost of investments sold

     882       7,030       566       1,072,045       713,109  

Net realized gain (loss) on sales of investments

     (21     (131     23       (412,633     (170,522

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     511       18,801       1,105       1,452,756       809,823  

Net gain (loss) on investments

     490       18,670       1,128       1,040,123       639,301  

Net increase (decrease) in net assets resulting from operations

   $ 490     $ 18,670     $ 1,128     $ 1,011,906     $ 631,138  
Year ended December 31, 2023 (continued)                      WA Var Global
Hi Yd Bond,
Cl I
    WA Var Global
Hi Yd Bond,
Cl II
 
Investment income           

Dividend income

         $ 915     $ 462  

Variable account expenses

                                    

Investment income (loss) — net

                             915       462  
          
Realized and unrealized gain (loss) on investments — net

 

 

Realized gain (loss) on sales of investments:

          

Proceeds from sales

           4,289       715  

Cost of investments sold

                             4,762       852  

Net realized gain (loss) on sales of investments

           (473     (137

Distributions from capital gains

                  

Net change in unrealized appreciation (depreciation) of investments

                             1,208       508  

Net gain (loss) on investments

                             735       371  

Net increase (decrease) in net assets resulting from operations

                           $ 1,650     $ 833  

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      41  


Statement of Changes in Net Assets

 

Year ended December 31, 2023    AB VPS Dyn
Asset Alloc,
Cl B
    AB VPS
Intl Val,
Cl B
    AB VPS
Lg Cap Gro,
Cl A
   

AB VPS
Lg Cap Gro,

Cl B

    AB VPS
Relative Val,
Cl B
 
Operations           

Investment income (loss) — net

   $ 2     $ 6,039     $     $ (8,313   $ 22,027  

Net realized gain (loss) on sales of investments

     (1     (1,468     (707     7,773       (20,935

Distributions from capital gains

                 17,653       181,316       211,019  

Net change in unrealized appreciation (depreciation) of investments

     55       336,369       60,499       504,944       54,176  

Net increase (decrease) in net assets resulting from operations

     56       340,940       77,445       685,720       266,287  
          
Contract transactions           

Contract purchase payments

           146,847       98,676       120,650       54,975  

Net transfers(1)

     (1     35,194       22,711       350,671       (149,703

Transfers for policy loans

           (15,983           (10,994     (39,544

Policy charges

           (94,588     (22,327     (57,218     (61,113

Contract terminations:

          

Surrender benefits

           (157,095           (8,227     (86,347

Death benefits

                       (4,064      

Increase (decrease) from transactions

     (1     (85,625     99,060       390,818       (281,732

Net assets at beginning of year

     427       2,447,319       172,948       1,722,770       2,530,737  

Net assets at end of year

   $ 482     $ 2,702,634     $ 349,453     $ 2,799,308     $ 2,515,292  
          
Accumulation unit activity           

Units outstanding at beginning of year

           1,515,962       116,625       391,837       697,622  

Units purchased

           143,647       70,476       79,062       39,124  

Units redeemed

           (196,445     (12,709     (16,521     (115,973

Units outstanding at end of year

           1,463,164       174,392       454,378       620,773  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

42    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Allspg VT
Index Asset Alloc,
Cl 2
   

Allspg VT
Intl Eq,

Cl 2

   

Allspg VT
Opp,

Cl 1

   

Allspg VT
Opp,

Cl 2

   

Allspg VT
Sm Cap Gro,

Cl 1

 
Operations           

Investment income (loss) — net

   $ 2,787     $ 8,107     $     $ (5,014   $  

Net realized gain (loss) on sales of investments

     (8,661     (58,854     (259     (9,349     (1,157

Distributions from capital gains

     15,863             1,269       108,986        

Net change in unrealized appreciation (depreciation) of investments

     66,871       186,585       2,659       201,628       11,188  

Net increase (decrease) in net assets resulting from operations

     76,860       135,838       3,669       296,251       10,031  
          
Contract transactions           

Contract purchase payments

     15,234       34,735       5,998       39,643       80,876  

Net transfers(1)

     (21,695     (6,870     395       (92,532     48,081  

Transfers for policy loans

     10,810       (10,933           (17,170      

Policy charges

     (16,344     (27,787     (1,325     (30,972     (16,441

Contract terminations:

          

Surrender benefits

     (23,479     (24,313           (20,602      

Death benefits

                              

Increase (decrease) from transactions

     (35,474     (35,168     5,068       (121,633     112,516  

Net assets at beginning of year

     494,712       925,493       11,799       1,192,460       157,353  

Net assets at end of year

   $ 536,098     $ 1,026,163     $ 20,536     $ 1,367,078     $ 279,900  
          
Accumulation unit activity           

Units outstanding at beginning of year

     260,262       484,439       8,443       286,753       132,071  

Units purchased

     20,725       56,197       3,986       13,281       106,645  

Units redeemed

     (34,724     (59,029     (842     (33,914     (13,590

Units outstanding at end of year

     246,263       481,607       11,587       266,120       225,126  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      43  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Allspg VT
Sm Cap Gro,
Cl 2
    ALPS Alerian
Engy Infr,
Class I
    ALPS Alerian
Engy Infr,
Class III
   

AC VP
Intl,

Cl I

   

AC VP
Intl,

Cl II

 
Operations           

Investment income (loss) — net

   $ (3,950   $ 1,626     $ 11,828     $ 4,939     $ 6,077  

Net realized gain (loss) on sales of investments

     (30,651     27       23,288       4,323       (9,623

Distributions from capital gains

           511       5,324              

Net change in unrealized appreciation (depreciation) of investments

     82,993       2,293       26,009       68,645       88,007  

Net increase (decrease) in net assets resulting from operations

     48,392       4,457       66,449       77,907       84,461  
          
Contract transactions           

Contract purchase payments

     69,022       21,247       19,393       23,179       30,919  

Net transfers(1)

     43,961       3,233       (10,251     (3,385     (366

Transfers for policy loans

     (10,614           (28,708     (11,516     (10,204

Policy charges

     (34,386     (1,923     (6,964     (22,557     (13,603

Contract terminations:

          

Surrender benefits

     (16,530           (29,784     (27,260     (5,811

Death benefits

     (84           (82            

Increase (decrease) from transactions

     51,369       22,557       (56,396     (41,539     935  

Net assets at beginning of year

     1,211,455       22,833       504,417       665,073       700,794  

Net assets at end of year

   $ 1,311,216     $ 49,847     $ 514,470     $ 701,441     $ 786,190  
          
Accumulation unit activity           

Units outstanding at beginning of year

     366,772       18,361       517,259       335,050       504,599  

Units purchased

     56,226       18,187       46,293       10,575       46,588  

Units redeemed

     (25,576     (1,463     (99,869     (30,184     (41,033

Units outstanding at end of year

     397,422       35,085       463,683       315,441       510,154  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

44    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

AC VP
Val,

Cl I

   

AC VP
Val,

Cl II

   

BlackRock
Global Alloc,

Cl I

   

BlackRock
Global Alloc,

Cl III

   

Calvert VP
EAFE Intl Index,

Cl F

 
Operations           

Investment income (loss) — net

   $ 66,901     $ 42,749     $ 3,765     $ 10,085     $ 55  

Net realized gain (loss) on sales of investments

     96,169       41,974       (3,486     (14,479      

Distributions from capital gains

     307,231       189,836                    

Net change in unrealized appreciation (depreciation) of investments

     (150,373     (88,352     18,992       57,522       144  

Net increase (decrease) in net assets resulting from operations

     319,928       186,207       19,271       53,128       199  
          
Contract transactions           

Contract purchase payments

     134,054       69,823       60,956       21,477        

Net transfers(1)

     (36,225     (189,505     37,721       29,180       1,430  

Transfers for policy loans

     16,959       (23,247     (2,831     (2,311      

Policy charges

     (153,729     (53,746     (14,985     (9,768      

Contract terminations:

          

Surrender benefits

     (211,439     (84,620     (29,876     (342      

Death benefits

                       (89      

Increase (decrease) from transactions

     (250,380     (281,295     50,985       38,147       1,430  

Net assets at beginning of year

     3,972,969       2,447,707       119,051       423,182       337  

Net assets at end of year

   $ 4,042,517     $ 2,352,619     $ 189,307     $ 514,457     $ 1,966  
          
Accumulation unit activity           

Units outstanding at beginning of year

     912,253       1,155,553       99,078       317,943        

Units purchased

     56,903       32,933       77,988       91,170       1,364  

Units redeemed

     (94,139     (167,774     (37,431     (62,090      

Units outstanding at end of year

     875,017       1,020,712       139,635       347,023       1,364  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      45  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Calvert VP

EAFE Intl Index,

Cl I

    Calvert VP
Nasdaq
100 Index,
Cl F
    Calvert VP
Nasdaq
100 Index,
Cl I
    Calv VP
Russ 2000
Sm Cap Ind,
Cl F
    Calv VP
Russ 2000
Sm Cap Ind,
Cl I
 
Operations           

Investment income (loss) — net

   $ 1,684     $ 56     $ 122     $ 3     $ 77  

Net realized gain (loss) on sales of investments

     162       11       62             (31

Distributions from capital gains

                             5  

Net change in unrealized appreciation (depreciation) of investments

     7,926       2,617       9,758       49       1,880  

Net increase (decrease) in net assets resulting from operations

     9,772       2,684       9,942       52       1,931  
          
Contract transactions           

Contract purchase payments

     45,587             61,147             17,374  

Net transfers(1)

     14,650       16,560       35,687             3,055  

Transfers for policy loans

                              

Policy charges

     (3,479           (3,009           (530

Contract terminations:

          

Surrender benefits

     (1,909     (498                 (338

Death benefits

                              

Increase (decrease) from transactions

     54,849       16,062       93,825             19,561  

Net assets at beginning of year

     37,535       365       5,397       319       319  

Net assets at end of year

   $ 102,156     $ 19,111     $ 109,164     $ 371     $ 21,811  
          
Accumulation unit activity           

Units outstanding at beginning of year

     38,254             6,316              

Units purchased

     55,125       14,544       78,874             20,136  

Units redeemed

     (4,978           (2,453           (527

Units outstanding at end of year

     88,401       14,544       82,737             19,609  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

46    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Calvert VP
SRI Bal,
Cl I
   

Col VP
Bal,

Cl 1

   

Col VP
Bal,

Cl 3

    Col VP
Commodity
Strategy,
Cl 1
    Col VP
Commodity
Strategy,
Cl 2
 
Operations           

Investment income (loss) — net

   $ 28,789     $     $ (123,137   $ 14,935     $ 8,006  

Net realized gain (loss) on sales of investments

     (8,932     (103     697,647       (5,588     (187

Distributions from capital gains

     9,938                          

Net change in unrealized appreciation (depreciation) of investments

     367,010       247,787       2,387,268       (13,443     (10,538

Net increase (decrease) in net assets resulting from operations

     396,805       247,684       2,961,778       (4,096     (2,719
          
Contract transactions           

Contract purchase payments

     129,031       181,221       595,079       23,832       2,621  

Net transfers(1)

     (7,930     127,702       92,689       5,207        

Transfers for policy loans

     (33,464           28,639       (1,923     866  

Policy charges

     (100,439     (51,436     (870,246     (4,084     (1,371

Contract terminations:

          

Surrender benefits

     (782           (749,120     (19,914      

Death benefits

                 (42,199            

Increase (decrease) from transactions

     (13,584     257,487       (945,158     3,118       2,116  

Net assets at beginning of year

     2,393,134       1,056,000       15,098,464       60,421       36,322  

Net assets at end of year

   $ 2,776,355     $ 1,561,171     $ 17,115,084     $ 59,443     $ 35,719  
          
Accumulation unit activity           

Units outstanding at beginning of year

     916,704       820,160       5,946,390       38,431       37,554  

Units purchased

     52,340       214,879       265,850       19,232       3,694  

Units redeemed

     (57,990     (36,219     (631,067     (17,087     (1,480

Units outstanding at end of year

     911,054       998,820       5,581,173       40,576       39,768  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      47  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP
Contrarian
Core,

Cl 1

    Col VP
Contrarian
Core,
Cl 2
   

Col VP
Disciplined
Core,

Cl 1

   

Col VP
Disciplined
Core,

Cl 2

   

Col VP
Disciplined
Core,

Cl 3

 
Operations           

Investment income (loss) — net

   $     $     $     $     $ (219,617

Net realized gain (loss) on sales of investments

     724       2,826       94       12,987       1,821,254  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     61,611       42,445       28,025       75,399       3,975,337  

Net increase (decrease) in net assets resulting from operations

     62,335       45,271       28,119       88,386       5,576,974  
          
Contract transactions           

Contract purchase payments

     83,092       21,236       20,356       18,772       876,711  

Net transfers(1)

     21,118       (876     24,713       13,170       (138,516

Transfers for policy loans

           14,186             (464     (39,332

Policy charges

     (22,885     (3,303     (9,555     (16,805     (1,355,993

Contract terminations:

          

Surrender benefits

           (1,977           (303     (1,315,704

Death benefits

                             (7,928

Increase (decrease) from transactions

     81,325       29,266       35,514       14,370       (1,980,762

Net assets at beginning of year

     154,841       126,915       101,131       361,814       25,011,204  

Net assets at end of year

   $ 298,501     $ 201,452     $ 164,764     $ 464,570     $ 28,607,416  
          
Accumulation unit activity           

Units outstanding at beginning of year

     105,207       51,257       73,560       122,779       9,379,493  

Units purchased

     61,620       12,584       28,967       9,592       367,177  

Units redeemed

     (13,416     (2,152     (6,159     (5,317     (1,032,844

Units outstanding at end of year

     153,411       61,689       96,368       127,054       8,713,826  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

48    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Col VP
Divd Opp,
Cl 1
   

Col VP
Divd Opp,

Cl 2

    Col VP
Divd Opp,
Cl 3
   

Col VP

Emerg

Mkts Bond,

Cl 1

   

Col VP

Emerg

Mkts Bond,

Cl 2

 
Operations           

Investment income (loss) — net

   $     $     $ (66,945   $ 1,445     $ 842  

Net realized gain (loss) on sales of investments

     1,236       2,737       564,582       (35     (1,642

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,670       5,857       (2,724     1,311       2,301  

Net increase (decrease) in net assets resulting from operations

     4,906       8,594       494,913       2,721       1,501  
          
Contract transactions           

Contract purchase payments

     67,606       5,848       390,239       9,966       716  

Net transfers(1)

     20,761       75,159       25,538       (1,516     (6,687

Transfers for policy loans

     (4,956     (833     (91,959            

Policy charges

     (16,689     (4,183     (431,054     (1,175     (563

Contract terminations:

          

Surrender benefits

     (51,554     (374     (590,115            

Death benefits

                 (28,330            

Increase (decrease) from transactions

     15,168       75,617       (725,681     7,275       (6,534

Net assets at beginning of year

     111,222       152,192       12,374,975       21,364       20,285  

Net assets at end of year

   $ 131,296     $ 236,403     $ 12,144,207     $ 31,360     $ 15,252  
          
Accumulation unit activity           

Units outstanding at beginning of year

     78,993       60,162       3,285,824       22,824       17,873  

Units purchased

     62,942       31,138       223,595       10,315       614  

Units redeemed

     (53,201     (2,164     (403,553     (2,800     (6,272

Units outstanding at end of year

     88,734       89,136       3,105,866       30,339       12,215  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      49  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP
Emer Mkts,

Cl 1

   

Col VP
Emer Mkts,

Cl 2

   

Col VP
Emer Mkts,

Cl 3

   

Col VP Global

Strategic Inc,
Cl 2

   

Col VP Global

Strategic Inc,

Cl 3

 
Operations           

Investment income (loss) — net

   $ 203     $     $ (10,211   $ 2,584     $ 32,530  

Net realized gain (loss) on sales of investments

     (3,516     (11,551     (156,600     (724     (32,096

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     20,741       40,132       323,906       5,814       107,697  

Net increase (decrease) in net assets resulting from operations

     17,428       28,581       157,095       7,674       108,131  
          
Contract transactions           

Contract purchase payments

     36,142       30,634       106,822       5,346       59,837  

Net transfers(1)

     204       (335     (79,584     (1,915     26,779  

Transfers for policy loans

           (68     (3,841     (75     638  

Policy charges

     (9,039     (13,642     (59,682     (2,854     (52,515

Contract terminations:

          

Surrender benefits

     (1,301           (84,497     (230     (53,679

Death benefits

           (2,916                 (9,593

Increase (decrease) from transactions

     26,006       13,673       (120,782     272       (28,533

Net assets at beginning of year

     168,016       307,545       1,880,309       80,775       1,185,156  

Net assets at end of year

   $ 211,450     $ 349,799     $ 1,916,622     $ 88,721     $ 1,264,754  
          
Accumulation unit activity           

Units outstanding at beginning of year

     171,305       252,716       828,849       92,681       1,038,278  

Units purchased

     35,780       24,194       63,008       5,930       77,013  

Units redeemed

     (10,120     (13,675     (123,829     (5,619     (98,596

Units outstanding at end of year

     196,965       263,235       768,028       92,992       1,016,695  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

50    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP Govt
Money Mkt,

Cl 1

    Col VP Govt
Money Mkt,
Cl 2
   

Col VP Govt

Money Mkt,
Cl 3

   

Col VP
Hi Yield Bond,

Cl 1

   

Col VP
Hi Yield Bond,

Cl 2

 
Operations           

Investment income (loss) — net

   $ 9,588     $ 22,177     $ 104,711     $ 4,524     $ 15,319  

Net realized gain (loss) on sales of investments

                 1       (364     (2,271

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

                 (1     7,030       20,221  

Net increase (decrease) in net assets resulting from operations

     9,588       22,177       104,711       11,190       33,269  
          
Contract transactions           

Contract purchase payments

     168,884       92,606       233,875       27,188       20,375  

Net transfers(1)

     228,006       (199,394     51,547       22,965       (6,983

Transfers for policy loans

           312       23,145             (144

Policy charges

     (11,321     (19,686     (254,416     (7,567     (10,461

Contract terminations:

          

Surrender benefits

           (1,604     (183,526           (314

Death benefits

           (508                  

Increase (decrease) from transactions

     385,569       (128,274     (129,375     42,586       2,473  

Net assets at beginning of year

     166,546       510,322       2,660,154       68,352       282,780  

Net assets at end of year

   $ 561,703     $ 404,225     $ 2,635,490     $ 122,128     $ 318,522  
          
Accumulation unit activity           

Units outstanding at beginning of year

     161,519       488,167       2,646,770       62,090       193,412  

Units purchased

     369,319       87,460       403,464       43,336       13,270  

Units redeemed

     (10,679     (205,484     (528,523     (6,545     (11,937

Units outstanding at end of year

     520,159       370,143       2,521,711       98,881       194,745  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      51  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Col VP
Hi Yield Bond,
Cl 3
    Col VP
Inc Opp,
Cl 1
   

Col VP
Inc Opp,

Cl 2

   

Col VP

Inc Opp,

Cl 3

    Col VP
Inter Bond,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 122,552     $ 1,027     $ 3,779     $ 46,470     $ 1,940  

Net realized gain (loss) on sales of investments

     (30,326     (96     (283     (37,297     (1,335

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     182,268       1,287       3,746       98,404       3,600  

Net increase (decrease) in net assets resulting from operations

     274,494       2,218       7,242       107,577       4,205  
          
Contract transactions           

Contract purchase payments

     80,437       90       3,565       26,656       12,308  

Net transfers(1)

     15,821       2,291       28,907       (5,568     20,383  

Transfers for policy loans

     (9,400           (1,352     (1,975      

Policy charges

     (90,646     (658     (2,318     (27,405     (5,955

Contract terminations:

          

Surrender benefits

     (38,611                 (31,335      

Death benefits

     (13,387                        

Increase (decrease) from transactions

     (55,786     1,723       28,802       (39,627     26,736  

Net assets at beginning of year

     2,419,410       18,112       43,709       1,014,684       56,149  

Net assets at end of year

   $ 2,638,118     $ 22,053     $ 79,753     $ 1,082,634     $ 87,090  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,040,505       16,588       30,601       536,141       56,158  

Units purchased

     91,535       2,094       22,007       51,249       31,617  

Units redeemed

     (81,114     (578     (2,470     (53,617     (5,864

Units outstanding at end of year

     1,050,926       18,104       50,138       533,773       81,911  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

52    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP
Inter Bond,

Cl 2

   

Col VP
Inter Bond,

Cl 3

    Col VP
Lg Cap Gro,
Cl 1
   

Col VP
Lg Cap Gro,

Cl 2

   

Col VP
Lg Cap Gro,

Cl 3

 
Operations           

Investment income (loss) — net

   $ 1,205     $ 85,698     $     $     $ (17,012

Net realized gain (loss) on sales of investments

     (2,277     (154,747     61       749       235,372  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,786       366,259       417,351       133,359       826,201  

Net increase (decrease) in net assets resulting from operations

     2,714       297,210       417,412       134,108       1,044,561  
          
Contract transactions           

Contract purchase payments

     15,549       232,306       494,740       50,365       67,453  

Net transfers(1)

     (768     15,274       134,754       (2,015     (23,644

Transfers for policy loans

     (1,269     (31,382           (165     (25,481

Policy charges

     (2,178     (264,334     (86,451     (10,014     (87,899

Contract terminations:

          

Surrender benefits

     (1,211     (187,200     (1,489     (283     (158,434

Death benefits

           (2,202                  

Increase (decrease) from transactions

     10,123       (237,538     541,554       37,888       (228,005

Net assets at beginning of year

     41,721       5,476,465       731,374       298,354       2,585,235  

Net assets at end of year

   $ 54,558     $ 5,536,137     $ 1,690,340     $ 470,350     $ 3,401,791  
          
Accumulation unit activity           

Units outstanding at beginning of year

     37,128       3,591,632       513,701       94,845       760,938  

Units purchased

     13,495       253,933       365,997       13,246       42,830  

Units redeemed

     (4,856     (385,485     (50,398     (3,360     (101,014

Units outstanding at end of year

     45,767       3,460,080       829,300       104,731       702,754  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      53  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP
Lg Cap Index,

Cl 1

   

Col VP
Lg Cap Index,

Cl 3

   

Col VP Limited

Duration Cr,

Cl 1

   

Col VP Limited

Duration Cr,

Cl 2

    Col VP
Long Govt/
Cr Bond,
Cl 1
 
Operations           

Investment income (loss) — net

   $     $ (63,052   $ 664     $ 21,482     $ 335  

Net realized gain (loss) on sales of investments

     21,974       524,761       (10     27,248       (434

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     803,456       2,442,787       646       16,001       800  

Net increase (decrease) in net assets resulting from operations

     825,430       2,904,496       1,300       64,731       701  
          
Contract transactions           

Contract purchase payments

     1,539,621       426,309       4,138       7,828       1,608  

Net transfers(1)

     816,269       435,513       226       (621,659     (2,370

Transfers for policy loans

     (190,000     (164,330           (3,240      

Policy charges

     (352,242     (306,976     (1,514     (17,566     (411

Contract terminations:

          

Surrender benefits

     (6,820     (468,045           (13,840      

Death benefits

                       (93      

Increase (decrease) from transactions

     1,806,828       (77,529     2,850       (648,570     (1,173

Net assets at beginning of year

     2,514,037       11,464,533       18,004       1,458,655       10,767  

Net assets at end of year

   $ 5,146,295     $ 14,291,500     $ 22,154     $ 874,816     $ 10,295  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,730,416       3,027,789       17,164       1,387,981       11,213  

Units purchased

     1,414,981       240,575       4,002       45,267       1,591  

Units redeemed

     (333,218     (217,765     (1,407     (612,753     (2,781

Units outstanding at end of year

     2,812,179       3,050,599       19,759       820,495       10,023  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

54    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP

Long Govt/Cr

Bond,

Cl 2

   

Col VP
Overseas Core,

Cl 1

   

Col VP
Overseas Core,

Cl 2

   

Col VP
Overseas Core,

Cl 3

   

Col VP Select

Lg Cap Val,
Cl 1

 
Operations           

Investment income (loss) — net

   $ 254     $ 3,348     $ 2,866     $ 43,942     $  

Net realized gain (loss) on sales of investments

     (8     (260     (1,400     34,916       104  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     297       25,043       22,356       531,091       35,494  

Net increase (decrease) in net assets resulting from operations

     543       28,131       23,822       609,949       35,598  
          
Contract transactions           

Contract purchase payments

     259       31,664       20,987       209,317       208,337  

Net transfers(1)

           13,185       (8,128     17,493       99,681  

Transfers for policy loans

                       (14,611      

Policy charges

     (77     (8,869     (4,361     (234,249     (39,723

Contract terminations:

          

Surrender benefits

                 (1     (240,551      

Death benefits

                 (3,506            

Increase (decrease) from transactions

     182       35,980       4,991       (262,601     268,295  

Net assets at beginning of year

     7,964       161,334       154,002       4,340,649       355,371  

Net assets at end of year

   $ 8,689     $ 225,445     $ 182,815     $ 4,687,997     $ 659,264  
          
Accumulation unit activity           

Units outstanding at beginning of year

     7,223       140,473       100,519       3,463,661       238,301  

Units purchased

     231       36,474       12,793       184,982       207,956  

Units redeemed

     (68     (7,202     (9,841     (383,361     (26,786

Units outstanding at end of year

     7,386       169,745       103,471       3,265,282       419,471  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      55  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP Select

Lg Cap Val,
Cl 2

   

Col VP Select

Lg Cap Val,
Cl 3

   

Col VP Select

Mid Cap Gro,

Cl 1

   

Col VP Select

Mid Cap Gro,
Cl 2

   

Col VP Select

Mid Cap Gro,
Cl 3

 
Operations           

Investment income (loss) — net

   $     $ (4,751   $     $     $ (4,814

Net realized gain (loss) on sales of investments

     3,610       35,676       445       348       27,519  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,539       11,520       55,654       17,801       177,538  

Net increase (decrease) in net assets resulting from operations

     7,149       42,445       56,099       18,149       200,243  
          
Contract transactions           

Contract purchase payments

     25,314       12,555       61,020       6,035       25,501  

Net transfers(1)

     (3,691     (38,581     2,922       5,436       28,430  

Transfers for policy loans

     928       (9,569                 3,939  

Policy charges

     (4,556     (19,975     (9,420     (1,915     (23,878

Contract terminations:

          

Surrender benefits

           (15,339           (271     (7,662

Death benefits

     (123                 (1,749      

Increase (decrease) from transactions

     17,872       (70,909     54,522       7,536       26,330  

Net assets at beginning of year

     120,562       939,700       202,734       69,687       803,851  

Net assets at end of year

   $ 145,583     $ 911,236     $ 313,355     $ 95,372     $ 1,030,424  
          
Accumulation unit activity           

Units outstanding at beginning of year

     38,721       283,166       159,618       27,379       220,479  

Units purchased

     8,416       8,103       43,957       4,015       44,942  

Units redeemed

     (2,654     (27,315     (6,585     (1,398     (9,444

Units outstanding at end of year

     44,483       263,954       196,990       29,996       255,977  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

56    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP Select

Mid Cap Val,
Cl 1

   

Col VP Select

Mid Cap Val,
Cl 2

   

Col VP Select
Mid Cap Val,

Cl 3

   

Col VP Select

Sm Cap Val,
Cl 1

   

Col VP Select

Sm Cap Val,
Cl 2

 
Operations           

Investment income (loss) — net

   $     $     $ (3,561   $     $  

Net realized gain (loss) on sales of investments

     233       1,576       29,280       159       891  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     27,043       12,945       53,322       9,399       15,929  

Net increase (decrease) in net assets resulting from operations

     27,276       14,521       79,041       9,558       16,820  
          
Contract transactions           

Contract purchase payments

     74,078       16,925       28,013       32,206       17,559  

Net transfers(1)

     5,599       (1,213     42,339       8,930       715  

Transfers for policy loans

                 (3,875            

Policy charges

     (17,414     (5,148     (20,916     (8,735     (5,532

Contract terminations:

          

Surrender benefits

                 (18,521           (338

Death benefits

                             (1,993

Increase (decrease) from transactions

     62,263       10,564       27,040       32,401       10,411  

Net assets at beginning of year

     200,684       132,775       799,636       57,325       123,261  

Net assets at end of year

   $ 290,223     $ 157,860     $ 905,717     $ 99,284     $ 150,492  
          
Accumulation unit activity           

Units outstanding at beginning of year

     138,674       47,109       215,676       46,522       49,883  

Units purchased

     54,989       5,913       43,688       31,449       7,154  

Units redeemed

     (11,843     (2,128     (9,849     (6,757     (3,067

Units outstanding at end of year

     181,820       50,894       249,515       71,214       53,970  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      57  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP Select

Sm Cap Val,
Cl 3

   

Col VP Sel

Gbl Tech,

Cl 1

    Col VP Sel
Gbl Tech,
Cl 2
    Col VP
Strategic Inc,
Cl 1
   

Col VP
Strategic Inc,

Cl 2

 
Operations           

Investment income (loss) — net

   $ (5,734   $     $     $ 4,113     $ 4,724  

Net realized gain (loss) on sales of investments

     49,872       1,179       5       (638     (5,331

Distributions from capital gains

           4,353       1,863              

Net change in unrealized appreciation (depreciation) of investments

     81,005       35,526       5,796       7,903       14,182  

Net increase (decrease) in net assets resulting from operations

     125,143       41,058       7,664       11,378       13,575  
          
Contract transactions           

Contract purchase payments

     30,001       64,448       1,152       29,484       43,059  

Net transfers(1)

     (2,363     33,939       30,463       18,814       57,848  

Transfers for policy loans

     1,029                         (5

Policy charges

     (35,705     (16,600     (26     (9,754     (63,079

Contract terminations:

          

Surrender benefits

     (13,255           (113            

Death benefits

                              

Increase (decrease) from transactions

     (20,293     81,787       31,476       38,544       37,823  

Net assets at beginning of year

     1,013,387       61,432       1,514       95,172       128,338  

Net assets at end of year

   $ 1,118,237     $ 184,277     $ 40,654     $ 145,094     $ 179,736  
          
Accumulation unit activity           

Units outstanding at beginning of year

     254,040       71,243       1,640       92,097       102,789  

Units purchased

     41,866       91,512       30,972       45,055       78,107  

Units redeemed

     (26,294     (15,659     (26     (9,129     (49,072

Units outstanding at end of year

     269,612       147,096       32,586       128,023       131,824  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

58    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Col VP US
Govt Mtge,

Cl 1

   

Col VP US

Govt Mtge,

Cl 2

   

Col VP US
Govt Mtge,

Cl 3

   

CS Commodity
Return,

Cl 1

   

CTIVP AC
Div Bond,

Cl 1

 
Operations           

Investment income (loss) — net

   $ 476     $ 494     $ 23,790     $ 92,676     $ 1,010  

Net realized gain (loss) on sales of investments

     (196     (287     (25,259     (28,980     (776

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     565       509       56,529       (111,889     1,392  

Net increase (decrease) in net assets resulting from operations

     845       716       55,060       (48,193     1,626  
          
Contract transactions           

Contract purchase payments

     4,861       539       61,182       23,016       4,636  

Net transfers(1)

     1,074       9,623       (1,129     (44,729     (3,561

Transfers for policy loans

           (1,267     8,047       (16,490      

Policy charges

     (1,762     (954     (66,338     (8,533     (1,857

Contract terminations:

          

Surrender benefits

                 (15,848     (184      

Death benefits

                              

Increase (decrease) from transactions

     4,173       7,941       (14,086     (46,920     (782

Net assets at beginning of year

     12,359       10,097       1,145,022       501,473       30,280  

Net assets at end of year

   $ 17,377     $ 18,754     $ 1,185,996     $ 406,360     $ 31,124  
          
Accumulation unit activity           

Units outstanding at beginning of year

     13,081       9,500       993,196       538,161       30,547  

Units purchased

     6,168       9,363       77,676       53,926       4,625  

Units redeemed

     (1,848     (2,126     (88,834     (107,028     (5,436

Units outstanding at end of year

     17,401       16,737       982,038       485,059       29,736  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      59  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

CTIVP AC
Div Bond,

Cl 2

    CTIVP BR
Gl Infl
Prot Sec,
Cl 1
    CTIVP BR
Gl Infl
Prot Sec,
Cl 2
    CTIVP BR
Gl Infl
Prot Sec,
Cl 3
   

CTIVP
CenterSquare
Real Est,

Cl 1

 
Operations           

Investment income (loss) — net

   $ 578     $ 5,767     $ 1,393     $ 45,107     $ 1,142  

Net realized gain (loss) on sales of investments

     (508     (8,818     (912     (27,068     (317

Distributions from capital gains

                             3,747  

Net change in unrealized appreciation (depreciation) of investments

     940       4,592       250       1,195       2,690  

Net increase (decrease) in net assets resulting from operations

     1,010       1,541       731       19,234       7,262  
          
Contract transactions           

Contract purchase payments

     2,424       6,103       3,071       31,204       14,648  

Net transfers(1)

     262       4,815       (4,486     (530     515  

Transfers for policy loans

     (2,413     (2,634     (4     819        

Policy charges

     (310     (2,213     (1,205     (25,957     (1,964

Contract terminations:

          

Surrender benefits

           (28,089           (37,584      

Death benefits

                              

Increase (decrease) from transactions

     (37     (22,018     (2,624     (32,048     13,199  

Net assets at beginning of year

     17,500       58,255       18,950       567,685       43,477  

Net assets at end of year

   $ 18,473     $ 37,778     $ 17,057     $ 554,871     $ 63,938  
          
Accumulation unit activity           

Units outstanding at beginning of year

     15,877       58,296       16,630       420,727       38,267  

Units purchased

     2,407       10,786       2,667       42,136       12,879  

Units redeemed

     (2,372     (32,766     (4,889     (62,695     (1,676

Units outstanding at end of year

     15,912       36,316       14,408       400,168       49,470  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

60    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

CTIVP
CenterSquare
Real Est,

Cl 2

   

CTIVP
MFS Val,

Cl 1

   

CTIVP
MFS Val,

Cl 2

   

CTIVP
MS Adv,

Cl 1

   

CTIVP
MS Adv,

Cl 2

 
Operations           

Investment income (loss) — net

   $ 3,580     $     $     $     $  

Net realized gain (loss) on sales of investments

     (6,437     1,096       664       (270     (1,706

Distributions from capital gains

     13,800                          

Net change in unrealized appreciation (depreciation) of investments

     14,657       14,027       16,912       32,902       17,531  

Net increase (decrease) in net assets resulting from operations

     25,600       15,123       17,576       32,632       15,825  
          
Contract transactions           

Contract purchase payments

     12,420       56,089       13,614       27,757       9,806  

Net transfers(1)

     (15,258     25,211       35,625       1,435       (1,477

Transfers for policy loans

     (219           (188           15  

Policy charges

     (6,295     (15,732     (4,653     (4,428     (4,574

Contract terminations:

          

Surrender benefits

                 (56            

Death benefits

     (64                        

Increase (decrease) from transactions

     (9,416     65,568       44,342       24,764       3,770  

Net assets at beginning of year

     197,120       127,103       190,500       93,634       50,950  

Net assets at end of year

   $ 213,304     $ 207,794     $ 252,418     $ 151,030     $ 70,545  
          
Accumulation unit activity           

Units outstanding at beginning of year

     120,784       89,870       69,283       84,550       19,838  

Units purchased

     7,396       57,148       17,667       22,955       3,295  

Units redeemed

     (13,084     (11,029     (1,769     (3,396     (2,104

Units outstanding at end of year

     115,096       135,989       85,181       104,109       21,029  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      61  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    CTIVP
Prin Blue
Chip Gro,
Cl 1
    CTIVP
Prin Blue
Chip Gro,
Cl 2
   

CTIVP
T Rowe Price
LgCap Val,

Cl 1

    CTIVP T
Rowe Price
LgCap Val,
Cl 2
   

CTIVP
TCW Core
Plus Bond,

Cl 1

 
Operations           

Investment income (loss) — net

   $     $     $     $     $ 1,470  

Net realized gain (loss) on sales of investments

     (42     687       178       715       (495

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     31,490       20,747       14,472       10,508       3,668  

Net increase (decrease) in net assets resulting from operations

     31,448       21,434       14,650       11,223       4,643  
          
Contract transactions           

Contract purchase payments

     20,782       6,455       59,831       7,452       28,745  

Net transfers(1)

     229             13,795       1,736        

Transfers for policy loans

                       (2,445      

Policy charges

     (6,195     (3,915     (16,145     (1,009     (4,473

Contract terminations:

          

Surrender benefits

                              

Death benefits

                              

Increase (decrease) from transactions

     14,816       2,540       57,481       5,734       24,272  

Net assets at beginning of year

     72,635       53,921       115,193       114,423       58,172  

Net assets at end of year

   $ 118,899     $ 77,895     $ 187,324     $ 131,380     $ 87,087  
          
Accumulation unit activity           

Units outstanding at beginning of year

     54,945       17,167       82,420       49,632       58,609  

Units purchased

     13,483       1,710       51,310       3,933       28,673  

Units redeemed

     (3,971     (1,062     (11,427     (1,418     (4,441

Units outstanding at end of year

     64,457       17,815       122,303       52,147       82,841  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

62    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

CTIVP
TCW Core
Plus Bond,

Cl 2

    CTIVP Vty
Sycamore
Estb Val,
Cl 1
    CTIVP Vty
Sycamore
Estb Val,
Cl 2
    CTIVP Vty
Sycamore
Estb Val,
Cl 3
   

CTIVP
Westfield
Mid Cap Gro,

Cl 1

 
Operations           

Investment income (loss) — net

   $ 497     $     $     $ (5,955   $  

Net realized gain (loss) on sales of investments

     (331     2,238       5,241       37,492       36  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     1,913       43,172       41,414       76,460       15,364  

Net increase (decrease) in net assets resulting from operations

     2,079       45,410       46,655       107,997       15,400  
          
Contract transactions           

Contract purchase payments

     1,334       155,183       41,184       22,454       14,456  

Net transfers(1)

     18,750       57,803       14,663       52,132       5,266  

Transfers for policy loans

     167       (4,023     (94     (4,262      

Policy charges

     (842     (23,357     (15,079     (18,205     (3,330

Contract terminations:

          

Surrender benefits

     (1,402     (41,809           (47,543      

Death benefits

                 (83            

Increase (decrease) from transactions

     18,007       143,797       40,591       4,576       16,392  

Net assets at beginning of year

     21,079       364,845       447,337       1,134,999       50,373  

Net assets at end of year

   $ 41,165     $ 554,052     $ 534,583     $ 1,247,572     $ 82,165  
          
Accumulation unit activity           

Units outstanding at beginning of year

     19,655       233,038       132,566       256,334       37,706  

Units purchased

     18,769       132,320       16,296       32,469       13,550  

Units redeemed

     (2,055     (43,417     (4,415     (18,279     (2,243

Units outstanding at end of year

     36,369       321,941       144,447       270,524       49,013  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      63  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    CTIVP
Westfield
Mid Cap Gro,
Cl 2
    Del Ivy
VIP Asset
Strategy,
Cl II
    DWS
Alt Asset
Alloc VIP,
Cl A
    DWS
Alt Asset
Alloc VIP,
Cl B
    EV VT
Floating-Rate Inc,
Init Cl
 
Operations           

Investment income (loss) — net

   $     $ 892     $ 999     $ 15,751     $ 103,538  

Net realized gain (loss) on sales of investments

     127       (2,860     (8     (1,193     (5,987

Distributions from capital gains

                 133       2,271        

Net change in unrealized appreciation (depreciation) of investments

     13,772       9,146       191       (3,119     39,141  

Net increase (decrease) in net assets resulting from operations

     13,899       7,178       1,315       13,710       136,692  
          
Contract transactions           

Contract purchase payments

     3,439       2,827       14,357       17,191       25,618  

Net transfers(1)

     (2,084     (323     13       (5,095     12,187  

Transfers for policy loans

                       (687     (643

Policy charges

     (576     (3,113     (666     (9,387     (34,812

Contract terminations:

          

Surrender benefits

           (75           (7,006     (14,176

Death benefits

           (14,504                  

Increase (decrease) from transactions

     779       (15,188     13,704       (4,984     (11,826

Net assets at beginning of year

     55,281       62,903       12,024       251,828       1,301,336  

Net assets at end of year

   $ 69,959     $ 54,893     $ 27,043     $ 260,554     $ 1,426,202  
          
Accumulation unit activity           

Units outstanding at beginning of year

     21,451       50,179       10,177       207,027       889,017  

Units purchased

     1,230       1,993       11,929       16,616       31,587  

Units redeemed

     (993     (14,760     (551     (21,524     (37,136

Units outstanding at end of year

     21,688       37,412       21,555       202,119       883,468  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

64    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Fid VIP
Contrafund,
Init Cl
    Fid VIP
Contrafund,
Serv Cl 2
    Fid VIP
Gro & Inc,
Serv Cl
    Fid VIP
Gro & Inc,
Serv Cl 2
    Fid VIP
Mid Cap,
Init Cl
 
Operations           

Investment income (loss) — net

   $ 2,989     $ (12,864   $ 40,440     $ 23,111     $ 2,423  

Net realized gain (loss) on sales of investments

     5,030       123,700       193,940       62,143       (1,834

Distributions from capital gains

     20,567       196,205       165,318       82,876       10,949  

Net change in unrealized appreciation (depreciation) of investments

     131,050       1,188,867       328,274       181,436       42,561  

Net increase (decrease) in net assets resulting from operations

     159,636       1,495,908       727,972       349,566       54,099  
          
Contract transactions           

Contract purchase payments

     179,445       145,405       125,609       51,103       85,596  

Net transfers(1)

     63,821       (77,717     15,785       (63,446     24,574  

Transfers for policy loans

     (6,522     (5,212     (99,604     16,320       (3,062

Policy charges

     (34,388     (107,097     (178,993     (53,346     (22,584

Contract terminations:

          

Surrender benefits

     (68,438     (270,365     (396,248     (26,717     (32,081

Death benefits

           (46,153                  

Increase (decrease) from transactions

     133,918       (361,139     (533,451     (76,086     52,443  

Net assets at beginning of year

     408,973       4,762,208       4,384,674       1,992,721       327,118  

Net assets at end of year

   $ 702,527     $ 5,896,977     $ 4,579,195     $ 2,266,201     $ 433,660  
          
Accumulation unit activity           

Units outstanding at beginning of year

     284,914       1,449,878       1,035,185       874,825       242,117  

Units purchased

     143,178       93,703       33,624       98,853       77,157  

Units redeemed

     (61,349     (204,074     (162,679     (108,104     (40,350

Units outstanding at end of year

     366,743       1,339,507       906,130       865,574       278,924  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      65  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Fid VIP
Mid Cap,
Serv Cl
    Fid VIP
Mid Cap,
Serv Cl 2
    Fid VIP
Overseas,
Serv Cl
    Fid VIP
Overseas,
Serv Cl 2
    Fid VIP
Strategic Inc,
Init Cl
 
Operations           

Investment income (loss) — net

   $ (9,551   $ 186     $ 3,520     $ 4,830     $ 15,158  

Net realized gain (loss) on sales of investments

     16,078       (35,921     21,537       6,813       (3,084

Distributions from capital gains

     150,031       151,643       3,681       3,099        

Net change in unrealized appreciation (depreciation) of investments

     574,434       592,328       218,598       181,933       14,517  

Net increase (decrease) in net assets resulting from operations

     730,992       708,236       247,336       196,675       26,591  
          
Contract transactions           

Contract purchase payments

     119,109       166,315       46,024       33,768       131,605  

Net transfers(1)

     (23,773     (15,098     (260     50,212       96,763  

Transfers for policy loans

     (53,543     (45,449     8,137       (8,625     (5,218

Policy charges

     (205,753     (120,746     (42,251     (19,454     (23,358

Contract terminations:

          

Surrender benefits

     (282,879     (247,115     (72,720     (12,017     (55,039

Death benefits

     (20,337     (272     (16,525            

Increase (decrease) from transactions

     (467,176     (262,365     (77,595     43,884       144,753  

Net assets at beginning of year

     5,428,770       5,126,036       1,301,213       983,620       187,893  

Net assets at end of year

   $ 5,692,586     $ 5,571,907     $ 1,470,954     $ 1,224,179     $ 359,237  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,061,809       2,545,751       605,324       682,105       178,361  

Units purchased

     22,740       225,253       23,985       68,824       209,659  

Units redeemed

     (110,275     (337,042     (58,917     (42,612     (76,335

Units outstanding at end of year

     974,274       2,433,962       570,392       708,317       311,685  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

66    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Fid VIP
Strategic Inc,

Serv Cl 2

   

Frank Global
Real Est,

Cl 2

   

Frank
Inc,

Cl 1

   

Frank
Inc,

Cl 2

   

Frank Mutual
Shares,

Cl 1

 
Operations           

Investment income (loss) — net

   $ 977     $ 47,463     $ 1,597     $ 18,550     $ 395  

Net realized gain (loss) on sales of investments

     (48     (71,656     (122     (2,455     6  

Distributions from capital gains

                 1,839       25,265       1,582  

Net change in unrealized appreciation (depreciation) of investments

     973       226,762       (699     (9,481     877  

Net increase (decrease) in net assets resulting from operations

     1,902       202,569       2,615       31,879       2,860  
          
Contract transactions           

Contract purchase payments

     2,207       88,614       22,313       11,897       4,608  

Net transfers(1)

     3,257       (86,402     16,102       41,737       1,920  

Transfers for policy loans

     880       16,195             (2,140      

Policy charges

     (668     (73,778     (3,659     (12,581     (1,907

Contract terminations:

          

Surrender benefits

           (65,110     (93     (75      

Death benefits

     (3,297                        

Increase (decrease) from transactions

     2,379       (120,481     34,663       38,838       4,621  

Net assets at beginning of year

     19,143       1,957,111       9,352       375,335       17,910  

Net assets at end of year

   $ 23,424     $ 2,039,199     $ 46,630     $ 446,052     $ 25,391  
          
Accumulation unit activity           

Units outstanding at beginning of year

     15,209       920,154       7,678       283,812       15,257  

Units purchased

     4,917       83,810       30,778       37,552       5,317  

Units redeemed

     (3,080     (113,867     (2,948     (11,149     (1,555

Units outstanding at end of year

     17,046       890,097       35,508       310,215       19,019  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      67  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Frank Mutual

Shares,

Cl 2

   

Frank
Sm Cap Val,

Cl 1

   

Frank Sm

Cap Val,

Cl 2

   

GS VIT
Mid Cap Val,

Inst

    GS VIT
Multi-Strategy Alt,
Advisor
 
Operations           

Investment income (loss) — net

   $ 22,548     $ 1,109     $ 795     $ 27,735     $ 2,053  

Net realized gain (loss) on sales of investments

     (51,457     (908     (63,957     (55,093     (310

Distributions from capital gains

     137,713       8,014       149,322       144,316        

Net change in unrealized appreciation (depreciation) of investments

     90,748       13,057       226,179       484,799       939  

Net increase (decrease) in net assets resulting from operations

     199,552       21,272       312,339       601,757       2,682  
          
Contract transactions           

Contract purchase payments

     65,348       66,299       70,086       157,770       1,637  

Net transfers(1)

     (171,686     33,390       25,074       (162,404     (9,550

Transfers for policy loans

     (11,651           (17,982     (48,802     (632

Policy charges

     (34,951     (15,532     (70,199     (157,058     (390

Contract terminations:

          

Surrender benefits

     (15,571     (1,278     (77,925     (208,270     (166

Death benefits

                              

Increase (decrease) from transactions

     (168,511     82,879       (70,946     (418,764     (9,101

Net assets at beginning of year

     1,661,678       108,148       2,614,209       5,909,788       42,117  

Net assets at end of year

   $ 1,692,719     $ 212,299     $ 2,855,602     $ 6,092,781     $ 35,698  
          
Accumulation unit activity           

Units outstanding at beginning of year

     679,466       82,439       660,934       1,381,349       42,654  

Units purchased

     40,380       73,193       87,178       75,732       2,465  

Units redeemed

     (126,880     (12,446     (69,340     (182,135     (11,397

Units outstanding at end of year

     592,966       143,186       678,772       1,274,946       33,722  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

68    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

GS VIT Sm Cap

Eq Insights,
Inst

   

GS VIT U.S.

Eq Insights,

Inst

   

Invesco VI

Am Fran,
Ser I

    Invesco VI
Am Fran,
Ser II
   

Invesco VI
Bal Risk Alloc,

Ser I

 
Operations           

Investment income (loss) — net

   $ 1,887     $ 5,057     $ (3,729   $ (3,843   $  

Net realized gain (loss) on sales of investments

     (2,423     19,317       (2,802     (30,046     (163

Distributions from capital gains

                 12,469       22,543        

Net change in unrealized appreciation (depreciation) of investments

     86,830       534,488       186,516       305,445       1,765  

Net increase (decrease) in net assets resulting from operations

     86,294       558,862       192,454       294,099       1,602  
          
Contract transactions           

Contract purchase payments

     12,532       66,416       9,999       27,366       8,108  

Net transfers(1)

     10,153       (48,576     (1,095     8,797       2,639  

Transfers for policy loans

     2,676       (1,604     (43,114     (4,620      

Policy charges

     (15,031     (62,859     (21,537     (14,443     (2,878

Contract terminations:

          

Surrender benefits

     (11,443     (44,571     (9,602     (45,115      

Death benefits

                              

Increase (decrease) from transactions

     (1,113     (91,194     (65,349     (28,015     7,869  

Net assets at beginning of year

     466,637       2,456,007       501,641       728,805       19,765  

Net assets at end of year

   $ 551,818     $ 2,923,675     $ 628,746     $ 994,889     $ 29,236  
          
Accumulation unit activity           

Units outstanding at beginning of year

     111,019       594,127       183,207       308,977       17,711  

Units purchased

     5,287       108,761       3,573       50,024       9,372  

Units redeemed

     (6,117     (73,360     (22,553     (39,576     (2,516

Units outstanding at end of year

     110,189       629,528       164,227       319,425       24,567  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      69  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Invesco VI
Bal Risk Alloc,

Ser II

    Invesco VI
Comstock,
Ser II
    Invesco VI
Core Eq,
Ser I
   

Invesco VI
Dis Mid Cap Gro,

Ser I

    Invesco VI
Div Divd,
Ser I
 
Operations           

Investment income (loss) — net

   $ (1,097   $ 3,301     $ (11,524   $ (4,368   $ 17,045  

Net realized gain (loss) on sales of investments

     (24,874     7,824       (21,791     (9,307     (6,503

Distributions from capital gains

           42,448       229,456             92,049  

Net change in unrealized appreciation (depreciation) of investments

     40,812       (12,201     1,743,334       107,276       (11,058

Net increase (decrease) in net assets resulting from operations

     14,841       41,372       1,939,475       93,601       91,533  
          
Contract transactions           

Contract purchase payments

     8,476       8,671       312,951       32,070       21,012  

Net transfers(1)

     7,692       (33,182     (827     87,415       (30,982

Transfers for policy loans

     2,883       (8,127     (25,184     2,240       7,099  

Policy charges

     (1,781     (6,378     (409,610     (19,191     (21,318

Contract terminations:

          

Surrender benefits

     (32,281     (11,470     (336,598     (12,413     (1,131

Death benefits

                 (20,027            

Increase (decrease) from transactions

     (15,011     (50,486     (479,295     90,121       (25,320

Net assets at beginning of year

     253,276       399,910       8,885,828       697,772       1,101,185  

Net assets at end of year

   $ 253,106     $ 390,796     $ 10,346,008     $ 881,494     $ 1,167,398  
          
Accumulation unit activity           

Units outstanding at beginning of year

     201,793       123,807       2,133,230       568,066       443,970  

Units purchased

     61,782       4,363       69,422       94,179       59,117  

Units redeemed

     (75,051     (15,617     (171,650     (24,828     (53,588

Units outstanding at end of year

     188,524       112,553       2,031,002       637,417       449,499  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

70    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Invesco VI
EQV Intl Eq,
Ser II
    Invesco VI
Global,
Ser I
    Invesco VI
Global,
Ser II
    Invesco VI
Gbl Strat Inc,
Ser I
    Invesco VI
Gbl Strat Inc,
Ser II
 
Operations           

Investment income (loss) — net

   $ (5,609   $ 941     $ (7,022   $     $ (7,606

Net realized gain (loss) on sales of investments

     (10,296     (1,027     (30,872     (36     (27,659

Distributions from capital gains

     803       47,600       198,454              

Net change in unrealized appreciation (depreciation) of investments

     182,401       50,822       309,233       2,186       157,074  

Net increase (decrease) in net assets resulting from operations

     167,299       98,336       469,793       2,150       121,809  
          
Contract transactions           

Contract purchase payments

     32,300       152,659       91,187       13,508       59,869  

Net transfers(1)

     (28,298     89,983       (38,825     2,011       21,590  

Transfers for policy loans

     (8,158           (6,825           6,392  

Policy charges

     (22,427     (27,199     (38,219     (3,738     (47,734

Contract terminations:

          

Surrender benefits

     (19,988           (38,040           (70,023

Death benefits

                 (95           (107

Increase (decrease) from transactions

     (46,571     215,443       (30,817     11,781       (30,013

Net assets at beginning of year

     989,373       185,393       1,384,338       16,883       1,533,011  

Net assets at end of year

   $ 1,110,101     $ 499,172     $ 1,823,314     $ 30,814     $ 1,624,807  
          
Accumulation unit activity           

Units outstanding at beginning of year

     501,161       159,699       519,758       18,008       1,140,181  

Units purchased

     14,627       179,178       77,866       16,025       90,284  

Units redeemed

     (38,582     (19,738     (84,661     (3,848     (102,255

Units outstanding at end of year

     477,206       319,139       512,963       30,185       1,128,210  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      71  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

Invesco VI
Mn St Sm Cap,

Ser I

   

Invesco VI
Mn St Sm Cap,

Ser II

   

Invesco VI
Tech,

Ser I

   

Invesco VI
Tech,

Ser II

    Janus
Henderson
VIT Bal,
Inst
 
Operations           

Investment income (loss) — net

   $ 2,553     $ 9,831     $ (5,103   $     $ 14,135  

Net realized gain (loss) on sales of investments

     (477     (5,384     (30,047           (77

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     34,793       265,462       403,317       633       77,226  

Net increase (decrease) in net assets resulting from operations

     36,869       269,909       368,167       633       91,284  
          
Contract transactions           

Contract purchase payments

     45,081       63,841       51,302             112,405  

Net transfers(1)

     4,302       4,607       102,258       5,625       23,940  

Transfers for policy loans

           13       4,803              

Policy charges

     (10,770     (30,991     (39,848           (29,896

Contract terminations:

          

Surrender benefits

           (65,303     (16,182            

Death benefits

                              

Increase (decrease) from transactions

     38,613       (27,833     102,333       5,625       106,449  

Net assets at beginning of year

     177,393       1,560,518       781,769       97       539,639  

Net assets at end of year

   $ 252,875     $ 1,802,594     $ 1,252,269     $ 6,355     $ 737,372  
          
Accumulation unit activity           

Units outstanding at beginning of year

     133,273       490,370       207,248             420,758  

Units purchased

     35,179       88,179       124,525       5,245       99,214  

Units redeemed

     (7,625     (81,053     (28,161           (21,820

Units outstanding at end of year

     160,827       497,496       303,612       5,245       498,152  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

72    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Janus
Henderson
VIT Bal,
Serv
    Janus
Henderson
VIT Enter,
Serv
    Janus
Henderson
VIT Flex Bd,
Inst
    Janus
Henderson
VIT Flex Bd,
Serv
   

Janus Hend
VIT Gbl Tech

Innov,

Srv

 
Operations           

Investment income (loss) — net

   $ 1,078     $ (3,336   $ 2,602     $ 790     $ (10,739

Net realized gain (loss) on sales of investments

     1,444       3,868       (96     (637     38,797  

Distributions from capital gains

           57,592                    

Net change in unrealized appreciation (depreciation) of investments

     7,114       61,242       1,842       693       808,002  

Net increase (decrease) in net assets resulting from operations

     9,636       119,366       4,348       846       836,060  
          
Contract transactions           

Contract purchase payments

     1,634       11,724       27,829       17,611       43,759  

Net transfers(1)

     (21,595     (21,140     17,726             29,052  

Transfers for policy loans

     (13     7,702                   (13,134

Policy charges

     (429     (15,981     (4,781     (479     (43,360

Contract terminations:

          

Surrender benefits

     (1     (11,493                 (166,985

Death benefits

                              

Increase (decrease) from transactions

     (20,404     (29,188     40,774       17,132       (150,668

Net assets at beginning of year

     74,836       710,063       36,113       8,146       1,611,899  

Net assets at end of year

   $ 64,068     $ 800,241     $ 81,235     $ 26,124     $ 2,297,291  
          
Accumulation unit activity           

Units outstanding at beginning of year

     55,242       122,714       35,331       7,224       325,654  

Units purchased

     1,108       3,057       44,614       15,200       51,460  

Units redeemed

     (15,268     (7,867     (4,616     (420     (65,592

Units outstanding at end of year

     41,082       117,904       75,329       22,004       311,522  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      73  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Janus
Henderson
VIT Overseas,
Serv
    Janus
Henderson
VIT Res,
Inst
    Janus
Henderson
VIT Res,
Serv
    Lazard Ret
Global Dyn MA,
Inv
    Lazard Ret
Global Dyn MA,
Serv
 
Operations           

Investment income (loss) — net

   $ 15,305     $ 61     $ (2,669   $     $ (89

Net realized gain (loss) on sales of investments

     21,426       (23     3,346       (83     (194

Distributions from capital gains

                       508       908  

Net change in unrealized appreciation (depreciation) of investments

     132,311       14,764       184,947       383       1,005  

Net increase (decrease) in net assets resulting from operations

     169,042       14,802       185,624       808       1,630  
          
Contract transactions           

Contract purchase payments

     72,590       5,998       20,834       3,649       317  

Net transfers(1)

     6,117       (120     (8,596     6,491       199  

Transfers for policy loans

     (25,173           (1,258           (838

Policy charges

     (64,876     (445     (13,963     (1,655     (606

Contract terminations:

          

Surrender benefits

     (70,917           (18,623     (79      

Death benefits

                              

Increase (decrease) from transactions

     (82,259     5,433       (21,606     8,406       (928

Net assets at beginning of year

     1,735,695       31,022       454,385       2,391       16,367  

Net assets at end of year

   $ 1,822,478     $ 51,257     $ 618,403     $ 11,605     $ 17,069  
          
Accumulation unit activity           

Units outstanding at beginning of year

     773,850       23,242       129,547       2,261       13,114  

Units purchased

     52,765       3,934       13,168       9,509       468  

Units redeemed

     (80,229     (354     (17,147     (1,558     (1,225

Units outstanding at end of year

     746,386       26,822       125,568       10,212       12,357  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

74    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    MFS Mass
Inv Gro Stock,
Serv Cl
   

MFS
New Dis,

Serv Cl

    MFS
Utilities,
Init Cl
    MFS
Utilities,
Serv Cl
   

MS
VIF Dis,

Cl I

 
Operations           

Investment income (loss) — net

   $ (14,617   $ (9,421   $ 2,214     $ 31,348     $  

Net realized gain (loss) on sales of investments

     8,776       (119,465     (61     2,729       (7,724

Distributions from capital gains

     150,573             3,426       60,958        

Net change in unrealized appreciation (depreciation) of investments

     447,821       374,087       (6,195     (128,849     95,116  

Net increase (decrease) in net assets resulting from operations

     592,553       245,201       (616     (33,814     87,392  
          
Contract transactions           

Contract purchase payments

     54,149       51,203       20,170       53,689       121,140  

Net transfers(1)

     25,839       23,220       8,285       (9,264     48,225  

Transfers for policy loans

     5,179       6,231             (3,714      

Policy charges

     (74,819     (51,060     (4,058     (49,341     (21,465

Contract terminations:

          

Surrender benefits

     (119,912     (86,255           (26,073      

Death benefits

                       (307      

Increase (decrease) from transactions

     (109,564     (56,661     24,397       (35,010     147,900  

Net assets at beginning of year

     2,623,189       1,822,357       51,308       1,130,292       127,150  

Net assets at end of year

   $ 3,106,178     $ 2,010,897     $ 75,089     $ 1,061,468     $ 362,442  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,183,680       448,137       36,715       323,834       134,684  

Units purchased

     97,391       51,922       21,194       32,795       150,342  

Units redeemed

     (143,201     (38,538     (3,020     (31,611     (19,045

Units outstanding at end of year

     1,137,870       461,521       54,889       325,018       265,981  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      75  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

MS

VIF Dis,
Cl II

    MS VIF
Global Real Est,
Cl II
    NB AMT
Sus Eq,
Cl I
    NB AMT
Sus Eq,
Cl S
    NB AMT
US Eq Index
PW Strat,
Cl S
 
Operations           

Investment income (loss) — net

   $ (3,308   $ 4,324     $ 87     $ 32     $ (67

Net realized gain (loss) on sales of investments

     (189,149     (6,128     2       (41     (651

Distributions from capital gains

                 412       668        

Net change in unrealized appreciation (depreciation) of investments

     430,216       31,645       4,720       8,967       4,625  

Net increase (decrease) in net assets resulting from operations

     237,759       29,841       5,221       9,626       3,907  
          
Contract transactions           

Contract purchase payments

     43,183       12,452       13,268       2,763       2,295  

Net transfers(1)

     49,992       (271     1,430       131       (4,616

Transfers for policy loans

     (22,731     (1,122                  

Policy charges

     (26,118     (8,032     (1,195     (1,079     (1,388

Contract terminations:

          

Surrender benefits

     (19,270     (4,297                  

Death benefits

                       (137      

Increase (decrease) from transactions

     25,056       (1,270     13,503       1,678       (3,709

Net assets at beginning of year

     528,771       299,834       13,894       34,971       28,311  

Net assets at end of year

   $ 791,586     $ 328,405     $ 32,618     $ 46,275     $ 28,509  
          
Accumulation unit activity           

Units outstanding at beginning of year

     163,037       219,997       10,239       12,792       23,572  

Units purchased

     37,860       12,177       9,492       989       1,757  

Units redeemed

     (24,723     (13,801     (790     (407     (4,646

Units outstanding at end of year

     176,174       218,373       18,941       13,374       20,683  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

76    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    PIMCO
VIT All Asset,
Advisor Cl
    PIMCO
VIT All Asset,
Inst Cl
    PIMCO VIT Glb
Man As Alloc,
Adv Cl
    PIMCO VIT
Tot Return,
Advisor Cl
    PIMCO VIT
Tot Return,
Inst Cl
 
Operations           

Investment income (loss) — net

   $ 13,633     $ 321     $ 115     $ 11,839     $ 3,082  

Net realized gain (loss) on sales of investments

     (21,089     (379     (84     (10,000     (456

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     50,815       945       614       19,354       3,493  

Net increase (decrease) in net assets resulting from operations

     43,359       887       645       21,193       6,119  
          
Contract transactions           

Contract purchase payments

     24,598       6,507             2,861       35,452  

Net transfers(1)

     (5,460                 37,030       14,489  

Transfers for policy loans

     (13,187                 (700      

Policy charges

     (20,958     (3,245     (305     (6,903     (7,275

Contract terminations:

          

Surrender benefits

     (23,166                        

Death benefits

                              

Increase (decrease) from transactions

     (38,173     3,262       (305     32,288       42,666  

Net assets at beginning of year

     611,067       8,617       5,200       381,878       66,648  

Net assets at end of year

   $ 616,253     $ 12,766     $ 5,540     $ 435,359     $ 115,433  
          
Accumulation unit activity           

Units outstanding at beginning of year

     325,107       7,265       3,833       367,081       67,595  

Units purchased

     35,972       5,333             78,530       50,000  

Units redeemed

     (63,363     (2,658     (214     (48,042     (7,243

Units outstanding at end of year

     297,716       9,940       3,619       397,569       110,352  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      77  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Put VT Global
Hlth Care,
Cl IA
   

Put VT Global
Hlth Care,

Cl IB

   

Put VT
Hi Yield,

Cl IB

    Put VT
Intl Eq,
Cl IB
   

Put VT
Sus Leaders,

Cl IA

 
Operations           

Investment income (loss) — net

   $ 95     $ (2,695   $ 11,003     $ (699   $ (13,008

Net realized gain (loss) on sales of investments

     5       (3,113     (3,377     1,001       115,828  

Distributions from capital gains

     1,371       105,810                   348,173  

Net change in unrealized appreciation (depreciation) of investments

     2,048       12,438       18,379       24,655       2,149,947  

Net increase (decrease) in net assets resulting from operations

     3,519       112,440       26,005       24,957       2,600,940  
          
Contract transactions           

Contract purchase payments

     20,536       28,984       10,110       3,807       244,207  

Net transfers(1)

     8,466       (5,275     1,348       (489     (18,688

Transfers for policy loans

           (16,587     14,625       (2,068     (82,708

Policy charges

     (1,611     (26,363     (11,440     (3,544     (373,543

Contract terminations:

          

Surrender benefits

     (74     (38,284     (23,470     (438     (390,051

Death benefits

                              

Increase (decrease) from transactions

     27,317       (57,525     (8,827     (2,732     (620,783

Net assets at beginning of year

     13,415       1,349,445       234,468       140,265       10,570,064  

Net assets at end of year

   $ 44,251     $ 1,404,360     $ 251,646     $ 162,490     $ 12,550,221  
          
Accumulation unit activity           

Units outstanding at beginning of year

     13,010       323,487       88,336       72,790       1,950,257  

Units purchased

     27,995       55,889       10,185       8,085       41,022  

Units redeemed

     (1,549     (54,962     (13,367     (7,381     (143,128

Units outstanding at end of year

     39,456       324,414       85,154       73,494       1,848,151  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

78    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    Put VT
Sus Leaders,
Cl IB
    Royce
Micro-Cap,
Invest Cl
    Temp
Global Bond,
Cl 1
    Temp
Global Bond,
Cl 2
    Third Ave
VST Third
Ave Value
 
Operations           

Investment income (loss) — net

   $ 22     $ (12,356   $     $ (713   $ 39,872  

Net realized gain (loss) on sales of investments

     177       (30,426     (11     (4,190     71,223  

Distributions from capital gains

     3,424                         152,640  

Net change in unrealized appreciation (depreciation) of investments

     24,459       344,645       824       9,500       164,972  

Net increase (decrease) in net assets resulting from operations

     28,082       301,863       813       4,597       428,707  
          
Contract transactions           

Contract purchase payments

     1,842       98,580       5,065       9,973       71,816  

Net transfers(1)

     27,323       2,037       533       21,829       (17,268

Transfers for policy loans

     (1,800     12,792             (230     (64,511

Policy charges

     (2,923     (80,826     (1,656     (4,833     (77,082

Contract terminations:

          

Surrender benefits

     (671     (77,003           (4,494     (84,246

Death benefits

                              

Increase (decrease) from transactions

     23,771       (44,420     3,942       22,245       (171,291

Net assets at beginning of year

     98,485       1,719,564       22,347       176,481       2,208,463  

Net assets at end of year

   $ 150,338     $ 1,977,007     $ 27,102     $ 203,323     $ 2,465,879  
          
Accumulation unit activity           

Units outstanding at beginning of year

     23,274       446,967       26,164       204,893       701,035  

Units purchased

     8,543       30,137       6,546       47,556       20,875  

Units redeemed

     (1,093     (41,201     (1,961     (22,908     (68,486

Units outstanding at end of year

     30,724       435,903       30,749       229,541       653,424  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      79  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    VanEck VIP
Global Gold,
Cl S
   

VP

Aggr,

Cl 1

   

VP

Aggr,

Cl 2

   

VP

Aggr,

Cl 4

    VP
Conserv,
Cl 1
 
Operations           

Investment income (loss) — net

   $ (508   $     $ (58,740   $ (108,554   $  

Net realized gain (loss) on sales of investments

     (224     1,873       227,790       614,731        

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     14,148       181,508       3,521,280       2,928,301       1  

Net increase (decrease) in net assets resulting from operations

     13,416       183,381       3,690,330       3,434,478       1  
          
Contract transactions           

Contract purchase payments

     5,449       562,736       1,140,911       511,208        

Net transfers(1)

     10,298       349,774       1,337,267       (432,035      

Transfers for policy loans

     81             10,499       (30,436      

Policy charges

     (1,866     (107,266     (418,214     (421,655      

Contract terminations:

          

Surrender benefits

     (9,522           (539,325     (637,408      

Death benefits

                              

Increase (decrease) from transactions

     4,440       805,244       1,531,138       (1,010,326      

Net assets at beginning of year

     127,270       680,721       20,898,787       21,226,626       21  

Net assets at end of year

   $ 145,126     $ 1,669,346     $ 26,120,255     $ 23,650,778     $ 22  
          
Accumulation unit activity           

Units outstanding at beginning of year

     112,480       558,717       10,747,281       10,359,397        

Units purchased

     12,898       688,688       1,438,588       438,949        

Units redeemed

     (9,404     (81,407     (618,378     (810,895      

Units outstanding at end of year

     115,974       1,165,998       11,567,491       9,987,451        

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

80    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    VP
Conserv,
Cl 2
    VP
Conserv,
Cl 4
   

VP Man
Vol Conserv,

Cl 1

    VP Man
Vol Conserv,
Cl 2
    VP Man
Vol Conserv Gro,
Cl 1
 
Operations           

Investment income (loss) — net

   $ (2,949   $ (2,332   $     $ (594   $  

Net realized gain (loss) on sales of investments

     9,273       6,697             (157     (234

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     46,933       28,231       2       7,100       5,444  

Net increase (decrease) in net assets resulting from operations

     53,257       32,596       2       6,349       5,210  
          
Contract transactions           

Contract purchase payments

     56,097       45,896                    

Net transfers(1)

     (9,241     (34,237                 2,208  

Transfers for policy loans

     (1,872     761                    

Policy charges

     (43,111     (40,968           (2,654     (1,772

Contract terminations:

          

Surrender benefits

     (22,235     (25,363                  

Death benefits

                              

Increase (decrease) from transactions

     (20,362     (53,911           (2,654     436  

Net assets at beginning of year

     550,429       453,131       20       90,298       50,418  

Net assets at end of year

   $ 583,324     $ 431,816     $ 22     $ 93,993     $ 56,064  
          
Accumulation unit activity           

Units outstanding at beginning of year

     436,006       343,645             84,249       48,159  

Units purchased

     43,721       34,146                   2,066  

Units redeemed

     (50,059     (73,131           (2,378     (1,627

Units outstanding at end of year

     429,668       304,660             81,871       48,598  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      81  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    VP Man
Vol Conserv Gro,
Cl 2
    VP Man
Vol Gro,
Cl 1
    VP Man
Vol Gro,
Cl 2
    VP Man
Vol Mod Gro,
Cl 1
    VP Man
Vol Mod Gro,
Cl 2
 
Operations           

Investment income (loss) — net

   $ (775   $     $ (6,204   $     $ (5,716

Net realized gain (loss) on sales of investments

     (220     (1,501     4,709       (833     7,760  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     12,946       104,673       280,793       24,517       191,382  

Net increase (decrease) in net assets resulting from operations

     11,951       103,172       279,298       23,684       193,426  
          
Contract transactions           

Contract purchase payments

     1,119       180,538       47,344       156,927       63,055  

Net transfers(1)

           252,191       (12,292     41,141       102,421  

Transfers for policy loans

     (556           (28,214           334  

Policy charges

     (10,162     (58,739     (23,227     (47,161     (73,762

Contract terminations:

          

Surrender benefits

           (983     (38           (28,413

Death benefits

                              

Increase (decrease) from transactions

     (9,599     373,007       (16,427     150,907       63,635  

Net assets at beginning of year

     133,914       468,252       1,975,750       120,953       1,604,176  

Net assets at end of year

   $ 136,266     $ 944,431     $ 2,238,621     $ 295,544     $ 1,861,237  
          
Accumulation unit activity           

Units outstanding at beginning of year

     118,382       422,144       1,558,022       111,825       1,315,479  

Units purchased

     964       369,827       37,079       172,636       128,518  

Units redeemed

     (9,136     (50,765     (50,780     (41,562     (79,782

Units outstanding at end of year

     110,210       741,206       1,544,321       242,899       1,364,215  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

82    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

VP

Mod,

Cl 1

   

VP

Mod,

Cl 2

   

VP

Mod,

Cl 4

   

VP Mod
Aggr,

Cl 1

   

VP Mod
Aggr,

Cl 2

 
Operations           

Investment income (loss) — net

   $     $ (124,477   $ (165,801   $     $ (144,158

Net realized gain (loss) on sales of investments

     (4,294     447,303       725,768       641       723,356  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     352,799       2,631,972       3,219,738       983,039       4,696,860  

Net increase (decrease) in net assets resulting from operations

     348,505       2,954,798       3,779,705       983,680       5,276,058  
          
Contract transactions           

Contract purchase payments

     1,043,020       1,245,122       1,263,281       1,600,974       2,007,900  

Net transfers(1)

     542,198       (221,116     (227,216     1,076,621       (939,256

Transfers for policy loans

           (14,297     57,763       (62,537     (486,792

Policy charges

     (167,852     (1,010,278     (1,480,027     (445,320     (1,060,361

Contract terminations:

          

Surrender benefits

     (977     (1,312,190     (1,098,432           (2,233,895

Death benefits

                              

Increase (decrease) from transactions

     1,416,389       (1,312,759     (1,484,631     2,169,738       (2,712,404

Net assets at beginning of year

     2,021,253       24,482,009       31,437,346       5,223,479       37,869,453  

Net assets at end of year

   $ 3,786,147     $ 26,124,048     $ 33,732,420     $ 8,376,897     $ 40,433,107  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,789,991       14,670,949       18,732,757       4,464,475       20,860,440  

Units purchased

     1,312,944       745,459       927,437       2,155,266       1,088,829  

Units redeemed

     (141,449     (1,473,802     (1,706,257     (406,216     (2,596,875

Units outstanding at end of year

     2,961,486       13,942,606       17,953,937       6,213,525       19,352,394  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      83  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

VP Mod
Aggr,

Cl 4

    VP Mod
Conserv,
Cl 1
    VP Mod
Conserv,
Cl 2
    VP Mod
Conserv,
Cl 4
   

VP Ptnrs
Core Bond,

Cl 1

 
Operations           

Investment income (loss) — net

   $ (258,484   $     $ (10,004   $ (13,422   $ 599  

Net realized gain (loss) on sales of investments

     2,029,052       101       44,094       56,623       (79

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     5,533,079       33,180       166,802       219,500       618  

Net increase (decrease) in net assets resulting from operations

     7,303,647       33,281       200,892       262,701       1,138  
          
Contract transactions           

Contract purchase payments

     1,946,699             127,490       147,977       2,253  

Net transfers(1)

     (631,191           10,841       (14,152     11,726  

Transfers for policy loans

     (349,450           23,702       (64      

Policy charges

     (1,348,430     (8,589     (117,304     (156,468     (1,355

Contract terminations:

          

Surrender benefits

     (4,508,204           (54,069     (101,301      

Death benefits

                              

Increase (decrease) from transactions

     (4,890,576     (8,589     (9,340     (124,008     12,624  

Net assets at beginning of year

     53,423,923       313,940       2,001,521       2,712,061       10,581  

Net assets at end of year

   $ 55,836,994     $ 338,632     $ 2,193,073     $ 2,850,754     $ 24,343  
          
Accumulation unit activity           

Units outstanding at beginning of year

     28,411,714       292,086       1,323,591       1,853,935       10,628  

Units purchased

     1,222,595             246,277       165,354       13,711  

Units redeemed

     (3,528,619     (7,671     (260,483     (239,308     (1,337

Units outstanding at end of year

     26,105,690       284,415       1,309,385       1,779,981       23,002  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

84    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    VP Ptnrs
Core Bond,
Cl 2
    VP Ptnrs
Core Eq,
Cl 1
    VP Ptnrs
Core Eq,
Cl 2
    VP Ptnrs
Core Eq,
Cl 3
    VP Ptnrs
Intl Core Eq,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 357     $     $     $ (2,047   $ 693  

Net realized gain (loss) on sales of investments

     (186     84       2       20,929       (2,703

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     358       287       2,312       66,073       11,616  

Net increase (decrease) in net assets resulting from operations

     529       371       2,314       84,955       9,606  
          
Contract transactions           

Contract purchase payments

     557       1,249       124       13,597       12,527  

Net transfers(1)

     11,136       (855     28,126       (10,974     (8,135

Transfers for policy loans

     (1,295                 (2,522      

Policy charges

     (1,286     (617     (5     (5,830     (4,201

Contract terminations:

          

Surrender benefits

     (80           (32     (25,882      

Death benefits

                              

Increase (decrease) from transactions

     9,032       (223     28,213       (31,611     191  

Net assets at beginning of year

     3,832       1,442       1,009       370,132       53,812  

Net assets at end of year

   $ 13,393     $ 1,590     $ 31,536     $ 423,476     $ 63,609  
          
Accumulation unit activity           

Units outstanding at beginning of year

     3,460       997       365       102,229       48,775  

Units purchased

     10,566       804       9,073       8,266       10,470  

Units redeemed

     (2,380     (923     (2     (15,563     (10,262

Units outstanding at end of year

     11,646       878       9,436       94,932       48,983  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      85  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    VP Ptnrs
Intl Core Eq,
Cl 2
    VP Ptnrs
Intl Gro,
Cl 1
   

VP Ptnrs

Intl Gro,
Cl 2

    VP Ptnrs
Intl Val,
Cl 1
    VP Ptnrs
Intl Val,
Cl 2
 
Operations           

Investment income (loss) — net

   $ 354     $ 652     $ 448     $ 523     $ 1,189  

Net realized gain (loss) on sales of investments

     (222     134       (1,656     46       (11

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     6,215       17,960       26,772       3,750       8,562  

Net increase (decrease) in net assets resulting from operations

     6,347       18,746       25,564       4,319       9,740  
          
Contract transactions           

Contract purchase payments

     1,590       16,832       14,467       19,012       3,401  

Net transfers(1)

     22,251       (657     (16,012     (1,783     3,423  

Transfers for policy loans

     (30           625             (2,231

Policy charges

     (1,886     (6,255     (7,147     (3,704     (1,727

Contract terminations:

          

Surrender benefits

     (1                       (1,531

Death benefits

                              

Increase (decrease) from transactions

     21,924       9,920       (8,067     13,525       1,335  

Net assets at beginning of year

     27,410       121,423       180,518       21,108       56,055  

Net assets at end of year

   $ 55,681     $ 150,089     $ 198,015     $ 38,952     $ 67,130  
          
Accumulation unit activity           

Units outstanding at beginning of year

     19,872       106,559       123,757       21,148       43,885  

Units purchased

     15,801       13,841       9,547       17,412       4,895  

Units redeemed

     (1,271     (5,631     (14,694     (5,244     (3,847

Units outstanding at end of year

     34,402       114,769       118,610       33,316       44,933  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

86    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    VP Ptnrs
Sm Cap Gro,
Cl 1
    VP Ptnrs
Sm Cap Gro,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 1
    VP Ptnrs
Sm Cap Val,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 3
 
Operations           

Investment income (loss) — net

   $     $     $     $     $ (3,028

Net realized gain (loss) on sales of investments

     (55     21       (12     107       18,785  

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     3,685       1,786       1,072       516       46,962  

Net increase (decrease) in net assets resulting from operations

     3,630       1,807       1,060       623       62,719  
          
Contract transactions           

Contract purchase payments

     12,081       3,526       1,032       635       25,843  

Net transfers(1)

     1,018             721             19,058  

Transfers for policy loans

                             503  

Policy charges

     (1,780     (618     (221     (278     (16,183

Contract terminations:

          

Surrender benefits

                       (604     (37,695

Death benefits

                              

Increase (decrease) from transactions

     11,319       2,908       1,532       (247     (8,474

Net assets at beginning of year

     42,633       23,929       8,275       5,796       605,181  

Net assets at end of year

   $ 57,582     $ 28,644     $ 10,867     $ 6,172     $ 659,426  
          
Accumulation unit activity           

Units outstanding at beginning of year

     38,919       12,078       7,239       2,925       186,649  

Units purchased

     11,713       1,747       1,485       313       29,111  

Units redeemed

     (1,596     (304     (188     (435     (23,622

Units outstanding at end of year

     49,036       13,521       8,536       2,803       192,138  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      87  


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)    VP US
Flex Conserv Gro,
Cl 1
    VP US
Flex Gro,
Cl 1
    VP US
Flex Mod Gro,
Cl 1
    Wanger
Acorn
    Wanger
Intl
 
Operations           

Investment income (loss) — net

   $     $     $     $ (28,217   $ (8,163

Net realized gain (loss) on sales of investments

     (21     (131     23       (412,633     (170,522

Distributions from capital gains

                              

Net change in unrealized appreciation (depreciation) of investments

     511       18,801       1,105       1,452,756       809,823  

Net increase (decrease) in net assets resulting from operations

     490       18,670       1,128       1,011,906       631,138  
          
Contract transactions           

Contract purchase payments

     2,692       46,694       4,293       157,853       161,937  

Net transfers(1)

     (746     2,651             (74,096     (197,028

Transfers for policy loans

                       (35,281     (18,710

Policy charges

     (172     (16,006     (1,027     (151,379     (118,339

Contract terminations:

          

Surrender benefits

                       (174,450     (131,777

Death benefits

                              

Increase (decrease) from transactions

     1,774       33,339       3,266       (277,353     (303,917

Net assets at beginning of year

     3,582       87,806       5,736       4,899,349       3,948,383  

Net assets at end of year

   $ 5,846     $ 139,815     $ 10,130     $ 5,633,902     $ 4,275,604  
          
Accumulation unit activity           

Units outstanding at beginning of year

     3,390       79,000       5,289       1,295,424       1,707,172  

Units purchased

     2,424       41,877       3,780       104,136       67,055  

Units redeemed

     (844     (13,491     (896     (129,416     (200,855

Units outstanding at end of year

     4,970       107,386       8,173       1,270,144       1,573,372  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

88    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2023 (continued)   

WA Var Global
Hi Yd Bond,

Cl I

   

WA Var Global
Hi Yd Bond,

Cl II

 
Operations     

Investment income (loss) — net

   $ 915     $ 462  

Net realized gain (loss) on sales of investments

     (473     (137

Distributions from capital gains

            

Net change in unrealized appreciation (depreciation) of investments

     1,208       508  

Net increase (decrease) in net assets resulting from operations

     1,650       833  
    
Contract transactions     

Contract purchase payments

     3,534       1,100  

Net transfers(1)

     (2,416      

Transfers for policy loans

           15  

Policy charges

     (1,802     (768

Contract terminations:

    

Surrender benefits

            

Death benefits

            

Increase (decrease) from transactions

     (684     347  

Net assets at beginning of year

     16,564       8,128  

Net assets at end of year

   $ 17,530     $ 9,308  
    
Accumulation unit activity     

Units outstanding at beginning of year

     16,341       6,721  

Units purchased

     3,388       899  

Units redeemed

     (4,044     (620

Units outstanding at end of year

     15,685       7,000  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      89  


Statement of Changes in Net Assets

 

Year ended December 31, 2022    AB VPS Dyn
Asset Alloc,
Cl B
    AB VPS
Intl Val,
Cl B
    AB VPS
Lg Cap Gro,
Cl A
    AB VPS
Lg Cap Gro,
Cl B
    AB VPS
Relative Val,
Cl B
 
Operations           

Investment income (loss) — net

   $ 11     $ 91,981     $     $ (6,159   $ 16,539  

Net realized gain (loss) on sales of investments

           (7,553     (2,200     2,619       16,877  

Distributions from capital gains

     147             17,413       241,564       412,088  

Net change in unrealized appreciation or depreciation of investments

     (256     (487,104     (61,857     (891,053     (578,281

Net increase (decrease) in net assets resulting from operations

     (98     (402,676     (46,644     (653,029     (132,777
          
Contract transactions           

Contract purchase payments

           147,976       75,394       125,874       65,312  

Net transfers(1)

           (18,761     33,842       102,845       (59,299

Transfers for policy loans

           (11,973           (5,974     (25,598

Policy charges

           (89,150     (11,628     (46,621     (59,713

Contract terminations:

          

Surrender benefits

           (46,211           (8,659     (13,226

Death benefits

                              

Increase (decrease) from transactions

           (18,119     97,608       167,465       (92,524

Net assets at beginning of year

     525       2,868,114       121,984       2,208,334       2,756,038  

Net assets at end of year

   $ 427     $ 2,447,319     $ 172,948     $ 1,722,770     $ 2,530,737  
          
Accumulation unit activity           

Units outstanding at beginning of year

           1,523,422       58,808       349,809       721,010  

Units purchased

           98,506       65,097       54,590       18,149  

Units redeemed

           (105,966     (7,280     (12,562     (41,537

Units outstanding at end of year

           1,515,962       116,625       391,837       697,622  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

90    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Allspg VT
Index Asset Alloc,
Cl 2
    Allspg VT
Intl Eq,
Cl 2
    Allspg VT
Opp,
Cl 1
    Allspg VT
Opp,
Cl 2
    Allspg VT
Sm Cap Gro,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 1,158     $ 28,056     $     $ (5,030   $  

Net realized gain (loss) on sales of investments

     (3,251     (32,004     (55     11,028       (5,082

Distributions from capital gains

     63,023             1,533       246,572       15,123  

Net change in unrealized appreciation or depreciation of investments

     (167,930     (125,702     (2,724     (579,190     (49,864

Net increase (decrease) in net assets resulting from operations

     (107,000     (129,650     (1,246     (326,620     (39,823
          
Contract transactions           

Contract purchase payments

     21,072       42,283       3,522       50,161       65,278  

Net transfers(1)

     (26,411     5,173       7,233       (44,398     58,999  

Transfers for policy loans

     3,087       77             (3,127      

Policy charges

     (15,729     (26,033     (570     (30,761     (9,873

Contract terminations:

          

Surrender benefits

     (1     (17,128     (140     (31,464      

Death benefits

                              

Increase (decrease) from transactions

     (17,982     4,372       10,045       (59,589     114,404  

Net assets at beginning of year

     619,694       1,050,771       3,000       1,578,669       82,772  

Net assets at end of year

   $ 494,712     $ 925,493     $ 11,799     $ 1,192,460     $ 157,353  
          
Accumulation unit activity           

Units outstanding at beginning of year

     268,474       482,056       1,604       297,509       45,645  

Units purchased

     12,264       29,271       7,228       13,375       94,136  

Units redeemed

     (20,476     (26,888     (389     (24,131     (7,710

Units outstanding at end of year

     260,262       484,439       8,443       286,753       132,071  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      91  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Allspg VT
Sm Cap Gro,
Cl 2
    ALPS Alerian
Engy Infr,
Class I
    ALPS Alerian
Engy Infr,
Class III
    AC VP
Intl,
Cl I
    AC VP
Intl,
Cl II
 
Operations           

Investment income (loss) — net

   $ (4,662   $ 1,056     $ 18,108     $ 5,604     $ 6,429  

Net realized gain (loss) on sales of investments

     (46,778     58       10,180       3,213       (3,621

Distributions from capital gains

     239,270                   110,995       110,745  

Net change in unrealized appreciation or depreciation of investments

     (862,445     (197     32,524       (355,884     (345,832

Net increase (decrease) in net assets resulting from operations

     (674,615     917       60,812       (236,072     (232,279
          
Contract transactions           

Contract purchase payments

     78,667       13,273       21,183       23,425       30,883  

Net transfers(1)

     (51,511     6,999       55,508       (17,757     5,906  

Transfers for policy loans

     (16,574           (11,257     7,183       (6,594

Policy charges

     (33,581     (366     (5,591     (21,683     (12,400

Contract terminations:

          

Surrender benefits

     (27,830     (226     (5,826     (17,581     (10,998

Death benefits

                              

Increase (decrease) from transactions

     (50,829     19,680       54,017       (26,413     6,797  

Net assets at beginning of year

     1,936,899       2,236       389,588       927,558       926,276  

Net assets at end of year

   $ 1,211,455     $ 22,833     $ 504,417     $ 665,073     $ 700,794  
          
Accumulation unit activity           

Units outstanding at beginning of year

     370,886       1,947       463,525       354,858       498,841  

Units purchased

     24,322       16,707       74,127       15,617       27,601  

Units redeemed

     (28,436     (293     (20,393     (35,425     (21,843

Units outstanding at end of year

     366,772       18,361       517,259       335,050       504,599  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

92    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    AC VP
Val,
Cl I
    AC VP
Val,
Cl II
    BlackRock
Global Alloc,
Cl I
    BlackRock
Global Alloc,
Cl III
    Calvert VP
EAFE Intl Index,
Cl F(2)
 
Operations           

Investment income (loss) — net

   $ 56,067     $ 37,673     $     $ (2,372   $ 12  

Net realized gain (loss) on sales of investments

     112,523       49,105       (772     (14,911      

Distributions from capital gains

     318,396       191,723       1,304       7,430        

Net change in unrealized appreciation or depreciation of investments

     (498,966     (278,248     (17,352     (79,479     (25

Net increase (decrease) in net assets resulting from operations

     (11,980     253       (16,820     (89,332     (13
          
Contract transactions           

Contract purchase payments

     141,192       75,400       33,339       23,248       350  

Net transfers(1)

     37,892       16,445       15,967       (29,127      

Transfers for policy loans

     (12,022     (19,185           (666      

Policy charges

     (147,188     (53,454     (8,590     (9,748      

Contract terminations:

          

Surrender benefits

     (134,150     (92,876           (7,497      

Death benefits

                              

Increase (decrease) from transactions

     (114,276     (73,670     40,716       (23,790     350  

Net assets at beginning of year

     4,099,225       2,521,124       95,155       536,304        

Net assets at end of year

   $ 3,972,969     $ 2,447,707     $ 119,051     $ 423,182     $ 337  
          
Accumulation unit activity           

Units outstanding at beginning of year

     917,928       1,181,672       66,633       336,061        

Units purchased

     77,544       65,644       39,353       16,282        

Units redeemed

     (83,219     (91,763     (6,908     (34,400      

Units outstanding at end of year

     912,253       1,155,553       99,078       317,943        

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

 

(2) 

For the period May 2, 2022 (commencement of operations) to December 31, 2022.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      93  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Calvert VP
EAFE Intl Index,
Cl I(2)
    Calvert VP
Nasdaq
100 Index,
Cl F(2)
    Calvert VP
Nasdaq
100 Index,
Cl I(2)
    Calv VP
Russ 2000
Sm Cap Ind,
Cl F(2)
    Calv VP
Russ 2000
Sm Cap Ind,
Cl I(2)
 
Operations           

Investment income (loss) — net

   $ 342     $ 1     $ 12     $ 3     $ 3  

Net realized gain (loss) on sales of investments

     (3           3              

Distributions from capital gains

           21       300       36       35  

Net change in unrealized appreciation or depreciation of investments

     45       (107     (1,154     (69     (69

Net increase (decrease) in net assets resulting from operations

     384       (85     (839     (30     (31
          
Contract transactions           

Contract purchase payments

     5,404       450       475       349       350  

Net transfers(1)

     32,719             6,209              

Transfers for policy loans

                              

Policy charges

     (649                        

Contract terminations:

          

Surrender benefits

     (323           (448            

Death benefits

                              

Increase (decrease) from transactions

     37,151       450       6,236       349       350  

Net assets at beginning of year

                              

Net assets at end of year

   $ 37,535     $ 365     $ 5,397     $ 319     $ 319  
          
Accumulation unit activity           

Units outstanding at beginning of year

                              

Units purchased

     38,973             6,316              

Units redeemed

     (719                        

Units outstanding at end of year

     38,254             6,316              

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

 

(2) 

For the period May 2, 2022 (commencement of operations) to December 31, 2022.

See accompanying notes to financial statements.

 

94    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Calvert VP
SRI Bal,
Cl I
    Col VP
Bal,
Cl 1
    Col VP
Bal,
Cl 3
    Col VP
Commodity
Strategy,
Cl 1
    Col VP
Commodity
Strategy,
Cl 2
 
Operations           

Investment income (loss) — net

   $ 18,338     $     $ (127,390   $ 13,743     $ 9,293  

Net realized gain (loss) on sales of investments

     (5,033     (420     659,544       130       1,243  

Distributions from capital gains

     244,424                          

Net change in unrealized appreciation or depreciation of investments

     (721,057     (191,334     (3,803,769     (6,837     (4,236

Net increase (decrease) in net assets resulting from operations

     (463,328     (191,754     (3,271,615     7,036       6,300  
          
Contract transactions           

Contract purchase payments

     21,330       98,577       643,563       14,401       2,648  

Net transfers(1)

     (11,785     96,443       (11,316     2,114       731  

Transfers for policy loans

     1,141             8,453             (2,803

Policy charges

     (90,669     (34,529     (869,056     (2,202     (1,305

Contract terminations:

          

Surrender benefits

     (301           (588,945            

Death benefits

                              

Increase (decrease) from transactions

     (80,284     160,491       (817,301     14,313       (729

Net assets at beginning of year

     2,936,746       1,087,263       19,187,380       39,072       30,751  

Net assets at end of year

   $ 2,393,134     $ 1,056,000     $ 15,098,464     $ 60,421     $ 36,322  
          
Accumulation unit activity           

Units outstanding at beginning of year

     946,502       703,868       6,268,126       29,596       37,741  

Units purchased

     8,606       141,733       279,593       10,219       3,680  

Units redeemed

     (38,404     (25,441     (601,329     (1,384     (3,867

Units outstanding at end of year

     916,704       820,160       5,946,390       38,431       37,554  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      95  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP
Contrarian
Core,
Cl 1
    Col VP
Contrarian
Core,
Cl 2
    Col VP
Disciplined
Core,
Cl 1
    Col VP
Disciplined
Core,
Cl 2
    Col VP
Disciplined
Core,
Cl 3
 
Operations           

Investment income (loss) — net

   $     $     $     $     $ (225,495

Net realized gain (loss) on sales of investments

     6       7,282       (131     12,155       1,467,799  

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (24,944     (37,876     (11,031     (96,221     (7,534,782

Net increase (decrease) in net assets resulting from operations

     (24,938     (30,594     (11,162     (84,066     (6,292,478
          
Contract transactions           

Contract purchase payments

     51,410       14,840       32,695       23,418       904,119  

Net transfers(1)

     36,668       5,001       42,815       699       (231,249

Transfers for policy loans

           (4,927           (9,450     (19,890

Policy charges

     (16,055     (3,071     (6,127     (16,754     (1,338,686

Contract terminations:

          

Surrender benefits

           (12,348           (1,101     (943,181

Death benefits

                             (14,120

Increase (decrease) from transactions

     72,023       (505     69,383       (3,188     (1,643,007

Net assets at beginning of year

     107,756       158,014       42,910       449,068       32,946,689  

Net assets at end of year

   $ 154,841     $ 126,915     $ 101,131     $ 361,814     $ 25,011,204  
          
Accumulation unit activity           

Units outstanding at beginning of year

     59,557       51,786       25,369       123,527       9,993,714  

Units purchased

     55,905       7,190       52,405       7,819       324,926  

Units redeemed

     (10,255     (7,719     (4,214     (8,567     (939,147

Units outstanding at end of year

     105,207       51,257       73,560       122,779       9,379,493  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

96    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP
Divd Opp,
Cl 1
    Col VP
Divd Opp,
Cl 2
    Col VP
Divd Opp,
Cl 3
   

Col VP

Emerg

Mkts Bond,

Cl 1

   

Col VP

Emerg

Mkts Bond,

Cl 2

 
Operations           

Investment income (loss) — net

   $     $     $ (71,172   $ 644     $ 819  

Net realized gain (loss) on sales of investments

     79       2,532       530,556       (40     (88

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (394     (4,400     (698,076     (1,153     (4,211

Net increase (decrease) in net assets resulting from operations

     (315     (1,868     (238,692     (549     (3,480
          
Contract transactions           

Contract purchase payments

     22,009       5,860       420,925       16,305       2,688  

Net transfers(1)

     16,841       37,679       (46,949     4,250        

Transfers for policy loans

                 21,915              

Policy charges

     (7,854     (2,866     (440,647     (879     (470

Contract terminations:

          

Surrender benefits

                 (443,786     (70      

Death benefits

                 (18,630            

Increase (decrease) from transactions

     30,996       40,673       (507,172     19,606       2,218  

Net assets at beginning of year

     80,541       113,387       13,120,839       2,307       21,547  

Net assets at end of year

   $ 111,222     $ 152,192     $ 12,374,975     $ 21,364     $ 20,285  
          
Accumulation unit activity           

Units outstanding at beginning of year

     56,566       44,199       3,424,864       1,995       15,918  

Units purchased

     28,108       17,113       127,746       21,768       2,369  

Units redeemed

     (5,681     (1,150     (266,786     (939     (414

Units outstanding at end of year

     78,993       60,162       3,285,824       22,824       17,873  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      97  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP
Emer Mkts,
Cl 1
    Col VP
Emer Mkts,
Cl 2
    Col VP
Emer Mkts,
Cl 3
    Col VP Global
Strategic Inc,
Cl 2
    Col VP Global
Strategic Inc,
Cl 3
 
Operations           

Investment income (loss) — net

   $     $     $ (11,603   $ 2,541     $ 34,465  

Net realized gain (loss) on sales of investments

     (2,188     (14,624     (80,559     (563     (21,846

Distributions from capital gains

     37,788       103,950       635,575              

Net change in unrealized appreciation or depreciation of investments

     (81,634     (240,676     (1,514,409     (14,455     (204,902

Net increase (decrease) in net assets resulting from operations

     (46,034     (151,350     (970,996     (12,477     (192,283
          
Contract transactions           

Contract purchase payments

     56,479       41,694       110,751       5,319       59,604  

Net transfers(1)

     51,999       (12,780     (20,971           6,515  

Transfers for policy loans

           (1,886     3,851       (1,769     (6,984

Policy charges

     (6,795     (16,684     (64,825     (2,935     (53,117

Contract terminations:

          

Surrender benefits

           (6,775     (104,725           (23,637

Death benefits

                              

Increase (decrease) from transactions

     101,683       3,569       (75,919     615       (17,619

Net assets at beginning of year

     112,367       455,326       2,927,224       92,637       1,395,058  

Net assets at end of year

   $ 168,016     $ 307,545     $ 1,880,309     $ 80,775     $ 1,185,156  
          
Accumulation unit activity           

Units outstanding at beginning of year

     76,876       250,402       847,968       91,808       1,049,829  

Units purchased

     100,892       31,516       58,120       5,886       59,499  

Units redeemed

     (6,463     (29,202     (77,239     (5,013     (71,050

Units outstanding at end of year

     171,305       252,716       828,849       92,681       1,038,278  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

98    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP Govt
Money Mkt,
Cl 1
    Col VP Govt
Money Mkt,
Cl 2
    Col VP Govt
Money Mkt,
Cl 3
    Col VP
Hi Yield Bond,
Cl 1
    Col VP
Hi Yield Bond,
Cl 2
 
Operations           

Investment income (loss) — net

   $ 1,661     $ 5,641     $ 15,502     $ 2,564     $ 14,284  

Net realized gain (loss) on sales of investments

           1       1       (294     (1,914

Distributions from capital gains

                       344       2,022  

Net change in unrealized appreciation or depreciation of investments

                       (6,629     (47,730

Net increase (decrease) in net assets resulting from operations

     1,661       5,642       15,503       (4,015     (33,338
          
Contract transactions           

Contract purchase payments

     100,174       102,474       240,507       27,764       30,037  

Net transfers(1)

     24,950       (59,322     (80,648     22,086       (7,374

Transfers for policy loans

           (7,386     28,165             (4,011

Policy charges

     (5,189     (23,033     (258,217     (4,175     (11,208

Contract terminations:

          

Surrender benefits

           (342     (19,556           (828

Death benefits

                              

Increase (decrease) from transactions

     119,935       12,391       (89,749     45,675       6,616  

Net assets at beginning of year

     44,950       492,289       2,734,400       26,692       309,502  

Net assets at end of year

   $ 166,546     $ 510,322     $ 2,660,154     $ 68,352     $ 282,780  
          
Accumulation unit activity           

Units outstanding at beginning of year

     44,118       476,129       2,736,771       21,689       188,870  

Units purchased

     122,478       98,937       343,080       44,129       20,169  

Units redeemed

     (5,077     (86,899     (433,081     (3,728     (15,627

Units outstanding at end of year

     161,519       488,167       2,646,770       62,090       193,412  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      99  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP
Hi Yield Bond,
Cl 3
    Col VP
Inc Opp,
Cl 1
    Col VP
Inc Opp,
Cl 2
    Col VP
Inc Opp,
Cl 3
    Col VP
Inter Bond,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 116,199     $ 1,001     $ 1,586     $ 49,837     $ 1,625  

Net realized gain (loss) on sales of investments

     (20,577     (67     (29     (16,791     (423

Distributions from capital gains

     17,898       669       1,116       38,127       34  

Net change in unrealized appreciation or depreciation of investments

     (431,307     (3,462     (5,990     (196,080     (10,287

Net increase (decrease) in net assets resulting from operations

     (317,787     (1,859     (3,317     (124,907     (9,051
          
Contract transactions           

Contract purchase payments

     86,630       2,277       3,685       29,329       15,413  

Net transfers(1)

     (52,980     168       12,797       (11,089     5,576  

Transfers for policy loans

     3,481                   (2,279      

Policy charges

     (97,453     (567     (767     (27,432     (4,283

Contract terminations:

          

Surrender benefits

     (86,863                 (31,145      

Death benefits

     (5,168                        

Increase (decrease) from transactions

     (152,353     1,878       15,715       (42,616     16,706  

Net assets at beginning of year

     2,889,550       18,093       31,311       1,182,207       48,494  

Net assets at end of year

   $ 2,419,410     $ 18,112     $ 43,709     $ 1,014,684     $ 56,149  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,113,218       14,911       19,681       553,960       40,227  

Units purchased

     39,544       2,183       11,445       16,623       19,964  

Units redeemed

     (112,257     (506     (525     (34,442     (4,033

Units outstanding at end of year

     1,040,505       16,588       30,601       536,141       56,158  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

100    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP
Inter Bond,
Cl 2
    Col VP
Inter Bond,
Cl 3
    Col VP
Lg Cap Gro,
Cl 1
    Col VP
Lg Cap Gro,
Cl 2
    Col VP
Lg Cap Gro,
Cl 3
 
Operations           

Investment income (loss) — net

   $ 1,272     $ 148,223     $     $     $ (17,074

Net realized gain (loss) on sales of investments

     (4,242     (83,839     (6,168     4,762       189,680  

Distributions from capital gains

     29       3,986                    

Net change in unrealized appreciation or depreciation of investments

     (7,932     (1,278,117     (159,031     (130,183     (1,412,391

Net increase (decrease) in net assets resulting from operations

     (10,873     (1,209,747     (165,199     (125,421     (1,239,785
          
Contract transactions           

Contract purchase payments

     16,990       239,027       440,576       53,564       113,351  

Net transfers(1)

     (27,495     14,402       162,975       (8,195     (64,612

Transfers for policy loans

     (1,167     (41,785           (5,538     (49,129

Policy charges

     (1,887     (282,453     (53,410     (8,126     (81,847

Contract terminations:

          

Surrender benefits

           (163,735                 (60,854

Death benefits

           (2,887                  

Increase (decrease) from transactions

     (13,559     (237,431     550,141       31,705       (143,091

Net assets at beginning of year

     66,153       6,923,643       346,432       392,070       3,968,111  

Net assets at end of year

   $ 41,721     $ 5,476,465     $ 731,374     $ 298,354     $ 2,585,235  
          
Accumulation unit activity           

Units outstanding at beginning of year

     48,732       3,717,812       166,962       85,336       809,388  

Units purchased

     13,351       196,112       380,622       15,233       35,172  

Units redeemed

     (24,955     (322,292     (33,883     (5,724     (83,622

Units outstanding at end of year

     37,128       3,591,632       513,701       94,845       760,938  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      101  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP
Lg Cap Index,
Cl 1
    Col VP
Lg Cap Index,
Cl 3
    Col VP Limited
Duration Cr,
Cl 1
    Col VP Limited
Duration Cr,
Cl 2
   

Col VP

Long Govt/

Cr Bond,

Cl 1

 
Operations           

Investment income (loss) — net

   $     $ (59,366   $ 112     $ (808   $ 317  

Net realized gain (loss) on sales of investments

     5,097       385,719       (695     (18,264     (1,204

Distributions from capital gains

                             347  

Net change in unrealized appreciation or depreciation of investments

     (339,229     (2,983,716     (310     (25,768     (2,104

Net increase (decrease) in net assets resulting from operations

     (334,132     (2,657,363     (893     (44,840     (2,644
          
Contract transactions           

Contract purchase payments

     1,265,346       390,014       45,519       826,756       10,525  

Net transfers(1)

     381,497       97,314       (36,011     22,799        

Transfers for policy loans

           (121,439           (2,189      

Policy charges

     (193,034     (275,261     (1,071     (14,355     (478

Contract terminations:

          

Surrender benefits

     (12,993     (165,975     (82     (10,647     (79

Death benefits

                              

Increase (decrease) from transactions

     1,440,816       (75,347     8,355       822,364       9,968  

Net assets at beginning of year

     1,407,353       14,197,243       10,542       681,131       3,443  

Net assets at end of year

   $ 2,514,037     $ 11,464,533     $ 18,004     $ 1,458,655     $ 10,767  
          
Accumulation unit activity           

Units outstanding at beginning of year

     790,988       3,011,939       9,364       635,866       2,523  

Units purchased

     1,075,432       140,951       42,978       789,384       9,137  

Units redeemed

     (136,004     (125,101     (35,178     (37,269     (447

Units outstanding at end of year

     1,730,416       3,027,789       17,164       1,387,981       11,213  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

102    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)   

Col VP

Long Govt/Cr

Bond,

Cl 2

    Col VP
Overseas Core,
Cl 1
    Col VP
Overseas Core,
Cl 2
    Col VP
Overseas Core,
Cl 3
    Col VP Select
Lg Cap Val,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 202     $ 611     $ 1,130     $ (1,511   $  

Net realized gain (loss) on sales of investments

     (91     (399     (1,705     31,774       (198

Distributions from capital gains

     250       7,678       11,684       333,003        

Net change in unrealized appreciation or depreciation of investments

     (3,131     (18,577     (37,093     (1,184,325     515  

Net increase (decrease) in net assets resulting from operations

     (2,770     (10,687     (25,984     (821,059     317  
          
Contract transactions           

Contract purchase payments

     1,341       55,436       21,759       224,747       109,137  

Net transfers(1)

           44,885       (2,640     (8,032     160,941  

Transfers for policy loans

                 (3,400     15,003        

Policy charges

     (316     (6,470     (5,698     (230,672     (20,838

Contract terminations:

          

Surrender benefits

                       (174,536      

Death benefits

                       (3,619      

Increase (decrease) from transactions

     1,025       93,851       10,021       (177,109     249,240  

Net assets at beginning of year

     9,709       78,170       169,965       5,338,817       105,814  

Net assets at end of year

   $ 7,964     $ 161,334     $ 154,002     $ 4,340,649     $ 355,371  
          
Accumulation unit activity           

Units outstanding at beginning of year

     6,367       58,074       94,407       3,611,334       69,647  

Units purchased

     1,118       88,075       13,765       197,064       183,012  

Units redeemed

     (262     (5,676     (7,653     (344,737     (14,358

Units outstanding at end of year

     7,223       140,473       100,519       3,463,661       238,301  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      103  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP Select
Lg Cap Val,
Cl 2
    Col VP Select
Lg Cap Val,
Cl 3
    Col VP Select
Mid Cap Gro,
Cl 1
    Col VP Select
Mid Cap Gro,
Cl 2
    Col VP Select
Mid Cap Gro,
Cl 3
 
Operations           

Investment income (loss) — net

   $     $ (4,857   $     $     $ (4,690

Net realized gain (loss) on sales of investments

     6,528       16,274       159       2,794       39,612  

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (9,058     (32,391     (49,050     (36,979     (421,838

Net increase (decrease) in net assets resulting from operations

     (2,530     (20,974     (48,891     (34,185     (386,916
          
Contract transactions           

Contract purchase payments

     13,211       14,086       113,711       9,971       27,572  

Net transfers(1)

     14,992       63,312       1,897       (9,529     (14,652

Transfers for policy loans

     (8,040     (2,572           180       (833

Policy charges

     (3,911     (18,455     (6,488     (3,092     (23,136

Contract terminations:

          

Surrender benefits

           (23,788           (2,704     (49,922

Death benefits

                              

Increase (decrease) from transactions

     16,252       32,583       109,120       (5,174     (60,971

Net assets at beginning of year

     106,840       928,091       142,505       109,046       1,251,738  

Net assets at end of year

   $ 120,562     $ 939,700     $ 202,734     $ 69,687     $ 803,851  
          
Accumulation unit activity           

Units outstanding at beginning of year

     33,606       276,336       77,603       29,557       244,520  

Units purchased

     9,012       23,249       86,800       3,673       15,767  

Units redeemed

     (3,897     (16,419     (4,785     (5,851     (39,808

Units outstanding at end of year

     38,721       283,166       159,618       27,379       220,479  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

104    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP Select
Mid Cap Val,
Cl 1
    Col VP Select
Mid Cap Val,
Cl 2
    Col VP Select
Mid Cap Val,
Cl 3
    Col VP Select
Sm Cap Val,
Cl 1
    Col VP Select
Sm Cap Val,
Cl 2
 
Operations           

Investment income (loss) — net

   $     $     $ (3,688   $     $  

Net realized gain (loss) on sales of investments

     78       947       26,487       194       1,123  

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (7,103     (13,322     (117,185     (4,398     (20,272

Net increase (decrease) in net assets resulting from operations

     (7,025     (12,375     (94,386     (4,204     (19,149
          
Contract transactions           

Contract purchase payments

     119,003       17,794       26,849       38,886       18,890  

Net transfers(1)

     33,245       9,477       4,671       2,035       10,037  

Transfers for policy loans

                 2,759              

Policy charges

     (10,616     (4,707     (19,827     (6,701     (5,850

Contract terminations:

          

Surrender benefits

           (2     (58,569            

Death benefits

                              

Increase (decrease) from transactions

     141,632       22,562       (44,117     34,220       23,077  

Net assets at beginning of year

     66,077       122,588       938,139       27,309       119,333  

Net assets at end of year

   $ 200,684     $ 132,775     $ 799,636     $ 57,325     $ 123,261  
          
Accumulation unit activity           

Units outstanding at beginning of year

     41,351       39,291       223,983       18,903       41,086  

Units purchased

     104,642       9,476       9,176       32,869       11,080  

Units redeemed

     (7,319     (1,658     (17,483     (5,250     (2,283

Units outstanding at end of year

     138,674       47,109       215,676       46,522       49,883  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      105  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP Select
Sm Cap Val,
Cl 3
    Col VP Sel
Gbl Tech,
Cl 1(2)
    Col VP Sel
Gbl Tech,
Cl 2(2)
    Col VP
Strategic Inc,
Cl 1
    Col VP
Strategic Inc,
Cl 2
 
Operations           

Investment income (loss) — net

   $ (6,025   $     $     $ 2,463     $ 3,328  

Net realized gain (loss) on sales of investments

     35,485       (265     (1,191     (433     (7,142

Distributions from capital gains

           27       1,601       3,432       5,114  

Net change in unrealized appreciation or depreciation of investments

     (221,654     (4,081     (76     (15,412     (19,542

Net increase (decrease) in net assets resulting from operations

     (192,194     (4,319     334       (9,950     (18,242
          
Contract transactions           

Contract purchase payments

     34,902       39,970       125       17,188       44,982  

Net transfers(1)

     (38,615     30,108       1,114       10,527       17,852  

Transfers for policy loans

     (521                       (52

Policy charges

     (34,896     (4,214     (59     (7,357     (71,577

Contract terminations:

          

Surrender benefits

     (16,624     (113                  

Death benefits

                              

Increase (decrease) from transactions

     (55,754     65,751       1,180       20,358       (8,795

Net assets at beginning of year

     1,261,335                   84,764       155,375  

Net assets at end of year

   $ 1,013,387     $ 61,432     $ 1,514     $ 95,172     $ 128,338  
          
Accumulation unit activity           

Units outstanding at beginning of year

     267,272                   72,700       110,112  

Units purchased

     7,545       75,949       1,703       26,292       47,967  

Units redeemed

     (20,777     (4,706     (63     (6,895     (55,290

Units outstanding at end of year

     254,040       71,243       1,640       92,097       102,789  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

 

(2) 

For the period May 2, 2022 (commencement of operations) to December 31, 2022.

See accompanying notes to financial statements.

 

106    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Col VP US
Govt Mtge,
Cl 1
    Col VP US
Govt Mtge,
Cl 2
    Col VP US
Govt Mtge,
Cl 3
    CS Commodity
Return,
Cl 1
    CTIVP AC
Div Bond,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 252     $ 193     $ 17,670     $ 73,304     $ 834  

Net realized gain (loss) on sales of investments

     (81     (33     (12,686     4,203       (141

Distributions from capital gains

                             699  

Net change in unrealized appreciation or depreciation of investments

     (1,492     (1,519     (205,136     (17,584     (4,410

Net increase (decrease) in net assets resulting from operations

     (1,321     (1,359     (200,152     59,923       (3,018
          
Contract transactions           

Contract purchase payments

     4,416       560       58,881       47,185       25,501  

Net transfers(1)

     4,433       4,406       (29,384     68,452       380  

Transfers for policy loans

                 4,446       (16,830      

Policy charges

     (1,245     (167     (70,901     (7,938     (1,604

Contract terminations:

          

Surrender benefits

     (80           (9,246     (40,135      

Death benefits

                              

Increase (decrease) from transactions

     7,524       4,799       (46,204     50,734       24,277  

Net assets at beginning of year

     6,156       6,657       1,391,378       390,816       9,021  

Net assets at end of year

   $ 12,359     $ 10,097     $ 1,145,022     $ 501,473     $ 30,280  
          
Accumulation unit activity           

Units outstanding at beginning of year

     5,520       5,366       1,027,006       491,069       7,709  

Units purchased

     8,824       4,283       51,964       114,188       24,388  

Units redeemed

     (1,263     (149     (85,774     (67,096     (1,550

Units outstanding at end of year

     13,081       9,500       993,196       538,161       30,547  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      107  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    CTIVP AC
Div Bond,
Cl 2
    CTIVP BR
Gl Infl
Prot Sec,
Cl 1
    CTIVP BR
Gl Infl
Prot Sec,
Cl 2
    CTIVP BR
Gl Infl
Prot Sec,
Cl 3
    CTIVP
CenterSquare
Real Est,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 504     $ 2,761     $ 874     $ 24,404     $ 598  

Net realized gain (loss) on sales of investments

     (26     (8,237     (78     (8,164     (116

Distributions from capital gains

     465       1,102       372       11,391       7,366  

Net change in unrealized appreciation or depreciation of investments

     (3,875     (14,429     (4,983     (152,547     (17,935

Net increase (decrease) in net assets resulting from operations

     (2,932     (18,803     (3,815     (124,916     (10,087
          
Contract transactions           

Contract purchase payments

     2,471       12,899       3,206       30,840       18,846  

Net transfers(1)

           12,057             (5,806     3,988  

Transfers for policy loans

                 (65     (2,715      

Policy charges

     (187     (1,966     (1,275     (22,823     (1,983

Contract terminations:

          

Surrender benefits

                       (26,800      

Death benefits

                              

Increase (decrease) from transactions

     2,284       22,990       1,866       (27,304     20,851  

Net assets at beginning of year

     18,148       54,068       20,899       719,905       32,713  

Net assets at end of year

   $ 17,500     $ 58,255     $ 18,950     $ 567,685     $ 43,477  
          
Accumulation unit activity           

Units outstanding at beginning of year

     13,911       44,629       15,095       436,600       21,848  

Units purchased

     2,126       15,470       2,619       21,457       18,003  

Units redeemed

     (160     (1,803     (1,084     (37,330     (1,584

Units outstanding at end of year

     15,877       58,296       16,630       420,727       38,267  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

108    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    CTIVP
CenterSquare
Real Est,
Cl 2
    CTIVP
MFS Val,
Cl 1
    CTIVP
MFS Val,
Cl 2
    CTIVP
MS Adv,
Cl 1
    CTIVP
MS Adv,
Cl 2
 
Operations           

Investment income (loss) — net

   $ 2,837     $     $     $     $  

Net realized gain (loss) on sales of investments

     (108     79       2,906       (5,603     (1,499

Distributions from capital gains

     41,953                          

Net change in unrealized appreciation or depreciation of investments

     (106,244     (2,132     (15,255     (18,473     (35,658

Net increase (decrease) in net assets resulting from operations

     (61,562     (2,053     (12,349     (24,076     (37,157
          
Contract transactions           

Contract purchase payments

     18,288       28,150       15,463       32,514       3,764  

Net transfers(1)

     (1,016     45,313       (5,617     57,068        

Transfers for policy loans

     (1,818           1,159             (1,286

Policy charges

     (7,378     (8,355     (4,531     (2,646     (4,834

Contract terminations:

          

Surrender benefits

     (486                        

Death benefits

                              

Increase (decrease) from transactions

     7,590       65,108       6,474       86,936       (2,356

Net assets at beginning of year

     251,092       64,048       196,375       30,774       90,463  

Net assets at end of year

   $ 197,120     $ 127,103     $ 190,500     $ 93,634     $ 50,950  
          
Accumulation unit activity           

Units outstanding at beginning of year

     116,421       42,525       66,881       16,377       20,706  

Units purchased

     10,134       53,410       6,116       70,268       1,270  

Units redeemed

     (5,771     (6,065     (3,714     (2,095     (2,138

Units outstanding at end of year

     120,784       89,870       69,283       84,550       19,838  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      109  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    CTIVP
Prin Blue
Chip Gro,
Cl 1
    CTIVP
Prin Blue
Chip Gro,
Cl 2
    CTIVP
T Rowe Price
LgCap Val,
Cl 1
    CTIVP
T Rowe Price
LgCap Val,
Cl 2
    CTIVP
TCW Core
Plus Bond,
Cl 1
 
Operations           

Investment income (loss) — net

   $     $     $     $     $ 653  

Net realized gain (loss) on sales of investments

     (3,429     2,775       823       82       (921

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (20,456     (24,860     (5,772     (5,179     (8,370

Net increase (decrease) in net assets resulting from operations

     (23,885     (22,085     (4,949     (5,097     (8,638
          
Contract transactions           

Contract purchase payments

     31,080       8,204       28,070       7,369       8,265  

Net transfers(1)

     912       (7,230     132       15,140       8,931  

Transfers for policy loans

                              

Policy charges

     (5,247     (3,605     (11,370     (862     (3,847

Contract terminations:

          

Surrender benefits

                              

Death benefits

                              

Increase (decrease) from transactions

     26,745       (2,631     16,832       21,647       13,349  

Net assets at beginning of year

     69,775       78,637       103,310       97,873       53,461  

Net assets at end of year

   $ 72,635     $ 53,921     $ 115,193     $ 114,423     $ 58,172  
          
Accumulation unit activity           

Units outstanding at beginning of year

     38,000       17,978       70,254       40,261       46,222  

Units purchased

     20,560       2,442       20,302       9,744       16,074  

Units redeemed

     (3,615     (3,253     (8,136     (373     (3,687

Units outstanding at end of year

     54,945       17,167       82,420       49,632       58,609  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

110    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    CTIVP
TCW Core
Plus Bond,
Cl 2
    CTIVP Vty
Sycamore
Estb Val,
Cl 1
    CTIVP Vty
Sycamore
Estb Val,
Cl 2
    CTIVP Vty
Sycamore
Estb Val,
Cl 3
    CTIVP
Westfield
Mid Cap Gro,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 192     $     $     $ (6,389   $  

Net realized gain (loss) on sales of investments

     (345     178       6,309       51,474       (76

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (3,411     (1,589     (19,382     (94,699     (6,267

Net increase (decrease) in net assets resulting from operations

     (3,564     (1,411     (13,073     (49,614     (6,343
          
Contract transactions           

Contract purchase payments

     1,874       151,751       42,491       25,635       5,003  

Net transfers(1)

           82,490       (15,483     (48,800     39,268  

Transfers for policy loans

     (2,398           345       (10,011      

Policy charges

     (827     (14,012     (12,794     (18,004     (2,036

Contract terminations:

          

Surrender benefits

                       (31,690      

Death benefits

                              

Increase (decrease) from transactions

     (1,351     220,229       14,559       (82,870     42,235  

Net assets at beginning of year

     25,994       146,027       445,851       1,267,483       14,481  

Net assets at end of year

   $ 21,079     $ 364,845     $ 447,337     $ 1,134,999     $ 50,373  
          
Accumulation unit activity           

Units outstanding at beginning of year

     20,770       90,704       128,161       273,332       8,065  

Units purchased

     1,644       151,485       12,902       8,873       31,060  

Units redeemed

     (2,759     (9,151     (8,497     (25,871     (1,419

Units outstanding at end of year

     19,655       233,038       132,566       256,334       37,706  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      111  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    CTIVP
Westfield
Mid Cap Gro,
Cl 2
    Del Ivy
VIP Asset
Strategy,
Cl II
    DWS
Alt Asset
Alloc VIP,
Cl A
   

DWS

Alt Asset

Alloc VIP,

Cl B

    EV VT
Floating-Rate Inc,
Init Cl
 
Operations           

Investment income (loss) — net

   $     $ 768     $ 191     $ 17,172     $ 52,413  

Net realized gain (loss) on sales of investments

     1,574       (427     (16     1,659       (6,238

Distributions from capital gains

           5,244       3       255        

Net change in unrealized appreciation or depreciation of investments

     (21,691     (16,877     (452     (39,920     (89,800

Net increase (decrease) in net assets resulting from operations

     (20,117     (11,292     (274     (20,834     (43,625
          
Contract transactions           

Contract purchase payments

     2,821       2,896       6,736       23,308       27,354  

Net transfers(1)

     (8,398     8       4,706       1,321       147,018  

Transfers for policy loans

                       (187     (11,377

Policy charges

     (494     (1,855     (1,046     (10,146     (28,689

Contract terminations:

          

Surrender benefits

           (1,116           (7,051     (41,859

Death benefits

                              

Increase (decrease) from transactions

     (6,071     (67     10,396       7,245       92,447  

Net assets at beginning of year

     81,469       74,262       1,902       265,417       1,252,514  

Net assets at end of year

   $ 55,281     $ 62,903     $ 12,024     $ 251,828     $ 1,301,336  
          
Accumulation unit activity           

Units outstanding at beginning of year

     23,462       50,503       1,491       201,750       827,165  

Units purchased

     1,017       2,098       9,557       21,059       117,796  

Units redeemed

     (3,028     (2,422     (871     (15,782     (55,944

Units outstanding at end of year

     21,451       50,179       10,177       207,027       889,017  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

112    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Fid VIP
Contrafund,
Init Cl
    Fid VIP
Contrafund,
Serv Cl 2
    Fid VIP
Gro & Inc,
Serv Cl
    Fid VIP
Gro & Inc,
Serv Cl 2
    Fid VIP
Mid Cap,
Init Cl
 
Operations           

Investment income (loss) — net

   $ 2,221     $ (13,362   $ 41,913     $ 22,053     $ 1,620  

Net realized gain (loss) on sales of investments

     (1,557     83,516       116,228       18,484       (878

Distributions from capital gains

     18,746       261,682       90,843       41,608       17,190  

Net change in unrealized appreciation or depreciation of investments

     (105,080     (2,125,935     (530,756     (196,208     (43,231

Net increase (decrease) in net assets resulting from operations

     (85,670     (1,794,099     (281,772     (114,063     (25,299
          
Contract transactions           

Contract purchase payments

     137,071       150,866       136,082       50,948       144,173  

Net transfers(1)

     83,100       (2,754     (113,016     4,605       34,643  

Transfers for policy loans

           (30,061     (31,494     (2,522      

Policy charges

     (20,052     (103,823     (176,611     (47,646     (15,565

Contract terminations:

          

Surrender benefits

           (193,478     (109,159     (10,442      

Death benefits

                              

Increase (decrease) from transactions

     200,119       (179,250     (294,198     (5,057     163,251  

Net assets at beginning of year

     294,524       6,735,557       4,960,644       2,111,841       189,166  

Net assets at end of year

   $ 408,973     $ 4,762,208     $ 4,384,674     $ 1,992,721     $ 327,118  
          
Accumulation unit activity           

Units outstanding at beginning of year

     151,193       1,513,591       1,114,009       875,671       119,370  

Units purchased

     146,861       64,805       33,413       31,694       134,185  

Units redeemed

     (13,140     (128,518     (112,237     (32,540     (11,438

Units outstanding at end of year

     284,914       1,449,878       1,035,185       874,825       242,117  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      113  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Fid VIP
Mid Cap,
Serv Cl
    Fid VIP
Mid Cap,
Serv Cl 2
    Fid VIP
Overseas,
Serv Cl
    Fid VIP
Overseas,
Serv Cl 2
    Fid VIP
Strategic Inc,
Init Cl
 
Operations           

Investment income (loss) —net

   $ (16,260   $ (5,848   $ 3,627     $ 4,698     $ 7,114  

Net realized gain (loss) on sales of investments

     35,228       (2,234     17,966       2,819       (1,079

Distributions from capital gains

     380,629       365,191       13,015       9,478       113  

Net change in unrealized appreciation or depreciation of investments

     (1,450,097     (1,307,703     (492,102     (343,134     (21,870

Net increase (decrease) in net assets resulting from operations

     (1,050,500     (950,594     (457,494     (326,139     (15,722
          
Contract transactions           

Contract purchase payments

     139,159       174,216       53,683       37,598       61,819  

Net transfers(1)

     (119,939     (74,912     10,937       (6,183     37,360  

Transfers for policy loans

     13,162       (30,765     (232     2,498        

Policy charges

     (209,007     (120,158     (44,099     (18,062     (10,840

Contract terminations:

          

Surrender benefits

     (208,592     (142,409     (94,537     (18,066      

Death benefits

     (15,707                        

Increase (decrease) from transactions

     (400,924     (194,028     (74,248     (2,215     88,339  

Net assets at beginning of year

     6,880,194       6,270,658       1,832,955       1,311,974       115,276  

Net assets at end of year

   $ 5,428,770     $ 5,126,036     $ 1,301,213     $ 983,620     $ 187,893  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,133,757       2,636,116       643,817       682,139       97,109  

Units purchased

     29,488       89,500       32,085       27,201       91,330  

Units redeemed

     (101,436     (179,865     (70,578     (27,235     (10,078

Units outstanding at end of year

     1,061,809       2,545,751       605,324       682,105       178,361  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

114    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Fid VIP
Strategic Inc,
Serv Cl 2
    Frank Global
Real Est,
Cl 2
    Frank
Inc,
Cl 1
    Frank
Inc,
Cl 2
    Frank Mutual
Shares,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 688     $ 41,841     $ 135     $ 16,149     $ 392  

Net realized gain (loss) on sales of investments

     (1,716     (14,921     (22     1,155       (371

Distributions from capital gains

     37       159,203       52       7,391       1,989  

Net change in unrealized appreciation or depreciation of investments

     (3,325     (896,597     (240     (47,937     (2,714

Net increase (decrease) in net assets resulting from operations

     (4,316     (710,474     (75     (23,242     (704
          
Contract transactions           

Contract purchase payments

     6,527       91,431       4,049       12,105       4,749  

Net transfers(1)

     (16,951     (30,492     3,768       36,204       (47

Transfers for policy loans

     (2,300     (3,590           128        

Policy charges

     (2,033     (79,045     (1,225     (10,842     (1,160

Contract terminations:

          

Surrender benefits

           (54,792           (475      

Death benefits

                              

Increase (decrease) from transactions

     (14,757     (76,488     6,592       37,120       3,542  

Net assets at beginning of year

     38,216       2,744,073       2,835       361,457       15,072  

Net assets at end of year

   $ 19,143     $ 1,957,111     $ 9,352     $ 375,335     $ 17,910  
          
Accumulation unit activity           

Units outstanding at beginning of year

     26,864       939,698       2,152       253,571       11,921  

Units purchased

     4,955       72,080       6,536       60,549       4,334  

Units redeemed

     (16,610     (91,624     (1,010     (30,308     (998

Units outstanding at end of year

     15,209       920,154       7,678       283,812       15,257  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      115  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Frank Mutual
Shares,
Cl 2
    Frank
Sm Cap Val,
Cl 1
   

Frank Sm

Cap Val,

Cl 2

    GS VIT
Mid Cap Val,
Inst
    GS VIT
Multi-Strategy Alt,
Advisor
 
Operations           

Investment income (loss) — net

   $ 23,858     $ 904     $ 13,301     $ 8,692     $ 1,174  

Net realized gain (loss) on sales of investments

     (6,265     20       (43,728     39,735       (95

Distributions from capital gains

     189,913       12,984       505,220       906,937        

Net change in unrealized appreciation or depreciation of investments

     (350,309     (20,123     (799,467     (1,692,945     (4,315

Net increase (decrease) in net assets resulting from operations

     (142,803     (6,215     (324,674     (737,581     (3,236
          
Contract transactions           

Contract purchase payments

     69,007       37,301       79,498       170,109       1,613  

Net transfers(1)

     (37,912     37,692       (149,194     (195,032     (2

Transfers for policy loans

     (6,947           41,493       (17,719     (8

Policy charges

     (33,463     (8,120     (71,107     (163,863     (358

Contract terminations:

          

Surrender benefits

     (36,245           (53,907     (138,821      

Death benefits

                              

Increase (decrease) from transactions

     (45,560     66,873       (153,217     (345,326     1,245  

Net assets at beginning of year

     1,850,041       47,490       3,092,100       6,992,695       44,108  

Net assets at end of year

   $ 1,661,678     $ 108,148     $ 2,614,209     $ 5,909,788     $ 42,117  
          
Accumulation unit activity           

Units outstanding at beginning of year

     690,270       32,647       692,152       1,439,545       41,432  

Units purchased

     40,052       56,025       33,432       44,363       1,950  

Units redeemed

     (50,856     (6,233     (64,650     (102,559     (728

Units outstanding at end of year

     679,466       82,439       660,934       1,381,349       42,654  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

116    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    GS VIT Sm Cap
Eq Insights,
Inst
    GS VIT U.S.
Eq Insights,
Inst
    Invesco VI
Am Fran,
Ser I
    Invesco VI
Am Fran,
Ser II
    Invesco VI
Bal Risk Alloc,
Ser I
 
Operations           

Investment income (loss) — net

   $ (1,727   $ 8,215     $ (3,724   $ (3,785   $ 1,552  

Net realized gain (loss) on sales of investments

     (5,900     (7,338     5,081       (54,902     (18

Distributions from capital gains

     5,359       14,217       154,457       287,700       723  

Net change in unrealized appreciation or depreciation of investments

     (117,234     (660,475     (395,211     (565,472     (5,152

Net increase (decrease) in net assets resulting from operations

     (119,502     (645,381     (239,397     (336,459     (2,895
          
Contract transactions           

Contract purchase payments

     14,568       76,882       8,815       27,200       5,250  

Net transfers(1)

     (4,708     (53,546     (2,145     24       672  

Transfers for policy loans

     (974     6,932       1,730       (110      

Policy charges

     (14,203     (61,678     (22,824     (14,506     (1,901

Contract terminations:

          

Surrender benefits

     (1,477     (99,521     (21,515     (455      

Death benefits

     (9,013                        

Increase (decrease) from transactions

     (15,807     (130,931     (35,939     12,153       4,021  

Net assets at beginning of year

     601,946       3,232,319       776,977       1,053,111       18,639  

Net assets at end of year

   $ 466,637     $ 2,456,007     $ 501,641     $ 728,805     $ 19,765  
          
Accumulation unit activity           

Units outstanding at beginning of year

     114,245       631,750       194,247       305,588       14,305  

Units purchased

     3,372       17,647       3,721       10,344       5,003  

Units redeemed

     (6,598     (55,270     (14,761     (6,955     (1,597

Units outstanding at end of year

     111,019       594,127       183,207       308,977       17,711  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      117  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Invesco VI
Bal Risk Alloc,
Ser II
    Invesco VI
Comstock,
Ser II
    Invesco VI
Core Eq,
Ser I
    Invesco VI
Dis Mid Cap Gro,
Ser I
    Invesco VI
Div Divd,
Ser I
 
Operations           

Investment income (loss) — net

   $ 19,394     $ 2,653     $ 6,514     $ (4,502   $ 15,675  

Net realized gain (loss) on sales of investments

     (3,980     10,271       49,172       (2,421     38,202  

Distributions from capital gains

     10,043       12,474       1,509,422       214,183       138,223  

Net change in unrealized appreciation or depreciation of investments

     (72,112     (26,491     (4,048,796     (564,226     (208,936

Net increase (decrease) in net assets resulting from operations

     (46,655     (1,093     (2,483,688     (356,966     (16,836
          
Contract transactions           

Contract purchase payments

     8,349       7,970       302,372       33,252       18,516  

Net transfers(1)

     (16,083     (37,071     (64,524     8,740       74,190  

Transfers for policy loans

     (12,569     (590     11,312       (1,305     (6,759

Policy charges

     (2,002     (6,413     (406,410     (18,544     (17,188

Contract terminations:

          

Surrender benefits

     (219     (4,033     (357,912     (124,680     (121,593

Death benefits

                 (2,839            

Increase (decrease) from transactions

     (22,524     (40,137     (518,001     (102,537     (52,834

Net assets at beginning of year

     322,455       441,140       11,887,517       1,157,275       1,170,855  

Net assets at end of year

   $ 253,276     $ 399,910     $ 8,885,828     $ 697,772     $ 1,101,185  
          
Accumulation unit activity           

Units outstanding at beginning of year

     218,539       134,548       2,247,588       646,889       473,428  

Units purchased

     21,823       2,116       69,849       32,686       49,535  

Units redeemed

     (38,569     (12,857     (184,207     (111,509     (78,993

Units outstanding at end of year

     201,793       123,807       2,133,230       568,066       443,970  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

118    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Invesco VI
EQV Intl Eq,
Ser II
    Invesco VI
Global,
Ser I
    Invesco VI
Global,
Ser II
    Invesco VI
Gbl Strat Inc,
Ser I
    Invesco VI
Gbl Strat Inc,
Ser II
 
Operations           

Investment income (loss) — net

   $ 9,322     $     $ (7,003   $     $ (7,721

Net realized gain (loss) on sales of investments

     (4,649     (2,385     (27,185     (103     (34,302

Distributions from capital gains

     116,273       25,306       280,106              

Net change in unrealized appreciation or depreciation of investments

     (358,761     (59,573     (947,737     (731     (171,810

Net increase (decrease) in net assets resulting from operations

     (237,815     (36,652     (701,819     (834     (213,833
          
Contract transactions           

Contract purchase payments

     35,052       85,279       93,202       11,326       59,917  

Net transfers(1)

     5,941       69,923       (101,958     3,559       (13,499

Transfers for policy loans

     (2,662           (9,732           14,187  

Policy charges

     (22,386     (13,059     (31,663     (2,280     (44,448

Contract terminations:

          

Surrender benefits

     (33,679           (58,237           (40,972

Death benefits

     (7,586                        

Increase (decrease) from transactions

     (25,320     142,143       (108,388     12,605       (24,815

Net assets at beginning of year

     1,252,508       79,902       2,194,545       5,112       1,771,659  

Net assets at end of year

   $ 989,373     $ 185,393     $ 1,384,338     $ 16,883     $ 1,533,011  
          
Accumulation unit activity           

Units outstanding at beginning of year

     520,535       46,965       549,737       4,828       1,155,435  

Units purchased

     20,152       123,390       43,896       15,615       58,096  

Units redeemed

     (39,526     (10,656     (73,875     (2,435     (73,350

Units outstanding at end of year

     501,161       159,699       519,758       18,008       1,140,181  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      119  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Invesco VI
Mn St Sm Cap,
Ser I
    Invesco VI
Mn St Sm Cap,
Ser II
    Invesco VI
Tech,
Ser I
    Invesco VI
Tech,
Ser II(2)
    Janus
Henderson
VIT Bal,
Inst
 
Operations           

Investment income (loss) — net

   $ 905     $ (1,712   $ (5,231   $     $ 6,731  

Net realized gain (loss) on sales of investments

     (446     12,654       258             (172

Distributions from capital gains

     19,643       198,802       357,118       48       16,095  

Net change in unrealized appreciation or depreciation of investments

     (43,596     (519,578     (873,743     (76     (115,553

Net increase (decrease) in net assets resulting from operations

     (23,494     (309,834     (521,598     (28     (92,899
          
Contract transactions           

Contract purchase payments

     43,486       64,280       60,279       125       69,423  

Net transfers(1)

     34,641       (17,248     (42,920           33,209  

Transfers for policy loans

           2,639       (10,881            

Policy charges

     (7,640     (30,286     (28,638           (14,012

Contract terminations:

          

Surrender benefits

           (54,808     (17,729            

Death benefits

                              

Increase (decrease) from transactions

     70,487       (35,423     (39,889     125       88,620  

Net assets at beginning of year

     130,400       1,905,775       1,343,256             543,918  

Net assets at end of year

   $ 177,393     $ 1,560,518     $ 781,769     $ 97     $ 539,639  
          
Accumulation unit activity           

Units outstanding at beginning of year

     82,456       508,370       185,085             354,538  

Units purchased

     56,392       33,699       56,331             76,868  

Units redeemed

     (5,575     (51,699     (34,168           (10,648

Units outstanding at end of year

     133,273       490,370       207,248             420,758  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

 

(2) 

For the period May 2, 2022 (commencement of operations) to December 31, 2022.

See accompanying notes to financial statements.

 

120    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Janus
Henderson
VIT Bal,
Serv
    Janus
Henderson
VIT Enter,
Serv
    Janus
Henderson
VIT Flex Bd,
Inst
    Janus
Henderson
VIT Flex Bd,
Serv
    Janus Hend
VIT Gbl Tech
Innov,
Srv
 
Operations           

Investment income (loss) — net

   $ 701     $ (3,322   $ 948     $ 161     $ (10,283

Net realized gain (loss) on sales of investments

     34       12,021       (55     (38     27,709  

Distributions from capital gains

     1,832       131,389       717       133       356,777  

Net change in unrealized appreciation or depreciation of investments

     (13,725     (284,537     (2,536     (1,423     (1,404,604

Net increase (decrease) in net assets resulting from operations

     (11,158     (144,449     (926     (1,167     (1,030,401
          
Contract transactions           

Contract purchase payments

     5,880       15,326       28,769       1,500       61,539  

Net transfers(1)

     19,405       (11,555     5,759             (92,167

Transfers for policy loans

     (140     (153                 (39,691

Policy charges

     (500     (14,656     (1,228     (308     (40,275

Contract terminations:

          

Surrender benefits

           (23,997     (78           (58,223

Death benefits

                              

Increase (decrease) from transactions

     24,645       (35,035     33,222       1,192       (168,817

Net assets at beginning of year

     61,349       889,547       3,817       8,121       2,811,117  

Net assets at end of year

   $ 74,836     $ 710,063     $ 36,113     $ 8,146     $ 1,611,899  
          
Accumulation unit activity           

Units outstanding at beginning of year

     37,748       129,330       3,149       6,201       359,401  

Units purchased

     17,948       3,695       33,358       1,285       10,031  

Units redeemed

     (454     (10,311     (1,176     (262     (43,778

Units outstanding at end of year

     55,242       122,714       35,331       7,224       325,654  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      121  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Janus
Henderson
VIT Overseas,
Serv
    Janus
Henderson
VIT Res,
Inst
    Janus
Henderson
VIT Res,
Serv
    Lazard Ret
Global Dyn MA,
Inv
    Lazard Ret
Global Dyn MA,
Serv
 
Operations           

Investment income (loss) — net

   $ 19,530     $ 55     $ (3,008   $ 6     $ (111

Net realized gain (loss) on sales of investments

     11,260       (15     3,382       (61     (887

Distributions from capital gains

           1,002       100,014       150       1,247  

Net change in unrealized appreciation or depreciation of investments

     (220,842     (4,148     (309,908     (478     (5,593

Net increase (decrease) in net assets resulting from operations

     (190,052     (3,106     (209,520     (383     (5,344
          
Contract transactions           

Contract purchase payments

     68,156       1,128       23,425       2,036       442  

Net transfers(1)

     (53,742     29,081       (4,750     71       (7,574

Transfers for policy loans

     18,663             (4,921           9  

Policy charges

     (57,813     (295     (13,334     (1,049     (797

Contract terminations:

          

Surrender benefits

     (64,628     (250     (33,762            

Death benefits

                              

Increase (decrease) from transactions

     (89,364     29,664       (33,342     1,058       (7,920

Net assets at beginning of year

     2,015,111       4,464       697,247       1,716       29,631  

Net assets at end of year

   $ 1,735,695     $ 31,022     $ 454,385     $ 2,391     $ 16,367  
          
Accumulation unit activity           

Units outstanding at beginning of year

     814,236       2,195       142,605       1,312       19,862  

Units purchased

     40,205       21,246       16,392       1,943       462  

Units redeemed

     (80,591     (199     (29,450     (994     (7,210

Units outstanding at end of year

     773,850       23,242       129,547       2,261       13,114  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

122    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    MFS Mass
Inv Gro Stock,
Serv Cl
    MFS
New Dis,
Serv Cl
    MFS
Utilities,
Init Cl
    MFS
Utilities,
Serv Cl
    MS
VIF Dis,
Cl I
 
Operations           

Investment income (loss) — net

   $ (16,552   $ (9,994   $ 948     $ 19,567     $  

Net realized gain (loss) on sales of investments

     26,865       (70,877     (1     19,899       (16,175

Distributions from capital gains

     395,775       715,690       1,503       43,890       47,859  

Net change in unrealized appreciation or depreciation of investments

     (1,101,837     (1,458,271     (2,177     (83,268     (131,322

Net increase (decrease) in net assets resulting from operations

     (695,749     (823,452     273       88       (99,638
          
Contract transactions           

Contract purchase payments

     59,308       56,640       12,021       56,690       88,014  

Net transfers(1)

     (96,206     16,628       8,937       7,232       73,133  

Transfers for policy loans

     (59,945     (8,501           7,145        

Policy charges

     (73,371     (50,350     (2,050     (50,563     (13,626

Contract terminations:

          

Surrender benefits

     (85,334     (98,049           (53,002      

Death benefits

                              

Increase (decrease) from transactions

     (255,548     (83,632     18,908       (32,498     147,521  

Net assets at beginning of year

     3,574,486       2,729,441       32,127       1,162,702       79,267  

Net assets at end of year

   $ 2,623,189     $ 1,822,357     $ 51,308     $ 1,130,292     $ 127,150  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,293,229       472,878       23,163       328,419       31,098  

Units purchased

     25,472       15,617       15,047       28,615       114,339  

Units redeemed

     (135,021     (40,358     (1,495     (33,200     (10,753

Units outstanding at end of year

     1,183,680       448,137       36,715       323,834       134,684  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      123  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    MS
VIF Dis,
Cl II
    MS VIF
Global Real Est,
Cl II
    NB AMT
Sus Eq,
Cl I
    NB AMT
Sus Eq,
Cl S
    NB AMT
US Eq Index
PW Strat,
Cl S
 
Operations           

Investment income (loss) — net

   $ (4,098   $ 13,477     $ 47     $ 46     $ (69

Net realized gain (loss) on sales of investments

     (235,676     (3,527     (11     (44     (71

Distributions from capital gains

     356,418       13,444       1,002       3,493       5,047  

Net change in unrealized appreciation or depreciation of investments

     (1,052,231     (130,148     (2,366     (9,969     (8,551

Net increase (decrease) in net assets resulting from operations

     (935,587     (106,754     (1,328     (6,474     (3,644
          
Contract transactions           

Contract purchase payments

     80,384       13,147       8,517       1,380       2,223  

Net transfers(1)

     (56,908     9,243       3,015       17,236       (292

Transfers for policy loans

     (29,863     (4,949                  

Policy charges

     (26,962     (9,073     (761     (1,073     (1,299

Contract terminations:

          

Surrender benefits

     (21,432     (1,621     (154            

Death benefits

                              

Increase (decrease) from transactions

     (54,781     6,747       10,617       17,543       632  

Net assets at beginning of year

     1,519,139       399,841       4,605       23,902       31,323  

Net assets at end of year

   $ 528,771     $ 299,834     $ 13,894     $ 34,971     $ 28,311  
          
Accumulation unit activity           

Units outstanding at beginning of year

     183,414       217,340       2,667       7,113       23,115  

Units purchased

     22,039       12,573       8,108       6,056       1,763  

Units redeemed

     (42,416     (9,916     (536     (377     (1,306

Units outstanding at end of year

     163,037       219,997       10,239       12,792       23,572  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

124    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    PIMCO
VIT All Asset,
Advisor Cl
    PIMCO
VIT All Asset,
Inst Cl
    PIMCO VIT Glb
Man As Alloc,
Adv Cl
    PIMCO VIT
Tot Return,
Advisor Cl
    PIMCO VIT
Tot Return,
Inst Cl
 
Operations           

Investment income (loss) — net

   $ 48,155     $ 540     $ 108     $ 7,454     $ 1,620  

Net realized gain (loss) on sales of investments

     (13,468     (353     (81     (3,274     (347

Distributions from capital gains

     56,621       450       1,011              

Net change in unrealized appreciation or depreciation of investments

     (188,588     (1,356     (2,266     (67,035     (8,407

Net increase (decrease) in net assets resulting from operations

     (97,280     (719     (1,228     (62,855     (7,134
          
Contract transactions           

Contract purchase payments

     31,879       6,534       48       1,975       37,756  

Net transfers(1)

     (43,290                 20,753       1,123  

Transfers for policy loans

     (1,723                 (7      

Policy charges

     (22,075     (2,735     (355     (4,180     (5,760

Contract terminations:

          

Surrender benefits

     (76,023                        

Death benefits

                              

Increase (decrease) from transactions

     (111,232     3,799       (307     18,541       33,119  

Net assets at beginning of year

     819,579       5,537       6,735       426,192       40,663  

Net assets at end of year

   $ 611,067     $ 8,617     $ 5,200     $ 381,878     $ 66,648  
          
Accumulation unit activity           

Units outstanding at beginning of year

     384,272       4,124       4,051       349,024       35,397  

Units purchased

     18,819       5,366       35       23,740       37,798  

Units redeemed

     (77,984     (2,225     (253     (5,683     (5,600

Units outstanding at end of year

     325,107       7,265       3,833       367,081       67,595  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      125  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Put VT Global
Hlth Care,
Cl IA(2)
    Put VT Global
Hlth Care,
Cl IB
    Put VT
Hi Yield,
Cl IB
    Put VT
Intl Eq,
Cl IB
    Put VT
Sus Leaders,
Cl IA
 
Operations           

Investment income (loss) — net

   $     $ (1,618   $ 13,443     $ 1,453     $ (2,316

Net realized gain (loss) on sales of investments

     5       2,310       (13,173     (280     127,704  

Distributions from capital gains

           118,885       585       15,337       1,712,527  

Net change in unrealized appreciation or depreciation of investments

     946       (195,439     (40,570     (41,668     (5,204,644

Net increase (decrease) in net assets resulting from operations

     951       (75,862     (39,715     (25,158     (3,366,729
          
Contract transactions           

Contract purchase payments

     11,978       39,398       11,415       3,521       236,312  

Net transfers(1)

     600       (7,331     (35,877     429       (72,888

Transfers for policy loans

           (10,953     (252     (374     (39,413

Policy charges

     (114     (26,062     (14,742     (3,164     (364,726

Contract terminations:

          

Surrender benefits

           (8,663     (14,262     (1,758     (443,497

Death benefits

                             (1,723

Increase (decrease) from transactions

     12,464       (13,611     (53,718     (1,346     (685,935

Net assets at beginning of year

           1,438,918       327,901       166,769       14,622,728  

Net assets at end of year

   $ 13,415     $ 1,349,445     $ 234,468     $ 140,265     $ 10,570,064  
          
Accumulation unit activity           

Units outstanding at beginning of year

           297,874       108,147       73,282       2,067,035  

Units purchased

     13,123       44,543       4,180       2,332       41,097  

Units redeemed

     (113     (18,930     (23,991     (2,824     (157,875

Units outstanding at end of year

     13,010       323,487       88,336       72,790       1,950,257  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

 

(2) 

For the period May 2, 2022 (commencement of operations) to December 31, 2022.

See accompanying notes to financial statements.

 

126    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    Put VT
Sus Leaders,
Cl IB
    Royce
Micro-Cap,
Invest Cl
    Temp
Global Bond,
Cl 1
    Temp
Global Bond,
Cl 2
    Third Ave
VST Third
Ave Value
 
Operations           

Investment income (loss) — net

   $ 99     $ (12,929   $     $ (789   $ 17,373  

Net realized gain (loss) on sales of investments

     469       13,462             (4,286     50,874  

Distributions from capital gains

     15,987       567,112                    

Net change in unrealized appreciation or depreciation of investments

     (46,724     (1,113,987     (1,036     (4,875     232,579  

Net increase (decrease) in net assets resulting from operations

     (30,169     (546,342     (1,036     (9,950     300,826  
          
Contract transactions           

Contract purchase payments

     2,020       95,119       4,338       11,891       78,894  

Net transfers(1)

     (2,294     (36,085           (4,290     45,584  

Transfers for policy loans

     (98     (2,293           275       10,642  

Policy charges

     (2,422     (82,471     (1,264     (4,618     (75,066

Contract terminations:

          

Surrender benefits

           (107,538           (3,649     (133,572

Death benefits

                              

Increase (decrease) from transactions

     (2,794     (133,268     3,074       (391     (73,518

Net assets at beginning of year

     131,448       2,399,174       20,309       186,822       1,981,155  

Net assets at end of year

   $ 98,485     $ 1,719,564     $ 22,347     $ 176,481     $ 2,208,463  
          
Accumulation unit activity           

Units outstanding at beginning of year

     23,942       479,589       22,626       206,020       721,009  

Units purchased

     400       23,501       5,020       13,933       74,305  

Units redeemed

     (1,068     (56,123     (1,482     (15,060     (94,279

Units outstanding at end of year

     23,274       446,967       26,164       204,893       701,035  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      127  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VanEck VIP
Global Gold,
Cl S
    VP
Aggr,
Cl 1
    VP
Aggr,
Cl 2
    VP
Aggr,
Cl 4
    VP
Conserv,
Cl 1
 
Operations           

Investment income (loss) — net

   $ (521   $     $ (56,782   $ (109,758   $  

Net realized gain (loss) on sales of investments

     (913     1,968       738,203       471,588        

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (18,777     (95,339     (5,419,334     (5,264,696     (3

Net increase (decrease) in net assets resulting from operations

     (20,211     (93,371     (4,737,913     (4,902,866     (3
          
Contract transactions           

Contract purchase payments

     5,666       273,422       855,144       1,269,244        

Net transfers(1)

     11,514       169,144       271,386       (308,031      

Transfers for policy loans

     (12,178           (105,470     37,080        

Policy charges

     (1,947     (68,728     (411,071     (419,053      

Contract terminations:

          

Surrender benefits

     (144           (256,029     (814,514      

Death benefits

                              

Increase (decrease) from transactions

     2,911       373,838       353,960       (235,274      

Net assets at beginning of year

     144,570       400,254       25,282,740       26,364,766       24  

Net assets at end of year

   $ 127,270     $ 680,721     $ 20,898,787     $ 21,226,626     $ 21  
          
Accumulation unit activity           

Units outstanding at beginning of year

     110,005       269,416       10,581,476       10,513,174        

Units purchased

     16,308       343,645       819,977       588,476        

Units redeemed

     (13,833     (54,344     (654,172     (742,253      

Units outstanding at end of year

     112,480       558,717       10,747,281       10,359,397        

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

128    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP
Conserv,
Cl 2
    VP
Conserv,
Cl 4
    VP Man
Vol Conserv,
Cl 1
    VP Man
Vol Conserv,
Cl 2
    VP Man
Vol Conserv Gro,
Cl 1
 
Operations           

Investment income (loss) — net

   $ (3,021   $ (3,255   $     $ (741   $  

Net realized gain (loss) on sales of investments

     15,838       15,623             (1,477     (139

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (116,245     (103,459     (4     (20,769     (10,142

Net increase (decrease) in net assets resulting from operations

     (103,428     (91,091     (4     (22,987     (10,281
          
Contract transactions           

Contract purchase payments

     49,208       32,328                    

Net transfers(1)

     61,748       (41,593                 1,206  

Transfers for policy loans

     (32,371     624                    

Policy charges

     (37,741     (42,850           (2,544     (1,004

Contract terminations:

          

Surrender benefits

     (20,202                 (26,905      

Death benefits

                              

Increase (decrease) from transactions

     20,642       (51,491           (29,449     202  

Net assets at beginning of year

     633,215       595,713       24       142,734       60,497  

Net assets at end of year

   $ 550,429     $ 453,131     $ 20     $ 90,298     $ 50,418  
          
Accumulation unit activity           

Units outstanding at beginning of year

     416,554       383,645             110,766       48,032  

Units purchased

     141,199       66,323                   1,045  

Units redeemed

     (121,747     (106,323           (26,517     (918

Units outstanding at end of year

     436,006       343,645             84,249       48,159  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      129  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP Man
Vol Conserv Gro,
Cl 2
    VP Man
Vol Gro,
Cl 1
    VP Man
Vol Gro,
Cl 2
    VP Man
Vol Mod Gro,
Cl 1
    VP Man
Vol Mod Gro,
Cl 2
 
Operations           

Investment income (loss) — net

   $ (830   $     $ (6,116   $     $ (5,989

Net realized gain (loss) on sales of investments

     98       (1,817     2,173       (1,597     21,939  

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (29,840     (87,722     (468,723     (16,482     (403,350

Net increase (decrease) in net assets resulting from operations

     (30,572     (89,539     (472,666     (18,079     (387,400
          
Contract transactions           

Contract purchase payments

     1,119       137,182       49,231       44,484       63,991  

Net transfers(1)

     (4,113     39,122       75,851       55,314       (90,416

Transfers for policy loans

     (627           (511           (3,279

Policy charges

     (7,078     (46,792     (22,299     (27,563     (71,036

Contract terminations:

          

Surrender benefits

                             (54,789

Death benefits

                              

Increase (decrease) from transactions

     (10,699     129,512       102,272       72,235       (155,529

Net assets at beginning of year

     175,185       428,279       2,346,144       66,797       2,147,105  

Net assets at end of year

   $ 133,914     $ 468,252     $ 1,975,750     $ 120,953     $ 1,604,176  
          
Accumulation unit activity           

Units outstanding at beginning of year

     127,474       311,895       1,487,100       50,678       1,436,041  

Units purchased

     930       150,334       88,482       85,616       61,349  

Units redeemed

     (10,022     (40,085     (17,560     (24,469     (181,911

Units outstanding at end of year

     118,382       422,144       1,558,022       111,825       1,315,479  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

130    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP
Mod,
Cl 1
    VP
Mod,
Cl 2
    VP
Mod,
Cl 4
    VP Mod
Aggr,
Cl 1
    VP Mod
Aggr,
Cl 2
 
Operations           

Investment income (loss) — net

   $     $ (133,216   $ (172,983   $     $ (152,704

Net realized gain (loss) on sales of investments

     (11,804     679,503       662,631       (13,062     874,101  

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (287,907     (5,741,201     (7,151,742     (710,759     (8,730,547

Net increase (decrease) in net assets resulting from operations

     (299,711     (5,194,914     (6,662,094     (723,821     (8,009,150
          
Contract transactions           

Contract purchase payments

     278,705       1,199,720       1,556,077       1,808,288       2,122,805  

Net transfers(1)

     537,771       33,684       (441,318     769,446       (27,750

Transfers for policy loans

           75,128       158,174       (62     938,875  

Policy charges

     (97,137     (989,249     (1,420,382     (274,024     (1,071,557

Contract terminations:

          

Surrender benefits

           (890,869     (933,256           (678,631

Death benefits

           (125,978     (36,735           (97,970

Increase (decrease) from transactions

     719,339       (697,564     (1,117,440     2,303,648       1,185,772  

Net assets at beginning of year

     1,601,625       30,374,487       39,216,880       3,643,652       44,692,831  

Net assets at end of year

   $ 2,021,253     $ 24,482,009     $ 31,437,346     $ 5,223,479     $ 37,869,453  
          
Accumulation unit activity           

Units outstanding at beginning of year

     1,185,491       15,164,209       19,360,326       2,573,072       20,137,966  

Units purchased

     687,158       1,416,874       968,416       2,117,771       2,673,510  

Units redeemed

     (82,658     (1,910,134     (1,595,985     (226,368     (1,951,036

Units outstanding at end of year

     1,789,991       14,670,949       18,732,757       4,464,475       20,860,440  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      131  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP Mod
Aggr,
Cl 4
    VP Mod
Conserv,
Cl 1
    VP Mod
Conserv,
Cl 2
    VP Mod
Conserv,
Cl 4
    VP Ptnrs
Core Bond,
Cl 1
 
Operations           

Investment income (loss) — net

   $ (274,527   $     $ (11,685   $ (14,008   $ 128  

Net realized gain (loss) on sales of investments

     1,207,874       164       24,177       50,184       (50

Distributions from capital gains

                             56  

Net change in unrealized appreciation or depreciation of investments

     (12,913,348     (60,747     (431,482     (565,601     (1,070

Net increase (decrease) in net assets resulting from operations

     (11,980,001     (60,583     (418,990     (529,425     (936
          
Contract transactions           

Contract purchase payments

     2,081,450             112,873       140,102       2,276  

Net transfers(1)

     (365,584           (219     130,743       4,433  

Transfers for policy loans

     (124,962           18,687       2,310        

Policy charges

     (1,304,301     (8,305     (171,430     (154,359     (601

Contract terminations:

          

Surrender benefits

     (2,526,002           (109,022     (90,251     (83

Death benefits

                              

Increase (decrease) from transactions

     (2,239,399     (8,305     (149,111     28,545       6,025  

Net assets at beginning of year

     67,643,323       382,828       2,569,622       3,212,941       5,492  

Net assets at end of year

   $ 53,423,923     $ 313,940     $ 2,001,521     $ 2,712,061     $ 10,581  
          
Accumulation unit activity           

Units outstanding at beginning of year

     29,528,484       299,444       1,425,217       1,831,635       4,708  

Units purchased

     1,093,833             98,092       183,213       6,504  

Units redeemed

     (2,210,603     (7,358     (199,718     (160,913     (584

Units outstanding at end of year

     28,411,714       292,086       1,323,591       1,853,935       10,628  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

132    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP Ptnrs
Core Bond,
Cl 2
    VP Ptnrs
Core Eq,
Cl 1
    VP Ptnrs
Core Eq,
Cl 2
    VP Ptnrs
Core Eq,
Cl 3
    VP Ptnrs
Intl Core Eq,
Cl 1
 
Operations           

Investment income (loss) — net

   $ 50     $     $     $ (2,059   $ 636  

Net realized gain (loss) on sales of investments

     (46                 41,258       (327

Distributions from capital gains

     26                         8,431  

Net change in unrealized appreciation or depreciation of investments

     (558     (181     (192     (125,735     (16,943

Net increase (decrease) in net assets resulting from operations

     (528     (181     (192     (86,536     (8,203
          
Contract transactions           

Contract purchase payments

     600       1,319       124       11,228       29,145  

Net transfers(1)

     283                   (15,476     17,587  

Transfers for policy loans

                       (5,375      

Policy charges

     (440     (633           (5,869     (3,302

Contract terminations:

          

Surrender benefits

                       (56,000      

Death benefits

                              

Increase (decrease) from transactions

     443       686       124       (71,492     43,430  

Net assets at beginning of year

     3,917       937       1,077       528,160       18,585  

Net assets at end of year

   $ 3,832     $ 1,442     $ 1,009     $ 370,132     $ 53,812  
          
Accumulation unit activity           

Units outstanding at beginning of year

     3,046       524       320       130,240       13,559  

Units purchased

     807       903       45       3,580       38,180  

Units redeemed

     (393     (430           (31,591     (2,964

Units outstanding at end of year

     3,460       997       365       102,229       48,775  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      133  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP Ptnrs
Intl Core Eq,
Cl 2
    VP Ptnrs
Intl Gro,
Cl 1
    VP Ptnrs
Intl Gro,
Cl 2
    VP Ptnrs
Intl Val,
Cl 1
    VP Ptnrs
Intl Val,
Cl 2
 
Operations           

Investment income (loss) — net

   $ 573     $     $     $ 247     $ 1,692  

Net realized gain (loss) on sales of investments

     (1,418     2,158       (4,788     (79     (2,349

Distributions from capital gains

     5,724       5,134       12,283              

Net change in unrealized appreciation or depreciation of investments

     (12,674     (37,605     (79,590     (625     (9,590

Net increase (decrease) in net assets resulting from operations

     (7,795     (30,313     (72,095     (457     (10,247
          
Contract transactions           

Contract purchase payments

     2,492       42,477       17,440       11,596       3,437  

Net transfers(1)

     (4,173     (8,097     (23,962     1,917       (23,161

Transfers for policy loans

     (1,461           (1,160           (2,407

Policy charges

     (1,664     (4,999     (7,337     (2,196     (1,528

Contract terminations:

          

Surrender benefits

                 (402            

Death benefits

                              

Increase (decrease) from transactions

     (4,806     29,381       (15,421     11,317       (23,659

Net assets at beginning of year

     40,011       122,355       268,034       10,248       89,961  

Net assets at end of year

   $ 27,410     $ 121,423     $ 180,518     $ 21,108     $ 56,055  
          
Accumulation unit activity           

Units outstanding at beginning of year

     23,312       78,714       134,375       9,090       62,150  

Units purchased

     1,773       38,074       11,535       14,291       2,652  

Units redeemed

     (5,213     (10,229     (22,153     (2,233     (20,917

Units outstanding at end of year

     19,872       106,559       123,757       21,148       43,885  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

134    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP Ptnrs
Sm Cap Gro,
Cl 1
    VP Ptnrs
Sm Cap Gro,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 1
    VP Ptnrs
Sm Cap Val,
Cl 2
    VP Ptnrs
Sm Cap Val,
Cl 3
 
Operations           

Investment income (loss) — net

   $     $     $     $     $ (3,357

Net realized gain (loss) on sales of investments

     (189     708       (32     12       21,930  

Distributions from capital gains

                              

Net change in unrealized appreciation or depreciation of investments

     (3,468     (10,289     (868     (848     (124,921

Net increase (decrease) in net assets resulting from operations

     (3,657     (9,581     (900     (836     (106,348
          
Contract transactions           

Contract purchase payments

     4,303       1,960       1,339       557       24,963  

Net transfers(1)

     36,543       (1,528     6,712             (43,914

Transfers for policy loans

                             (1,689

Policy charges

     (1,384     (688     (161     (239     (17,964

Contract terminations:

          

Surrender benefits

                 (143           (35,192

Death benefits

                              

Increase (decrease) from transactions

     39,462       (256     7,747       318       (73,796

Net assets at beginning of year

     6,828       33,766       1,428       6,314       785,325  

Net assets at end of year

   $ 42,633     $ 23,929     $ 8,275     $ 5,796     $ 605,181  
          
Accumulation unit activity           

Units outstanding at beginning of year

     4,427       12,078       961       2,767       210,015  

Units purchased

     35,682       909       6,415       275       7,671  

Units redeemed

     (1,190     (909     (137     (117     (31,037

Units outstanding at end of year

     38,919       12,078       7,239       2,925       186,649  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      135  


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    VP US
Flex Conserv Gro,
Cl 1
    VP US
Flex Gro,
Cl 1
    VP US
Flex Mod Gro,
Cl 1
    Wanger
Acorn
    Wanger
Intl
 
Operations           

Investment income (loss) — net

   $     $     $     $ (28,960   $ 16,940  

Net realized gain (loss) on sales of investments

     (1     (343           (184,097     (103,681

Distributions from capital gains

                       1,909,424       768,223  

Net change in unrealized appreciation or depreciation of investments

     (253     (10,219     (1,160     (4,220,878     (2,713,043

Net increase (decrease) in net assets resulting from operations

     (254     (10,562     (1,160     (2,524,511     (2,031,561
          
Contract transactions           

Contract purchase payments

     1,601       36,044       748       170,578       177,536  

Net transfers(1)

     1,479       53,440             39,344       29,430  

Transfers for policy loans

                       6,276       53,631  

Policy charges

     (162     (11,328     (519     (149,794     (119,836

Contract terminations:

          

Surrender benefits

                       (102,467     (77,053

Death benefits

                              

Increase (decrease) from transactions

     2,918       78,156       229       (36,063     63,708  

Net assets at beginning of year

     918       20,212       6,667       7,459,923       5,916,236  

Net assets at end of year

   $ 3,582     $ 87,806     $ 5,736     $ 4,899,349     $ 3,948,383  
          
Accumulation unit activity           

Units outstanding at beginning of year

     710       14,814       5,081       1,293,174       1,667,326  

Units purchased

     2,827       73,932       663       63,571       139,609  

Units redeemed

     (147     (9,746     (455     (61,321     (99,763

Units outstanding at end of year

     3,390       79,000       5,289       1,295,424       1,707,172  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

136    RIVERSOURCE OF NEW YORK ACCOUNT  8


Statement of Changes in Net Assets

 

Year ended December 31, 2022 (continued)    WA Var Global
Hi Yd Bond,
Cl I
    WA Var Global
Hi Yd Bond,
Cl II
 
Operations     

Investment income (loss) — net

   $ 1,133     $ 530  

Net realized gain (loss) on sales of investments

     (128     (345

Distributions from capital gains

            

Net change in unrealized appreciation or depreciation of investments

     (2,260     (1,680

Net increase (decrease) in net assets resulting from operations

     (1,255     (1,495
    
Contract transactions     

Contract purchase payments

     6,225       1,077  

Net transfers(1)

     5,950        

Transfers for policy loans

           (1,122

Policy charges

     (1,897     (632

Contract terminations:

    

Surrender benefits

            

Death benefits

            

Increase (decrease) from transactions

     10,278       (677

Net assets at beginning of year

     7,541       10,300  

Net assets at end of year

   $ 16,564     $ 8,128  
    
Accumulation unit activity     

Units outstanding at beginning of year

     6,419       7,336  

Units purchased

     11,742       862  

Units redeemed

     (1,820     (1,477

Units outstanding at end of year

     16,341       6,721  

 

(1) 

Includes transfer activity from (to) other divisions and transfers from (to) RiverSource Life of NY’s fixed account.

See accompanying notes to financial statements.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      137  


Notes to Financial Statements

1. ORGANIZATION

RiverSource of New York Account 8 (the Account) was established under New York law as a segregated asset account of RiverSource Life Insurance Co. of New York (RiverSource Life of NY). The Account is registered as a unit investment trust under the Investment Company Act of 1940, as amended (the 1940 Act) and exists in accordance with the rules and regulations of the New York State Department of Financial Services.

The Account is used as a funding vehicle for individual variable life insurance policies issued by RiverSource Life of NY. The following is a list of each variable life insurance product funded through the Account.

RiverSource Succession Select® Variable Life Insurance (Succession Select)*

RiverSource® Variable Second-To-Die Life Insurance (V2D)*

RiverSource® Variable Universal Life Insurance (VUL)*

RiverSource® Variable Universal Life Insurance III (VUL III)*

RiverSource® Variable Universal Life IV (VUL IV)*

RiverSource® Variable Universal Life IV – Estate Series (VUL IV – ES)*

RiverSource® Variable Universal Life 5 (VUL 5)*

RiverSource® Variable Universal Life 5 – Estate Series (VUL 5 – ES)*

RiverSource® Variable Universal Life 6 Insurance (VUL 6)

RiverSource® Survivorship Variable Universal Life Insurance (SVUL)

 

*

New contracts are no longer being issued for this product. As a result, an annual contract prospectus and statement of additional information are no longer distributed. An annual report for this product is distributed to all current contract holders.

The Account is comprised of various divisions. Each division invests exclusively in shares of the following funds or portfolios (collectively, the Funds), which are registered under the 1940 Act as open-end management investment companies. The name of each Fund and the corresponding division name are provided below. Each division is comprised of subaccounts. Individual variable life insurance policies invest in subaccounts. For each division, the financial statements are comprised of a statement of assets and liabilities as of December 31, 2023, a related statement of operations for the year then ended and statements of changes in net assets for each of the two years in the period then ended, all presented to reflect a full twelve month period except as noted below.

 

Division    Fund

AB VPS Dyn Asset Alloc, Cl B

  

AB VPS Dynamic Asset Allocation Portfolio (Class B)

AB VPS Intl Val, Cl B

  

AB VPS International Value Portfolio (Class B)

AB VPS Lg Cap Gro, Cl A

  

AB VPS Large Cap Growth Portfolio (Class A)

AB VPS Lg Cap Gro, Cl B

  

AB VPS Large Cap Growth Portfolio (Class B)

AB VPS Relative Val, Cl B

  

AB VPS Relative Value Portfolio (Class B)
(previously AB VPS Growth and Income Portfolio (Class B))

Allspg VT Index Asset Alloc, Cl 2

  

Allspring VT Index Asset Allocation Fund – Class 2

Allspg VT Intl Eq, Cl 2

  

Allspring VT International Equity Fund – Class 2(1)

Allspg VT Opp, Cl 1

  

Allspring VT Opportunity Fund – Class 1

Allspg VT Opp, Cl 2

  

Allspring VT Opportunity Fund – Class 2

Allspg VT Sm Cap Gro, Cl 1

  

Allspring VT Small Cap Growth Fund – Class 1

Allspg VT Sm Cap Gro, Cl 2

  

Allspring VT Small Cap Growth Fund – Class 2

ALPS Alerian Engy Infr, Class I

  

ALPS/Alerian Energy Infrastructure Portfolio: Class I

ALPS Alerian Engy Infr, Class III

  

ALPS/Alerian Energy Infrastructure Portfolio: Class III

AC VP Intl, Cl I

  

American Century VP International, Class I(2)

AC VP Intl, Cl II

  

American Century VP International, Class II(3)

AC VP Val, Cl I

  

American Century VP Value, Class I(4)

AC VP Val, Cl II

  

American Century VP Value, Class II(5)

BlackRock Global Alloc, Cl I

  

BlackRock Global Allocation V.I. Fund (Class I)

BlackRock Global Alloc, Cl III

  

BlackRock Global Allocation V.I. Fund (Class III)

Calvert VP EAFE Intl Index, Cl F

  

Calvert VP EAFE International Index Portfolio – Class F(6)
(renamed to CVT EAFE International Index Portfolio – Class F effective sometime during the second quarter of 2024)

Calvert VP EAFE Intl Index, Cl I

  

Calvert VP EAFE International Index Portfolio – Class I(6)
(renamed to CVT EAFE International Index Portfolio – Class I effective sometime during the second quarter of 2024)

 

138    RIVERSOURCE OF NEW YORK ACCOUNT  8


Division    Fund

Calvert VP Nasdaq 100 Index, Cl F

  

Calvert VP Nasdaq 100 Index Portfolio – Class F(6)
(renamed to CVT Nasdaq 100 Index Portfolio – Class F effective sometime during the second quarter of 2024)

Calvert VP Nasdaq 100 Index, Cl I

  

Calvert VP Nasdaq 100 Index Portfolio – Class I(6)
(renamed to CVT Nasdaq 100 Index Portfolio – Class I effective sometime during the second quarter of 2024)

Calv VP Russ 2000 Sm Cap Ind, Cl F

  

Calvert VP Russell 2000® Small Cap Index Portfolio – Class F(6)
(renamed to CVT Russell 2000® Small Cap Index Portfolio – Class F effective sometime during the second quarter of 2024)

Calv VP Russ 2000 Sm Cap Ind, Cl I

  

Calvert VP Russell 2000® Small Cap Index Portfolio – Class I(6)
(renamed to CVT Russell 2000® Small Cap Index Portfolio – Class I effective sometime during the second quarter of 2024)

Calvert VP SRI Bal, Cl I

  

Calvert VP SRI Balanced Portfolio – Class I

Col VP Bal, Cl 1

  

Columbia Variable Portfolio – Balanced Fund (Class 1)

Col VP Bal, Cl 3

  

Columbia Variable Portfolio – Balanced Fund (Class 3)

Col VP Commodity Strategy, Cl 1

  

Columbia Variable Portfolio – Commodity Strategy Fund (Class 1)

Col VP Commodity Strategy, Cl 2

  

Columbia Variable Portfolio – Commodity Strategy Fund (Class 2)

Col VP Contrarian Core, Cl 1

  

Columbia Variable Portfolio – Contrarian Core Fund (Class 1)

Col VP Contrarian Core, Cl 2

  

Columbia Variable Portfolio – Contrarian Core Fund (Class 2)

Col VP Disciplined Core, Cl 1

  

Columbia Variable Portfolio – Disciplined Core Fund (Class 1)

Col VP Disciplined Core, Cl 2

  

Columbia Variable Portfolio – Disciplined Core Fund (Class 2)

Col VP Disciplined Core, Cl 3

  

Columbia Variable Portfolio – Disciplined Core Fund (Class 3)

Col VP Divd Opp, Cl 1

  

Columbia Variable Portfolio – Dividend Opportunity Fund (Class 1)

Col VP Divd Opp, Cl 2

  

Columbia Variable Portfolio – Dividend Opportunity Fund (Class 2)

Col VP Divd Opp, Cl 3

  

Columbia Variable Portfolio – Dividend Opportunity Fund (Class 3)

Col VP Emerg Mkts Bond, Cl 1

  

Columbia Variable Portfolio – Emerging Markets Bond Fund (Class 1)

Col VP Emerg Mkts Bond, Cl 2

  

Columbia Variable Portfolio – Emerging Markets Bond Fund (Class 2)

Col VP Emer Mkts, Cl 1

  

Columbia Variable Portfolio – Emerging Markets Fund (Class 1)

Col VP Emer Mkts, Cl 2

  

Columbia Variable Portfolio – Emerging Markets Fund (Class 2)

Col VP Emer Mkts, Cl 3

  

Columbia Variable Portfolio – Emerging Markets Fund (Class 3)

Col VP Global Strategic Inc, Cl 2

  

Columbia Variable Portfolio – Global Strategic Income Fund (Class 2)

Col VP Global Strategic Inc, Cl 3

  

Columbia Variable Portfolio – Global Strategic Income Fund (Class 3)

Col VP Govt Money Mkt, Cl 1

  

Columbia Variable Portfolio – Government Money Market Fund (Class 1)

Col VP Govt Money Mkt, Cl 2

  

Columbia Variable Portfolio – Government Money Market Fund (Class 2)

Col VP Govt Money Mkt, Cl 3

  

Columbia Variable Portfolio – Government Money Market Fund (Class 3)

Col VP Hi Yield Bond, Cl 1

  

Columbia Variable Portfolio – High Yield Bond Fund (Class 1)

Col VP Hi Yield Bond, Cl 2

  

Columbia Variable Portfolio – High Yield Bond Fund (Class 2)

Col VP Hi Yield Bond, Cl 3

  

Columbia Variable Portfolio – High Yield Bond Fund (Class 3)

Col VP Inc Opp, Cl 1

  

Columbia Variable Portfolio – Income Opportunities Fund (Class 1)

Col VP Inc Opp, Cl 2

  

Columbia Variable Portfolio – Income Opportunities Fund (Class 2)

Col VP Inc Opp, Cl 3

  

Columbia Variable Portfolio – Income Opportunities Fund (Class 3)

Col VP Inter Bond, Cl 1

  

Columbia Variable Portfolio – Intermediate Bond Fund (Class 1)

Col VP Inter Bond, Cl 2

  

Columbia Variable Portfolio – Intermediate Bond Fund (Class 2)

Col VP Inter Bond, Cl 3

  

Columbia Variable Portfolio – Intermediate Bond Fund (Class 3)

Col VP Lg Cap Gro, Cl 1

  

Columbia Variable Portfolio – Large Cap Growth Fund (Class 1)

Col VP Lg Cap Gro, Cl 2

  

Columbia Variable Portfolio – Large Cap Growth Fund (Class 2)

Col VP Lg Cap Gro, Cl 3

  

Columbia Variable Portfolio – Large Cap Growth Fund (Class 3)

Col VP Lg Cap Index, Cl 1

  

Columbia Variable Portfolio – Large Cap Index Fund (Class 1)

Col VP Lg Cap Index, Cl 3

  

Columbia Variable Portfolio – Large Cap Index Fund (Class 3)

Col VP Limited Duration Cr, Cl 1

  

Columbia Variable Portfolio – Limited Duration Credit Fund (Class 1)

Col VP Limited Duration Cr, Cl 2

  

Columbia Variable Portfolio – Limited Duration Credit Fund (Class 2)

Col VP Long Govt/Cr Bond, Cl 1

  

Columbia Variable Portfolio – Long Government/Credit Bond Fund (Class 1)

Col VP Long Govt/Cr Bond, Cl 2

  

Columbia Variable Portfolio – Long Government/Credit Bond Fund (Class 2)

Col VP Overseas Core, Cl 1

  

Columbia Variable Portfolio – Overseas Core Fund (Class 1)

Col VP Overseas Core, Cl 2

  

Columbia Variable Portfolio – Overseas Core Fund (Class 2)

Col VP Overseas Core, Cl 3

  

Columbia Variable Portfolio – Overseas Core Fund (Class 3)

Col VP Select Lg Cap Val, Cl 1

  

Columbia Variable Portfolio – Select Large Cap Value Fund (Class 1)

Col VP Select Lg Cap Val, Cl 2

  

Columbia Variable Portfolio – Select Large Cap Value Fund (Class 2)

Col VP Select Lg Cap Val, Cl 3

  

Columbia Variable Portfolio – Select Large Cap Value Fund (Class 3)

Col VP Select Mid Cap Gro, Cl 1

  

Columbia Variable Portfolio – Select Mid Cap Growth Fund (Class 1)

Col VP Select Mid Cap Gro, Cl 2

  

Columbia Variable Portfolio – Select Mid Cap Growth Fund (Class 2)

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      139  


Division    Fund

Col VP Select Mid Cap Gro, Cl 3

  

Columbia Variable Portfolio – Select Mid Cap Growth Fund (Class 3)

Col VP Select Mid Cap Val, Cl 1

  

Columbia Variable Portfolio – Select Mid Cap Value Fund (Class 1)

Col VP Select Mid Cap Val, Cl 2

  

Columbia Variable Portfolio – Select Mid Cap Value Fund (Class 2)

Col VP Select Mid Cap Val, Cl 3

  

Columbia Variable Portfolio – Select Mid Cap Value Fund (Class 3)

Col VP Select Sm Cap Val, Cl 1

  

Columbia Variable Portfolio – Select Small Cap Value Fund (Class 1)

Col VP Select Sm Cap Val, Cl 2

  

Columbia Variable Portfolio – Select Small Cap Value Fund (Class 2)

Col VP Select Sm Cap Val, Cl 3

  

Columbia Variable Portfolio – Select Small Cap Value Fund (Class 3)

Col VP Sel Gbl Tech, Cl 1

  

Columbia Variable Portfolio – Seligman Global Technology Fund (Class 1)(6)

Col VP Sel Gbl Tech, Cl 2

  

Columbia Variable Portfolio – Seligman Global Technology Fund (Class 2)(6)

Col VP Strategic Inc, Cl 1

  

Columbia Variable Portfolio – Strategic Income Fund (Class 1)

Col VP Strategic Inc, Cl 2

  

Columbia Variable Portfolio – Strategic Income Fund (Class 2)

Col VP US Govt Mtge, Cl 1

  

Columbia Variable Portfolio – U.S. Government Mortgage Fund (Class 1)

Col VP US Govt Mtge, Cl 2

  

Columbia Variable Portfolio – U.S. Government Mortgage Fund (Class 2)

Col VP US Govt Mtge, Cl 3

  

Columbia Variable Portfolio – U.S. Government Mortgage Fund (Class 3)

CS Commodity Return, Cl 1

  

Credit Suisse Trust – Commodity Return Strategy Portfolio, Class 1

CTIVP AC Div Bond, Cl 1

  

CTIVP® – American Century Diversified Bond Fund (Class 1)

CTIVP AC Div Bond, Cl 2

  

CTIVP® – American Century Diversified Bond Fund (Class 2)

CTIVP BR Gl Infl Prot Sec, Cl 1

  

CTIVP® – BlackRock Global Inflation-Protected Securities Fund (Class 1)

CTIVP BR Gl Infl Prot Sec, Cl 2

  

CTIVP® – BlackRock Global Inflation-Protected Securities Fund (Class 2)

CTIVP BR Gl Infl Prot Sec, Cl 3

  

CTIVP® – BlackRock Global Inflation-Protected Securities Fund (Class 3)

CTIVP CenterSquare Real Est, Cl 1

  

CTIVP® –CenterSquare Real Estate Fund (Class 1)

CTIVP CenterSquare Real Est, Cl 2

  

CTIVP® –CenterSquare Real Estate Fund (Class 2)

CTIVP MFS Val, Cl 1

  

CTIVP® – MFS® Value Fund (Class 1)

CTIVP MFS Val, Cl 2

  

CTIVP® – MFS® Value Fund (Class 2)

CTIVP MS Adv, Cl 1

  

CTIVP® – Morgan Stanley Advantage Fund (Class 1)
(renamed to CTIVP® – Westfield Select Large Cap Growth Fund (Class 1) effective sometime during the second quarter of 2024)

CTIVP MS Adv, Cl 2

  

CTIVP® – Morgan Stanley Advantage Fund (Class 2)
(renamed to CTIVP® – Westfield Select Large Cap Growth Fund (Class 2) effective sometime during the second quarter of 2024)

CTIVP Prin Blue Chip Gro, Cl 1

  

CTIVP® – Principal Blue Chip Growth Fund (Class 1)

CTIVP Prin Blue Chip Gro, Cl 2

  

CTIVP® – Principal Blue Chip Growth Fund (Class 2)

CTIVP T Rowe Price LgCap Val, Cl 1

  

CTIVP® – T. Rowe Price Large Cap Value Fund (Class 1)

CTIVP T Rowe Price LgCap Val, Cl 2

  

CTIVP® – T. Rowe Price Large Cap Value Fund (Class 2)

CTIVP TCW Core Plus Bond, Cl 1

  

CTIVP® – TCW Core Plus Bond Fund (Class 1)

CTIVP TCW Core Plus Bond, Cl 2

  

CTIVP® – TCW Core Plus Bond Fund (Class 2)

CTIVP Vty Sycamore Estb Val, Cl 1

  

CTIVP® – Victory Sycamore Established Value Fund (Class 1)

CTIVP Vty Sycamore Estb Val, Cl 2

  

CTIVP® – Victory Sycamore Established Value Fund (Class 2)

CTIVP Vty Sycamore Estb Val, Cl 3

  

CTIVP® – Victory Sycamore Established Value Fund (Class 3)

CTIVP Westfield Mid Cap Gro, Cl 1

  

CTIVP® – Westfield Mid Cap Growth Fund (Class 1)

CTIVP Westfield Mid Cap Gro, Cl 2

  

CTIVP® – Westfield Mid Cap Growth Fund (Class 2)

Del Ivy VIP Asset Strategy, Cl II

  

Delaware Ivy VIP Asset Strategy, Class II
(renamed to Macquarie VIP Asset Strategy Series – Service Class effective sometime during the second quarter of 2024)

DWS Alt Asset Alloc VIP, Cl A

  

DWS Alternative Asset Allocation VIP, Class A

DWS Alt Asset Alloc VIP, Cl B

  

DWS Alternative Asset Allocation VIP, Class B

EV VT Floating-Rate Inc, Init Cl

  

Eaton Vance VT Floating-Rate Income Fund – Initial Class

Fid VIP Contrafund, Init Cl

  

Fidelity® VIP ContrafundSM Portfolio Initial Class

Fid VIP Contrafund, Serv Cl 2

  

Fidelity® VIP ContrafundSM Portfolio Service Class 2

Fid VIP Gro & Inc, Serv Cl

  

Fidelity® VIP Growth & Income Portfolio Service Class

Fid VIP Gro & Inc, Serv Cl 2

  

Fidelity® VIP Growth & Income Portfolio Service Class 2

Fid VIP Mid Cap, Init Cl

  

Fidelity® VIP Mid Cap Portfolio Initial Class

Fid VIP Mid Cap, Serv Cl

  

Fidelity® VIP Mid Cap Portfolio Service Class

Fid VIP Mid Cap, Serv Cl 2

  

Fidelity® VIP Mid Cap Portfolio Service Class 2

Fid VIP Overseas, Serv Cl

  

Fidelity® VIP Overseas Portfolio Service Class

Fid VIP Overseas, Serv Cl 2

  

Fidelity® VIP Overseas Portfolio Service Class 2

Fid VIP Strategic Inc, Init Cl

  

Fidelity® VIP Strategic Income Portfolio Initial Class

Fid VIP Strategic Inc, Serv Cl 2

  

Fidelity® VIP Strategic Income Portfolio Service Class 2

Frank Global Real Est, Cl 2

  

Franklin Global Real Estate VIP Fund – Class 2

Frank Inc, Cl 1

  

Franklin Income VIP Fund – Class 1

Frank Inc, Cl 2

  

Franklin Income VIP Fund – Class 2

Frank Mutual Shares, Cl 1

  

Franklin Mutual Shares VIP Fund – Class 1

Frank Mutual Shares, Cl 2

  

Franklin Mutual Shares VIP Fund – Class 2

 

140    RIVERSOURCE OF NEW YORK ACCOUNT  8


Division    Fund

Frank Sm Cap Val, Cl 1

  

Franklin Small Cap Value VIP Fund – Class 1

Frank Sm Cap Val, Cl 2

  

Franklin Small Cap Value VIP Fund – Class 2

GS VIT Mid Cap Val, Inst

  

Goldman Sachs VIT Mid Cap Value Fund – Institutional Shares

GS VIT Multi-Strategy Alt, Advisor

  

Goldman Sachs VIT Multi-Strategy Alternatives Portfolio – Advisor Shares

GS VIT Sm Cap Eq Insights, Inst

  

Goldman Sachs VIT Small Cap Equity Insights Fund – Institutional Shares

GS VIT U.S. Eq Insights, Inst

  

Goldman Sachs VIT U.S. Equity Insights Fund – Institutional Shares

Invesco VI Am Fran, Ser I

  

Invesco V.I. American Franchise Fund, Series I Shares

Invesco VI Am Fran, Ser II

  

Invesco V.I. American Franchise Fund, Series II Shares

Invesco VI Bal Risk Alloc, Ser I

  

Invesco V.I. Balanced-Risk Allocation Fund, Series I Shares

Invesco VI Bal Risk Alloc, Ser II

  

Invesco V.I. Balanced-Risk Allocation Fund, Series II Shares

Invesco VI Comstock, Ser II

  

Invesco V.I. Comstock Fund, Series II Shares

Invesco VI Core Eq, Ser I

  

Invesco V.I. Core Equity Fund, Series I Shares

Invesco VI Dis Mid Cap Gro, Ser I

  

Invesco V.I. Discovery Mid Cap Growth Fund, Series I Shares

Invesco VI Div Divd, Ser I

  

Invesco V.I. Diversified Dividend Fund, Series I Shares

Invesco VI EQV Intl Eq, Ser II

  

Invesco V.I. EQV International Equity Fund, Series II Shares

Invesco VI Global, Ser I

  

Invesco V.I. Global Fund, Series I Shares

Invesco VI Global, Ser II

  

Invesco V.I. Global Fund, Series II Shares

Invesco VI Gbl Strat Inc, Ser I

  

Invesco V.I. Global Strategic Income Fund, Series I Shares

Invesco VI Gbl Strat Inc, Ser II

  

Invesco V.I. Global Strategic Income Fund, Series II Shares

Invesco VI Mn St Sm Cap, Ser I

  

Invesco V.I. Main Street Small Cap Fund®, Series I Shares

Invesco VI Mn St Sm Cap, Ser II

  

Invesco V.I. Main Street Small Cap Fund®, Series II Shares

Invesco VI Tech, Ser I

  

Invesco V.I. Technology Fund, Series I Shares

Invesco VI Tech, Ser II

  

Invesco V.I. Technology Fund, Series II Shares(6)

Janus Henderson VIT Bal, Inst

  

Janus Henderson VIT Balanced Portfolio: Institutional Shares

Janus Henderson VIT Bal, Serv

  

Janus Henderson VIT Balanced Portfolio: Service Shares

Janus Henderson VIT Enter, Serv

  

Janus Henderson VIT Enterprise Portfolio: Service Shares

Janus Henderson VIT Flex Bd, Inst

  

Janus Henderson VIT Flexible Bond Portfolio: Institutional Shares

Janus Henderson VIT Flex Bd, Serv

  

Janus Henderson VIT Flexible Bond Portfolio: Service Shares

Janus Hend VIT Gbl Tech Innov, Srv

  

Janus Henderson VIT Global Technology and Innovation Portfolio: Service Shares

Janus Henderson VIT Overseas, Serv

  

Janus Henderson VIT Overseas Portfolio: Service Shares

Janus Henderson VIT Res, Inst

  

Janus Henderson VIT Research Portfolio: Institutional Shares

Janus Henderson VIT Res, Serv

  

Janus Henderson VIT Research Portfolio: Service Shares

Lazard Ret Global Dyn MA, Inv

  

Lazard Retirement Global Dynamic Multi-Asset Portfolio – Investor Shares

Lazard Ret Global Dyn MA, Serv

  

Lazard Retirement Global Dynamic Multi-Asset Portfolio – Service Shares

MFS Mass Inv Gro Stock, Serv Cl

  

MFS® Massachusetts Investors Growth Stock Portfolio – Service Class

MFS New Dis, Serv Cl

  

MFS® New Discovery Series – Service Class

MFS Utilities, Init Cl

  

MFS® Utilities Series – Initial Class

MFS Utilities, Serv Cl

  

MFS® Utilities Series – Service Class

MS VIF Dis, Cl I

  

Morgan Stanley VIF Discovery Portfolio, Class I Shares

MS VIF Dis, Cl II

  

Morgan Stanley VIF Discovery Portfolio, Class II Shares

MS VIF Global Real Est, Cl II

  

Morgan Stanley VIF Global Real Estate Portfolio, Class II Shares

NB AMT Sus Eq, Cl I

  

Neuberger Berman AMT Sustainable Equity Portfolio (Class I)

NB AMT Sus Eq, Cl S

  

Neuberger Berman AMT Sustainable Equity Portfolio (Class S)

NB AMT US Eq Index PW Strat, Cl S

  

Neuberger Berman AMT U.S. Equity Index PutWrite Strategy Portfolio (Class S)(7)

PIMCO VIT All Asset, Advisor Cl

  

PIMCO VIT All Asset Portfolio, Advisor Class

PIMCO VIT All Asset, Inst Cl

  

PIMCO VIT All Asset Portfolio, Institutional Class

PIMCO VIT Glb Man As Alloc, Adv Cl

  

PIMCO VIT Global Managed Asset Allocation Portfolio, Advisor Class

PIMCO VIT Tot Return, Advisor Cl

  

PIMCO VIT Total Return Portfolio, Advisor Class

PIMCO VIT Tot Return, Inst Cl

  

PIMCO VIT Total Return Portfolio, Institutional Class

Put VT Global Hlth Care, Cl IA

  

Putnam VT Global Health Care Fund – Class IA Shares(6)

Put VT Global Hlth Care, Cl IB

  

Putnam VT Global Health Care Fund – Class IB Shares

Put VT Hi Yield, Cl IB

  

Putnam VT High Yield Fund – Class IB Shares

Put VT Intl Eq, Cl IB

  

Putnam VT International Equity Fund – Class IB Shares

Put VT Sus Leaders, Cl IA

  

Putnam VT Sustainable Leaders Fund – Class IA Shares

Put VT Sus Leaders, Cl IB

  

Putnam VT Sustainable Leaders Fund – Class IB Shares

Royce Micro-Cap, Invest Cl

  

Royce Capital Fund – Micro-Cap Portfolio, Investment Class

Temp Global Bond, Cl 1

  

Templeton Global Bond VIP Fund – Class 1

Temp Global Bond, Cl 2

  

Templeton Global Bond VIP Fund – Class 2

Third Ave VST Third Ave Value

  

Third Avenue VST Third Avenue Value Portfolio

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      141  


Division    Fund

VanEck VIP Global Gold, Cl S

  

VanEck VIP Global Gold Fund (Class S Shares)

VP Aggr, Cl 1

  

Variable Portfolio – Aggressive Portfolio (Class 1)

VP Aggr, Cl 2

  

Variable Portfolio – Aggressive Portfolio (Class 2)

VP Aggr, Cl 4

  

Variable Portfolio – Aggressive Portfolio (Class 4)

VP Conserv, Cl 1

  

Variable Portfolio – Conservative Portfolio (Class 1)

VP Conserv, Cl 2

  

Variable Portfolio – Conservative Portfolio (Class 2)

VP Conserv, Cl 4

  

Variable Portfolio – Conservative Portfolio (Class 4)

VP Man Vol Conserv, Cl 1

  

Variable Portfolio – Managed Volatility Conservative Fund (Class 1)

VP Man Vol Conserv, Cl 2

  

Variable Portfolio – Managed Volatility Conservative Fund (Class 2)

VP Man Vol Conserv Gro, Cl 1

  

Variable Portfolio – Managed Volatility Conservative Growth Fund (Class 1)

VP Man Vol Conserv Gro, Cl 2

  

Variable Portfolio – Managed Volatility Conservative Growth Fund (Class 2)

VP Man Vol Gro, Cl 1

  

Variable Portfolio – Managed Volatility Growth Fund (Class 1)

VP Man Vol Gro, Cl 2

  

Variable Portfolio – Managed Volatility Growth Fund (Class 2)

VP Man Vol Mod Gro, Cl 1

  

Variable Portfolio – Managed Volatility Moderate Growth Fund (Class 1)

VP Man Vol Mod Gro, Cl 2

  

Variable Portfolio – Managed Volatility Moderate Growth Fund (Class 2)

VP Mod, Cl 1

  

Variable Portfolio – Moderate Portfolio (Class 1)

VP Mod, Cl 2

  

Variable Portfolio – Moderate Portfolio (Class 2)

VP Mod, Cl 4

  

Variable Portfolio – Moderate Portfolio (Class 4)

VP Mod Aggr, Cl 1

  

Variable Portfolio – Moderately Aggressive Portfolio (Class 1)

VP Mod Aggr, Cl 2

  

Variable Portfolio – Moderately Aggressive Portfolio (Class 2)

VP Mod Aggr, Cl 4

  

Variable Portfolio – Moderately Aggressive Portfolio (Class 4)

VP Mod Conserv, Cl 1

  

Variable Portfolio – Moderately Conservative Portfolio (Class 1)

VP Mod Conserv, Cl 2

  

Variable Portfolio – Moderately Conservative Portfolio (Class 2)

VP Mod Conserv, Cl 4

  

Variable Portfolio – Moderately Conservative Portfolio (Class 4)

VP Ptnrs Core Bond, Cl 1

  

Variable Portfolio – Partners Core Bond Fund (Class 1)

VP Ptnrs Core Bond, Cl 2

  

Variable Portfolio – Partners Core Bond Fund (Class 2)

VP Ptnrs Core Eq, Cl 1

  

Variable Portfolio – Partners Core Equity Fund (Class 1)

VP Ptnrs Core Eq, Cl 2

  

Variable Portfolio – Partners Core Equity Fund (Class 2)

VP Ptnrs Core Eq, Cl 3

  

Variable Portfolio – Partners Core Equity Fund (Class 3)

VP Ptnrs Intl Core Eq, Cl 1

  

Variable Portfolio – Partners International Core Equity Fund (Class 1)

VP Ptnrs Intl Core Eq, Cl 2

  

Variable Portfolio – Partners International Core Equity Fund (Class 2)

VP Ptnrs Intl Gro, Cl 1

  

Variable Portfolio – Partners International Growth Fund (Class 1)

VP Ptnrs Intl Gro, Cl 2

  

Variable Portfolio – Partners International Growth Fund (Class 2)

VP Ptnrs Intl Val, Cl 1

  

Variable Portfolio – Partners International Value Fund (Class 1)

VP Ptnrs Intl Val, Cl 2

  

Variable Portfolio – Partners International Value Fund (Class 2)

VP Ptnrs Sm Cap Gro, Cl 1

  

Variable Portfolio – Partners Small Cap Growth Fund (Class 1)

VP Ptnrs Sm Cap Gro, Cl 2

  

Variable Portfolio – Partners Small Cap Growth Fund (Class 2)

VP Ptnrs Sm Cap Val, Cl 1

  

Variable Portfolio – Partners Small Cap Value Fund (Class 1)

VP Ptnrs Sm Cap Val, Cl 2

  

Variable Portfolio – Partners Small Cap Value Fund (Class 2)

VP Ptnrs Sm Cap Val, Cl 3

  

Variable Portfolio – Partners Small Cap Value Fund (Class 3)

VP US Flex Conserv Gro, Cl 1

  

Variable Portfolio – U.S. Flexible Conservative Growth Fund (Class 1)

VP US Flex Gro, Cl 1

  

Variable Portfolio – U.S. Flexible Growth Fund (Class 1)

VP US Flex Mod Gro, Cl 1

  

Variable Portfolio – U.S. Flexible Moderate Growth Fund (Class 1)

Wanger Acorn

  

Wanger Acorn

Wanger Intl

  

Wanger International

WA Var Global Hi Yd Bond, Cl I

  

Western Asset Variable Global High Yield Bond Portfolio – Class I

WA Var Global Hi Yd Bond, Cl II

  

Western Asset Variable Global High Yield Bond Portfolio – Class II

 

(1) 

Allspring VT International Equity Fund – Class 2 is scheduled to liquidate sometime during the second quarter of 2024.

(2) 

American Century VP International, Class I is scheduled to reorganize into LVIP American Century International Fund, Standard Class II sometime during the second quarter of 2024.

(3) 

American Century VP International, Class II is scheduled to reorganize into LVIP American Century International Fund, Service Class sometime during the second quarter of 2024.

(4) 

American Century VP Value, Class I is scheduled to reorganize into LVIP American Century Value Fund, Standard Class II sometime during the second quarter of 2024.

(5) 

American Century VP Value, Class II is scheduled to reorganize into LVIP American Century Value Fund, Service Class sometime during the second quarter of 2024.

(6) 

For the period May 2, 2022 (commencement of operations) to December 31, 2022.

(7) 

Neuberger Berman AMT U.S. Equity Index PutWrite Strategy Portfolio (Class S) is scheduled to liquidate sometime during the second quarter of 2024.

The assets of each division of the Account are not chargeable with liabilities arising out of the business conducted by any other segregated asset account or by RiverSource Life of NY.

RiverSource Life of NY serves as issuer of the variable life insurance policies.

 

142    RIVERSOURCE OF NEW YORK ACCOUNT  8


2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Investments in the Funds

Investment transactions are accounted for on the date the shares are purchased and sold. Realized gains and losses on the sales of investments are computed using the average cost method. Income from dividends and gains from realized capital gain distributions are reinvested in additional shares of the Funds and are recorded as income by the divisions on the ex-dividend date.

Unrealized appreciation or depreciation of investments in the accompanying financial statements represents the division’s share of the Funds’ undistributed net investment income, undistributed realized gain or loss and the unrealized appreciation or depreciation on their investment securities.

The Account categorizes its fair value measurements according to a three-level hierarchy. An investment’s level within the fair value hierarchy is based on the lowest level of any input that is deemed significant to the fair value measurement. The three levels of the fair value hierarchy are defined as follows:

Level 1 – Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.

Level 2 – Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.

Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

The Funds in the Accounts have been measured at fair value using the net asset value per share (or its equivalent) as a practical expedient and are therefore not categorized in the fair value hierarchy. There were no transfers between levels in the period ended December 31, 2023.

Federal Income Taxes

RiverSource Life of NY is taxed as a life insurance company. The Account is treated as part of RiverSource Life of NY for federal income tax purposes. Under existing federal income tax law, no income taxes are payable with respect to any investment income of the Account to the extent the earnings are credited under the policies. Based on this, no charge is being made currently to the Account for federal income taxes. RiverSource Life of NY will review periodically the status of this policy. In the event of changes in the tax law, a charge may be made in future years for any federal income taxes that would be attributable to the policies.

Subsequent Events

Management has evaluated Account related events and transactions that occurred through the date the financial statements were issued. Management noted there were no items requiring adjustments or additional disclosures in the Account’s financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      143  


3. VARIABLE ACCOUNT EXPENSES

RiverSource Life of NY deducts a daily mortality and expense risk fee equal, on an annual basis, to the following percent of the average daily net assets of each subaccount.

 

Product    Mortality and expense risk fee

Succession Select

  

0.45% or 0.90%

(depending on the policy selected)

V2D

  

0.90%

VUL

  

0.90%

VUL III

  

0.45% or 0.90%

(depending on the policy selected)

VUL IV

  

0.30%, 0.45% or 0.90%

(depending on the policy selected)

VUL IV – ES

  

0.20%, 0.30% or 0.90%

(depending on the policy selected)

VUL 5

  

0.00%

VUL 5 – ES

  

0.00%

VUL 6

  

0.00%

SVUL

  

0.00%

4. POLICY CHARGES

A monthly deduction is made for the cost of insurance and the policy fee. The cost of insurance for the policy month is determined on the monthly date by determining the net amount at risk, as of that day, and by then applying the cost of insurance rates to the net amount at risk which RiverSource Life of NY is assuming for the succeeding month. The monthly deduction will be taken from the subaccounts as specified in the application for the policy.

A policy fee is deducted each month to reimburse RiverSource Life of NY for expenses incurred in administering the policy, such as processing claims, maintaining records, making policy changes and communicating with owners of policies.

RiverSource Life of NY deducts a premium expense charge from each premium payment. It partially compensates RiverSource Life of NY for expenses associated with administering and distributing the policy, including the agents’ compensation, advertising and printing the prospectus and sales literature. It also compensates RiverSource Life of NY for paying premium taxes imposed by the state of New York.

Each month RiverSource Life of NY deducts charges for any optional insurance benefits added to the policy by rider.

Some products may also charge a death benefit guarantee charge or a no lapse guarantee charge.

5. SURRENDER CHARGES

RiverSource Life of NY may assess a surrender charge to help it recover certain expenses related to the issuance of the policy. Such charges are not treated as a separate expense of the divisions as they are ultimately deducted from surrender benefits paid by RiverSource Life of NY. Charges by RiverSource Life of NY for surrenders are not identified on an individual division basis.

6. RELATED PARTY TRANSACTIONS

RiverSource Life of NY is a wholly-owned subsidiary of RiverSource Life Insurance Company, which is a wholly-owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial).

The following table reflects fees paid by certain affiliated funds to Ameriprise Financial and its affiliates.

 

Fee Agreement:    Fees Paid To:

Management Agreement

  

Columbia Management Investment Advisers, LLC

Shareholder Services Agreement

  

Columbia Management Investment Services Corp.

Plan and Agreement of Distribution

  

Columbia Management Investment Distributors, Inc.

Investment Advisory Agreement

  

Columbia Wanger Asset Management, LLC

Administrative Services Agreement

  

Columbia Wanger Asset Management, LLC

 

144    RIVERSOURCE OF NEW YORK ACCOUNT  8


7. INVESTMENT TRANSACTIONS

The divisions’ purchases of Funds’ shares, including reinvestment of dividend distributions, for the year ended December 31, 2023 were as follows:

 

Division    Purchases  

AB VPS Dyn Asset Alloc, Cl B

   $ 3  

AB VPS Intl Val, Cl B

       254,015  

AB VPS Lg Cap Gro, Cl A

     127,587  

AB VPS Lg Cap Gro, Cl B

     744,322  

AB VPS Relative Val, Cl B

     386,301  

Allspg VT Index Asset Alloc, Cl 2

     54,039  

Allspg VT Intl Eq, Cl 2

     92,239  

Allspg VT Opp, Cl 1

     8,747  

Allspg VT Opp, Cl 2

     150,381  

Allspg VT Sm Cap Gro, Cl 1

     117,041  

Allspg VT Sm Cap Gro, Cl 2

     157,970  

ALPS Alerian Engy Infr, Class I

     25,455  

ALPS Alerian Engy Infr, Class III

     78,357  

AC VP Intl, Cl I

     26,671  

AC VP Intl, Cl II

     81,799  

AC VP Val, Cl I

     524,459  

AC VP Val, Cl II

     438,532  

BlackRock Global Alloc, Cl I

     92,966  

BlackRock Global Alloc, Cl III

     151,622  

Calvert VP EAFE Intl Index, Cl F

     1,485  

Calvert VP EAFE Intl Index, Cl I

     59,158  

Calvert VP Nasdaq 100 Index, Cl F

     16,615  

Calvert VP Nasdaq 100 Index, Cl I

     95,395  

Calv VP Russ 2000 Sm Cap Ind, Cl F

     3  

Calv VP Russ 2000 Sm Cap Ind, Cl I

     20,298  

Calvert VP SRI Bal, Cl I

     185,913  

Col VP Bal, Cl 1

     264,210  

Col VP Bal, Cl 3

     323,049  

Col VP Commodity Strategy, Cl 1

     40,363  

Col VP Commodity Strategy, Cl 2

     11,212  

Col VP Contrarian Core, Cl 1

     92,204  

Col VP Contrarian Core, Cl 2

     38,722  

Col VP Disciplined Core, Cl 1

     42,114  

Col VP Disciplined Core, Cl 2

     49,794  

Col VP Disciplined Core, Cl 3

     459,807  

Col VP Divd Opp, Cl 1

     73,529  

Col VP Divd Opp, Cl 2

     102,462  

Col VP Divd Opp, Cl 3

     483,336  

Col VP Emerg Mkts Bond, Cl 1

     9,500  

Col VP Emerg Mkts Bond, Cl 2

     1,474  

Col VP Emer Mkts, Cl 1

     34,756  

Col VP Emer Mkts, Cl 2

     32,965  

Col VP Emer Mkts, Cl 3

     134,360  

Col VP Global Strategic Inc, Cl 2

     6,947  

Col VP Global Strategic Inc, Cl 3

     129,150  

Col VP Govt Money Mkt, Cl 1

     742,118  

Col VP Govt Money Mkt, Cl 2

     147,596  

Col VP Govt Money Mkt, Cl 3

     550,742  

Col VP Hi Yield Bond, Cl 1

     53,438  

Col VP Hi Yield Bond, Cl 2

     36,247  

Col VP Hi Yield Bond, Cl 3

     295,515  

Col VP Inc Opp, Cl 1

     3,357  

Col VP Inc Opp, Cl 2

     35,267  

Col VP Inc Opp, Cl 3

     164,578  

Col VP Inter Bond, Cl 1

     36,054  

Col VP Inter Bond, Cl 2

     23,408  

Col VP Inter Bond, Cl 3

     476,531  
Division    Purchases  

Col VP Lg Cap Gro, Cl 1

   $ 584,279  

Col VP Lg Cap Gro, Cl 2

     41,838  

Col VP Lg Cap Gro, Cl 3

     197,211  

Col VP Lg Cap Index, Cl 1

     2,090,336  

Col VP Lg Cap Index, Cl 3

     931,384  

Col VP Limited Duration Cr, Cl 1

     11,745  

Col VP Limited Duration Cr, Cl 2

     319,258  

Col VP Long Govt/Cr Bond, Cl 1

     1,916  

Col VP Long Govt/Cr Bond, Cl 2

     459  

Col VP Overseas Core, Cl 1

     44,770  

Col VP Overseas Core, Cl 2

     27,973  

Col VP Overseas Core, Cl 3

     210,850  

Col VP Select Lg Cap Val, Cl 1

     284,247  

Col VP Select Lg Cap Val, Cl 2

     34,210  

Col VP Select Lg Cap Val, Cl 3

     61,374  

Col VP Select Mid Cap Gro, Cl 1

     59,444  

Col VP Select Mid Cap Gro, Cl 2

     8,898  

Col VP Select Mid Cap Gro, Cl 3

     135,324  

Col VP Select Mid Cap Val, Cl 1

     69,077  

Col VP Select Mid Cap Val, Cl 2

     16,719  

Col VP Select Mid Cap Val, Cl 3

     121,546  

Col VP Select Sm Cap Val, Cl 1

     36,361  

Col VP Select Sm Cap Val, Cl 2

     15,782  

Col VP Select Sm Cap Val, Cl 3

     125,780  

Col VP Sel Gbl Tech, Cl 1

     99,920  

Col VP Sel Gbl Tech, Cl 2

     33,479  

Col VP Strategic Inc, Cl 1

     49,524  

Col VP Strategic Inc, Cl 2

     88,886  

Col VP US Govt Mtge, Cl 1

     6,531  

Col VP US Govt Mtge, Cl 2

     10,578  

Col VP US Govt Mtge, Cl 3

     140,552  

CS Commodity Return, Cl 1

     141,109  

CTIVP AC Div Bond, Cl 1

     4,906  

CTIVP AC Div Bond, Cl 2

     3,061  

CTIVP BR Gl Infl Prot Sec, Cl 1

     15,679  

CTIVP BR Gl Infl Prot Sec, Cl 2

     4,025  

CTIVP BR Gl Infl Prot Sec, Cl 3

     112,134  

CTIVP CenterSquare Real Est, Cl 1

     19,545  

CTIVP CenterSquare Real Est, Cl 2

     25,683  

CTIVP MFS Val, Cl 1

     80,537  

CTIVP MFS Val, Cl 2

     47,019  

CTIVP MS Adv, Cl 1

     28,739  

CTIVP MS Adv, Cl 2

     13,181  

CTIVP Prin Blue Chip Gro, Cl 1

     16,061  

CTIVP Prin Blue Chip Gro, Cl 2

     4,596  

CTIVP T Rowe Price LgCap Val, Cl 1

     63,321  

CTIVP T Rowe Price LgCap Val, Cl 2

     9,038  

CTIVP TCW Core Plus Bond, Cl 1

     28,664  

CTIVP TCW Core Plus Bond, Cl 2

     20,516  

CTIVP Vty Sycamore Estb Val, Cl 1

     198,597  

CTIVP Vty Sycamore Estb Val, Cl 2

     56,200  

CTIVP Vty Sycamore Estb Val, Cl 3

     110,418  

CTIVP Westfield Mid Cap Gro, Cl 1

     17,773  

CTIVP Westfield Mid Cap Gro, Cl 2

     3,044  

Del Ivy VIP Asset Strategy, Cl II

     3,766  

DWS Alt Asset Alloc VIP, Cl A

     16,622  

DWS Alt Asset Alloc VIP, Cl B

     36,306  
 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      145  


Division    Purchases  

EV VT Floating-Rate Inc, Init Cl

   $   192,785  

Fid VIP Contrafund, Init Cl

     239,719  

Fid VIP Contrafund, Serv Cl 2

     561,701  

Fid VIP Gro & Inc, Serv Cl

     319,318  

Fid VIP Gro & Inc, Serv Cl 2

     350,882  

Fid VIP Mid Cap, Init Cl

     102,655  

Fid VIP Mid Cap, Serv Cl

     251,678  

Fid VIP Mid Cap, Serv Cl 2

     662,647  

Fid VIP Overseas, Serv Cl

     63,153  

Fid VIP Overseas, Serv Cl 2

     114,149  

Fid VIP Strategic Inc, Init Cl

     230,532  

Fid VIP Strategic Inc, Serv Cl 2

     3,870  

Frank Global Real Est, Cl 2

     201,834  

Frank Inc, Cl 1

     39,867  

Frank Inc, Cl 2

     111,501  

Frank Mutual Shares, Cl 1

     7,571  

Frank Mutual Shares, Cl 2

     275,806  

Frank Sm Cap Val, Cl 1

     99,883  

Frank Sm Cap Val, Cl 2

     366,493  

GS VIT Mid Cap Val, Inst

     446,330  

GS VIT Multi-Strategy Alt, Advisor

     4,654  

GS VIT Sm Cap Eq Insights, Inst

     25,651  

GS VIT U.S. Eq Insights, Inst

     323,185  

Invesco VI Am Fran, Ser I

     24,198  

Invesco VI Am Fran, Ser II

     166,734  

Invesco VI Bal Risk Alloc, Ser I

     8,771  

Invesco VI Bal Risk Alloc, Ser II

     86,622  

Invesco VI Comstock, Ser II

     64,931  

Invesco VI Core Eq, Ser I

     453,913  

Invesco VI Dis Mid Cap Gro, Ser I

     123,124  

Invesco VI Div Divd, Ser I

     292,400  

Invesco VI EQV Intl Eq, Ser II

     78,124  

Invesco VI Global, Ser I

     278,815  

Invesco VI Global, Ser II

     442,245  

Invesco VI Gbl Strat Inc, Ser I

     13,702  

Invesco VI Gbl Strat Inc, Ser II

     109,997  

Invesco VI Mn St Sm Cap, Ser I

     45,733  

Invesco VI Mn St Sm Cap, Ser II

     160,209  

Invesco VI Tech, Ser I

     226,244  

Invesco VI Tech, Ser II

     5,625  

Janus Henderson VIT Bal, Inst

     141,249  

Janus Henderson VIT Bal, Serv

     2,491  

Janus Henderson VIT Enter, Serv

     67,960  

Janus Henderson VIT Flex Bd, Inst

     45,121  

Janus Henderson VIT Flex Bd, Serv

     25,975  

Janus Hend VIT Gbl Tech Innov, Srv

     188,372  

Janus Henderson VIT Overseas, Serv

     120,434  

Janus Henderson VIT Res, Inst

     6,186  

Janus Henderson VIT Res, Serv

     53,737  

Lazard Ret Global Dyn MA, Inv

     9,957  

Lazard Ret Global Dyn MA, Serv

     1,748  

MFS Mass Inv Gro Stock, Serv Cl

     408,388  

MFS New Dis, Serv Cl

     136,431  

MFS Utilities, Init Cl

     32,186  

MFS Utilities, Serv Cl

     199,791  

MS VIF Dis, Cl I

     160,656  

MS VIF Dis, Cl II

     130,919  

MS VIF Global Real Est, Cl II

     21,269  

NB AMT Sus Eq, Cl I

     14,202  

NB AMT Sus Eq, Cl S

     3,142  

NB AMT US Eq Index PW Strat, Cl S

     2,454  
Division    Purchases  

PIMCO VIT All Asset, Advisor Cl

   $ 83,460  

PIMCO VIT All Asset, Inst Cl

     6,779  

PIMCO VIT Glb Man As Alloc, Adv Cl

     116  

PIMCO VIT Tot Return, Advisor Cl

     108,843  

PIMCO VIT Tot Return, Inst Cl

     49,358  

Put VT Global Hlth Care, Cl IA

     29,745  

Put VT Global Hlth Care, Cl IB

     183,043  

Put VT Hi Yield, Cl IB

     21,022  

Put VT Intl Eq, Cl IB

     22,300  

Put VT Sus Leaders, Cl IA

     544,810  

Put VT Sus Leaders, Cl IB

     40,581  

Royce Micro-Cap, Invest Cl

     96,165  

Temp Global Bond, Cl 1

     4,047  

Temp Global Bond, Cl 2

     39,621  

Third Ave VST Third Ave Value

     275,434  

VanEck VIP Global Gold, Cl S

     19,280  

VP Aggr, Cl 1

     875,143  

VP Aggr, Cl 2

     2,873,265  

VP Aggr, Cl 4

     735,501  

VP Conserv, Cl 1

      

VP Conserv, Cl 2

     432,280  

VP Conserv, Cl 4

     37,173  

VP Man Vol Conserv, Cl 1

      

VP Man Vol Conserv, Cl 2

      

VP Man Vol Conserv Gro, Cl 1

     2,148  

VP Man Vol Conserv Gro, Cl 2

     929  

VP Man Vol Gro, Cl 1

     408,393  

VP Man Vol Gro, Cl 2

     42,761  

VP Man Vol Mod Gro, Cl 1

     178,707  

VP Man Vol Mod Gro, Cl 2

     145,550  

VP Mod, Cl 1

     1,542,075  

VP Mod, Cl 2

     925,420  

VP Mod, Cl 4

     1,062,313  

VP Mod Aggr, Cl 1

     2,384,582  

VP Mod Aggr, Cl 2

     2,205,498  

VP Mod Aggr, Cl 4

     1,686,857  

VP Mod Conserv, Cl 1

      

VP Mod Conserv, Cl 2

     358,457  

VP Mod Conserv, Cl 4

     272,311  

VP Ptnrs Core Bond, Cl 1

     14,771  

VP Ptnrs Core Bond, Cl 2

     12,013  

VP Ptnrs Core Eq, Cl 1

     673  

VP Ptnrs Core Eq, Cl 2

     28,250  

VP Ptnrs Core Eq, Cl 3

     28,818  

VP Ptnrs Intl Core Eq, Cl 1

     13,609  

VP Ptnrs Intl Core Eq, Cl 2

     24,047  

VP Ptnrs Intl Gro, Cl 1

     13,946  

VP Ptnrs Intl Gro, Cl 2

     10,827  

VP Ptnrs Intl Val, Cl 1

     19,773  

VP Ptnrs Intl Val, Cl 2

     7,626  

VP Ptnrs Sm Cap Gro, Cl 1

     12,273  

VP Ptnrs Sm Cap Gro, Cl 2

     3,483  

VP Ptnrs Sm Cap Val, Cl 1

     1,736  

VP Ptnrs Sm Cap Val, Cl 2

     451  

VP Ptnrs Sm Cap Val, Cl 3

     80,626  

VP US Flex Conserv Gro, Cl 1

     2,635  

VP US Flex Gro, Cl 1

     40,238  

VP US Flex Mod Gro, Cl 1

     3,855  

Wanger Acorn

     353,842  

Wanger Intl

     230,507  

WA Var Global Hi Yd Bond, Cl I

     4,520  

WA Var Global Hi Yd Bond, Cl II

     1,524  
 

 

146    RIVERSOURCE OF NEW YORK ACCOUNT  8


8. FINANCIAL HIGHLIGHTS

The table below shows certain financial information regarding the divisions.

 

     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

AB VPS Dyn Asset Alloc, Cl B

 

                                

2023

              $1.42       to       $1.22          $0          0.61      0.00     to       0.90      13.48     to       12.46

2022

              $1.25       to       $1.08          $0          2.56      0.00     to       0.90      (18.68 %)      to       (19.40 %) 

2021

              $1.54       to       $1.34          $1          1.56      0.00     to       0.90      9.28     to       8.30

2020

              $1.41       to       $1.24          $0          1.45      0.00     to       0.90      4.87     to       3.92

2019

              $1.34       to       $1.19          $0                1.82      0.00     to       0.90      15.24     to       14.21

AB VPS Intl Val, Cl B

 

                                

2023

     1,463          $1.36       to       $1.79          $2,703          0.70      0.20     to       0.90      14.60     to       13.80

2022

     1,516          $1.18       to       $1.58          $2,447          4.22      0.20     to       0.90      18.83 %(8)      to       (14.57 %) 

2021

     1,523          $1.32       to       $1.84          $2,868          1.72      0.30     to       0.90      10.52     to       9.86

2020

     1,530          $1.19       to       $1.68          $2,626          1.55      0.30     to       0.90      1.90     to       1.30

2019

     1,608          $1.17       to       $1.66          $2,711                0.81      0.30     to       0.90      16.44     to       15.74

AB VPS Lg Cap Gro, Cl A

 

                                

2023

     174          $2.00       to       $2.00          $349                 0.00     to       0.00      35.13     to       35.13

2022

     117          $1.48       to       $1.48          $173                 0.00     to       0.00      (28.51 %)      to       (28.51 %) 

2021

     59          $2.07       to       $2.07          $122                 0.00     to       0.00      28.97     to       28.97

2020

     28          $1.61       to       $1.61          $46                 0.00     to       0.00      35.49     to       35.49

2019

     16          $1.19       to       $1.19          $20                       0.00     to       0.00      10.78 %(5)      to       10.78 %(5) 

AB VPS Lg Cap Gro, Cl B

 

                                

2023

     454          $5.26       to       $5.02          $2,799                 0.00     to       0.90      34.79     to       33.59

2022

     392          $3.90       to       $3.76          $1,723                 0.00     to       0.90      (28.69 %)      to       (29.33 %) 

2021

     350          $5.47       to       $5.32          $2,208                 0.00     to       0.90      28.65     to       27.50

2020

     410          $4.25       to       $4.17          $2,022                 0.00     to       0.90      35.15     to       33.94

2019

     357          $3.15       to       $3.11          $1,282                       0.00     to       0.90      34.37     to       33.16

AB VPS Relative Val, Cl B

 

                                

2023

     621          $1.23       to       $4.27          $2,515          1.33      0.20     to       0.90      11.50     to       10.72

2022

     698          $1.10       to       $3.86          $2,531          1.10      0.20     to       0.90      10.30 %(8)      to       (5.27 %) 

2021

     721          $2.35       to       $4.07          $2,756          0.64      0.30     to       0.90      27.45     to       26.69

2020

     761          $1.85       to       $3.21          $2,331          1.33      0.30     to       0.90      2.17     to       1.55

2019

     783          $1.81       to       $3.17          $2,337                1.03      0.30     to       0.90      23.24     to       22.50

Allspg VT Index Asset Alloc, Cl 2

 

                                

2023

     246          $1.21       to       $3.77          $536          0.96      0.20     to       0.90      16.47     to       15.66

2022

     260          $1.04       to       $3.26          $495          0.63      0.20     to       0.90      4.13 %(8)      to       (17.76 %) 

2021

     268          $2.32       to       $3.96          $620          0.56      0.30     to       0.90      15.65     to       14.96

2020

     309          $2.01       to       $3.45          $617          0.83      0.30     to       0.90      16.24     to       15.54

2019

     297          $1.73       to       $2.98          $527                1.09      0.30     to       0.90      19.80     to       19.08

Allspg VT Intl Eq, Cl 2

 

                                

2023

     482          $1.33       to       $2.11          $1,026          1.45      0.20     to       0.90      15.34     to       14.52

2022

     484          $1.15       to       $1.84          $925          3.65      0.20     to       0.90      16.17 %(8)      to       (12.67 %) 

2021

     482          $1.43       to       $2.11          $1,051          1.07      0.30     to       0.90      6.55     to       5.91

2020

     514          $1.34       to       $1.99          $1,054          2.55      0.30     to       0.90      4.62     to       3.99

2019

     532          $1.28       to       $1.92          $1,047                3.69      0.30     to       0.90      15.14     to       14.45

Allspg VT Opp, Cl 1

 

                                

2023

     12          $1.77       to       $1.77          $21                 0.00     to       0.00      26.83     to       26.83

2022

     8          $1.40       to       $1.40          $12                 0.00     to       0.00      (20.61 %)      to       (20.61 %) 

2021

     2          $1.76       to       $1.76          $3          0.23      0.00     to       0.00      25.06     to       25.06

2020

     1          $1.41       to       $1.41          $1          0.74      0.00     to       0.00      21.32     to       21.32

2019

     0          $1.16       to       $1.16          $0                0.87      0.00     to       0.00      10.25 %(5)      to       10.25 %(5) 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      147  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Allspg VT Opp, Cl 2

 

                                

2023

     266          $3.58       to       $6.01          $1,367                 0.00     to       0.90      26.50     to       25.37

2022

     287          $2.83       to       $4.79          $1,192                 0.00     to       0.90      (20.81 %)      to       (21.52 %) 

2021

     298          $3.57       to       $6.11          $1,579          0.04      0.00     to       0.90      24.78     to       23.66

2020

     300          $2.86       to       $4.94          $1,291          0.43      0.00     to       0.90      21.01     to       19.92

2019

     354          $2.37       to       $4.12          $1,276                0.28      0.00     to       0.90      31.46     to       30.29

Allspg VT Sm Cap Gro, Cl 1

 

                                

2023

     225          $1.24       to       $1.24          $280                 0.00     to       0.00      4.35     to       4.35

2022

     132          $1.19       to       $1.19          $157                 0.00     to       0.00      (34.30 %)      to       (34.30 %) 

2021

     46          $1.81       to       $1.81          $83                 0.00     to       0.00      7.93     to       7.93

2020

     13          $1.68       to       $1.68          $22                 0.00     to       0.00      58.10     to       58.10

2019

     0          $1.06       to       $1.06          $0                       0.00     to       0.00      3.90 %(5)      to       3.90 %(5) 

Allspg VT Sm Cap Gro, Cl 2

 

                                

2023

     397          $2.74       to       $5.51          $1,311                 0.00     to       0.90      4.11     to       3.18

2022

     367          $2.63       to       $5.34          $1,211                 0.00     to       0.90      (34.42 %)      to       (35.01 %) 

2021

     371          $4.01       to       $8.21          $1,937                 0.00     to       0.90      7.64     to       6.68

2020

     380          $3.72       to       $7.70          $1,837                 0.00     to       0.90      57.78     to       56.37

2019

     381          $2.36       to       $4.92          $1,249                       0.00     to       0.90      24.83     to       23.71

ALPS Alerian Engy Infr, Class I

 

                                

2023

     35          $1.42       to       $1.42          $50          5.14      0.00     to       0.00      14.25     to       14.25

2022

     18          $1.24       to       $1.24          $23          10.76      0.00     to       0.00      17.84     to       17.84

2021

     2          $1.06       to       $1.06          $2          5.09      0.00     to       0.00      38.25     to       38.25

2020

     0          $0.76       to       $0.76          $0          5.30      0.00     to       0.00      (24.85 %)      to       (24.85 %) 

2019

              $1.02       to       $1.02          $0                3.88      0.00     to       0.00      0.35 %(5)      to       0.35 %(5) 

ALPS Alerian Engy Infr, Class III

 

                                

2023

     464          $1.41       to       $1.05          $514          2.87      0.00     to       0.90      13.91     to       12.89

2022

     517          $1.24       to       $0.93          $504          4.42      0.00     to       0.90      17.32     to       16.27

2021

     464          $1.05       to       $0.80          $390          1.76      0.00     to       0.90      37.78     to       36.54

2020

     709          $0.77       to       $0.59          $432          2.76      0.00     to       0.90      (25.12 %)      to       (25.80 %) 

2019

     526          $1.02       to       $0.79          $431                1.51      0.00     to       0.90      20.41     to       19.33

AC VP Intl, Cl I

 

                                

2023

     315          $3.05       to       $1.79          $701          1.40      0.45     to       0.90      12.07     to       11.57

2022

     335          $2.72       to       $1.60          $665          1.48      0.45     to       0.90      (25.09 %)      to       (25.43 %) 

2021

     355          $3.63       to       $2.15          $928          0.16      0.45     to       0.90      8.26     to       7.78

2020

     355          $3.35       to       $2.00          $856          0.48      0.45     to       0.90      25.32     to       24.75

2019

     376          $2.68       to       $1.60          $721                0.89      0.45     to       0.90      27.84     to       27.27

AC VP Intl, Cl II

 

                                

2023

     510          $1.29       to       $2.88          $786          1.22      0.20     to       0.90      12.20     to       11.43

2022

     505          $1.15       to       $2.59          $701          1.29      0.20     to       0.90      15.50 %(8)      to       (25.54 %) 

2021

     499          $1.87       to       $3.47          $926          0.02      0.30     to       0.90      8.28     to       7.63

2020

     507          $1.73       to       $3.23          $881          0.39      0.30     to       0.90      25.28     to       24.53

2019

     536          $1.38       to       $2.59          $774                0.73      0.30     to       0.90      27.76     to       26.99

AC VP Val, Cl I

 

                                

2023

     875          $1.57       to       $5.16          $4,043          2.39      0.00     to       0.90      9.10     to       8.12

2022

     912          $1.44       to       $4.77          $3,973          2.10      0.00     to       0.90      0.54     to       (0.36 %) 

2021

     918          $1.43       to       $4.79          $4,099          1.75      0.00     to       0.90      24.51     to       23.39

2020

     940          $1.15       to       $3.88          $3,445          2.31      0.00     to       0.90      0.98     to       0.07

2019

     1,014          $1.14       to       $3.88          $3,737                2.11      0.00     to       0.90      12.02 %(5)      to       25.90

AC VP Val, Cl II

 

                                

2023

     1,021          $2.93       to       $4.29          $2,353          2.21      0.00     to       0.90      9.02     to       8.05

2022

     1,156          $2.69       to       $3.97          $2,448          1.95      0.00     to       0.90      0.31     to       (0.59 %) 

2021

     1,182          $2.68       to       $4.00          $2,521          1.60      0.00     to       0.90      24.28     to       23.17

2020

     1,206          $2.16       to       $3.24          $2,099          2.17      0.00     to       0.90      0.83     to       (0.07 %) 

2019

     1,271          $2.14       to       $3.25          $2,214                1.97      0.00     to       0.90      26.92     to       25.78

 

148    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

BlackRock Global Alloc, Cl I

 

                                

2023

     140          $1.36       to       $1.36          $189          2.45      0.00     to       0.00      12.83     to       12.83

2022

     99          $1.20       to       $1.20          $119                 0.00     to       0.00      (15.86 %)      to       (15.86 %) 

2021

     67          $1.43       to       $1.43          $95          1.20      0.00     to       0.00      6.67     to       6.67

2020

     19          $1.34       to       $1.34          $25          3.35      0.00     to       0.00      21.01     to       21.01

2019

     0          $1.11       to       $1.11          $0                2.95      0.00     to       0.00      6.61 %(5)      to       6.61 %(5) 

BlackRock Global Alloc, Cl III

 

                                

2023

     347          $1.81       to       $1.40          $514          2.63      0.00     to       0.90      12.49     to       11.48

2022

     318          $1.61       to       $1.26          $423                 0.00     to       0.90      (16.07 %)      to       (16.82 %) 

2021

     336          $1.92       to       $1.51          $536          0.84      0.00     to       0.90      6.42     to       5.46

2020

     334          $1.80       to       $1.44          $502          1.40      0.00     to       0.90      20.71     to       19.63

2019

     319          $1.49       to       $1.20          $400                1.46      0.00     to       0.90      17.75     to       16.70

Calvert VP EAFE Intl Index, Cl F

 

                                

2023

     1          $1.15       to       $1.15          $2          3.12      0.00     to       0.00      17.53     to       17.53

2022

              $0.98       to       $0.98          $0                5.68      0.00     to       0.00      (1.64 %)(7)      to       (1.64 %)(7) 

Calvert VP EAFE Intl Index, Cl I

 

                                

2023

     88          $1.16       to       $1.16          $102          3.20      0.00     to       0.00      17.77     to       17.77

2022

     38          $0.98       to       $0.98          $38                5.16      0.00     to       0.00      (1.51 %)(7)      to       (1.51 %)(7) 

Calvert VP Nasdaq 100 Index, Cl F

 

                                

2023

     15          $1.31       to       $1.31          $19          0.57      0.00     to       0.00      54.02     to       54.02

2022

              $0.85       to       $0.85          $0                0.31      0.00     to       0.00      (16.12 %)(7)      to       (16.12 %)(7) 

Calvert VP Nasdaq 100 Index, Cl I

 

                                

2023

     83          $1.32       to       $1.32          $109          0.46      0.00     to       0.00      54.40     to       54.40

2022

     6          $0.85       to       $0.85          $5                0.42      0.00     to       0.00      (15.98 %)(7)      to       (15.98 %)(7) 

Calv VP Russ 2000 Sm Cap Ind, Cl F

 

                                

2023

              $1.11       to       $1.11          $0          0.90      0.00     to       0.00      16.36     to       16.36

2022

              $0.95       to       $0.95          $0                1.32      0.00     to       0.00      (5.66 %)(7)      to       (5.66 %)(7) 

Calv VP Russ 2000 Sm Cap Ind, Cl I

 

                                

2023

     20          $1.11       to       $1.11          $22          1.44      0.00     to       0.00      16.60     to       16.60

2022

              $0.95       to       $0.95          $0                1.31      0.00     to       0.00      (5.55 %)(7)      to       (5.55 %)(7) 

Calvert VP SRI Bal, Cl I

                                   

2023

     911          $1.21       to       $2.55          $2,776          1.59      0.20     to       0.90      16.60     to       15.77

2022

     917          $1.04       to       $2.20          $2,393          1.21      0.20     to       0.90      4.47 %(8)      to       (16.17 %) 

2021

     947          $2.15       to       $2.63          $2,937          1.24      0.30     to       0.90      14.77     to       14.08

2020

     691          $1.87       to       $2.30          $1,827          2.59      0.30     to       0.90      14.91     to       14.22

2019

     208          $1.63       to       $2.02          $483                2.01      0.30     to       0.90      24.03     to       23.29

Col VP Bal, Cl 1

                                   

2023

     999          $1.56       to       $1.56          $1,561                 0.00     to       0.00      21.40     to       21.40

2022

     820          $1.29       to       $1.29          $1,056                 0.00     to       0.00      (16.65 %)      to       (16.65 %) 

2021

     704          $1.54       to       $1.54          $1,087                 0.00     to       0.00      14.87     to       14.87

2020

     287          $1.34       to       $1.34          $386                 0.00     to       0.00      17.77     to       17.77

2019

              $1.14       to       $1.14          $0                       0.00     to       0.00      7.86 %(5)      to       7.86 %(5) 

Col VP Bal, Cl 3

                                   

2023

     5,581          $2.59       to       $2.80          $17,115                 0.00     to       0.90      21.23     to       20.15

2022

     5,946          $2.14       to       $2.33          $15,098                 0.00     to       0.90      (16.74 %)      to       (17.49 %) 

2021

     6,268          $2.57       to       $2.83          $19,187                 0.00     to       0.90      14.74     to       13.71

2020

     6,627          $2.24       to       $2.49          $17,721                 0.00     to       0.90      17.59     to       16.53

2019

     6,990          $1.90       to       $2.13          $15,642                       0.00     to       0.90      22.78     to       21.68

Col VP Commodity Strategy, Cl 1

 

                                

2023

     41          $1.46       to       $1.46          $59          22.73      0.00     to       0.00      (6.82 %)      to       (6.82 %) 

2022

     38          $1.57       to       $1.57          $60          25.52      0.00     to       0.00      19.09     to       19.09

2021

     30          $1.32       to       $1.32          $39          0.21      0.00     to       0.00      32.63     to       32.63

2020

     11          $1.00       to       $1.00          $11          2.45      0.00     to       0.00      (1.29 %)      to       (1.29 %) 

2019

              $1.01       to       $1.01          $0                2.30      0.00     to       0.00      3.06 %(5)      to       3.06 %(5) 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      149  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Col VP Commodity Strategy, Cl 2

 

                                

2023

     40          $0.90       to       $0.90          $36          21.97      0.00     to       0.00      (7.13 %)      to       (7.13 %) 

2022

     38          $0.97       to       $0.97          $36          24.92      0.00     to       0.00      18.70     to       18.70

2021

     38          $0.81       to       $0.81          $31                 0.00     to       0.00      32.01     to       32.01

2020

     31          $0.62       to       $0.62          $19          19.21      0.00     to       0.00      (1.55 %)      to       (1.55 %) 

2019

     30          $0.63       to       $0.63          $19                0.92      0.00     to       0.00      7.78     to       7.78

Col VP Contrarian Core, Cl 1

                                   

2023

     153          $1.95       to       $1.95          $299                 0.00     to       0.00      32.21     to       32.21

2022

     105          $1.47       to       $1.47          $155                 0.00     to       0.00      (18.65 %)      to       (18.65 %) 

2021

     60          $1.81       to       $1.81          $108                 0.00     to       0.00      24.28     to       24.28

2020

     21          $1.46       to       $1.46          $31                 0.00     to       0.00      22.35     to       22.35

2019

              $1.19       to       $1.19          $0                       0.00     to       0.00      11.36 %(5)      to       11.36 %(5) 

Col VP Contrarian Core, Cl 2

                                   

2023

     62          $3.27       to       $3.27          $201                 0.00     to       0.00      31.89     to       31.89

2022

     51          $2.48       to       $2.48          $127                 0.00     to       0.00      (18.85 %)      to       (18.85 %) 

2021

     52          $3.05       to       $3.05          $158                 0.00     to       0.00      23.96     to       23.96

2020

     49          $2.46       to       $2.46          $120                 0.00     to       0.00      22.00     to       22.00

2019

     46          $2.02       to       $2.02          $92                       0.00     to       0.00      32.81     to       32.81

Col VP Disciplined Core, Cl 1

                                   

2023

     96          $1.71       to       $1.71          $165                 0.00     to       0.00      24.36     to       24.36

2022

     74          $1.37       to       $1.37          $101                 0.00     to       0.00      (18.72 %)      to       (18.72 %) 

2021

     25          $1.69       to       $1.69          $43                 0.00     to       0.00      32.74     to       32.74

2020

     0          $1.27       to       $1.27          $0                 0.00     to       0.00      14.12     to       14.12

2019

              $1.12       to       $1.12          $0                       0.00     to       0.00      8.51 %(5)      to       8.51 %(5) 

Col VP Disciplined Core, Cl 2

                                   

2023

     127          $3.66       to       $3.66          $465                 0.00     to       0.00      24.08     to       24.08

2022

     123          $2.95       to       $2.95          $362                 0.00     to       0.00      (18.94 %)      to       (18.94 %) 

2021

     124          $3.64       to       $3.64          $449                 0.00     to       0.00      32.43     to       32.43

2020

     121          $2.75       to       $2.75          $333                 0.00     to       0.00      13.83     to       13.83

2019

     114          $2.41       to       $2.41          $274                       0.00     to       0.00      24.47     to       24.47

Col VP Disciplined Core, Cl 3

                                   

2023

     8,714          $1.30       to       $2.97          $28,607                 0.20     to       0.90      23.98     to       23.12

2022

     9,379          $1.05       to       $2.41          $25,011                 0.20     to       0.90      5.12 %(8)      to       (19.56 %) 

2021

     9,994          $3.02       to       $3.00          $32,947                 0.30     to       0.90      32.17     to       31.38

2020

     10,852          $2.29       to       $2.28          $27,201                 0.30     to       0.90      13.64     to       12.96

2019

     11,866          $2.01       to       $2.02          $26,226                       0.30     to       0.90      24.26     to       23.52

Col VP Divd Opp, Cl 1

                                   

2023

     89          $1.48       to       $1.48          $131                 0.00     to       0.00      5.09     to       5.09

2022

     79          $1.41       to       $1.41          $111                 0.00     to       0.00      (1.11 %)      to       (1.11 %) 

2021

     57          $1.42       to       $1.42          $81                 0.00     to       0.00      26.16     to       26.16

2020

     10          $1.13       to       $1.13          $11                 0.00     to       0.00      1.15     to       1.15

2019

     0          $1.12       to       $1.12          $0                       0.00     to       0.00      7.17 %(5)      to       7.17 %(5) 

Col VP Divd Opp, Cl 2

                                   

2023

     89          $2.65       to       $2.65          $236                 0.00     to       0.00      4.84     to       4.84

2022

     60          $2.53       to       $2.53          $152                 0.00     to       0.00      (1.39 %)      to       (1.39 %) 

2021

     44          $2.57       to       $2.57          $113                 0.00     to       0.00      25.89     to       25.89

2020

     43          $2.04       to       $2.04          $88                 0.00     to       0.00      0.90     to       0.90

2019

     39          $2.02       to       $2.02          $79                       0.00     to       0.00      23.76     to       23.76

Col VP Divd Opp, Cl 3

                                   

2023

     3,106          $1.17       to       $4.34          $12,144                 0.20     to       0.90      4.74     to       4.02

2022

     3,286          $1.12       to       $4.18          $12,375                 0.20     to       0.90      12.24 %(8)      to       (2.12 %) 

2021

     3,425          $2.13       to       $4.27          $13,121                 0.30     to       0.90      25.64     to       24.89

2020

     3,630          $1.70       to       $3.42          $11,064                 0.30     to       0.90      0.72     to       0.12

2019

     3,919          $1.69       to       $3.41          $11,865                       0.30     to       0.90      23.55     to       22.81

 

150    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Col VP Emerg Mkts Bond, Cl 1

                                   

2023

     30          $1.03       to       $1.03          $31          5.72      0.00     to       0.00      10.43     to       10.43

2022

     23          $0.94       to       $0.94          $21          5.56      0.00     to       0.00      (16.03 %)      to       (16.03 %) 

2021

     2          $1.11       to       $1.11          $2          4.23      0.00     to       0.00      (2.20 %)      to       (2.20 %) 

2020

     0          $1.14       to       $1.14          $0          4.21      0.00     to       0.00      7.43     to       7.43

2019

              $1.06       to       $1.06          $0                9.53      0.00     to       0.00      1.46 %(5)      to       1.46 %(5) 

Col VP Emerg Mkts Bond, Cl 2

                                   

2023

     12          $1.25       to       $1.25          $15          4.98      0.00     to       0.00      10.02     to       10.02

2022

     18          $1.13       to       $1.13          $20          4.21      0.00     to       0.00      (16.16 %)      to       (16.16 %) 

2021

     16          $1.35       to       $1.35          $22          3.66      0.00     to       0.00      (2.45 %)      to       (2.45 %) 

2020

     8          $1.39       to       $1.39          $11          3.32      0.00     to       0.00      7.16     to       7.16

2019

     7          $1.29       to       $1.29          $9                4.78      0.00     to       0.00      12.09     to       12.09

Col VP Emer Mkts, Cl 1

                                   

2023

     197          $1.07       to       $1.07          $211          0.11      0.00     to       0.00      9.46     to       9.46

2022

     171          $0.98       to       $0.98          $168                 0.00     to       0.00      (32.90 %)      to       (32.90 %) 

2021

     77          $1.46       to       $1.46          $112          0.92      0.00     to       0.00      (7.20 %)      to       (7.20 %) 

2020

     31          $1.58       to       $1.58          $48          0.30      0.00     to       0.00      33.54     to       33.54

2019

     7          $1.18       to       $1.18          $9                0.01      0.00     to       0.00      12.89 %(5)      to       12.89 %(5) 

Col VP Emer Mkts, Cl 2

                                   

2023

     263          $1.33       to       $1.33          $350                 0.00     to       0.00      9.19     to       9.19

2022

     253          $1.22       to       $1.22          $308                 0.00     to       0.00      (33.07 %)      to       (33.07 %) 

2021

     250          $1.82       to       $1.82          $455          0.85      0.00     to       0.00      (7.47 %)      to       (7.47 %) 

2020

     235          $1.97       to       $1.97          $461          0.41      0.00     to       0.00      33.17     to       33.17

2019

     226          $1.48       to       $1.48          $333                0.14      0.00     to       0.00      31.27     to       31.27

Col VP Emer Mkts, Cl 3

                                   

2023

     768          $1.15       to       $3.51          $1,917                 0.20     to       0.90      9.09     to       8.33

2022

     829          $1.05       to       $3.24          $1,880                 0.20     to       0.90      6.78 %(8)      to       (33.58 %) 

2021

     848          $1.80       to       $4.88          $2,927          0.99      0.30     to       0.90      (7.61 %)      to       (8.16 %) 

2020

     833          $1.95       to       $5.32          $3,231          0.55      0.30     to       0.90      32.96     to       32.17

2019

     945          $1.47       to       $4.02          $2,752                0.18      0.30     to       0.90      31.03     to       30.25

Col VP Global Strategic Inc, Cl 2

 

                           

2023

     93          $0.95       to       $0.95          $89          3.09      0.00     to       0.00      9.47     to       9.47

2022

     93          $0.87       to       $0.87          $81          3.07      0.00     to       0.00      (13.63 %)      to       (13.63 %) 

2021

     92          $1.01       to       $1.01          $93          3.85      0.00     to       0.00      1.03     to       1.03

2020

     93          $1.00       to       $1.00          $93          4.87      0.00     to       0.00      4.59     to       4.59

2019

     89          $0.95       to       $0.95          $85                       0.00     to       0.00      10.75     to       10.75

Col VP Global Strategic Inc, Cl 3

 

                           

2023

     1,017          $1.12       to       $1.72          $1,265          3.20      0.20     to       0.90      9.59     to       8.82

2022

     1,038          $1.02       to       $1.58          $1,185          3.32      0.20     to       0.90      2.78 %(8)      to       (14.38 %) 

2021

     1,050          $1.06       to       $1.84          $1,395          3.84      0.30     to       0.90      0.84     to       0.23

2020

     1,023          $1.05       to       $1.84          $1,377          5.18      0.30     to       0.90      4.37     to       3.74

2019

     1,131          $1.01       to       $1.77          $1,478                       0.30     to       0.90      10.57     to       9.91

Col VP Govt Money Mkt, Cl 1

                                   

2023

     520          $1.08       to       $1.08          $562          4.69      0.00     to       0.00      4.73     to       4.73

2022

     162          $1.03       to       $1.03          $167          1.82      0.00     to       0.00      1.20     to       1.20

2021

     44          $1.02       to       $1.02          $45          0.01      0.00     to       0.00      0.01     to       0.01

2020

     3          $1.02       to       $1.02          $5          0.20      0.00     to       0.00      0.30     to       0.30

2019

              $1.02       to       $1.02          $2                2.87      0.00     to       0.00      0.89 %(5)      to       0.89 %(5) 

Col VP Govt Money Mkt, Cl 2

                                   

2023

     370          $1.09       to       $1.09          $404          4.37      0.00     to       0.00      4.46     to       4.46

2022

     488          $1.05       to       $1.05          $510          1.03      0.00     to       0.00      1.10     to       1.10

2021

     476          $1.03       to       $1.03          $492          0.01      0.00     to       0.00      0.02     to       0.02

2020

     375          $1.03       to       $1.03          $387          0.10      0.00     to       0.00      0.24     to       0.24

2019

     131          $1.03       to       $1.03          $135                1.58      0.00     to       0.00      1.64     to       1.64

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      151  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Col VP Govt Money Mkt, Cl 3

                                   

2023

     2,522          $1.08       to       $1.09          $2,635          4.51      0.20     to       0.90      4.39     to       3.66

2022

     2,647          $1.04       to       $1.05          $2,660          1.16      0.20     to       0.90      0.96     to       0.26

2021

     2,737          $1.03       to       $1.05          $2,734          0.01      0.20     to       0.90      (0.17 %)      to       (0.86 %) 

2020

     3,622          $1.03       to       $1.06          $3,637          0.23      0.20     to       0.90      0.08     to       (0.61 %) 

2019

     2,794          $1.03       to       $1.06          $2,820                1.71      0.20     to       0.90      1.56     to       0.86

Col VP Hi Yield Bond, Cl 1

                                   

2023

     99          $1.24       to       $1.24          $122          5.24      0.00     to       0.00      12.19     to       12.19

2022

     62          $1.10       to       $1.10          $68          5.76      0.00     to       0.00      (10.54 %)      to       (10.54 %) 

2021

     22          $1.23       to       $1.23          $27          4.97      0.00     to       0.00      4.98     to       4.98

2020

     9          $1.17       to       $1.17          $11          2.20      0.00     to       0.00      6.67     to       6.67

2019

              $1.10       to       $1.10          $0                10.99      0.00     to       0.00      4.96 %(5)      to       4.96 %(5) 

Col VP Hi Yield Bond, Cl 2

                                   

2023

     195          $1.64       to       $1.64          $319          5.30      0.00     to       0.00      11.87     to       11.87

2022

     193          $1.46       to       $1.46          $283          5.05      0.00     to       0.00      (10.78 %)      to       (10.78 %) 

2021

     189          $1.64       to       $1.64          $310          4.84      0.00     to       0.00      4.79     to       4.79

2020

     185          $1.56       to       $1.56          $290          5.62      0.00     to       0.00      6.31     to       6.31

2019

     178          $1.47       to       $1.47          $261                5.79      0.00     to       0.00      16.52     to       16.52

Col VP Hi Yield Bond, Cl 3

                                   

2023

     1,051          $1.14       to       $3.24          $2,638          5.42      0.20     to       0.90      11.86     to       11.08

2022

     1,041          $1.02       to       $2.92          $2,419          5.10      0.20     to       0.90      2.27 %(8)      to       (11.50 %) 

2021

     1,113          $1.53       to       $3.30          $2,890          4.98      0.30     to       0.90      4.55     to       3.92

2020

     1,091          $1.46       to       $3.17          $2,798          5.76      0.30     to       0.90      6.23     to       5.59

2019

     1,154          $1.38       to       $3.00          $2,857                5.81      0.30     to       0.90      16.37     to       15.67

Col VP Inc Opp, Cl 1

                                   

2023

     18          $1.22       to       $1.22          $22          5.21      0.00     to       0.00      11.56     to       11.56

2022

     17          $1.09       to       $1.09          $18          5.62      0.00     to       0.00      (10.01 %)      to       (10.01 %) 

2021

     15          $1.21       to       $1.21          $18          9.06      0.00     to       0.00      4.50     to       4.50

2020

     15          $1.16       to       $1.16          $17          0.05      0.00     to       0.00      5.90     to       5.90

2019

              $1.10       to       $1.10          $0                9.50      0.00     to       0.00      4.80 %(5)      to       4.80 %(5) 

Col VP Inc Opp, Cl 2

                                   

2023

     50          $1.59       to       $1.59          $80          5.57      0.00     to       0.00      11.36     to       11.36

2022

     31          $1.43       to       $1.43          $44          4.99      0.00     to       0.00      (10.22 %)      to       (10.22 %) 

2021

     20          $1.59       to       $1.59          $31          7.51      0.00     to       0.00      4.14     to       4.14

2020

     24          $1.53       to       $1.53          $36          4.49      0.00     to       0.00      5.67     to       5.67

2019

     19          $1.45       to       $1.45          $28                4.90      0.00     to       0.00      16.13     to       16.13

Col VP Inc Opp, Cl 3

                                   

2023

     534          $1.14       to       $2.32          $1,083          5.04      0.20     to       0.90      11.29     to       10.51

2022

     536          $1.02       to       $2.10          $1,015          5.25      0.20     to       0.90      2.16 %(8)      to       (11.02 %) 

2021

     554          $1.50       to       $2.36          $1,182          8.90      0.30     to       0.90      4.16     to       3.54

2020

     570          $1.44       to       $2.28          $1,181          4.67      0.30     to       0.90      5.42     to       4.79

2019

     626          $1.37       to       $2.17          $1,248                4.89      0.30     to       0.90      15.88     to       15.19

Col VP Inter Bond, Cl 1

                                   

2023

     82          $1.06       to       $1.06          $87          2.48      0.00     to       0.00      6.34     to       6.34

2022

     56          $1.00       to       $1.00          $56          3.29      0.00     to       0.00      (17.06 %)      to       (17.06 %) 

2021

     40          $1.21       to       $1.21          $48          3.30      0.00     to       0.00      (0.24 %)      to       (0.24 %) 

2020

     24          $1.21       to       $1.21          $29          1.31      0.00     to       0.00      12.58     to       12.58

2019

              $1.07       to       $1.07          $0                6.03      0.00     to       0.00      2.25 %(5)      to       2.25 %(5) 

Col VP Inter Bond, Cl 2

                                   

2023

     46          $1.19       to       $1.19          $55          2.13      0.00     to       0.00      6.08     to       6.08

2022

     37          $1.12       to       $1.12          $42          2.44      0.00     to       0.00      (17.22 %)      to       (17.22 %) 

2021

     49          $1.36       to       $1.36          $66          3.01      0.00     to       0.00      (0.58 %)      to       (0.58 %) 

2020

     48          $1.37       to       $1.37          $65          2.62      0.00     to       0.00      12.28     to       12.28

2019

     30          $1.22       to       $1.22          $36                2.96      0.00     to       0.00      9.03     to       9.03

 

152    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Col VP Inter Bond, Cl 3

                                   

2023

     3,460          $1.08       to       $1.83          $5,536          2.20      0.20     to       0.90      5.98     to       5.24

2022

     3,592          $1.02       to       $1.74          $5,476          3.08      0.20     to       0.90      1.80 %(8)      to       (17.91 %) 

2021

     3,718          $1.37       to       $2.12          $6,924          3.19      0.30     to       0.90      (0.65 %)      to       (1.25 %) 

2020

     3,859          $1.38       to       $2.15          $7,336          2.77      0.30     to       0.90      12.11     to       11.44

2019

     3,987          $1.23       to       $1.93          $6,835                3.09      0.30     to       0.90      8.79     to       8.14

Col VP Lg Cap Gro, Cl 1

                                   

2023

     829          $2.04       to       $2.04          $1,690                 0.00     to       0.00      43.16     to       43.16

2022

     514          $1.42       to       $1.42          $731                 0.00     to       0.00      (31.38 %)      to       (31.38 %) 

2021

     167          $2.07       to       $2.07          $346                 0.00     to       0.00      28.73     to       28.73

2020

     58          $1.61       to       $1.61          $94                 0.00     to       0.00      34.74     to       34.74

2019

     0          $1.20       to       $1.20          $0                       0.00     to       0.00      11.18 %(5)      to       11.18 %(5) 

Col VP Lg Cap Gro, Cl 2

                                   

2023

     105          $4.49       to       $4.49          $470                 0.00     to       0.00      42.77     to       42.77

2022

     95          $3.15       to       $3.15          $298                 0.00     to       0.00      (31.53 %)      to       (31.53 %) 

2021

     85          $4.59       to       $4.59          $392                 0.00     to       0.00      28.35     to       28.35

2020

     73          $3.58       to       $3.58          $261                 0.00     to       0.00      34.41     to       34.41

2019

     49          $2.66       to       $2.66          $131                       0.00     to       0.00      35.53     to       35.53

Col VP Lg Cap Gro, Cl 3

                                   

2023

     703          $1.45       to       $2.91          $3,402                 0.20     to       0.90      42.66     to       41.67

2022

     761          $1.01       to       $2.06          $2,585                 0.20     to       0.90      2.68 %(8)      to       (32.06 %) 

2021

     809          $3.90       to       $3.03          $3,968                 0.30     to       0.90      28.15     to       27.39

2020

     928          $3.04       to       $2.38          $3,407                 0.30     to       0.90      34.16     to       33.36

2019

     982          $2.27       to       $1.78          $2,612                       0.30     to       0.90      35.35     to       34.54

Col VP Lg Cap Index, Cl 1

                                   

2023

     2,812          $1.83       to       $1.83          $5,146                 0.00     to       0.00      25.96     to       25.96

2022

     1,730          $1.45       to       $1.45          $2,514                 0.00     to       0.00      (18.34 %)      to       (18.34 %) 

2021

     791          $1.78       to       $1.78          $1,407                 0.00     to       0.00      28.39     to       28.39

2020

     261          $1.39       to       $1.39          $361                 0.00     to       0.00      18.03     to       18.03

2019

     9          $1.17       to       $1.17          $10                       0.00     to       0.00      10.64 %(5)      to       10.64 %(5) 

Col VP Lg Cap Index, Cl 3

                                   

2023

     3,051          $3.88       to       $3.98          $14,291                 0.00     to       0.90      25.81     to       24.69

2022

     3,028          $3.08       to       $3.19          $11,465                 0.00     to       0.90      (18.45 %)      to       (19.18 %) 

2021

     3,012          $3.78       to       $3.95          $14,197                 0.00     to       0.90      28.22     to       27.07

2020

     3,144          $2.95       to       $3.11          $11,530                 0.00     to       0.90      17.90     to       16.85

2019

     3,292          $2.50       to       $2.66          $10,253                       0.00     to       0.90      30.95     to       29.78

Col VP Limited Duration Cr, Cl 1

 

                           

2023

     20          $1.12       to       $1.12          $22          3.31      0.00     to       0.00      6.89     to       6.89

2022

     17          $1.05       to       $1.05          $18          0.75      0.00     to       0.00      (6.08 %)      to       (6.08 %) 

2021

     9          $1.12       to       $1.12          $11          0.21      0.00     to       0.00      (0.60 %)      to       (0.60 %) 

2020

              $1.12       to       $1.12          $0          2.71      0.00     to       0.00      5.90     to       5.90

2019

              $1.06       to       $1.06          $0                4.43      0.00     to       0.00      2.29 %(5)      to       2.29 %(5) 

Col VP Limited Duration Cr, Cl 2

 

                           

2023

     820          $1.20       to       $1.03          $875          2.34      0.00     to       0.90      6.66     to       5.70

2022

     1,388          $1.12       to       $0.97          $1,459          0.39      0.00     to       0.90      (6.36 %)      to       (7.20 %) 

2021

     636          $1.20       to       $1.05          $681          1.39      0.00     to       0.90      (0.84 %)      to       (1.74 %) 

2020

     569          $1.21       to       $1.06          $617          2.40      0.00     to       0.90      5.57     to       4.62

2019

     543          $1.14       to       $1.02          $560                1.99      0.00     to       0.90      7.47     to       6.50

Col VP Long Govt/Cr Bond, Cl 1

 

                                

2023

     10          $1.03       to       $1.03          $10          3.45      0.00     to       0.00      6.97     to       6.97

2022

     11          $0.96       to       $0.96          $11          3.53      0.00     to       0.00      (27.55 %)      to       (27.55 %) 

2021

     3          $1.33       to       $1.33          $3          2.54      0.00     to       0.00      (3.21 %)      to       (3.21 %) 

2020

     1          $1.37       to       $1.37          $1          2.75      0.00     to       0.00      17.25     to       17.25

2019

     0          $1.17       to       $1.17          $0                4.66      0.00     to       0.00      5.74 %(5)      to       5.74 %(5) 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      153  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Col VP Long Govt/Cr Bond, Cl 2

 

                                

2023

     7          $1.18       to       $1.18          $9          3.12      0.00     to       0.00      6.68     to       6.68

2022

     7          $1.10       to       $1.10          $8          2.49      0.00     to       0.00      (27.70 %)      to       (27.70 %) 

2021

     6          $1.53       to       $1.53          $10          1.75      0.00     to       0.00      (3.47 %)      to       (3.47 %) 

2020

     6          $1.58       to       $1.58          $10          2.69      0.00     to       0.00      17.07     to       17.07

2019

     2          $1.35       to       $1.35          $2                0.33      0.00     to       0.00      19.42     to       19.42

Col VP Overseas Core, Cl 1

 

                                

2023

     170          $1.33       to       $1.33          $225          1.79      0.00     to       0.00      15.64     to       15.64

2022

     140          $1.15       to       $1.15          $161          0.61      0.00     to       0.00      (14.68 %)      to       (14.68 %) 

2021

     58          $1.35       to       $1.35          $78          1.39      0.00     to       0.00      9.96     to       9.96

2020

              $1.22       to       $1.22          $0          1.69      0.00     to       0.00      9.11     to       9.11

2019

              $1.12       to       $1.12          $0                3.96      0.00     to       0.00      10.34 %(5)      to       10.34 %(5) 

Col VP Overseas Core, Cl 2

 

                                

2023

     103          $1.77       to       $1.77          $183          1.71      0.00     to       0.00      15.32     to       15.32

2022

     101          $1.53       to       $1.53          $154          0.73      0.00     to       0.00      (14.90 %)      to       (14.90 %) 

2021

     94          $1.80       to       $1.80          $170          1.10      0.00     to       0.00      9.74     to       9.74

2020

     80          $1.64       to       $1.64          $132          1.46      0.00     to       0.00      8.83     to       8.83

2019

     66          $1.51       to       $1.51          $99                1.81      0.00     to       0.00      25.15     to       25.15

Col VP Overseas Core, Cl 3

 

                                

2023

     3,265          $1.32       to       $1.33          $4,688          1.82      0.20     to       0.90      15.24     to       14.44

2022

     3,464          $1.14       to       $1.16          $4,341          0.79      0.20     to       0.90      15.40 %(8)      to       (15.56 %) 

2021

     3,611          $1.55       to       $1.38          $5,339          1.18      0.30     to       0.90      9.55     to       8.90

2020

     3,879          $1.41       to       $1.27          $5,232          1.56      0.30     to       0.90      8.60     to       7.95

2019

     4,209          $1.30       to       $1.17          $5,266                1.97      0.30     to       0.90      24.95     to       24.20

Col VP Select Lg Cap Val, Cl 1

 

                                

2023

     419          $1.57       to       $1.57          $659                 0.00     to       0.00      5.39     to       5.39

2022

     238          $1.49       to       $1.49          $355                 0.00     to       0.00      (1.84 %)      to       (1.84 %) 

2021

     70          $1.52       to       $1.52          $106                 0.00     to       0.00      26.29     to       26.29

2020

     4          $1.20       to       $1.20          $5                 0.00     to       0.00      7.08     to       7.08

2019

     0          $1.12       to       $1.12          $0                       0.00     to       0.00      11.84 %(5)      to       11.84 %(5) 

Col VP Select Lg Cap Val, Cl 2

 

                                

2023

     44          $3.27       to       $3.27          $146                 0.00     to       0.00      5.11     to       5.11

2022

     39          $3.11       to       $3.11          $121                 0.00     to       0.00      (2.06 %)      to       (2.06 %) 

2021

     34          $3.18       to       $3.18          $107                 0.00     to       0.00      25.98     to       25.98

2020

     32          $2.52       to       $2.52          $81                 0.00     to       0.00      6.81     to       6.81

2019

     28          $2.36       to       $2.36          $66                       0.00     to       0.00      26.43     to       26.43

Col VP Select Lg Cap Val, Cl 3

 

                           

2023

     264          $1.17       to       $3.29          $911                 0.20     to       0.90      5.02     to       4.29

2022

     283          $1.11       to       $3.15          $940                 0.20     to       0.90      12.68 %(8)      to       (2.83 %) 

2021

     276          $2.41       to       $3.24          $928                 0.30     to       0.90      25.77     to       25.02

2020

     264          $1.91       to       $2.59          $710                 0.30     to       0.90      6.63     to       6.00

2019

     270          $1.79       to       $2.45          $694                       0.30     to       0.90      26.16     to       25.41

Col VP Select Mid Cap Gro, Cl 1

 

                           

2023

     197          $1.59       to       $1.59          $313                 0.00     to       0.00      25.24     to       25.24

2022

     160          $1.27       to       $1.27          $203                 0.00     to       0.00      (30.83 %)      to       (30.83 %) 

2021

     78          $1.84       to       $1.84          $143                 0.00     to       0.00      16.57     to       16.57

2020

     52          $1.58       to       $1.58          $82                 0.00     to       0.00      35.42     to       35.42

2019

     0          $1.16       to       $1.16          $0                       0.00     to       0.00      8.21 %(5)      to       8.21 %(5) 

Col VP Select Mid Cap Gro, Cl 2

 

                           

2023

     30          $3.18       to       $3.18          $95                 0.00     to       0.00      24.92     to       24.92

2022

     27          $2.55       to       $2.55          $70                 0.00     to       0.00      (31.01 %)      to       (31.01 %) 

2021

     30          $3.69       to       $3.69          $109                 0.00     to       0.00      16.27     to       16.27

2020

     28          $3.17       to       $3.17          $90                 0.00     to       0.00      35.08     to       35.08

2019

     28          $2.35       to       $2.35          $67                       0.00     to       0.00      34.83     to       34.83

 

154    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Col VP Select Mid Cap Gro, Cl 3

 

                           

2023

     256          $1.26       to       $4.41          $1,030                 0.20     to       0.90      24.84     to       23.97

2022

     220          $1.01       to       $3.56          $804                 0.20     to       0.90      2.87 %(8)      to       (31.54 %) 

2021

     245          $3.04       to       $5.20          $1,252                 0.30     to       0.90      16.06     to       15.36

2020

     244          $2.62       to       $4.51          $1,122                 0.30     to       0.90      34.83     to       34.02

2019

     246          $1.94       to       $3.36          $913                       0.30     to       0.90      34.61     to       33.81

Col VP Select Mid Cap Val, Cl 1

 

                           

2023

     182          $1.60       to       $1.60          $290                 0.00     to       0.00      10.30     to       10.30

2022

     139          $1.45       to       $1.45          $201                 0.00     to       0.00      (9.44 %)      to       (9.44 %) 

2021

     41          $1.60       to       $1.60          $66                 0.00     to       0.00      32.33     to       32.33

2020

     4          $1.21       to       $1.21          $5                 0.00     to       0.00      7.48     to       7.48

2019

     2          $1.12       to       $1.12          $2                       0.00     to       0.00      9.78 %(5)      to       9.78 %(5) 

Col VP Select Mid Cap Val, Cl 2

 

                           

2023

     51          $3.10       to       $3.10          $158                 0.00     to       0.00      10.05     to       10.05

2022

     47          $2.82       to       $2.82          $133                 0.00     to       0.00      (9.66 %)      to       (9.66 %) 

2021

     39          $3.12       to       $3.12          $123                 0.00     to       0.00      31.97     to       31.97

2020

     35          $2.36       to       $2.36          $84                 0.00     to       0.00      7.25     to       7.25

2019

     28          $2.20       to       $2.20          $61                       0.00     to       0.00      31.25     to       31.25

Col VP Select Mid Cap Val, Cl 3

 

                           

2023

     250          $1.19       to       $3.06          $906                 0.20     to       0.90      9.96     to       9.20

2022

     216          $1.08       to       $2.80          $800                 0.20     to       0.90      9.03 %(8)      to       (10.37 %) 

2021

     224          $2.35       to       $3.13          $938                 0.30     to       0.90      31.74     to       30.95

2020

     229          $1.78       to       $2.39          $726                 0.30     to       0.90      7.09     to       6.45

2019

     244          $1.66       to       $2.25          $724                       0.30     to       0.90      31.03     to       30.24

Col VP Select Sm Cap Val, Cl 1

 

                           

2023

     71          $1.39       to       $1.39          $99                 0.00     to       0.00      13.14     to       13.14

2022

     47          $1.23       to       $1.23          $57                 0.00     to       0.00      (14.70 %)      to       (14.70 %) 

2021

     19          $1.44       to       $1.44          $27                 0.00     to       0.00      30.93     to       30.93

2020

     6          $1.10       to       $1.10          $7                 0.00     to       0.00      9.19     to       9.19

2019

              $1.01       to       $1.01          $0                       0.00     to       0.00      5.21 %(5)      to       5.21 %(5) 

Col VP Select Sm Cap Val, Cl 2

 

                           

2023

     54          $2.79       to       $2.79          $150                 0.00     to       0.00      12.85     to       12.85

2022

     50          $2.47       to       $2.47          $123                 0.00     to       0.00      (14.93 %)      to       (14.93 %) 

2021

     41          $2.90       to       $2.90          $119                 0.00     to       0.00      30.62     to       30.62

2020

     37          $2.22       to       $2.22          $82                 0.00     to       0.00      8.92     to       8.92

2019

     33          $2.04       to       $2.04          $67                       0.00     to       0.00      17.44     to       17.44

Col VP Select Sm Cap Val, Cl 3

 

                           

2023

     270          $1.19       to       $3.89          $1,118                 0.20     to       0.90      12.75     to       11.97

2022

     254          $1.05       to       $3.48          $1,013                 0.20     to       0.90      5.87 %(8)      to       (15.58 %) 

2021

     267          $2.09       to       $4.12          $1,261                 0.30     to       0.90      30.41     to       29.63

2020

     328          $1.60       to       $3.18          $1,182                 0.30     to       0.90      8.73     to       8.08

2019

     359          $1.47       to       $2.94          $1,202                       0.30     to       0.90      17.23     to       16.53

Col VP Sel Gbl Tech, Cl 1

 

                           

2023

     147          $1.25       to       $1.25          $184                 0.00     to       0.00      45.28     to       45.28

2022

     71          $0.86       to       $0.86          $61                       0.00     to       0.00      (15.48 %)(7)      to       (15.48 %)(7) 

Col VP Sel Gbl Tech, Cl 2

 

                           

2023

     33          $1.25       to       $1.25          $41                 0.00     to       0.00      44.87     to       44.87

2022

     2          $0.86       to       $0.86          $2                       0.00     to       0.00      (15.57 %)(7)      to       (15.57 %)(7) 

Col VP Strategic Inc, Cl 1

 

                           

2023

     128          $1.13       to       $1.13          $145          3.67      0.00     to       0.00      9.67     to       9.67

2022

     92          $1.03       to       $1.03          $95          2.87      0.00     to       0.00      (11.37 %)      to       (11.37 %) 

2021

     73          $1.17       to       $1.17          $85          5.75      0.00     to       0.00      2.09     to       2.09

2020

     57          $1.14       to       $1.14          $65          4.79      0.00     to       0.00      6.82     to       6.82

2019

              $1.07       to       $1.07          $0                7.17      0.00     to       0.00      2.95 %(5)      to       2.95 %(5) 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      155  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Col VP Strategic Inc, Cl 2

 

                           

2023

     132          $1.36       to       $1.36          $180          3.31      0.00     to       0.00      9.20     to       9.20

2022

     103          $1.25       to       $1.25          $128          2.45      0.00     to       0.00      (11.52 %)      to       (11.52 %) 

2021

     110          $1.41       to       $1.41          $155          5.10      0.00     to       0.00      1.63     to       1.63

2020

     111          $1.39       to       $1.39          $154          3.36      0.00     to       0.00      6.62     to       6.62

2019

     77          $1.30       to       $1.30          $101                4.15      0.00     to       0.00      10.22     to       10.22

Col VP US Govt Mtge, Cl 1

 

                           

2023

     17          $1.00       to       $1.00          $17          3.16      0.00     to       0.00      5.70     to       5.70

2022

     13          $0.94       to       $0.94          $12          2.52      0.00     to       0.00      (14.14 %)      to       (14.14 %) 

2021

     6          $1.10       to       $1.10          $6          1.78      0.00     to       0.00      (0.95 %)      to       (0.95 %) 

2020

     2          $1.11       to       $1.11          $2          4.40      0.00     to       0.00      5.09     to       5.09

2019

              $1.06       to       $1.06          $0                5.18      0.00     to       0.00      2.15 %(5)      to       2.15 %(5) 

Col VP US Govt Mtge, Cl 2

 

                           

2023

     17          $1.12       to       $1.12          $19          2.64      0.00     to       0.00      5.43     to       5.43

2022

     9          $1.06       to       $1.06          $10          2.03      0.00     to       0.00      (14.32 %)      to       (14.32 %) 

2021

     5          $1.24       to       $1.24          $7          1.85      0.00     to       0.00      (1.20 %)      to       (1.20 %) 

2020

     4          $1.26       to       $1.26          $6          2.43      0.00     to       0.00      4.85     to       4.85

2019

     4          $1.20       to       $1.20          $5                2.55      0.00     to       0.00      6.50     to       6.50

Col VP US Govt Mtge, Cl 3

 

                           

2023

     982          $1.07       to       $1.29          $1,186          2.66      0.20     to       0.90      5.35     to       4.61

2022

     993          $1.02       to       $1.24          $1,145          2.02      0.20     to       0.90      2.31 %(8)      to       (15.03 %) 

2021

     1,027          $1.26       to       $1.46          $1,391          1.95      0.30     to       0.90      (1.36 %)      to       (1.96 %) 

2020

     1,040          $1.27       to       $1.49          $1,435          2.43      0.30     to       0.90      4.64     to       4.01

2019

     1,066          $1.22       to       $1.43          $1,413                2.65      0.30     to       0.90      6.29     to       5.66

CS Commodity Return, Cl 1

 

                           

2023

     485          $0.88       to       $0.61          $406          20.79      0.20     to       0.90      (9.30 %)      to       (9.93 %) 

2022

     538          $0.97       to       $0.68          $501          15.76      0.20     to       0.90      (2.05 %)(8)      to       14.99

2021

     491          $0.82       to       $0.59          $391          4.98      0.30     to       0.90      27.52     to       26.75

2020

     510          $0.64       to       $0.46          $296          5.78      0.30     to       0.90      (1.77 %)      to       (2.36 %) 

2019

     553          $0.65       to       $0.48          $317                0.87      0.30     to       0.90      6.37     to       5.73

CTIVP AC Div Bond, Cl 1

 

                           

2023

     30          $1.05       to       $1.05          $31          3.37      0.00     to       0.00      5.59     to       5.59

2022

     31          $0.99       to       $0.99          $30          3.72      0.00     to       0.00      (15.29 %)      to       (15.29 %) 

2021

     8          $1.17       to       $1.17          $9          1.74      0.00     to       0.00      0.45     to       0.45

2020

     2          $1.16       to       $1.16          $3          0.44      0.00     to       0.00      8.55     to       8.55

2019

     0          $1.07       to       $1.07          $0                10.24      0.00     to       0.00      2.34 %(5)      to       2.34 %(5) 

CTIVP AC Div Bond, Cl 2

 

                           

2023

     16          $1.16       to       $1.16          $18          3.10      0.00     to       0.00      5.33     to       5.33

2022

     16          $1.10       to       $1.10          $17          2.92      0.00     to       0.00      (15.51 %)      to       (15.51 %) 

2021

     14          $1.30       to       $1.30          $18          2.31      0.00     to       0.00      0.29     to       0.29

2020

     0          $1.30       to       $1.30          $1          2.73      0.00     to       0.00      8.24     to       8.24

2019

     2          $1.20       to       $1.20          $2                5.17      0.00     to       0.00      9.40     to       9.40

CTIVP BR Gl Infl Prot Sec, Cl 1

 

                           

2023

     36          $1.04       to       $1.04          $38          9.56      0.00     to       0.00      4.10     to       4.10

2022

     58          $1.00       to       $1.00          $58          2.80      0.00     to       0.00      (17.51 %)      to       (17.51 %) 

2021

     45          $1.21       to       $1.21          $54          0.66      0.00     to       0.00      4.56     to       4.56

2020

     7          $1.16       to       $1.16          $8          0.69      0.00     to       0.00      9.37     to       9.37

2019

     6          $1.06       to       $1.06          $7                0.18      0.00     to       0.00      0.83 %(5)      to       0.83 %(5) 

CTIVP BR Gl Infl Prot Sec, Cl 2

 

                           

2023

     14          $1.18       to       $1.18          $17          8.11      0.00     to       0.00      3.89     to       3.89

2022

     17          $1.14       to       $1.14          $19          4.47      0.00     to       0.00      (17.69 %)      to       (17.69 %) 

2021

     15          $1.38       to       $1.38          $21          0.55      0.00     to       0.00      4.43     to       4.43

2020

     16          $1.33       to       $1.33          $21          0.46      0.00     to       0.00      8.97     to       8.97

2019

     18          $1.22       to       $1.22          $22                2.99      0.00     to       0.00      7.63     to       7.63

 

156    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

CTIVP BR Gl Infl Prot Sec, Cl 3

 

                           

2023

     400          $1.07       to       $1.46          $555          8.72      0.20     to       0.90      3.75     to       3.02

2022

     421          $1.03       to       $1.41          $568          4.44      0.20     to       0.90      5.32 %(8)      to       (18.32 %) 

2021

     437          $1.40       to       $1.73          $720          0.68      0.30     to       0.90      4.17     to       3.54

2020

     429          $1.34       to       $1.67          $682          0.56      0.30     to       0.90      8.79     to       8.14

2019

     470          $1.23       to       $1.54          $692                3.17      0.30     to       0.90      7.49     to       6.85

CTIVP CenterSquare Real Est, Cl 1

 

                           

2023

     49          $1.29       to       $1.29          $64          2.17      0.00     to       0.00      13.76     to       13.76

2022

     38          $1.14       to       $1.14          $43          1.71      0.00     to       0.00      (24.12 %)      to       (24.12 %) 

2021

     22          $1.50       to       $1.50          $33          1.38      0.00     to       0.00      41.44     to       41.44

2020

     16          $1.06       to       $1.06          $17          0.72      0.00     to       0.00      (4.86 %)      to       (4.86 %) 

2019

     0          $1.11       to       $1.11          $0                2.21      0.00     to       0.00      5.32 %(5)      to       5.32 %(5) 

CTIVP CenterSquare Real Est, Cl 2

 

                           

2023

     115          $1.85       to       $1.85          $213          1.81      0.00     to       0.00      13.56     to       13.56

2022

     121          $1.63       to       $1.63          $197          1.33      0.00     to       0.00      (24.33 %)      to       (24.33 %) 

2021

     116          $2.16       to       $2.16          $251          1.13      0.00     to       0.00      41.20     to       41.20

2020

     95          $1.53       to       $1.53          $146          4.29      0.00     to       0.00      (5.19 %)      to       (5.19 %) 

2019

     86          $1.61       to       $1.61          $139                1.64      0.00     to       0.00      26.16     to       26.16

CTIVP MFS Val, Cl 1

 

                           

2023

     136          $1.53       to       $1.53          $208                 0.00     to       0.00      8.04     to       8.04

2022

     90          $1.41       to       $1.41          $127                 0.00     to       0.00      (6.10 %)      to       (6.10 %) 

2021

     43          $1.51       to       $1.51          $64                 0.00     to       0.00      25.43     to       25.43

2020

     24          $1.20       to       $1.20          $29                 0.00     to       0.00      3.57     to       3.57

2019

     21          $1.16       to       $1.16          $24                       0.00     to       0.00      9.71 %(5)      to       9.71 %(5) 

CTIVP MFS Val, Cl 2

 

                           

2023

     85          $2.96       to       $2.96          $252                 0.00     to       0.00      7.77     to       7.77

2022

     69          $2.75       to       $2.75          $191                 0.00     to       0.00      (6.36 %)      to       (6.36 %) 

2021

     67          $2.94       to       $2.94          $196                 0.00     to       0.00      25.11     to       25.11

2020

     65          $2.35       to       $2.35          $153                 0.00     to       0.00      3.34     to       3.34

2019

     78          $2.27       to       $2.27          $177                       0.00     to       0.00      29.51     to       29.51

CTIVP MS Adv, Cl 1

 

                           

2023

     104          $1.45       to       $1.45          $151                 0.00     to       0.00      31.00     to       31.00

2022

     85          $1.11       to       $1.11          $94                 0.00     to       0.00      (41.07 %)      to       (41.07 %) 

2021

     16          $1.88       to       $1.88          $31                 0.00     to       0.00      (4.11 %)      to       (4.11 %) 

2020

     4          $1.96       to       $1.96          $9                 0.00     to       0.00      75.91     to       75.91

2019

     0          $1.11       to       $1.11          $0                       0.00     to       0.00      (0.42 %)(5)      to       (0.42 %)(5) 

CTIVP MS Adv, Cl 2

 

                           

2023

     21          $3.35       to       $3.35          $71                 0.00     to       0.00      30.62     to       30.62

2022

     20          $2.57       to       $2.57          $51                 0.00     to       0.00      (41.21 %)      to       (41.21 %) 

2021

     21          $4.37       to       $4.37          $90                 0.00     to       0.00      (4.35 %)      to       (4.35 %) 

2020

     13          $4.57       to       $4.57          $59                 0.00     to       0.00      75.49     to       75.49

2019

     7          $2.60       to       $2.60          $19                       0.00     to       0.00      26.86     to       26.86

CTIVP Prin Blue Chip Gro, Cl 1

 

                           

2023

     64          $1.84       to       $1.84          $119                 0.00     to       0.00      39.54     to       39.54

2022

     55          $1.32       to       $1.32          $73                 0.00     to       0.00      (28.00 %)      to       (28.00 %) 

2021

     38          $1.84       to       $1.84          $70                 0.00     to       0.00      18.57     to       18.57

2020

     1          $1.55       to       $1.55          $2                 0.00     to       0.00      31.93     to       31.93

2019

              $1.17       to       $1.17          $0                       0.00     to       0.00      7.59 %(5)      to       7.59 %(5) 

CTIVP Prin Blue Chip Gro, Cl 2

 

                           

2023

     18          $4.37       to       $4.37          $78                 0.00     to       0.00      39.21     to       39.21

2022

     17          $3.14       to       $3.14          $54                 0.00     to       0.00      (28.19 %)      to       (28.19 %) 

2021

     18          $4.37       to       $4.37          $79                 0.00     to       0.00      18.28     to       18.28

2020

     17          $3.70       to       $3.70          $65                 0.00     to       0.00      31.61     to       31.61

2019

     17          $2.81       to       $2.81          $47                       0.00     to       0.00      31.43     to       31.43

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      157  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

CTIVP T Rowe Price LgCap Val, Cl 1

 

                           

2023

     122          $1.53       to       $1.53          $187                 0.00     to       0.00      9.59     to       9.59

2022

     82          $1.40       to       $1.40          $115                 0.00     to       0.00      (4.96 %)      to       (4.96 %) 

2021

     70          $1.47       to       $1.47          $103                 0.00     to       0.00      25.29     to       25.29

2020

     12          $1.17       to       $1.17          $14                 0.00     to       0.00      2.67     to       2.67

2019

              $1.14       to       $1.14          $0                       0.00     to       0.00      9.26 %(5)      to       9.26 %(5) 

CTIVP T Rowe Price LgCap Val, Cl 2

 

                           

2023

     52          $2.52       to       $2.52          $131                 0.00     to       0.00      9.28     to       9.28

2022

     50          $2.31       to       $2.31          $114                 0.00     to       0.00      (5.17 %)      to       (5.17 %) 

2021

     40          $2.43       to       $2.43          $98                 0.00     to       0.00      24.98     to       24.98

2020

     29          $1.95       to       $1.95          $57                 0.00     to       0.00      2.43     to       2.43

2019

     14          $1.90       to       $1.90          $26                       0.00     to       0.00      26.22     to       26.22

CTIVP TCW Core Plus Bond, Cl 1

 

                           

2023

     83          $1.05       to       $1.05          $87          2.36      0.00     to       0.00      5.92     to       5.92

2022

     59          $0.99       to       $0.99          $58          1.16      0.00     to       0.00      (14.19 %)      to       (14.19 %) 

2021

     46          $1.16       to       $1.16          $53          1.38      0.00     to       0.00      (1.14 %)      to       (1.14 %) 

2020

     41          $1.17       to       $1.17          $48          3.12      0.00     to       0.00      8.88     to       8.88

2019

     0          $1.07       to       $1.07          $0                3.28      0.00     to       0.00      2.59 %(5)      to       2.59 %(5) 

CTIVP TCW Core Plus Bond, Cl 2

 

                           

2023

     36          $1.13       to       $1.13          $41          1.96      0.00     to       0.00      5.54     to       5.54

2022

     20          $1.07       to       $1.07          $21          0.87      0.00     to       0.00      (14.31 %)      to       (14.31 %) 

2021

     21          $1.25       to       $1.25          $26          1.16      0.00     to       0.00      (1.41 %)      to       (1.41 %) 

2020

     18          $1.27       to       $1.27          $23          2.53      0.00     to       0.00      8.67     to       8.67

2019

     6          $1.17       to       $1.17          $7                2.83      0.00     to       0.00      8.58     to       8.58

CTIVP Vty Sycamore Estb Val, Cl 1

 

                           

2023

     322          $1.72       to       $1.72          $554                 0.00     to       0.00      9.92     to       9.92

2022

     233          $1.57       to       $1.57          $365                 0.00     to       0.00      (2.75 %)      to       (2.75 %) 

2021

     91          $1.61       to       $1.61          $146                 0.00     to       0.00      31.90     to       31.90

2020

     19          $1.22       to       $1.22          $23                 0.00     to       0.00      8.05     to       8.05

2019

     14          $1.13       to       $1.13          $16                       0.00     to       0.00      9.03 %(5)      to       9.03 %(5) 

CTIVP Vty Sycamore Estb Val, Cl 2

 

                           

2023

     144          $3.70       to       $3.70          $535                 0.00     to       0.00      9.67     to       9.67

2022

     133          $3.37       to       $3.37          $447                 0.00     to       0.00      (3.00 %)      to       (3.00 %) 

2021

     128          $3.48       to       $3.48          $446                 0.00     to       0.00      31.55     to       31.55

2020

     130          $2.64       to       $2.64          $343                 0.00     to       0.00      7.80     to       7.80

2019

     103          $2.45       to       $2.45          $254                       0.00     to       0.00      27.85     to       27.85

CTIVP Vty Sycamore Estb Val, Cl 3

 

                           

2023

     271          $1.21       to       $4.11          $1,248                 0.20     to       0.90      9.59     to       8.83

2022

     256          $1.10       to       $3.78          $1,135                 0.20     to       0.90      10.35 %(8)      to       (3.75 %) 

2021

     273          $2.76       to       $3.92          $1,267                 0.30     to       0.90      31.35     to       30.57

2020

     267          $2.10       to       $3.00          $919                 0.30     to       0.90      7.58     to       6.94

2019

     260          $1.95       to       $2.81          $817                       0.30     to       0.90      27.63     to       26.86

CTIVP Westfield Mid Cap Gro, Cl 1

 

                           

2023

     49          $1.68       to       $1.68          $82                 0.00     to       0.00      25.48     to       25.48

2022

     38          $1.34       to       $1.34          $50                 0.00     to       0.00      (25.60 %)      to       (25.60 %) 

2021

     8          $1.80       to       $1.80          $14                 0.00     to       0.00      16.72     to       16.72

2020

     1          $1.54       to       $1.54          $2                 0.00     to       0.00      27.50     to       27.50

2019

     0          $1.21       to       $1.21          $0                       0.00     to       0.00      12.05 %(5)      to       12.05 %(5) 

CTIVP Westfield Mid Cap Gro, Cl 2

 

                           

2023

     22          $3.23       to       $3.23          $70                 0.00     to       0.00      25.17     to       25.17

2022

     21          $2.58       to       $2.58          $55                 0.00     to       0.00      (25.79 %)      to       (25.79 %) 

2021

     23          $3.47       to       $3.47          $81                 0.00     to       0.00      16.41     to       16.41

2020

     20          $2.98       to       $2.98          $61                 0.00     to       0.00      27.18     to       27.18

2019

     11          $2.35       to       $2.35          $25                       0.00     to       0.00      41.80     to       41.80

 

158    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Del Ivy VIP Asset Strategy, Cl II

 

                           

2023

     37          $1.53       to       $1.32          $55          1.78      0.00     to       0.90      13.94     to       12.92

2022

     50          $1.35       to       $1.17          $63          1.60      0.00     to       0.90      (14.74 %)      to       (15.50 %) 

2021

     51          $1.58       to       $1.38          $74          1.32      0.00     to       0.90      10.44     to       9.45

2020

     94          $1.43       to       $1.26          $124          1.95      0.00     to       0.90      13.88     to       12.86

2019

     123          $1.26       to       $1.12          $142                2.46      0.00     to       0.90      21.78     to       20.69

DWS Alt Asset Alloc VIP, Cl A

 

                           

2023

     22          $1.25       to       $1.25          $27          5.79      0.00     to       0.00      6.19     to       6.19

2022

     10          $1.18       to       $1.18          $12          3.95      0.00     to       0.00      (7.42 %)      to       (7.42 %) 

2021

     1          $1.28       to       $1.28          $2          1.99      0.00     to       0.00      12.74     to       12.74

2020

     0          $1.13       to       $1.13          $1          0.99      0.00     to       0.00      5.71     to       5.71

2019

              $1.07       to       $1.07          $0                7.09      0.00     to       0.00      4.22 %(5)      to       4.22 %(5) 

DWS Alt Asset Alloc VIP, Cl B

 

                           

2023

     202          $1.31       to       $1.13          $261          6.38      0.00     to       0.90      5.67     to       4.73

2022

     207          $1.24       to       $1.08          $252          6.92      0.00     to       0.90      (7.74 %)      to       (8.57 %) 

2021

     202          $1.35       to       $1.18          $265          1.64      0.00     to       0.90      12.35     to       11.34

2020

     199          $1.20       to       $1.06          $233          2.37      0.00     to       0.90      5.32     to       4.38

2019

     186          $1.14       to       $1.02          $207                3.44      0.00     to       0.90      14.35     to       13.32

EV VT Floating-Rate Inc, Init Cl

 

                           

2023

     883          $1.13       to       $1.53          $1,426          8.20      0.20     to       0.90      10.99     to       10.22

2022

     889          $1.02       to       $1.39          $1,301          4.64      0.20     to       0.90      1.54 %(8)      to       (3.61 %) 

2021

     827          $1.25       to       $1.44          $1,253          2.90      0.30     to       0.90      3.32     to       2.70

2020

     895          $1.21       to       $1.40          $1,276          3.31      0.30     to       0.90      1.69     to       1.09

2019

     1,032          $1.19       to       $1.39          $1,492                4.29      0.30     to       0.90      6.76     to       6.12

Fid VIP Contrafund, Init Cl

 

                           

2023

     367          $1.92       to       $1.92          $703          0.53      0.00     to       0.00      33.45     to       33.45

2022

     285          $1.44       to       $1.44          $409          0.74      0.00     to       0.00      (26.31 %)      to       (26.31 %) 

2021

     151          $1.95       to       $1.95          $295          0.04      0.00     to       0.00      27.83     to       27.83

2020

     62          $1.52       to       $1.52          $95          0.31      0.00     to       0.00      30.57     to       30.57

2019

     19          $1.17       to       $1.17          $22                1.70      0.00     to       0.00      8.97 %(5)      to       8.97 %(5) 

Fid VIP Contrafund, Serv Cl 2

 

                           

2023

     1,340          $3.79       to       $3.68          $5,897          0.26      0.00     to       0.90      33.12     to       31.93

2022

     1,450          $2.85       to       $2.79          $4,762          0.26      0.00     to       0.90      (26.49 %)      to       (27.14 %) 

2021

     1,514          $3.87       to       $3.83          $6,736          0.03      0.00     to       0.90      27.51     to       26.37

2020

     1,642          $3.04       to       $3.03          $5,736          0.08      0.00     to       0.90      30.23     to       29.07

2019

     1,819          $2.33       to       $2.35          $4,800                0.22      0.00     to       0.90      31.28     to       30.10

Fid VIP Gro & Inc, Serv Cl

 

                           

2023

     906          $6.32       to       $3.89          $4,579          1.56      0.45     to       0.90      18.05     to       17.52

2022

     1,035          $5.35       to       $3.31          $4,385          1.57      0.45     to       0.90      (5.45 %)      to       (5.87 %) 

2021

     1,114          $5.66       to       $3.52          $4,961          2.34      0.45     to       0.90      25.20     to       24.64

2020

     1,147          $4.52       to       $2.82          $4,071          2.06      0.45     to       0.90      7.25     to       6.77

2019

     1,207          $4.21       to       $2.64          $4,004                3.56      0.45     to       0.90      29.36     to       28.78

Fid VIP Gro & Inc, Serv Cl 2

 

                           

2023

     866          $1.29       to       $4.48          $2,266          1.51      0.20     to       0.90      18.13     to       17.32

2022

     875          $1.09       to       $3.82          $1,993          1.52      0.20     to       0.90      10.16 %(8)      to       (6.02 %) 

2021

     876          $2.43       to       $4.06          $2,112          2.23      0.30     to       0.90      25.26     to       24.51

2020

     924          $1.94       to       $3.26          $1,780          1.93      0.30     to       0.90      7.27     to       6.63

2019

     967          $1.81       to       $3.06          $1,749                3.37      0.30     to       0.90      29.29     to       28.52

Fid VIP Mid Cap, Init Cl

 

                           

2023

     279          $1.55       to       $1.55          $434          0.64      0.00     to       0.00      15.08     to       15.08

2022

     242          $1.35       to       $1.35          $327          0.71      0.00     to       0.00      (14.74 %)      to       (14.74 %) 

2021

     119          $1.58       to       $1.58          $189          0.79      0.00     to       0.00      25.60     to       25.60

2020

     57          $1.26       to       $1.26          $73          1.55      0.00     to       0.00      18.19     to       18.19

2019

     0          $1.07       to       $1.07          $0                2.02      0.00     to       0.00      7.10 %(5)      to       7.10 %(5) 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      159  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Fid VIP Mid Cap, Serv Cl

 

                           

2023

     974          $5.37       to       $6.40          $5,693          0.51      0.45     to       0.90      14.49     to       13.98

2022

     1,062          $4.69       to       $5.61          $5,429          0.40      0.45     to       0.90      (15.24 %)      to       (15.62 %) 

2021

     1,134          $5.53       to       $6.65          $6,880          0.51      0.45     to       0.90      24.94     to       24.38

2020

     1,205          $4.43       to       $5.35          $5,875          0.56      0.45     to       0.90      17.51     to       16.98

2019

     1,283          $3.77       to       $4.57          $5,350                0.79      0.45     to       0.90      22.79     to       22.24

Fid VIP Mid Cap, Serv Cl 2

 

                           

2023

     2,434          $2.92       to       $6.05          $5,572          0.38      0.00     to       0.90      14.80     to       13.78

2022

     2,546          $2.55       to       $5.31          $5,126          0.27      0.00     to       0.90      (14.97 %)      to       (15.73 %) 

2021

     2,636          $3.00       to       $6.30          $6,271          0.37      0.00     to       0.90      25.31     to       24.18

2020

     2,664          $2.39       to       $5.08          $5,083          0.40      0.00     to       0.90      17.87     to       16.81

2019

     2,874          $2.03       to       $4.35          $4,711                0.66      0.00     to       0.90      23.17     to       22.07

Fid VIP Overseas, Serv Cl

 

                           

2023

     570          $3.17       to       $2.19          $1,471          0.94      0.45     to       0.90      19.87     to       19.33

2022

     605          $2.65       to       $1.84          $1,301          0.95      0.45     to       0.90      (24.92 %)      to       (25.26 %) 

2021

     644          $3.52       to       $2.46          $1,833          0.44      0.45     to       0.90      19.04     to       18.50

2020

     663          $2.96       to       $2.07          $1,591          0.37      0.45     to       0.90      14.98     to       14.46

2019

     662          $2.57       to       $1.81          $1,371                1.66      0.45     to       0.90      27.10     to       26.53

Fid VIP Overseas, Serv Cl 2

 

                           

2023

     708          $1.37       to       $3.05          $1,224          0.83      0.20     to       0.90      19.98     to       19.15

2022

     682          $1.14       to       $2.56          $984          0.86      0.20     to       0.90      15.16 %(8)      to       (25.36 %) 

2021

     682          $1.94       to       $3.43          $1,312          0.34      0.30     to       0.90      19.03     to       18.32

2020

     600          $1.63       to       $2.90          $977          0.20      0.30     to       0.90      14.99     to       14.30

2019

     714          $1.42       to       $2.54          $1,010                1.37      0.30     to       0.90      27.12     to       26.36

Fid VIP Strategic Inc, Init Cl

 

                           

2023

     312          $1.15       to       $1.15          $359          5.34      0.00     to       0.00      9.41     to       9.41

2022

     178          $1.05       to       $1.05          $188          4.92      0.00     to       0.00      (11.26 %)      to       (11.26 %) 

2021

     97          $1.19       to       $1.19          $115          5.17      0.00     to       0.00      3.74     to       3.74

2020

     12          $1.14       to       $1.14          $14          38.78      0.00     to       0.00      7.51     to       7.51

2019

              $1.06       to       $1.06          $0                6.26      0.00     to       0.00      2.50 %(5)      to       2.50 %(5) 

Fid VIP Strategic Inc, Serv Cl 2

 

                           

2023

     17          $1.37       to       $1.37          $23          4.57      0.00     to       0.00      9.18     to       9.18

2022

     15          $1.26       to       $1.26          $19          1.96      0.00     to       0.00      (11.52 %)      to       (11.52 %) 

2021

     27          $1.42       to       $1.42          $38          2.59      0.00     to       0.00      3.53     to       3.53

2020

     23          $1.37       to       $1.37          $32          2.98      0.00     to       0.00      7.16     to       7.16

2019

     23          $1.28       to       $1.28          $29                3.71      0.00     to       0.00      10.66     to       10.66

Frank Global Real Est, Cl 2

 

                           

2023

     890          $1.21       to       $2.77          $2,039          2.92      0.20     to       0.90      11.21     to       10.44

2022

     920          $1.09       to       $2.51          $1,957          2.39      0.20     to       0.90      10.23 %(8)      to       (26.72 %) 

2021

     940          $1.72       to       $3.43          $2,744          0.89      0.30     to       0.90      26.41     to       25.66

2020

     898          $1.36       to       $2.73          $2,127          3.20      0.30     to       0.90      (5.67 %)      to       (6.24 %) 

2019

     947          $1.44       to       $2.91          $2,410                2.62      0.30     to       0.90      22.01     to       21.28

Frank Inc, Cl 1

 

                           

2023

     36          $1.31       to       $1.31          $47          5.34      0.00     to       0.00      8.87     to       8.87

2022

     8          $1.21       to       $1.21          $9          3.30      0.00     to       0.00      (5.24 %)      to       (5.24 %) 

2021

     2          $1.27       to       $1.27          $3          0.60      0.00     to       0.00      17.01     to       17.01

2020

              $1.09       to       $1.09          $0          5.91      0.00     to       0.00      0.97     to       0.97

2019

              $1.08       to       $1.08          $0                10.16      0.00     to       0.00      4.62 %(5)      to       4.62 %(5) 

Frank Inc, Cl 2

 

                           

2023

     310          $1.71       to       $1.38          $446          5.15      0.00     to       0.90      8.62     to       7.65

2022

     284          $1.58       to       $1.28          $375          4.85      0.00     to       0.90      (5.47 %)      to       (6.32 %) 

2021

     254          $1.67       to       $1.37          $361          4.67      0.00     to       0.90      16.75     to       15.71

2020

     252          $1.43       to       $1.18          $309          6.22      0.00     to       0.90      0.69     to       (0.21 %) 

2019

     205          $1.42       to       $1.18          $245                4.95      0.00     to       0.90      16.06     to       15.02

 

160    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Frank Mutual Shares, Cl 1

 

                           

2023

     19          $1.34       to       $1.34          $25          2.04      0.00     to       0.00      13.73     to       13.73

2022

     15          $1.17       to       $1.17          $18          2.59      0.00     to       0.00      (7.15 %)      to       (7.15 %) 

2021

     12          $1.26       to       $1.26          $15          3.03      0.00     to       0.00      19.52     to       19.52

2020

     22          $1.06       to       $1.06          $23          2.61      0.00     to       0.00      (4.85 %)      to       (4.85 %) 

2019

     10          $1.11       to       $1.11          $11                0.07      0.00     to       0.00      8.95 %(5)      to       8.95 %(5) 

Frank Mutual Shares, Cl 2

 

                           

2023

     593          $2.17       to       $3.08          $1,693          1.84      0.00     to       0.90      13.46     to       12.45

2022

     679          $1.91       to       $2.74          $1,662          1.86      0.00     to       0.90      (7.43 %)      to       (8.26 %) 

2021

     690          $2.06       to       $2.99          $1,850          2.89      0.00     to       0.90      19.17     to       18.10

2020

     705          $1.73       to       $2.53          $1,607          2.82      0.00     to       0.90      (5.04 %)      to       (5.89 %) 

2019

     733          $1.82       to       $2.69          $1,796                1.82      0.00     to       0.90      22.57     to       21.47

Frank Sm Cap Val, Cl 1

 

                           

2023

     143          $1.48       to       $1.48          $212          0.72      0.00     to       0.00      13.02     to       13.02

2022

     82          $1.31       to       $1.31          $108          1.20      0.00     to       0.00      (9.82 %)      to       (9.82 %) 

2021

     33          $1.45       to       $1.45          $47          1.10      0.00     to       0.00      25.67     to       25.67

2020

     17          $1.16       to       $1.16          $19          1.12      0.00     to       0.00      5.41     to       5.41

2019

     2          $1.10       to       $1.10          $3                0.26      0.00     to       0.00      15.15 %(5)      to       15.15 %(5) 

Frank Sm Cap Val, Cl 2

 

                           

2023

     679          $2.86       to       $6.26          $2,856          0.52      0.00     to       0.90      12.75     to       11.74

2022

     661          $2.54       to       $5.60          $2,614          0.98      0.00     to       0.90      (10.06 %)      to       (10.87 %) 

2021

     692          $2.82       to       $6.29          $3,092          1.00      0.00     to       0.90      25.37     to       24.24

2020

     683          $2.25       to       $5.06          $2,456          1.47      0.00     to       0.90      5.19     to       4.25

2019

     700          $2.14       to       $4.85          $2,441                1.05      0.00     to       0.90      26.35     to       25.22

GS VIT Mid Cap Val, Inst

 

                           

2023

     1,275          $1.20       to       $6.87          $6,093          1.01      0.20     to       0.90      11.20     to       10.42

2022

     1,381          $1.08       to       $6.23          $5,910          0.68      0.20     to       0.90      8.14 %(8)      to       (10.79 %) 

2021

     1,440          $2.27       to       $6.98          $6,993          0.48      0.30     to       0.90      30.56     to       29.78

2020

     1,564          $1.74       to       $5.38          $5,804          0.62      0.30     to       0.90      8.08     to       7.43

2019

     1,721          $1.61       to       $5.01          $6,002                0.79      0.30     to       0.90      31.13     to       30.35

GS VIT Multi-Strategy Alt, Advisor

 

                           

2023

     34          $1.10       to       $1.01          $36          5.67      0.00     to       0.90      7.53     to       6.57

2022

     43          $1.02       to       $0.95          $42          3.23      0.00     to       0.90      (6.85 %)      to       (7.68 %) 

2021

     41          $1.10       to       $1.02          $44          1.57      0.00     to       0.90      4.66     to       3.72

2020

     40          $1.05       to       $0.99          $40          1.77      0.00     to       0.90      6.58     to       5.62

2019

     42          $0.98       to       $0.94          $40                2.47      0.00     to       0.90      8.60     to       7.63

GS VIT Sm Cap Eq Insights, Inst

 

                           

2023

     110          $5.75       to       $4.33          $552          1.04      0.45     to       0.90      18.74     to       18.21

2022

     111          $4.85       to       $3.67          $467          0.32      0.45     to       0.90      (19.74 %)      to       (20.10 %) 

2021

     114          $6.04       to       $4.59          $602          0.46      0.45     to       0.90      23.23     to       22.68

2020

     121          $4.90       to       $3.74          $515          0.22      0.45     to       0.90      8.09     to       7.61

2019

     127          $4.53       to       $3.48          $502                0.49      0.45     to       0.90      24.28     to       23.72

GS VIT U.S. Eq Insights, Inst

 

                           

2023

     630          $1.29       to       $3.75          $2,924          0.70      0.20     to       0.90      23.57     to       22.70

2022

     594          $1.05       to       $3.05          $2,456          0.82      0.20     to       0.90      5.39 %(8)      to       (20.46 %) 

2021

     632          $3.08       to       $3.84          $3,232          0.81      0.30     to       0.90      29.02     to       28.25

2020

     685          $2.38       to       $2.99          $2,717          0.86      0.30     to       0.90      17.19     to       16.49

2019

     741          $2.03       to       $2.57          $2,509                1.23      0.30     to       0.90      24.84     to       24.09

Invesco VI Am Fran, Ser I

 

                           

2023

     164          $3.92       to       $3.72          $629                 0.45     to       0.90      40.30     to       39.67

2022

     183          $2.79       to       $2.66          $502                 0.45     to       0.90      (31.42 %)      to       (31.73 %) 

2021

     194          $4.07       to       $3.90          $777                 0.45     to       0.90      11.42     to       10.92

2020

     205          $3.66       to       $3.52          $737          0.07      0.45     to       0.90      41.71     to       41.08

2019

     227          $2.58       to       $2.49          $577                       0.45     to       0.90      36.14     to       35.53

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      161  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Invesco VI Am Fran, Ser II

 

                           

2023

     319          $1.41       to       $3.61          $995                 0.20     to       0.90      40.32     to       39.34

2022

     309          $1.01       to       $2.59          $729                 0.20     to       0.90      1.87 %(8)      to       (31.91 %) 

2021

     306          $3.48       to       $3.81          $1,053                 0.30     to       0.90      11.31     to       10.65

2020

     291          $3.13       to       $3.44          $926                 0.30     to       0.90      41.57     to       40.73

2019

     318          $2.21       to       $2.44          $713                       0.30     to       0.90      36.02     to       35.20

Invesco VI Bal Risk Alloc, Ser I

 

                           

2023

     25          $1.19       to       $1.19          $29                 0.00     to       0.00      6.63     to       6.63

2022

     18          $1.12       to       $1.12          $20          8.24      0.00     to       0.00      (14.35 %)      to       (14.35 %) 

2021

     14          $1.30       to       $1.30          $19          3.60      0.00     to       0.00      9.55     to       9.55

2020

     10          $1.19       to       $1.19          $12          10.34      0.00     to       0.00      10.22     to       10.22

2019

              $1.08       to       $1.08          $0                       0.00     to       0.00      4.30 %(5)      to       4.30 %(5) 

Invesco VI Bal Risk Alloc, Ser II

 

                           

2023

     189          $1.45       to       $1.27          $253                 0.00     to       0.90      6.40     to       5.45

2022

     202          $1.37       to       $1.20          $253          7.29      0.00     to       0.90      (14.52 %)      to       (15.28 %) 

2021

     219          $1.60       to       $1.42          $322          3.01      0.00     to       0.90      9.26     to       8.28

2020

     207          $1.46       to       $1.31          $280          8.21      0.00     to       0.90      9.99     to       9.00

2019

     192          $1.33       to       $1.20          $239                       0.00     to       0.90      14.88     to       13.85

Invesco VI Comstock, Ser II

 

                           

2023

     113          $1.24       to       $2.73          $391          1.59      0.20     to       0.90      11.87     to       11.09

2022

     124          $1.11       to       $2.46          $400          1.28      0.20     to       0.90      11.38 %(8)      to       (0.06 %) 

2021

     135          $2.14       to       $2.46          $441          1.75      0.30     to       0.90      32.65     to       31.85

2020

     129          $1.62       to       $1.87          $297          2.08      0.30     to       0.90      (1.38 %)      to       (1.97 %) 

2019

     137          $1.64       to       $1.90          $313                1.79      0.30     to       0.90      24.57     to       23.82

Invesco VI Core Eq, Ser I

 

                           

2023

     2,031          $4.43       to       $5.19          $10,346          0.74      0.45     to       0.90      22.81     to       22.26

2022

     2,133          $3.60       to       $4.25          $8,886          0.91      0.45     to       0.90      (20.90 %)      to       (21.26 %) 

2021

     2,248          $4.56       to       $5.40          $11,888          0.66      0.45     to       0.90      27.17     to       26.59

2020

     2,427          $3.58       to       $4.26          $10,146          1.35      0.45     to       0.90      13.34     to       12.83

2019

     2,558          $3.16       to       $3.78          $9,470                0.95      0.45     to       0.90      28.39     to       27.81

Invesco VI Dis Mid Cap Gro, Ser I

 

                           

2023

     637          $1.13       to       $1.36          $881                 0.20     to       0.90      12.93     to       12.14

2022

     568          $1.00       to       $1.22          $698                 0.20     to       0.90      1.14 %(8)      to       (31.60 %) 

2021

     647          $1.80       to       $1.78          $1,157                 0.30     to       0.90      18.74     to       18.03

2020

     636          $1.51       to       $1.51          $961                0.05      0.30     to       0.90      51.28 %(6)      to       50.66 %(6) 

Invesco VI Div Divd, Ser I

 

                           

2023

     449          $1.19       to       $2.71          $1,167          2.07      0.20     to       0.90      8.82     to       8.07

2022

     444          $1.09       to       $2.51          $1,101          1.94      0.20     to       0.90      10.06 %(8)      to       (2.56 %) 

2021

     473          $2.05       to       $2.58          $1,171          2.15      0.30     to       0.90      18.54     to       17.83

2020

     490          $1.73       to       $2.19          $1,031          3.12      0.30     to       0.90      (0.16 %)      to       (0.76 %) 

2019

     496          $1.73       to       $2.20          $1,104                2.94      0.30     to       0.90      24.72     to       23.97

Invesco VI EQV Intl Eq, Ser II

 

                           

2023

     477          $1.31       to       $1.54          $1,110                 0.20     to       0.90      17.63     to       16.81

2022

     501          $1.11       to       $1.32          $989          1.44      0.20     to       0.90      12.44 %(8)      to       (19.23 %) 

2021

     521          $1.68       to       $1.63          $1,253          1.05      0.30     to       0.90      5.29     to       4.66

2020

     550          $1.59       to       $1.56          $1,240          2.17      0.30     to       0.90      13.40     to       12.72

2019

     617          $1.40       to       $1.38          $1,232                1.30      0.30     to       0.90      27.85     to       27.09

Invesco VI Global, Ser I

 

                           

2023

     319          $1.56       to       $1.56          $499          0.28      0.00     to       0.00      34.74     to       34.74

2022

     160          $1.16       to       $1.16          $185                 0.00     to       0.00      (31.76 %)      to       (31.76 %) 

2021

     47          $1.70       to       $1.70          $80                 0.00     to       0.00      15.49     to       15.49

2020

     17          $1.47       to       $1.47          $25          1.74      0.00     to       0.00      27.64     to       27.64

2019

     2          $1.15       to       $1.15          $2                0.42      0.00     to       0.00      9.75 %(5)      to       9.75 %(5) 

 

162    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Invesco VI Global, Ser II

 

                           

2023

     513          $2.92       to       $2.89          $1,823                 0.00     to       0.90      34.45     to       33.25

2022

     520          $2.17       to       $2.17          $1,384                 0.00     to       0.90      (31.94 %)      to       (32.55 %) 

2021

     550          $3.20       to       $3.21          $2,195                 0.00     to       0.90      15.17     to       14.14

2020

     734          $2.77       to       $2.81          $2,338          0.47      0.00     to       0.90      27.34     to       26.20

2019

     691          $2.18       to       $2.23          $1,763                0.63      0.00     to       0.90      31.45     to       30.28

Invesco VI Gbl Strat Inc, Ser I

 

                           

2023

     30          $1.02       to       $1.02          $31                 0.00     to       0.00      8.88     to       8.88

2022

     18          $0.94       to       $0.94          $17                 0.00     to       0.00      (11.46 %)      to       (11.46 %) 

2021

     5          $1.06       to       $1.06          $5          6.56      0.00     to       0.00      (3.41 %)      to       (3.41 %) 

2020

     1          $1.10       to       $1.10          $2          14.11      0.00     to       0.00      3.40     to       3.40

2019

              $1.06       to       $1.06          $0                7.06      0.00     to       0.00      2.26 %(5)      to       2.26 %(5) 

Invesco VI Gbl Strat Inc, Ser II

 

                           

2023

     1,128          $1.14       to       $1.46          $1,625                 0.00     to       0.90      8.60     to       7.63

2022

     1,140          $1.05       to       $1.36          $1,533                 0.00     to       0.90      (11.71 %)      to       (12.51 %) 

2021

     1,155          $1.19       to       $1.55          $1,772          4.30      0.00     to       0.90      (3.56 %)      to       (4.43 %) 

2020

     1,150          $1.24       to       $1.63          $1,835          5.38      0.00     to       0.90      2.99     to       2.07

2019

     1,285          $1.20       to       $1.59          $2,030                3.31      0.00     to       0.90      10.61     to       9.61

Invesco VI Mn St Sm Cap, Ser I

 

                           

2023

     161          $1.57       to       $1.57          $253          1.24      0.00     to       0.00      18.13     to       18.13

2022

     133          $1.33       to       $1.33          $177          0.60      0.00     to       0.00      (15.83 %)      to       (15.83 %) 

2021

     82          $1.58       to       $1.58          $130          0.47      0.00     to       0.00      22.55     to       22.55

2020

     42          $1.29       to       $1.29          $54          1.38      0.00     to       0.00      19.93     to       19.93

2019

     10          $1.08       to       $1.08          $11                0.01      0.00     to       0.00      11.74 %(5)      to       11.74 %(5) 

Invesco VI Mn St Sm Cap, Ser II

 

                           

2023

     497          $3.33       to       $3.28          $1,803          0.95      0.00     to       0.90      17.82     to       16.77

2022

     490          $2.83       to       $2.81          $1,561          0.26      0.00     to       0.90      (16.04 %)      to       (16.79 %) 

2021

     508          $3.37       to       $3.37          $1,906          0.19      0.00     to       0.90      22.26     to       21.17

2020

     521          $2.76       to       $2.78          $1,566          0.38      0.00     to       0.90      19.64     to       18.56

2019

     519          $2.30       to       $2.35          $1,285                       0.00     to       0.90      26.13     to       25.00

Invesco VI Tech, Ser I

 

                           

2023

     304          $1.19       to       $5.56          $1,252                 0.00     to       0.90      46.94     to       45.63

2022

     207          $0.81       to       $3.82          $782                 0.00     to       0.90      (20.38 %)(7)      to       (40.49 %) 

2021

     185          $3.87       to       $6.41          $1,343                 0.30     to       0.90      14.07     to       13.39

2020

     188          $3.39       to       $5.65          $1,184                 0.30     to       0.90      45.68     to       44.81

2019

     172          $2.33       to       $3.90          $735                       0.30     to       0.90      35.47     to       34.66

Invesco VI Tech, Ser II

 

                           

2023

     5          $1.18       to       $1.18          $6                 0.00     to       0.00      46.72     to       46.72

2022

              $0.81       to       $0.81          $0                       0.00     to       0.00      (20.54 %)(7)      to       (20.54 %)(7) 

Janus Henderson VIT Bal, Inst

 

                           

2023

     498          $1.48       to       $1.48          $737          2.24      0.00     to       0.00      15.41     to       15.41

2022

     421          $1.28       to       $1.28          $540          1.32      0.00     to       0.00      (16.40 %)      to       (16.40 %) 

2021

     355          $1.53       to       $1.53          $544          0.92      0.00     to       0.00      17.20     to       17.20

2020

     300          $1.31       to       $1.31          $392          6.41      0.00     to       0.00      14.31     to       14.31

2019

     0          $1.15       to       $1.15          $1                4.18      0.00     to       0.00      8.35 %(5)      to       8.35 %(5) 

Janus Henderson VIT Bal, Serv

 

                           

2023

     41          $1.56       to       $1.56          $64          1.58      0.00     to       0.00      15.13     to       15.13

2022

     55          $1.36       to       $1.36          $75          1.17      0.00     to       0.00      (16.62 %)      to       (16.62 %) 

2021

     38          $1.63       to       $1.63          $61          0.70      0.00     to       0.00      16.91     to       16.91

2020

     33          $1.39       to       $1.39          $46          1.84      0.00     to       0.00      14.03     to       14.03

2019

     12          $1.22       to       $1.22          $14                2.12      0.00     to       0.00      22.27     to       22.27

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      163  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Janus Henderson VIT Enter, Serv

 

                           

2023

     118          $8.39       to       $3.57          $800          0.09      0.45     to       0.90      17.25     to       16.72

2022

     123          $7.15       to       $3.06          $710          0.08      0.45     to       0.90      (16.53 %)      to       (16.90 %) 

2021

     129          $8.57       to       $3.68          $890          0.24      0.45     to       0.90      16.02     to       15.50

2020

     145          $7.39       to       $3.19          $835                 0.45     to       0.90      18.65     to       18.11

2019

     161          $6.23       to       $2.70          $752                0.05      0.45     to       0.90      34.55     to       33.95

Janus Henderson VIT Flex Bd, Inst

 

                           

2023

     75          $1.08       to       $1.08          $81          5.78      0.00     to       0.00      5.50     to       5.50

2022

     35          $1.02       to       $1.02          $36          4.36      0.00     to       0.00      (13.66 %)      to       (13.66 %) 

2021

     3          $1.18       to       $1.18          $4          2.32      0.00     to       0.00      (0.90 %)      to       (0.90 %) 

2020

     1          $1.19       to       $1.19          $1          4.52      0.00     to       0.00      10.48     to       10.48

2019

     0          $1.08       to       $1.08          $0                6.68      0.00     to       0.00      3.34 %(5)      to       3.34 %(5) 

Janus Henderson VIT Flex Bd, Serv

 

                           

2023

     22          $1.19       to       $1.19          $26          3.92      0.00     to       0.00      5.29     to       5.29

2022

     7          $1.13       to       $1.13          $8          2.08      0.00     to       0.00      (13.90 %)      to       (13.90 %) 

2021

     6          $1.31       to       $1.31          $8          1.72      0.00     to       0.00      (1.11 %)      to       (1.11 %) 

2020

     4          $1.32       to       $1.32          $6          2.72      0.00     to       0.00      10.25     to       10.25

2019

     1          $1.20       to       $1.20          $1                2.96      0.00     to       0.00      9.28     to       9.28

Janus Hend VIT Gbl Tech Innov, Srv

 

                           

2023

     312          $1.56       to       $4.21          $2,297                 0.20     to       0.90      53.97     to       52.90

2022

     326          $1.01       to       $2.75          $1,612                 0.20     to       0.90      3.74 %(8)      to       (37.69 %) 

2021

     359          $5.42       to       $4.41          $2,811          0.11      0.30     to       0.90      17.39     to       16.69

2020

     446          $4.61       to       $3.78          $2,770                 0.30     to       0.90      50.28     to       49.38

2019

     486          $3.07       to       $2.53          $1,933                       0.30     to       0.90      44.38     to       43.52

Janus Henderson VIT Overseas, Serv

 

                           

2023

     746          $1.28       to       $2.24          $1,822          1.43      0.20     to       0.90      10.36     to       9.60

2022

     774          $1.16       to       $2.04          $1,736          1.69      0.20     to       0.90      17.25 %(8)      to       (9.65 %) 

2021

     814          $1.50       to       $2.26          $2,015          1.03      0.30     to       0.90      12.95     to       12.27

2020

     849          $1.33       to       $2.01          $1,855          1.21      0.30     to       0.90      15.67     to       14.98

2019

     937          $1.15       to       $1.75          $1,771                1.83      0.30     to       0.90      26.33     to       25.57

Janus Henderson VIT Res, Inst

 

                           

2023

     27          $1.91       to       $1.91          $51          0.14      0.00     to       0.00      43.17     to       43.17

2022

     23          $1.33       to       $1.33          $31          0.67      0.00     to       0.00      (29.89 %)      to       (29.89 %) 

2021

     2          $1.90       to       $1.90          $4          0.11      0.00     to       0.00      20.33     to       20.33

2020

     0          $1.58       to       $1.58          $0          0.44      0.00     to       0.00      32.96     to       32.96

2019

              $1.19       to       $1.19          $0                0.84      0.00     to       0.00      9.65 %(5)      to       9.65 %(5) 

Janus Henderson VIT Res, Serv

 

                           

2023

     126          $4.12       to       $3.86          $618          0.06      0.00     to       0.90      42.81     to       41.54

2022

     130          $2.88       to       $2.73          $454                 0.00     to       0.90      (30.06 %)      to       (30.69 %) 

2021

     143          $4.12       to       $3.94          $697          0.02      0.00     to       0.90      20.05     to       18.97

2020

     152          $3.43       to       $3.31          $612          0.22      0.00     to       0.90      32.58     to       31.39

2019

     157          $2.59       to       $2.52          $481                0.30      0.00     to       0.90      35.23     to       34.01

Lazard Ret Global Dyn MA, Inv

 

                           

2023

     10          $1.14       to       $1.14          $12                 0.00     to       0.00      11.06     to       11.06

2022

     2          $1.02       to       $1.02          $2          0.28      0.00     to       0.00      (17.28 %)      to       (17.28 %) 

2021

     1          $1.24       to       $1.24          $2          3.53      0.00     to       0.00      12.16     to       12.16

2020

              $1.10       to       $1.10          $0          0.77      0.00     to       0.00      0.96     to       0.96

2019

              $1.09       to       $1.09          $0                0.10      0.00     to       0.00      5.04 %(5)      to       5.04 %(5) 

Lazard Ret Global Dyn MA, Serv

 

                           

2023

     12          $1.55       to       $1.29          $17                 0.00     to       0.90      10.81     to       9.82

2022

     13          $1.40       to       $1.17          $16          0.08      0.00     to       0.90      (17.37 %)      to       (18.11 %) 

2021

     20          $1.69       to       $1.43          $30          2.76      0.00     to       0.90      11.94     to       10.93

2020

     30          $1.51       to       $1.29          $40          0.53      0.00     to       0.90      0.81     to       (0.10 %) 

2019

     52          $1.50       to       $1.29          $68                0.04      0.00     to       0.90      17.79     to       16.73

 

164    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

MFS Mass Inv Gro Stock, Serv Cl

 

                           

2023

     1,138          $1.32       to       $2.65          $3,106          0.05      0.20     to       0.90      23.45     to       22.60

2022

     1,184          $1.07       to       $2.16          $2,623                 0.20     to       0.90      8.09 %(8)      to       (20.17 %) 

2021

     1,293          $2.82       to       $2.71          $3,574          0.03      0.30     to       0.90      25.28     to       24.53

2020

     1,319          $2.25       to       $2.17          $2,917          0.22      0.30     to       0.90      21.83     to       21.10

2019

     1,371          $1.85       to       $1.79          $2,493                0.35      0.30     to       0.90      39.17     to       38.33

MFS New Dis, Serv Cl

 

                           

2023

     462          $1.18       to       $3.69          $2,011                 0.20     to       0.90      14.03     to       13.23

2022

     448          $1.04       to       $3.26          $1,822                 0.20     to       0.90      5.44 %(8)      to       (30.62 %) 

2021

     473          $2.81       to       $4.70          $2,729                 0.30     to       0.90      1.27     to       0.66

2020

     493          $2.78       to       $4.67          $2,823                 0.30     to       0.90      45.15     to       44.28

2019

     489          $1.91       to       $3.24          $1,888                       0.30     to       0.90      40.85     to       40.01

MFS Utilities, Init Cl

 

                           

2023

     55          $1.37       to       $1.37          $75          3.73      0.00     to       0.00      (2.11 %)      to       (2.11 %) 

2022

     37          $1.40       to       $1.40          $51          2.48      0.00     to       0.00      0.76     to       0.76

2021

     23          $1.39       to       $1.39          $32          1.80      0.00     to       0.00      14.09     to       14.09

2020

     16          $1.22       to       $1.22          $19          2.37      0.00     to       0.00      5.90     to       5.90

2019

     6          $1.15       to       $1.15          $7                0.38      0.00     to       0.00      6.69 %(5)      to       6.69 %(5) 

MFS Utilities, Serv Cl

 

                           

2023

     325          $2.16       to       $5.95          $1,061          3.38      0.00     to       0.90      (2.33 %)      to       (3.20 %) 

2022

     324          $2.22       to       $6.14          $1,130          2.23      0.00     to       0.90      0.48     to       (0.42 %) 

2021

     328          $2.20       to       $6.17          $1,163          1.54      0.00     to       0.90      13.82     to       12.80

2020

     340          $1.94       to       $5.47          $1,083          2.17      0.00     to       0.90      5.62     to       4.67

2019

     355          $1.83       to       $5.23          $1,175                3.74      0.00     to       0.90      24.80     to       23.68

MS VIF Dis, Cl I

 

                           

2023

     266          $1.36       to       $1.36          $362                 0.00     to       0.00      44.34     to       44.34

2022

     135          $0.94       to       $0.94          $127                 0.00     to       0.00      (62.96 %)      to       (62.96 %) 

2021

     31          $2.55       to       $2.55          $79                 0.00     to       0.00      (11.06 %)      to       (11.06 %) 

2020

     3          $2.87       to       $2.87          $8                 0.00     to       0.00      152.29     to       152.29

2019

              $1.14       to       $1.14          $0                       0.00     to       0.00      (3.13 %)(5)      to       (3.13 %)(5) 

MS VIF Dis, Cl II

 

                           

2023

     176          $3.14       to       $3.22          $792                 0.00     to       0.90      44.13     to       42.84

2022

     163          $2.18       to       $2.26          $529                 0.00     to       0.90      (62.97 %)      to       (63.30 %) 

2021

     183          $5.87       to       $6.15          $1,519                 0.00     to       0.90      (11.19 %)      to       (11.99 %) 

2020

     266          $6.61       to       $6.98          $2,293                 0.00     to       0.90      152.04     to       149.79

2019

     204          $2.62       to       $2.80          $669                       0.00     to       0.90      39.97     to       38.71

MS VIF Global Real Est, Cl II

 

                           

2023

     218          $1.21       to       $1.03          $328          1.94      0.20     to       0.90      10.25     to       9.48

2022

     220          $1.09       to       $0.94          $300          4.52      0.20     to       0.90      10.43 %(8)      to       (26.86 %) 

2021

     217          $1.41       to       $1.28          $400          2.33      0.30     to       0.90      23.46     to       22.72

2020

     230          $1.14       to       $1.04          $335          4.38      0.30     to       0.90      (15.11 %)      to       (15.62 %) 

2019

     235          $1.35       to       $1.24          $392                2.53      0.30     to       0.90      17.70     to       17.00

NB AMT Sus Eq, Cl I

 

                           

2023

     19          $1.72       to       $1.72          $33          0.40      0.00     to       0.00      26.90     to       26.90

2022

     10          $1.36       to       $1.36          $14          0.61      0.00     to       0.00      (18.45 %)      to       (18.45 %) 

2021

     3          $1.66       to       $1.66          $5          0.56      0.00     to       0.00      23.48     to       23.48

2020

     1          $1.35       to       $1.35          $1          0.52      0.00     to       0.00      19.56     to       19.56

2019

              $1.13       to       $1.13          $0                0.78      0.00     to       0.00      10.59 %(5)      to       10.59 %(5) 

NB AMT Sus Eq, Cl S

 

                           

2023

     13          $3.46       to       $3.46          $46          0.08      0.00     to       0.00      26.57     to       26.57

2022

     13          $2.73       to       $2.73          $35          0.14      0.00     to       0.00      (18.65 %)      to       (18.65 %) 

2021

     7          $3.36       to       $3.36          $24          0.19      0.00     to       0.00      23.16     to       23.16

2020

     4          $2.73       to       $2.73          $11          0.36      0.00     to       0.00      19.28     to       19.28

2019

     2          $2.29       to       $2.29          $5                0.29      0.00     to       0.00      25.58     to       25.58

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      165  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

NB AMT US Eq Index PW Strat, Cl S

 

                           

2023

     21          $1.40       to       $1.28          $29                 0.00     to       0.90      15.00     to       13.97

2022

     24          $1.21       to       $1.12          $28                 0.00     to       0.90      (11.28 %)      to       (12.07 %) 

2021

     23          $1.37       to       $1.28          $31          0.36      0.00     to       0.90      17.94     to       16.89

2020

     16          $1.16       to       $1.09          $19          0.90      0.00     to       0.90      8.26     to       7.29

2019

     10          $1.07       to       $1.02          $11                0.17      0.00     to       0.90      15.26     to       14.22

PIMCO VIT All Asset, Advisor Cl

 

                           

2023

     298          $1.50       to       $1.81          $616          2.84      0.00     to       0.90      8.02     to       7.05

2022

     325          $1.39       to       $1.69          $611          7.44      0.00     to       0.90      (11.87 %)      to       (12.66 %) 

2021

     384          $1.58       to       $1.94          $820          11.21      0.00     to       0.90      16.04     to       15.00

2020

     649          $1.36       to       $1.68          $1,123          4.83      0.00     to       0.90      7.91     to       6.94

2019

     667          $1.26       to       $1.57          $1,083                2.81      0.00     to       0.90      11.74     to       10.74

PIMCO VIT All Asset, Inst Cl

 

                           

2023

     10          $1.28       to       $1.28          $13          3.17      0.00     to       0.00      8.28     to       8.28

2022

     7          $1.19       to       $1.19          $9          8.47      0.00     to       0.00      (11.66 %)      to       (11.66 %) 

2021

     4          $1.34       to       $1.34          $6          12.05      0.00     to       0.00      16.41     to       16.41

2020

              $1.15       to       $1.15          $0          5.12      0.00     to       0.00      8.17     to       8.17

2019

              $1.07       to       $1.07          $0                5.82      0.00     to       0.00      3.76 %(5)      to       3.76 %(5) 

PIMCO VIT Glb Man As Alloc, Adv Cl

 

                           

2023

     4          $1.53       to       $1.53          $6          2.18      0.00     to       0.00      12.85     to       12.85

2022

     4          $1.36       to       $1.36          $5          1.92      0.00     to       0.00      (18.40 %)      to       (18.40 %) 

2021

     4          $1.66       to       $1.66          $7          2.31      0.00     to       0.00      12.60     to       12.60

2020

     4          $1.48       to       $1.48          $6          7.85      0.00     to       0.00      16.71     to       16.71

2019

     3          $1.26       to       $1.26          $4                2.13      0.00     to       0.00      16.96     to       16.96

PIMCO VIT Tot Return, Advisor Cl

 

                           

2023

     398          $1.17       to       $1.05          $435          3.48      0.00     to       0.90      5.83     to       4.88

2022

     367          $1.11       to       $1.00          $382          2.53      0.00     to       0.90      (14.39 %)      to       (15.15 %) 

2021

     349          $1.29       to       $1.18          $426          1.73      0.00     to       0.90      (1.37 %)      to       (2.25 %) 

2020

     237          $1.31       to       $1.21          $297          2.02      0.00     to       0.90      8.54     to       7.57

2019

     221          $1.21       to       $1.12          $256                2.86      0.00     to       0.90      8.25     to       7.28

PIMCO VIT Tot Return, Inst Cl

 

                           

2023

     110          $1.05       to       $1.05          $115          3.73      0.00     to       0.00      6.09     to       6.09

2022

     68          $0.99       to       $0.99          $67          2.87      0.00     to       0.00      (14.17 %)      to       (14.17 %) 

2021

     35          $1.15       to       $1.15          $41          1.98      0.00     to       0.00      (1.12 %)      to       (1.12 %) 

2020

     18          $1.16       to       $1.16          $24          2.25      0.00     to       0.00      8.81     to       8.81

2019

              $1.07       to       $1.07          $2                4.45      0.00     to       0.00      2.31 %(5)      to       2.31 %(5) 

Put VT Global Hlth Care, Cl IA

 

                           

2023

     39          $1.12       to       $1.12          $44          0.39      0.00     to       0.00      9.39     to       9.39

2022

     13          $1.03       to       $1.03          $13                       0.00     to       0.00      3.27 %(7)      to       3.27 %(7) 

Put VT Global Hlth Care, Cl IB

 

                           

2023

     324          $1.12       to       $5.40          $1,404          0.30      0.00     to       0.90      9.14     to       8.16

2022

     323          $1.02       to       $4.99          $1,349          0.40      0.00     to       0.90      3.12 %(7)      to       (5.53 %) 

2021

     298          $2.72       to       $5.29          $1,439          1.10      0.30     to       0.90      19.04     to       18.33

2020

     305          $2.29       to       $4.47          $1,243          0.47      0.30     to       0.90      15.93     to       15.24

2019

     289          $1.97       to       $3.88          $1,055                       0.30     to       0.90      29.90     to       29.13

Put VT Hi Yield, Cl IB

 

                           

2023

     85          $2.79       to       $3.09          $252          5.32      0.45     to       0.90      11.64     to       11.13

2022

     88          $2.50       to       $2.78          $234          5.48      0.45     to       0.90      (12.00 %)      to       (12.39 %) 

2021

     108          $2.84       to       $3.17          $328          5.61      0.45     to       0.90      4.51     to       4.03

2020

     147          $2.72       to       $3.05          $429          5.71      0.45     to       0.90      4.74     to       4.26

2019

     154          $2.60       to       $2.93          $432                5.90      0.45     to       0.90      13.89     to       13.37

 

166    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

Put VT Intl Eq, Cl IB

 

                           

2023

     73          $1.37       to       $2.51          $162          0.04      0.20     to       0.90      18.26     to       17.45

2022

     73          $1.15       to       $2.14          $140          1.54      0.20     to       0.90      16.28 %(8)      to       (15.53 %) 

2021

     73          $1.58       to       $2.53          $167          1.20      0.30     to       0.90      8.50     to       7.85

2020

     80          $1.45       to       $2.34          $173          1.61      0.30     to       0.90      11.76     to       11.09

2019

     82          $1.30       to       $2.11          $160                1.46      0.30     to       0.90      24.78     to       24.03

Put VT Sus Leaders, Cl IA

 

                           

2023

     1,848          $7.94       to       $6.68          $12,550          0.75      0.45     to       0.90      25.85     to       25.29

2022

     1,950          $6.31       to       $5.33          $10,570          0.83      0.45     to       0.90      (23.07 %)      to       (23.41 %) 

2021

     2,067          $8.20       to       $6.96          $14,623          0.34      0.45     to       0.90      23.28     to       22.73

2020

     2,248          $6.65       to       $5.67          $12,946          0.63      0.45     to       0.90      28.48     to       27.91

2019

     2,376          $5.18       to       $4.43          $10,692                0.68      0.45     to       0.90      36.11     to       35.50

Put VT Sus Leaders, Cl IB

 

                           

2023

     31          $1.31       to       $4.98          $150          0.46      0.20     to       0.90      25.86     to       24.98

2022

     23          $1.04       to       $3.99          $98          0.54      0.20     to       0.90      5.04 %(8)      to       (23.60 %) 

2021

     24          $3.73       to       $5.22          $131          0.15      0.30     to       0.90      23.16     to       22.43

2020

     28          $3.03       to       $4.26          $123          0.40      0.30     to       0.90      28.51     to       27.74

2019

     33          $2.36       to       $3.34          $109                0.48      0.30     to       0.90      35.95     to       35.14

Royce Micro-Cap, Invest Cl

 

                           

2023

     436          $4.06       to       $5.08          $1,977                 0.45     to       0.90      18.25     to       17.72

2022

     447          $3.43       to       $4.32          $1,720                 0.45     to       0.90      (22.78 %)      to       (23.13 %) 

2021

     480          $4.45       to       $5.61          $2,399                 0.45     to       0.90      29.40     to       28.82

2020

     519          $3.44       to       $4.36          $2,010                 0.45     to       0.90      23.24     to       22.68

2019

     616          $2.79       to       $3.55          $1,931                       0.45     to       0.90      19.02     to       18.48

Temp Global Bond, Cl 1

 

                           

2023

     31          $0.88       to       $0.88          $27                 0.00     to       0.00      3.19     to       3.19

2022

     26          $0.85       to       $0.85          $22                 0.00     to       0.00      (4.85 %)      to       (4.85 %) 

2021

     23          $0.90       to       $0.90          $20                 0.00     to       0.00      (4.62 %)      to       (4.62 %) 

2020

     17          $0.94       to       $0.94          $16          0.74      0.00     to       0.00      (5.08 %)      to       (5.08 %) 

2019

              $0.99       to       $0.99          $0                13.50      0.00     to       0.00      (0.89 %)(5)      to       (0.89 %)(5) 

Temp Global Bond, Cl 2

 

                           

2023

     230          $0.95       to       $0.84          $203                 0.00     to       0.90      2.88     to       1.97

2022

     205          $0.93       to       $0.82          $176                 0.00     to       0.90      (4.95 %)      to       (5.80 %) 

2021

     206          $0.98       to       $0.87          $187                 0.00     to       0.90      (4.99 %)      to       (5.84 %) 

2020

     209          $1.03       to       $0.92          $200          8.55      0.00     to       0.90      (5.28 %)      to       (6.13 %) 

2019

     200          $1.08       to       $0.98          $201                6.87      0.00     to       0.90      2.01     to       1.10

Third Ave VST Third Ave Value

 

                           

2023

     653          $3.66       to       $3.95          $2,466          2.36      0.45     to       0.90      20.27     to       19.73

2022

     701          $3.04       to       $3.30          $2,208          1.51      0.45     to       0.90      15.59     to       15.07

2021

     721          $2.63       to       $2.87          $1,981          0.69      0.45     to       0.90      21.51     to       20.97

2020

     758          $2.17       to       $2.37          $1,718          2.73      0.45     to       0.90      (2.83 %)      to       (3.27 %) 

2019

     757          $2.23       to       $2.45          $1,764                0.27      0.45     to       0.90      11.96     to       11.45

VanEck VIP Global Gold, Cl S

 

                           

2023

     116          $1.35       to       $1.17          $145                 0.00     to       0.90      10.41     to       9.42

2022

     112          $1.23       to       $1.07          $127                 0.00     to       0.90      (13.36 %)      to       (14.13 %) 

2021

     110          $1.42       to       $1.25          $145          11.22      0.00     to       0.90      (14.01 %)      to       (14.78 %) 

2020

     92          $1.65       to       $1.46          $142          1.78      0.00     to       0.90      38.62     to       37.38

2019

     190          $1.19       to       $1.07          $210                       0.00     to       0.90      38.75     to       37.50

VP Aggr, Cl 1

 

                           

2023

     1,166          $1.43       to       $1.43          $1,669                 0.00     to       0.00      17.51     to       17.51

2022

     559          $1.22       to       $1.22          $681                 0.00     to       0.00      (17.99 %)      to       (17.99 %) 

2021

     269          $1.49       to       $1.49          $400                 0.00     to       0.00      16.03     to       16.03

2020

     100          $1.28       to       $1.28          $128                 0.00     to       0.00      15.30     to       15.30

2019

     0          $1.11       to       $1.11          $1                       0.00     to       0.00      6.79 %(5)      to       6.79 %(5) 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      167  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
      

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

VP Aggr, Cl 2

 

                             

2023

     11,567          $2.28       to       $2.48          $26,120                   0.00     to       0.90      17.22     to       16.18

2022

     10,747          $1.94       to       $2.14          $20,899                   0.00     to       0.90      (18.19 %)      to       (18.92 %) 

2021

     10,581          $2.38       to       $2.64          $25,283                   0.00     to       0.90      15.76     to       14.72

2020

     10,139          $2.05       to       $2.30          $21,679                   0.00     to       0.90      14.99     to       13.96

2019

     9,514          $1.78       to       $2.02          $17,831                         0.00     to       0.90      21.59     to       20.50

VP Aggr, Cl 4

 

                             

2023

     9,987          $1.25       to       $2.49          $23,651                   0.20     to       0.90      16.96     to       16.15

2022

     10,359          $1.07       to       $2.14          $21,227                   0.20     to       0.90      7.96 %(8)      to       (18.92 %) 

2021

     10,513          $2.04       to       $2.64          $26,365                   0.30     to       0.90      15.43     to       14.74

2020

     10,695          $1.77       to       $2.30          $23,320                   0.30     to       0.90      14.62     to       13.93

2019

     10,708          $1.54       to       $2.02          $20,414                         0.30     to       0.90      21.31     to       20.59

VP Conserv, Cl 1

 

                             

2023

              $1.12       to       $1.12          $0                   0.00     to       0.00      8.65     to       8.65

2022

              $1.03       to       $1.03          $0                   0.00     to       0.00      (15.26 %)      to       (15.26 %) 

2021

              $1.21       to       $1.21          $0                   0.00     to       0.00      3.05     to       3.05

2020

              $1.18       to       $1.18          $0                   0.00     to       0.00      9.55     to       9.55

2019

              $1.07       to       $1.07          $0                         0.00     to       0.00      3.03 %(5)      to       3.03 %(5) 

VP Conserv, Cl 2

 

                             

2023

     430          $1.33       to       $1.36          $583                   0.00     to       0.90      8.46     to       7.49

2022

     436          $1.22       to       $1.26          $550                   0.00     to       0.90      (15.54 %)      to       (16.30 %) 

2021

     417          $1.45       to       $1.51          $633                   0.00     to       0.90      2.82     to       1.89

2020

     579          $1.41       to       $1.48          $876                   0.00     to       0.90      9.30     to       8.32

2019

     457          $1.29       to       $1.37          $628                         0.00     to       0.90      10.75     to       9.76

VP Conserv, Cl 4

 

                             

2023

     305          $1.11       to       $1.36          $432                   0.20     to       0.90      8.18     to       7.42

2022

     344          $1.03       to       $1.26          $453                   0.20     to       0.90      3.31 %(8)      to       (16.25 %) 

2021

     384          $1.39       to       $1.51          $596                   0.30     to       0.90      2.51     to       1.90

2020

     395          $1.35       to       $1.48          $601                   0.30     to       0.90      8.91     to       8.26

2019

     668          $1.24       to       $1.37          $898                         0.30     to       0.90      10.42     to       9.76

VP Man Vol Conserv, Cl 1

 

                             

2023

              $1.10       to       $1.10          $0                   0.00     to       0.00      8.05     to       8.05

2022

              $1.02       to       $1.02          $0                   0.00     to       0.00      (15.75 %)      to       (15.75 %) 

2021

              $1.21       to       $1.21          $0                   0.00     to       0.00      2.91     to       2.91

2020

              $1.18       to       $1.18          $0                   0.00     to       0.00      8.35     to       8.35

2019

              $1.08       to       $1.08          $0                         0.00     to       0.00      3.76 %(5)      to       3.76 %(5) 

VP Man Vol Conserv, Cl 2

 

                             

2023

     82          $1.22       to       $1.12          $94                   0.00     to       0.90      7.87     to       6.90

2022

     84          $1.13       to       $1.05          $90                   0.00     to       0.90      (15.99 %)      to       (16.74 %) 

2021

     111          $1.35       to       $1.26          $143                   0.00     to       0.90      2.63     to       1.71

2020

     92          $1.31       to       $1.24          $117                   0.00     to       0.90      8.12     to       7.15

2019

     21          $1.21       to       $1.16          $25                         0.00     to       0.90      11.92     to       10.91

VP Man Vol Conserv Gro, Cl 1

 

                             

2023

     49          $1.15       to       $1.15          $56                   0.00     to       0.00      10.19     to       10.19

2022

     48          $1.05       to       $1.05          $50                   0.00     to       0.00      (16.88 %)      to       (16.88 %) 

2021

     48          $1.26       to       $1.26          $60                   0.00     to       0.00      5.77     to       5.77

2020

              $1.19       to       $1.19          $0                   0.00     to       0.00      9.35     to       9.35

2019

              $1.09       to       $1.09          $0                         0.00     to       0.00      4.34 %(5)      to       4.34 %(5) 

VP Man Vol Conserv Gro, Cl 2

 

                             

2023

     110          $1.31       to       $1.20          $136                   0.00     to       0.90      9.98     to       8.99

2022

     118          $1.19       to       $1.10          $134                   0.00     to       0.90      (17.06 %)      to       (17.81 %) 

2021

     127          $1.43       to       $1.34          $175                   0.00     to       0.90      5.45     to       4.51

2020

     124          $1.36       to       $1.28          $163                   0.00     to       0.90      9.15     to       8.17

2019

     40          $1.24       to       $1.18          $48                         0.00     to       0.90      14.00     to       12.97

 

168    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
      

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

VP Man Vol Gro, Cl 1

 

                             

2023

     741          $1.27       to       $1.27          $944                   0.00     to       0.00      14.87     to       14.87

2022

     422          $1.11       to       $1.11          $468                   0.00     to       0.00      (19.22 %)      to       (19.22 %) 

2021

     312          $1.37       to       $1.37          $428                   0.00     to       0.00      12.22     to       12.22

2020

     31          $1.22       to       $1.22          $37                   0.00     to       0.00      11.56     to       11.56

2019

     8          $1.10       to       $1.10          $8                         0.00     to       0.00      5.50 %(5)      to       5.50 %(5) 

VP Man Vol Gro, Cl 2

 

                             

2023

     1,544          $1.49       to       $1.37          $2,239                   0.00     to       0.90      14.59     to       13.57

2022

     1,558          $1.30       to       $1.20          $1,976                   0.00     to       0.90      (19.43 %)      to       (20.15 %) 

2021

     1,487          $1.61       to       $1.51          $2,346                   0.00     to       0.90      11.89     to       10.89

2020

     1,439          $1.44       to       $1.36          $2,035                   0.00     to       0.90      11.30     to       10.30

2019

     1,434          $1.30       to       $1.23          $1,827                         0.00     to       0.90      18.26     to       17.20

VP Man Vol Mod Gro, Cl 1

 

                             

2023

     243          $1.22       to       $1.22          $296                   0.00     to       0.00      12.49     to       12.49

2022

     112          $1.08       to       $1.08          $121                   0.00     to       0.00      (17.94 %)      to       (17.94 %) 

2021

     51          $1.32       to       $1.32          $67                   0.00     to       0.00      9.02     to       9.02

2020

     31          $1.21       to       $1.21          $38                   0.00     to       0.00      10.62     to       10.62

2019

     4          $1.09       to       $1.09          $5                         0.00     to       0.00      4.93 %(5)      to       4.93 %(5) 

VP Man Vol Mod Gro, Cl 2

 

                             

2023

     1,364          $1.41       to       $1.29          $1,861                   0.00     to       0.90      12.27     to       11.27

2022

     1,315          $1.26       to       $1.16          $1,604                   0.00     to       0.90      (18.15 %)      to       (18.89 %) 

2021

     1,436          $1.53       to       $1.43          $2,147                   0.00     to       0.90      8.70     to       7.72

2020

     1,279          $1.41       to       $1.33          $1,765                   0.00     to       0.90      10.37     to       9.38

2019

     1,304          $1.28       to       $1.22          $1,635                         0.00     to       0.90      16.17     to       15.13

VP Mod, Cl 1

 

                             

2023

     2,961          $1.28       to       $1.28          $3,786                   0.00     to       0.00      13.22     to       13.22

2022

     1,790          $1.13       to       $1.13          $2,021                   0.00     to       0.00      (16.42 %)      to       (16.42 %) 

2021

     1,185          $1.35       to       $1.35          $1,602                   0.00     to       0.00      9.31     to       9.31

2020

     59          $1.24       to       $1.24          $73                   0.00     to       0.00      13.12     to       13.12

2019

              $1.09       to       $1.09          $0                         0.00     to       0.00      4.75 %(5)      to       4.75 %(5) 

VP Mod, Cl 2

 

                             

2023

     13,943          $1.76       to       $1.89          $26,124                   0.00     to       0.90      12.96     to       11.95

2022

     14,671          $1.56       to       $1.69          $24,482                   0.00     to       0.90      (16.61 %)      to       (17.35 %) 

2021

     15,164          $1.87       to       $2.05          $30,374                   0.00     to       0.90      9.00     to       8.03

2020

     15,047          $1.72       to       $1.90          $28,331                   0.00     to       0.90      12.86     to       11.85

2019

     15,836          $1.52       to       $1.69          $26,566                         0.00     to       0.90      16.13     to       15.09

VP Mod, Cl 4

 

                             

2023

     17,954          $1.18       to       $1.90          $33,732                   0.20     to       0.90      12.72     to       11.93

2022

     18,733          $1.05       to       $1.70          $31,437                   0.20     to       0.90      5.51 %(8)      to       (17.33 %) 

2021

     19,360          $1.70       to       $2.05          $39,217                   0.30     to       0.90      8.72     to       8.07

2020

     19,863          $1.56       to       $1.90          $37,194                   0.30     to       0.90      12.45     to       11.78

2019

     21,370          $1.39       to       $1.70          $35,568                         0.30     to       0.90      15.83     to       15.14

VP Mod Aggr, Cl 1

 

                             

2023

     6,214          $1.35       to       $1.35          $8,377                   0.00     to       0.00      15.23     to       15.23

2022

     4,464          $1.17       to       $1.17          $5,223                   0.00     to       0.00      (17.38 %)      to       (17.38 %) 

2021

     2,573          $1.42       to       $1.42          $3,644                   0.00     to       0.00      12.61     to       12.61

2020

     532          $1.26       to       $1.26          $669                   0.00     to       0.00      14.26     to       14.26

2019

     53          $1.10       to       $1.10          $59                         0.00     to       0.00      5.74 %(5)      to       5.74 %(5) 

VP Mod Aggr, Cl 2

 

                             

2023

     19,352          $2.00       to       $2.17          $40,433                   0.00     to       0.90      14.93     to       13.91

2022

     20,860          $1.74       to       $1.90          $37,869                   0.00     to       0.90      (17.59 %)      to       (18.33 %) 

2021

     20,138          $2.11       to       $2.33          $44,693                   0.00     to       0.90      12.31     to       11.30

2020

     20,342          $1.88       to       $2.10          $40,777                   0.00     to       0.90      14.03     to       13.01

2019

     20,092          $1.65       to       $1.85          $35,918                         0.00     to       0.90      18.71     to       17.65

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      169  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

VP Mod Aggr, Cl 4

 

                           

2023

     26,106          $1.22       to       $2.17          $55,837                 0.20     to       0.90      14.68     to       13.88

2022

     28,412          $1.06       to       $1.91          $53,424                 0.20     to       0.90      6.74 %(8)      to       (18.30 %) 

2021

     29,528          $1.86       to       $2.34          $67,643                 0.30     to       0.90      12.00     to       11.33

2020

     30,763          $1.66       to       $2.10          $62,979                 0.30     to       0.90      13.67     to       12.99

2019

     33,208          $1.46       to       $1.86          $59,867                       0.30     to       0.90      18.39     to       17.68

VP Mod Conserv, Cl 1

 

                           

2023

     284          $1.19       to       $1.19          $339                 0.00     to       0.00      10.78     to       10.78

2022

     292          $1.07       to       $1.07          $314                 0.00     to       0.00      (15.93 %)      to       (15.93 %) 

2021

     299          $1.28       to       $1.28          $383                 0.00     to       0.00      5.99     to       5.99

2020

     306          $1.21       to       $1.21          $369                 0.00     to       0.00      11.28     to       11.28

2019

              $1.08       to       $1.08          $0                       0.00     to       0.00      3.93 %(5)      to       3.93 %(5) 

VP Mod Conserv, Cl 2

 

                           

2023

     1,309          $1.52       to       $1.60          $2,193                 0.00     to       0.90      10.50     to       9.51

2022

     1,324          $1.38       to       $1.46          $2,002                 0.00     to       0.90      (16.09 %)      to       (16.84 %) 

2021

     1,425          $1.64       to       $1.76          $2,570                 0.00     to       0.90      5.74     to       4.79

2020

     1,396          $1.56       to       $1.68          $2,378                 0.00     to       0.90      11.00     to       10.01

2019

     1,357          $1.40       to       $1.52          $2,077                       0.00     to       0.90      13.51     to       12.50

VP Mod Conserv, Cl 4

 

                           

2023

     1,780          $1.15       to       $1.60          $2,851                 0.20     to       0.90      10.26     to       9.49

2022

     1,854          $1.04       to       $1.46          $2,712                 0.20     to       0.90      4.54 %(8)      to       (16.85 %) 

2021

     1,832          $1.54       to       $1.76          $3,213                 0.30     to       0.90      5.47     to       4.84

2020

     2,518          $1.46       to       $1.68          $4,184                 0.30     to       0.90      10.65     to       9.99

2019

     2,780          $1.32       to       $1.53          $4,290                       0.30     to       0.90      13.15     to       12.47

VP Ptnrs Core Bond, Cl 1

 

                           

2023

     23          $1.06       to       $1.06          $24          2.75      0.00     to       0.00      6.30     to       6.30

2022

     11          $1.00       to       $1.00          $11          1.67      0.00     to       0.00      (13.29 %)      to       (13.29 %) 

2021

     5          $1.15       to       $1.15          $5          1.21      0.00     to       0.00      (1.24 %)      to       (1.24 %) 

2020

     0          $1.16       to       $1.16          $1          2.37      0.00     to       0.00      8.27     to       8.27

2019

     0          $1.07       to       $1.07          $0                4.19      0.00     to       0.00      2.47 %(5)      to       2.47 %(5) 

VP Ptnrs Core Bond, Cl 2

 

                           

2023

     12          $1.15       to       $1.15          $13          2.62      0.00     to       0.00      6.06     to       6.06

2022

     3          $1.08       to       $1.08          $4          1.38      0.00     to       0.00      (13.60 %)      to       (13.60 %) 

2021

     3          $1.25       to       $1.25          $4          1.19      0.00     to       0.00      (1.41 %)      to       (1.41 %) 

2020

     3          $1.27       to       $1.27          $3          2.22      0.00     to       0.00      7.97     to       7.97

2019

     4          $1.18       to       $1.18          $4                2.14      0.00     to       0.00      8.39     to       8.39

VP Ptnrs Core Eq, Cl 1

 

                           

2023

     1          $1.76       to       $1.76          $2                 0.00     to       0.00      24.71     to       24.71

2022

     1          $1.41       to       $1.41          $1                 0.00     to       0.00      (17.33 %)      to       (17.33 %) 

2021

     1          $1.71       to       $1.71          $1                 0.00     to       0.00      29.45     to       29.45

2020

     0          $1.32       to       $1.32          $0                 0.00     to       0.00      17.02     to       17.02

2019

              $1.13       to       $1.13          $0                       0.00     to       0.00      8.80 %(5)      to       8.80 %(5) 

VP Ptnrs Core Eq, Cl 2

 

                           

2023

     9          $3.34       to       $3.34          $32                 0.00     to       0.00      24.43     to       24.43

2022

     0          $2.69       to       $2.69          $1                 0.00     to       0.00      (17.55 %)      to       (17.55 %) 

2021

     0          $3.26       to       $3.26          $1                 0.00     to       0.00      29.18     to       29.18

2020

     0          $2.52       to       $2.52          $1                 0.00     to       0.00      16.73     to       16.73

2019

     0          $2.16       to       $2.16          $0                       0.00     to       0.00      26.20     to       26.20

VP Ptnrs Core Eq, Cl 3

 

                           

2023

     95          $1.31       to       $2.77          $423                 0.20     to       0.90      24.30     to       23.44

2022

     102          $1.06       to       $2.24          $370                 0.20     to       0.90      6.59 %(8)      to       (18.17 %) 

2021

     130          $2.73       to       $2.74          $528                 0.30     to       0.90      28.95     to       28.18

2020

     140          $2.11       to       $2.14          $438                 0.30     to       0.90      16.49     to       15.80

2019

     132          $1.81       to       $1.85          $343                       0.30     to       0.90      26.00     to       25.25

 

170    RIVERSOURCE OF NEW YORK ACCOUNT  8


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

VP Ptnrs Intl Core Eq, Cl 1

 

                           

2023

     49          $1.30       to       $1.30          $64          1.35      0.00     to       0.00      17.70     to       17.70

2022

     49          $1.10       to       $1.10          $54          1.50      0.00     to       0.00      (19.51 %)      to       (19.51 %) 

2021

     14          $1.37       to       $1.37          $19          1.19      0.00     to       0.00      13.55     to       13.55

2020

     4          $1.21       to       $1.21          $5          0.01      0.00     to       0.00      11.17     to       11.17

2019

              $1.09       to       $1.09          $0                5.40      0.00     to       0.00      5.22 %(5)      to       5.22 %(5) 

VP Ptnrs Intl Core Eq, Cl 2

 

                           

2023

     34          $1.62       to       $1.62          $56          1.02      0.00     to       0.00      17.34     to       17.34

2022

     20          $1.38       to       $1.38          $27          1.75      0.00     to       0.00      (19.64 %)      to       (19.64 %) 

2021

     23          $1.72       to       $1.72          $40          1.81      0.00     to       0.00      13.18     to       13.18

2020

     27          $1.52       to       $1.52          $41          0.20      0.00     to       0.00      10.96     to       10.96

2019

     24          $1.37       to       $1.37          $32                2.48      0.00     to       0.00      18.41     to       18.41

VP Ptnrs Intl Gro, Cl 1

 

                           

2023

     115          $1.31       to       $1.31          $150          0.48      0.00     to       0.00      14.77     to       14.77

2022

     107          $1.14       to       $1.14          $121                 0.00     to       0.00      (26.69 %)      to       (26.69 %) 

2021

     79          $1.55       to       $1.55          $122          0.06      0.00     to       0.00      10.63     to       10.63

2020

     66          $1.41       to       $1.41          $92          0.00      0.00     to       0.00      22.62     to       22.62

2019

     0          $1.15       to       $1.15          $0                1.28      0.00     to       0.00      9.35 %(5)      to       9.35 %(5) 

VP Ptnrs Intl Gro, Cl 2

 

                           

2023

     119          $1.67       to       $1.67          $198          0.24      0.00     to       0.00      14.45     to       14.45

2022

     124          $1.46       to       $1.46          $181                 0.00     to       0.00      (26.87 %)      to       (26.87 %) 

2021

     134          $1.99       to       $1.99          $268                 0.00     to       0.00      10.33     to       10.33

2020

     119          $1.81       to       $1.81          $215          0.08      0.00     to       0.00      22.30     to       22.30

2019

     110          $1.48       to       $1.48          $163                0.89      0.00     to       0.00      26.36     to       26.36

VP Ptnrs Intl Val, Cl 1

 

                           

2023

     33          $1.17       to       $1.17          $39          1.82      0.00     to       0.00      17.14     to       17.14

2022

     21          $1.00       to       $1.00          $21          1.96      0.00     to       0.00      (11.46 %)      to       (11.46 %) 

2021

     9          $1.13       to       $1.13          $10          1.97      0.00     to       0.00      11.80     to       11.80

2020

     6          $1.01       to       $1.01          $6          0.70      0.00     to       0.00      (3.82 %)      to       (3.82 %) 

2019

     2          $1.05       to       $1.05          $2                3.48      0.00     to       0.00      4.88 %(5)      to       4.88 %(5) 

VP Ptnrs Intl Val, Cl 2

 

                           

2023

     45          $1.49       to       $1.49          $67          1.93      0.00     to       0.00      16.96     to       16.96

2022

     44          $1.28       to       $1.28          $56          2.19      0.00     to       0.00      (11.75 %)      to       (11.75 %) 

2021

     62          $1.45       to       $1.45          $90          1.99      0.00     to       0.00      11.64     to       11.64

2020

     59          $1.30       to       $1.30          $76          0.80      0.00     to       0.00      (4.14 %)      to       (4.14 %) 

2019

     53          $1.35       to       $1.35          $71                3.55      0.00     to       0.00      13.20     to       13.20

VP Ptnrs Sm Cap Gro, Cl 1

 

                           

2023

     49          $1.17       to       $1.17          $58                 0.00     to       0.00      7.20     to       7.20

2022

     39          $1.10       to       $1.10          $43                 0.00     to       0.00      (28.97 %)      to       (28.97 %) 

2021

     4          $1.54       to       $1.54          $7                 0.00     to       0.00      8.29     to       8.29

2020

     1          $1.42       to       $1.42          $1                 0.00     to       0.00      38.77     to       38.77

2019

              $1.03       to       $1.03          $0                       0.00     to       0.00      5.62 %(5)      to       5.62 %(5) 

VP Ptnrs Sm Cap Gro, Cl 2

 

                           

2023

     14          $2.12       to       $2.12          $29                 0.00     to       0.00      6.93     to       6.93

2022

     12          $1.98       to       $1.98          $24                 0.00     to       0.00      (29.13 %)      to       (29.13 %) 

2021

     12          $2.80       to       $2.80          $34                 0.00     to       0.00      8.02     to       8.02

2020

     24          $2.59       to       $2.59          $62                 0.00     to       0.00      38.43     to       38.43

2019

     16          $1.87       to       $1.87          $30                       0.00     to       0.00      20.95     to       20.95

VP Ptnrs Sm Cap Val, Cl 1

 

                           

2023

     9          $1.27       to       $1.27          $11                 0.00     to       0.00      11.38     to       11.38

2022

     7          $1.14       to       $1.14          $8                 0.00     to       0.00      (12.94 %)      to       (12.94 %) 

2021

     1          $1.31       to       $1.31          $1                 0.00     to       0.00      24.01     to       24.01

2020

     0          $1.06       to       $1.06          $0                 0.00     to       0.00      4.27     to       4.27

2019

              $1.02       to       $1.02          $0                       0.00     to       0.00      6.96 %(5)      to       6.96 %(5) 

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      171  


     At December 31            For the year ended December 31  
     Units
(000s)
       Accumulation unit value
lowest to highest(1)
       Net assets
(000s)
            Investment
income ratio(2)
    

Expense ratio

lowest to highest(3)

    

Total return

lowest to highest(1)(4)

 

VP Ptnrs Sm Cap Val, Cl 2

 

                           

2023

     3          $2.20       to       $2.20          $6                 0.00     to       0.00      11.08     to       11.08

2022

     3          $1.98       to       $1.98          $6                 0.00     to       0.00      (13.16 %)      to       (13.16 %) 

2021

     3          $2.28       to       $2.28          $6                 0.00     to       0.00      23.75     to       23.75

2020

     3          $1.84       to       $1.84          $5                 0.00     to       0.00      3.99     to       3.99

2019

     2          $1.77       to       $1.77          $4                       0.00     to       0.00      19.53     to       19.53

VP Ptnrs Sm Cap Val, Cl 3

 

                           

2023

     192          $1.20       to       $3.89          $659                 0.20     to       0.90      11.04     to       10.27

2022

     187          $1.08       to       $3.52          $605                 0.20     to       0.90      8.27 %(8)      to       (13.84 %) 

2021

     210          $1.76       to       $4.09          $785                 0.30     to       0.90      23.52     to       22.78

2020

     203          $1.42       to       $3.33          $610                 0.30     to       0.90      3.80     to       3.18

2019

     208          $1.37       to       $3.23          $606                       0.30     to       0.90      19.30     to       18.58

VP US Flex Conserv Gro, Cl 1

 

                           

2023

     5          $1.17       to       $1.17          $6                 0.00     to       0.00      11.53     to       11.53

2022

     3          $1.05       to       $1.05          $4                 0.00     to       0.00      (16.54 %)      to       (16.54 %) 

2021

     1          $1.26       to       $1.26          $1                 0.00     to       0.00      7.76     to       7.76

2020

     0          $1.17       to       $1.17          $0                 0.00     to       0.00      6.18     to       6.18

2019

              $1.10       to       $1.10          $0                       0.00     to       0.00      4.90 %(5)      to       4.90 %(5) 

VP US Flex Gro, Cl 1

 

                           

2023

     107          $1.30       to       $1.30          $140                 0.00     to       0.00      17.14     to       17.14

2022

     79          $1.11       to       $1.11          $88                 0.00     to       0.00      (18.54 %)      to       (18.54 %) 

2021

     15          $1.36       to       $1.36          $20                 0.00     to       0.00      15.76     to       15.76

2020

     8          $1.18       to       $1.18          $9                 0.00     to       0.00      5.07     to       5.07

2019

              $1.12       to       $1.12          $0                       0.00     to       0.00      6.85 %(5)      to       6.85 %(5) 

VP US Flex Mod Gro, Cl 1

 

                           

2023

     8          $1.24       to       $1.24          $10                 0.00     to       0.00      14.29     to       14.29

2022

     5          $1.08       to       $1.08          $6                 0.00     to       0.00      (17.36 %)      to       (17.36 %) 

2021

     5          $1.31       to       $1.31          $7                 0.00     to       0.00      11.71     to       11.71

2020

     8          $1.17       to       $1.17          $9                 0.00     to       0.00      5.74     to       5.74

2019

              $1.11       to       $1.11          $0                       0.00     to       0.00      5.92 %(5)      to       5.92 %(5) 

Wanger Acorn

 

                           

2023

     1,270          $1.22       to       $5.54          $5,634                 0.20     to       0.90      21.49     to       20.65

2022

     1,295          $1.01       to       $4.60          $4,899                 0.20     to       0.90      2.29 %(8)      to       (34.06 %) 

2021

     1,293          $2.64       to       $6.97          $7,460          0.76      0.30     to       0.90      8.57     to       7.92

2020

     1,354          $2.43       to       $6.46          $7,196                 0.30     to       0.90      23.86     to       23.12

2019

     1,499          $1.96       to       $5.25          $6,511                0.26      0.30     to       0.90      30.71     to       29.93

Wanger Intl

 

                           

2023

     1,573          $1.34       to       $3.39          $4,276          0.32      0.20     to       0.90      16.72     to       15.91

2022

     1,707          $1.15       to       $2.93          $3,948          0.92      0.20     to       0.90      15.79 %(8)      to       (34.44 %) 

2021

     1,667          $1.98       to       $4.46          $5,916          0.55      0.30     to       0.90      18.45     to       17.74

2020

     1,719          $1.68       to       $3.79          $5,227          2.02      0.30     to       0.90      14.02     to       13.34

2019

     1,829          $1.47       to       $3.35          $4,881                0.81      0.30     to       0.90      29.60     to       28.83

WA Var Global Hi Yd Bond, Cl I

 

                           

2023

     16          $1.12       to       $1.12          $18          5.63      0.00     to       0.00      10.26     to       10.26

2022

     16          $1.01       to       $1.01          $17          9.59      0.00     to       0.00      (13.72 %)      to       (13.72 %) 

2021

     6          $1.17       to       $1.17          $8          8.92      0.00     to       0.00      1.33     to       1.33

2020

     0          $1.16       to       $1.16          $1          5.74      0.00     to       0.00      7.32     to       7.32

2019

     0          $1.08       to       $1.08          $0                16.70      0.00     to       0.00      2.66 %(5)      to       2.66 %(5) 

WA Var Global Hi Yd Bond, Cl II

 

                           

2023

     7          $1.33       to       $1.33          $9          5.39      0.00     to       0.00      9.96     to       9.96

2022

     7          $1.21       to       $1.21          $8          5.98      0.00     to       0.00      (13.87 %)      to       (13.87 %) 

2021

     7          $1.40       to       $1.40          $10          5.04      0.00     to       0.00      1.04     to       1.04

2020

     3          $1.39       to       $1.39          $5          4.14      0.00     to       0.00      7.12     to       7.12

2019

     3          $1.30       to       $1.30          $3                5.57      0.00     to       0.00      14.01     to       14.01

 

172    RIVERSOURCE OF NEW YORK ACCOUNT  8


(1)

The accumulation unit values and total returns are presented as a range of values based on the life insurance policies with the lowest and highest expense ratios.

(2)

These amounts represent the dividends, excluding distributions of capital gains, received by the division from the underlying fund, net of management fees assessed by the fund manager, divided by the average net assets. These ratios exclude variable account expenses that result in direct reductions in the unit values. The recognition of investment income by the division is affected by the timing of the declaration of dividends by the underlying fund in which the division invests. These ratios are annualized for periods less than one year.

(3)

These ratios represent the annualized policy expenses of the separate account, consisting primarily of mortality and expense charges, for each period indicated. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to policy owner accounts through the redemption of units and expenses of the underlying fund are excluded.

(4)

These amounts represent the total return for the periods indicated, including changes in the value of the underlying fund, and reflect deductions for all items included in the expense ratio. The total return does not include any expenses assessed through the redemption of units; inclusion of these expenses in the calculation would result in a reduction in the total return presented. Investment options with a date notation indicate the effective date of that investment option in the variable account. The total return is calculated for the period indicated or from the effective date through the end of the reporting period. Although the total return is presented as a range of values based on the subaccounts representing the lowest and highest expense ratios, some individual subaccount total returns are not within the ranges presented due to the introduction of new subaccounts during the year and other market factors.

(5) 

New subaccount operations commenced on June 24, 2019.

(6) 

New subaccount operations commenced on April 24, 2020.

(7) 

New subaccount operations commenced on May 2, 2022.

(8) 

New subaccount operations commenced on October 10, 2022.

 

RIVERSOURCE OF NEW YORK ACCOUNT  8      173  


REPORT OF INDEPENDENT AUDITORS

TO THE BOARD OF DIRECTORS AND SHAREHOLDER OF RIVERSOURCE LIFE INSURANCE CO. OF NEW YORK

Opinion

We have audited the accompanying financial statements of RiverSource Life Insurance Co. of New York (the “Company”), which comprise the balance sheets as of December 31, 2023 and 2022, and the related statements of income, of comprehensive income, of shareholder’s equity and of cash flows for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the “financial statements”).

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023 in accordance with accounting principles generally accepted in the United States of America.

Basis for Opinion

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (US GAAS). Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Emphasis of Matter

As discussed in Note 3 to the financial statements, the Company changed the manner in which it accounts for long-duration insurance contracts in 2023. Our opinion is not modified with respect to this matter.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are available to be issued.

Auditors’ Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with US GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with US GAAS, we:

 

   

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

F-1 


   

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

 

   

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

   

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

 

   

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ PricewaterhouseCoopers LLP

Minneapolis, Minnesota

April 19, 2024

 

 F-2


RiverSource Life Insurance Co. of New York

 

 

BALANCE SHEETS

(in thousands, except share amounts)

 

December 31,    2023      2022(1)  
Assets      

Investments:

     

Available-for-Sale:

     

Fixed maturities, at fair value (amortized cost: 2023, $1,680,232; 2022, $1,678,575; allowance for credit losses: 2023, $365; 2022, $572)

   $ 1,585,541      $ 1,528,743  

Mortgage loans, at amortized cost (allowance for credit losses: 2023, $554; 2022, $965)

     144,910        157,068  

Policy loans

     53,615        50,791  

Other investments

     597        547  

Total investments

     1,784,663        1,737,149  

Cash and cash equivalents

     80,082        204,760  

Market risk benefits

     94,641        64,498  

Reinsurance recoverables (allowance for credit losses: 2023, $3,800; 2022, $3,500)

     205,915        195,547  

Receivables

     7,863        8,569  

Accrued investment income

     15,376        14,722  

Deferred acquisition costs

     166,933        174,038  

Other assets

     160,302        194,909  

Separate account assets

     4,515,324        4,230,890  

Total assets

   $ 7,031,099      $ 6,825,082  
     
Liabilities and Shareholder’s Equity      

Liabilities:

     

Policyholder account balances, future policy benefits and claims

   $ 1,916,999      $ 1,949,996  

Market risk benefits

     47,166        68,635  

Other liabilities

     127,513        180,631  

Separate account liabilities

     4,515,324        4,230,890  

Total liabilities

     6,607,002        6,430,152  

Shareholder’s Equity:

     

Common stock, $10 par value; 200,000 shares authorized, issued and outstanding

     2,000        2,000  

Additional paid-in capital

     106,926        106,926  

Retained earnings

     405,131        408,564  

Accumulated other comprehensive income (loss), net of tax

     (89,960      (122,560

Total shareholder’s equity

     424,097        394,930  

Total liabilities and shareholder’s equity

   $ 7,031,099      $ 6,825,082  

 

(1)

Certain prior period amounts have been restated. See Note 3 for more information.

See Notes to Financial Statements.

 

F-3 


RiverSource Life Insurance Co. of New York

 

 

STATEMENTS OF INCOME

(in thousands)

 

Years Ended December 31,    2023        2022(1)        2021(1)  
Revenues             

Premiums

   $ 21,413        $ 16,693        $ 15,416  

Net investment income

     84,585          72,209          65,369  

Policy and contract charges

     123,750          125,296          138,136  

Other revenues

     22,102          23,617          27,360  

Net realized investment gains (losses)

     187          (3,452        11,580  

Total revenues

     252,037          234,363          257,861  
            
Benefits and Expenses             

Benefits, claims, losses and settlement expenses

     48,540          37,994          42,481  

Interest credited to fixed accounts

     51,609          51,588          47,165  

Remeasurement (gains) losses of future policy benefit reserves

     2,003          2,225          55  

Change in fair value of market risk benefits

     45,118          40,393          (8,080

Amortization of deferred acquisition costs

     14,822          15,529          15,974  

Other insurance and operating expenses

     35,823          34,835          36,639  

Total benefits and expenses

     197,915          182,564          134,234  

Pretax income (loss)

     54,122          51,799          123,627  

Income tax provision (benefit)

     7,555          7,380          23,399  

Net income

   $ 46,567        $ 44,419        $ 100,228  

 

(1)

Certain prior period amounts have been restated. See Note 3 for more information.

See Notes to Financial Statements.

STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

 

Years Ended December 31,    2023        2022(1)        2021(1)  

Net income

   $ 46,567        $ 44,419        $ 100,228  

Other comprehensive income (loss), net of tax:

            

Net unrealized gains (losses) on securities

     41,675          (213,461        (49,020

Effect of changes in discount rate assumptions on certain long-duration contracts

     (6,125        61,911          17,386  

Effect of changes in instrument-specific credit risk on market risk benefits

     (2,950        18,837          4,564  

Total other comprehensive income (loss), net of tax

     32,600          (132,713        (27,070

Total comprehensive income (loss)

   $ 79,167        $ (88,294      $ 73,158  

 

(1)

Certain prior period amounts have been restated. See Note 3 for more information.

See Notes to Financial Statements.

 

 F-4


RiverSource Life Insurance Co. of New York

 

 

STATEMENTS OF SHAREHOLDER’S EQUITY

(in thousands)

 

       

Common

Stock

    

Additional

Paid-In

Capital

    

Retained

Earnings

    

Accumulated Other

Comprehensive

Income (Loss)

     Total  

Balances at January 1, 2021

     $ 2,000      $ 106,926      $ 350,273      $ 90,117      $ 549,316  

Cumulative effect of adoption of long-duration contracts guidance

                     (23,356      (52,894      (76,250

Net income

                     100,228               100,228  

Other comprehensive loss, net of tax

                            (27,070      (27,070

Balances at December 31, 2021(1)

       2,000        106,926        427,145        10,153        546,224  

Net income

                     44,419               44,419  

Other comprehensive loss, net of tax

                            (132,713      (132,713

Cash dividend to RiverSource Life Insurance Company

                     (63,000             (63,000

Balances at December 31, 2022(1)

       2,000        106,926        408,564        (122,560      394,930  

Net income

                     46,567               46,567  

Other comprehensive income, net of tax

                            32,600        32,600  

Cash dividend to RiverSource Life Insurance Company

                     (50,000             (50,000

Balances at December 31, 2023

     $ 2,000      $ 106,926      $ 405,131      $ (89,960    $ 424,097  

 

(1)

Certain prior period amounts have been restated. See Note 3 for more information.

See Notes to Financial Statements.

 

F-5 


RiverSource Life Insurance Co. of New York

 

 

STATEMENTS OF CASH FLOWS

(in thousands)

 

Years Ended December 31,    2023        2022(1)        2021(1)  
Cash Flows from Operating Activities   

Net income

   $ 46,567        $ 44,419        $ 100,228  

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

            

Depreciation, amortization and accretion, net

     2,049          2,971          2,903  

Deferred income tax (benefit) expense

     (1,519        (4,674        112  

Contractholder and policyholder charges, non-cash

     (27,744        (27,193        (26,825

(Gain) loss from equity method investments

     (72        96          (44

Net realized investment (gains) losses

     431          1,918          (11,901

Impairments and provision for loan losses

     (618        1,534          321  

Changes in operating assets and liabilities:

            

Deferred acquisition costs

     7,105          6,074          1,783  

Policyholder account balances, future policy benefits and claims, and market risk benefits, net

     (42,580        (46,805        (89,204

Derivatives, net of collateral

     (36,844        (136,006        93,328  

Reinsurance recoverables

     (4,765        (9,928        (3,151

Receivables

     553          5,261          (5,580

Accrued investment income

     (654        (1,282        213  

Current income tax, net

     (3,253        3,339          (19,210

Other, net

     4,121          3,254          12,338  

Net cash provided by (used in) operating activities

     (57,223        (157,022        55,311  
            
Cash Flows from Investing Activities             

Available-for-Sale securities:

            

Proceeds from sales

     902          152,436          15,898  

Maturities, sinking fund payments and calls

     115,763          229,741          322,473  

Purchases

     (120,653        (356,097        (361,731

Proceeds from maturities and repayments of mortgage loans

     15,195          12,845          18,041  

Funding of mortgage loans

     (2,626        (14,299        (5,700

Proceeds from sales of other investments

     22                   47  

Purchase of other investments

              (131        (9

Change in policy loans, net

     (2,824        1,277          (3,356

Net cash provided by (used in) investing activities

     5,779          25,772          (14,337
            
Cash Flows from Financing Activities             

Policyholder account balances:

            

Deposits and other additions

     105,284          92,918          119,937  

Net transfers from (to) separate accounts

     (5,907        (3,275        (13,581

Surrenders and other benefits

     (132,933        (90,640        (91,215

Proceeds from line of credit with Ameriprise Financial, Inc.

                       5,800  

Payments on line of credit with Ameriprise Financial, Inc.

                       (5,800

Cash received for purchased options with deferred premiums

     10,823          30,753          53,361  

Cash paid for purchased options with deferred premiums

     (501        (983        (1,248

Cash dividends to RiverSource Life Insurance Company

     (50,000        (63,000         

Net cash provided by (used in) financing activities

     (73,234        (34,227        67,254  

Net increase (decrease) in cash and cash equivalents

     (124,678        (165,477        108,228  

Cash and cash equivalents at beginning of period

     204,760          370,237          262,009  

Cash and cash equivalents at end of period

   $ 80,082        $ 204,760        $ 370,237  

Supplemental Disclosures:

            

Income taxes paid (received), net

   $ 12,777        $ 10,115        $ 42,497  

 

(1)

Certain prior period amounts have been restated. See Note 3 for more information.

See Notes to Financial Statements.

 

 F-6


RiverSource Life Insurance Co. of New York

 

 

NOTES TO FINANCIAL STATEMENTS

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION

RiverSource Life Insurance Co. of New York (the “Company”) is a stock life insurance company which is domiciled and holds a Certificate of Authority in the State of New York. The Company is a wholly owned subsidiary of RiverSource Life Insurance Company (“RiverSource Life”), which is domiciled in Minnesota. RiverSource Life is a wholly owned subsidiary of Ameriprise Financial, Inc. (“Ameriprise Financial”). The Company issues insurance and annuity products to customers in the State of New York.

The accompanying financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) which vary in certain respects from reporting practices prescribed or permitted by the New York State Department of Financial Services (“New York Department”) (the Company’s primary regulator) as described in Note 15. Certain reclassifications of prior period amounts have been made to conform with the current presentation.

The Company evaluated events or transactions that occurred after the balance sheet date for potential recognition or disclosure through April 19, 2024, the date the financial statements were issued. No subsequent events or transactions requiring recognition or disclosure were identified.

The Company’s principal products are variable annuities, universal life (“UL”) insurance, including indexed universal life (“IUL”) and variable universal life (“VUL”) insurance, which are issued primarily to individuals. Waiver of premium and accidental death benefit riders are generally available with UL products, in addition to other benefit riders. Variable annuity contract purchasers can choose to add an optional guaranteed minimum death benefit (“GMDB”) rider to their contract.

The Company also offers payout annuities, term life insurance and disability income (“DI”) insurance.

The Company’s business is sold through the advisor network of Ameriprise Financial Services, LLC (“AFS”), a subsidiary of Ameriprise Financial. RiverSource Distributors, Inc., a subsidiary of Ameriprise Financial, serves as the principal underwriter and distributor of variable annuity and life insurance products issued by the Company.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The Company adopted Accounting Standards Update (“ASU”), Financial Services – Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”), effective January 1, 2023 with a transition date of January 1, 2021. The significant accounting policies for market risk benefits (“MRB”); deferred acquisition costs (“DAC”); deferred sales inducement costs (“DSIC”); reinsurance; policyholder account balances, future policy benefits and claims; and unearned revenue liability were added or updated as a result of adopting the new accounting standard. See Note 3 for additional information related to the transition approach and adoption impact.

Amounts Based on Estimates and Assumptions

Accounting estimates are an integral part of the financial statements. In part, they are based upon assumptions concerning future events. Among the more significant are those that relate to investment securities valuation and the recognition of credit losses or impairments, valuation of derivative instruments, future policy benefits, market risk benefits, and income taxes and the recognition of deferred tax assets and liabilities. These accounting estimates reflect the best judgment of management and actual results could differ.

Investments

Available-for-Sale Securities

Available-for-Sale securities are carried at fair value with unrealized gains (losses) recorded in accumulated other comprehensive income (loss) (“AOCI”), net of impacts to benefit reserves, reinsurance recoverables and income taxes. Gains and losses are recognized on a trade date basis in the Statements of Income upon disposition of the securities.

Available-for-Sale securities are impaired when the fair value of an investment is less than its amortized cost. When an Available-for-Sale security is impaired, the Company first assesses whether or not: (i) it has the intent to sell the security (i.e., made a decision to sell) or (ii) it is more likely than not that the Company will be required to sell the security before its anticipated recovery. If either of these conditions exist, the Company recognizes an impairment by reducing the book value of the security for the difference between the investment’s amortized cost and its fair value with a corresponding charge to earnings. Subsequent increases in the fair value of Available-for-Sale securities that occur in periods after a write-down has occurred are recorded as unrealized gains in other comprehensive income (loss) (“OCI”), while subsequent decreases in fair value would continue to be recorded as reductions of book value with a charge to earnings.

For securities that do not meet the above criteria, the Company determines whether the decrease in fair value is due to a credit loss or due to other factors. The amount of impairment due to credit-related factors, if any, is recognized as an allowance for credit losses with a related charge to net realized investment gains (losses). The allowance for credit losses is limited to the amount by which the security’s amortized cost basis exceeds its fair value. The amount of the impairment related to other factors is recognized in OCI.

 

F-7 


RiverSource Life Insurance Co. of New York

 

 

Factors the Company considers in determining whether declines in the fair value of fixed maturity securities are due to credit-related factors include: (i) the extent to which the market value is below amortized cost; (ii) fundamental analysis of the liquidity, business prospects and overall financial condition of the issuer; and (iii) market events that could impact credit ratings, economic and business climate, litigation and government actions, and similar external business factors.

If through subsequent evaluation there is a sustained increase in cash flows expected, both the allowance and related charge to earnings may be reversed to reflect the increase in expected principal and interest payments.

In order to determine the amount of the credit loss component for corporate debt securities, a best estimate of the present value of cash flows expected to be collected discounted at the security’s effective interest rate is compared to the amortized cost basis of the security. The significant inputs to cash flow projections consider potential debt restructuring terms, projected cash flows available to pay creditors and the Company’s position in the debtor’s overall capital structure. When assessing potential credit-related impairments for structured investments (e.g., residential mortgage backed securities, commercial mortgage backed securities and asset backed securities), the Company also considers credit-related factors such as overall deal structure and its position within the structure, quality of underlying collateral, delinquencies and defaults, loss severities, recoveries, prepayments and cumulative loss projections.

Management has elected to exclude accrued interest in its measurement of the allowance for credit losses for Available-for-Sale securities. Accrued interest on Available-for-Sale securities is recorded as earned in Accrued investment income. Available-for-Sale securities are generally placed on nonaccrual status when the accrued balance becomes 90 days past due or earlier based on management’s evaluation of the facts and circumstances of each security under review. All previously accrued interest is reversed through Net investment income.

Financing Receivables

Financing receivables are comprised of mortgage loans and policy loans.

Mortgage Loans

Mortgage loans are loans on commercial properties that are originated by the Company and are recorded at amortized cost less the allowance for loan losses. 

Interest income is accrued as earned on the unpaid principal balances of the loans. Interest income recognized on mortgage loans is recorded in Net investment income.

Policy Loans

Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, there is no allowance for credit losses.

Interest income is accrued as earned on the unpaid principal balances of the loans. Interest income recognized on policy loans is recorded in Net investment income.

Allowance for Credit Losses

The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected over the asset’s expected life, considering past events, current conditions and reasonable and supportable forecasts of future economic conditions. Estimates of expected credit losses consider both historical charge-off and recovery experience as well as current economic conditions and management’s expectation of future charge-off and recovery levels. Expected losses related to risks other than credit risk are excluded from the allowance for credit losses. The allowance for credit losses is measured and recorded upon initial recognition of the loan, regardless of whether it is originated or purchased.

The allowance for credit losses for mortgage loans utilizes a probability of default and loss severity approach to estimate lifetime expected credit losses. Actual historical default and loss severity data is adjusted for current conditions and reasonable and supportable forecasts of future economic conditions to develop the probability of default and loss severity assumptions that are applied to the amortized cost basis of the loans over the expected life of each portfolio. The allowance for credit losses on mortgage loans is recorded through provisions charged to Net realized investment gains (losses) and is reduced/increased by net charge-offs/recoveries.

Management determines the adequacy of the allowance for credit losses based on the overall loan portfolio composition, recent and historical loss experience, and other pertinent factors, including when applicable, internal risk ratings, loan-to-value (“LTV”) ratios, and occupancy rates, along with reasonable and supportable forecasts of economic and market conditions. This evaluation is inherently subjective as it requires estimates, which may be susceptible to significant change. While the Company may attribute portions of the allowance to specific loan pools as part of the allowance estimation process, the entire allowance is available to absorb losses expected over the life of the loan portfolio.

 

 F-8


RiverSource Life Insurance Co. of New York

 

 

Nonaccrual Loans

Mortgage loans are placed on nonaccrual status when either the collection of interest or principal has become 90 days past due or is otherwise considered doubtful of collection. When a loan is placed on nonaccrual status, unpaid accrued interest is reversed. Interest payments received on loans on nonaccrual status are generally applied to principal unless the remaining principal balance has been determined to be fully collectible. Management has elected to exclude accrued interest in its measurement of the allowance for credit losses for mortgage loans.

Loan Modifications

A loan is modified when the Company makes certain concessionary modifications to contractual terms such as principal forgiveness, interest rate reductions, other-than-insignificant payment delays, and/or term extensions in an attempt to make the loan more affordable to a borrower experiencing financial difficulties. Generally, performance prior to the modification or significant events that coincide with the modification are considered in assessing whether the borrower can meet the new terms which may result in the loan being returned to accrual status at the time of the modification or after a performance period. If the borrower’s ability to meet the revised payment schedule is not reasonably assured, the loan remains on nonaccrual status.

Charge-off and Foreclosure

Charge-offs are recorded when the Company concludes that all or a portion of the mortgage loan is uncollectible. Factors used by the Company to determine whether all amounts due on mortgage loans will be collected, include but are not limited to, the financial condition of the borrower, performance of the underlying properties, collateral and/or guarantees on the loan, and the borrower’s estimated future ability to pay based on property type and geographic location.

If it is determined that foreclosure on a mortgage loan is probable and the fair value is less than the current loan balance, expected credit losses are measured as the difference between the amortized cost basis of the asset and fair value less estimated costs to sell, if applicable. Upon foreclosure, the mortgage loan and related allowance are reversed, and the foreclosed property is recorded as real estate owned within Other assets.

Cash and Cash Equivalents

Cash equivalents include highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less.

Reinsurance

The Company cedes insurance risk to other insurers under reinsurance agreements.

Reinsurance premiums paid and benefits received are accounted for consistently with the basis used in accounting for the policies from which risk is reinsured and consistently with the terms of the reinsurance contracts. Reinsurance premiums paid for traditional life, long term care (“LTC”) and DI insurance and life contingent payout annuities, net of the change in any prepaid reinsurance asset, are reported as a reduction of Premiums. Reinsurance recoveries are reported as components of Benefits, claims, losses and settlement expenses.

UL and VUL reinsurance premiums are reported as a reduction of Policy and contract charges. In addition, for UL and VUL insurance policies, the net cost of reinsurance ceded, which represents the discounted amount of the expected cash flows between the reinsurer and the Company, is classified as an asset and amortized based on estimated gross profits over the period the reinsurance policies are in-force. Changes in the net cost of reinsurance are reflected as a component of Policy and contract charges.

Insurance liabilities are reported before the effects of reinsurance. Policyholder account balances, future policy benefits and claims recoverable under reinsurance contracts are recorded within Reinsurance recoverables, net of the allowance for credit losses. The Company evaluates the financial condition of its reinsurers prior to entering into new reinsurance contracts and on a periodic basis during the contract term. The allowance for credit losses related to reinsurance recoverable is based on applying observable industry data including insurer ratings, default and loss severity data to the Company’s reinsurance recoverable balances. Management evaluates the results of the calculation and considers differences between the industry data and the Company’s data. Such differences include that the Company has no actual history of significant losses and that industry data may contain non-life insurers. This evaluation is inherently subjective as it requires estimates, which may be susceptible to significant change given the long-term nature of these receivables. The allowance for credit losses on reinsurance recoverable is recorded through provisions charged to Benefits, claims, losses and settlement expenses.

The Company also assumes life insurance risk from other insurers in limited circumstances. Reinsurance premiums received and benefits paid are accounted for consistently with the basis used in accounting for the policies from which risk is reinsured and consistently with the terms of the reinsurance contracts. Liabilities for assumed business are recorded within Policyholder account balances, future policy benefits and claims.

See Note 9 for additional information on reinsurance.

 

F-9 


RiverSource Life Insurance Co. of New York

 

 

Derivative Instruments and Hedging Activities

Freestanding derivative instruments are recorded at fair value and are reflected in Other assets or Other liabilities. The Company’s policy is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. The accounting for changes in the fair value of a derivative instrument depends on its intended use and the resulting hedge designation, if any. The Company primarily uses derivatives as economic hedges that are not designated as accounting hedges or do not qualify for hedge accounting treatment.

Derivative instruments that are entered into for hedging purposes are designated as such at the time the Company enters into the contract. For all derivative instruments that are designated for hedging activities, the Company documents all of the hedging relationships between the hedge instruments and the hedged items at the inception of the relationships. Management also documents its risk management objectives and strategies for entering into the hedge transactions. The Company assesses, at inception and on a quarterly basis, whether derivatives designated as hedges are highly effective in offsetting the fair value or cash flows of hedged items. If it is determined that a derivative is no longer highly effective as a hedge, the Company will discontinue the application of hedge accounting.

For derivative instruments that do not qualify for hedge accounting or are not designated as accounting hedges, changes in fair value are recognized in current period earnings. Changes in fair value of derivatives are presented in the Statements of Income based on the nature and use of the instrument. Changes in fair value of derivatives used as economic hedges are presented in the Statements of Income with the corresponding change in the hedged asset or liability.

The equity component of IUL obligations is considered an embedded derivative. Additionally, certain annuities contain guaranteed minimum accumulation benefits (“GMAB”), guaranteed minimum withdrawal benefits (“GMWB”) and GMDB provisions. These provisions are accounted for as market risk benefits under ASU 2018-12.

See Note 13 for information regarding the Company’s fair value measurement of derivative instruments and Note 17 for the impact of derivatives on the Statements of Income.

Market Risk Benefits

Market risk benefits are contracts or contract features that both provide protection to the contractholder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Market risk benefits include certain contract features on variable annuity products that provide minimum guarantees to contractholders. Guarantees accounted for as market risk benefits include GMDB, guaranteed minimum income benefit (“GMIB”), GMWB and GMAB. If a contract contains multiple market risk benefits, those market risk benefits are bundled together as a single compound market risk benefit.

Market risk benefits are measured at fair value, at the individual contract level, using a non-option-based valuation approach or an option-based valuation approach dependent upon the fee structure of the contract. Changes in fair value are recognized in net income each period with the exception of the portion of the change in fair value due to a change in the instrument-specific credit risk, which is recognized in OCI.

Deferred Acquisition Costs

The Company incurs costs in connection with acquiring new and renewal insurance and annuity businesses. The portion of these costs which are incremental and direct to the acquisition of a new or renewal insurance policy or annuity contract are deferred. Significant costs capitalized include sales based compensation related to the acquisition of new and renewal insurance policies and annuity contracts, medical inspection costs for successful sales, and a portion of employee compensation and benefit costs based upon the amount of time spent on successful sales. Sales based compensation paid to Ameriprise Financial’s advisors and employees and third-party distributors is capitalized. Employee compensation and benefits costs which are capitalized relate primarily to sales efforts, underwriting and processing. All other costs which are not incremental direct costs of acquiring an insurance policy or annuity contract are expensed as incurred. The DAC associated with insurance policies or annuity contracts that are significantly modified or internally replaced with another contract are accounted for as write-offs. These transactions are anticipated in establishing amortization periods and other valuation assumptions.

The Company monitors other DAC amortization assumptions, such as persistency, mortality, morbidity, and variable annuity benefit utilization each quarter and, when assessed independently, each could impact the Company’s DAC balances. Unamortized DAC are reduced for actual experience in excess of expected experience.

The analysis of DAC balances and the corresponding amortization considers all relevant factors and assumptions described previously. Unless the Company’s management identifies a significant deviation over the course of the quarterly monitoring, management reviews and updates these DAC amortization assumptions annually in the third quarter of each year.

DAC are amortized on a constant-level basis for the grouped contracts over the expected contract term to approximate straight-line amortization. Contracts are grouped by contract type and issue year into cohorts consistent with the grouping used in estimating the associated liability for future policy benefits. DAC related to all long-duration product types (except for life contingent payout annuities) are grouped on a calendar-year annual basis for each legal entity. Further disaggregation is reported

 

 F-10


RiverSource Life Insurance Co. of New York

 

 

for any contracts that include an additional liability for death or other insurance benefit. DAC related to life contingent payout annuities are grouped on a calendar-year annual basis for each legal entity for policies issued prior to 2021 and on a quarterly basis for each legal entity thereafter.

DAC related to annuity products (including variable deferred annuities, fixed deferred annuities, and life contingent payout annuities) are amortized based on initial premium. DAC related to life insurance products (including UL insurance, VUL insurance, IUL insurance, term life insurance, and whole life insurance) are amortized based on original specified amount (i.e., face amount). DAC related to DI insurance are amortized based on original monthly benefit.

The accounting contract term for annuity products (except for life contingent payout annuities) is the projected accumulation period. Life contingent payout annuities are amortized over the period which annuity payments are expected to be paid. The accounting contract term for life insurance products is the projected life of the contract. DI insurance is amortized over the projected life of the contract, including the claim paying period.

Deferred Sales Inducement Costs

Deferred sales inducements are contract features that are intended to attract new customers or to persuade existing customers to keep their current policy. Sales inducement costs consist of bonus interest credits and premium credits added to certain annuity contract and insurance policy values. These benefits are capitalized to the extent they are incremental to amounts that would be credited on similar contracts without the applicable feature. The amounts capitalized are amortized on a constant-level basis using the same methodology and assumptions used to amortize DAC on a constant-level basis. DSIC are recorded in Other assets and amortization of DSIC is recorded in Benefits, claims, losses and settlement expenses.

Separate Account Assets and Liabilities

Separate account assets represent funds held for the benefit of and Separate account liabilities represent the obligation to the variable annuity contractholders and variable life insurance policyholders who have a contractual right to receive the benefits of their contract or policy and bear the related investment risk. Gains and losses on separate account assets accrue directly to the contractholder or policyholder and are not reported in the Company’s Statements of Income. Separate account assets are recorded at fair value and Separate account liabilities are equal to the assets recognized.

Policyholder Account Balances, Future Policy Benefits and Claims

The Company establishes reserves to cover the benefits associated with non-traditional and traditional long-duration products. Non-traditional long-duration products include variable annuity contracts, fixed annuity contracts and UL and VUL policies. Traditional long-duration products include term life, whole life, DI, and LTC insurance products and life contingent payout annuity products. 

Non-Traditional Long-Duration Products

The liabilities for non-traditional long-duration products include fixed account values on variable and fixed annuities and UL and VUL policies, non-life contingent payout annuities, liabilities for guaranteed benefits associated with variable annuities and embedded derivatives for IUL products.

Liabilities for fixed account values on variable and fixed deferred annuities and UL and VUL policies are equal to accumulation values, which are the cumulative gross deposits and credited interest less withdrawals and various charges. The liability for non-life contingent payout annuities is recognized as the present value of future payments using the effective yield at inception of the contract.

A portion of the Company’s UL and VUL policies have product features that result in profits followed by losses from the insurance component of the contract. These profits followed by losses can be generated by the cost structure of the product or secondary guarantees in the contract. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. The liability for these future losses is determined at the reporting date by estimating the death benefits in excess of account value and recognizing the excess over the estimated life based on expected assessments (e.g., cost of insurance charges, contractual administrative charges, similar fees and investment margin). See Note 10 for information regarding the liability for contracts with secondary guarantees. Liabilities for IUL products are equal to the accumulation of host contract values, guaranteed benefits, and the fair value of embedded derivatives.

See Note 12 for information regarding variable annuity guarantees.

Embedded Derivatives

The fair value of embedded derivatives related to IUL fluctuates based on equity markets and interest rates and the estimate of the Company’s nonperformance risk and is recorded in Policyholder account balances, future policy benefits and claims. See Note 13 for information regarding the fair value measurement of embedded derivatives.

 

F-11 


RiverSource Life Insurance Co. of New York

 

 

Traditional Long-Duration Products

The liabilities for traditional long-duration products include cash flows related to unpaid amounts on reported claims, estimates of benefits payable on claims incurred but not yet reported and estimates of benefits that will become payable on term life, whole life, DI, LTC, and life contingent payout annuity policies as claims are incurred in the future. The claim liability (also referred to as disabled life reserve) is presented together as one liability for future policy benefits.

A liability for future policy benefits, which is the present value of estimated future policy benefits to be paid to or on behalf of policyholders and certain related expenses less the present value of estimated future net premiums to be collected from policyholders, is accrued as premium revenue is recognized. Expected insurance benefits are accrued over the life of the contract in proportion to premium revenue recognized (referred to as the net premium approach). The net premium ratio reflects cash flows from contract inception to contract termination (i.e., through the claim paying period) and cannot exceed 100%.

Assumptions utilized in the net premium approach, including mortality, morbidity, and terminations, are reviewed as part of experience studies at least annually or more frequently if suggested by evidence. Expense assumptions and actual expenses are updated within the net premium calculation consistent with other policyholder assumptions.

The updated cash flows used in the calculation are discounted using a forward rate curve. The discount rate represents an upper-medium-grade (i.e., low credit risk) fixed-income instrument yield (i.e., an A rating) that reflects the duration characteristics of the liability. Discount rates are locked in annually, at the end of each year for all products, except life contingent payout annuities, and calculated as the monthly average discount rate curves for the year. For life contingent payout annuities, the discount rates are locked in quarterly at the end of each quarter based on the average of the three months for the quarter.

The liability for future policy benefits will be updated for actual experience at least on an annual basis and concurrent with changes to cash flow assumptions. When net premiums are updated for cash flow changes, the estimated cash flows over the entire life of a group of contracts are updated using historical experience and updated future cash flow assumptions.

The revised net premiums are used to calculate an updated liability for future policy benefits as of the beginning of the reporting period, discounted at the original locked in rate (i.e., contract issuance rate). The updated liability for future policy benefits as of the beginning of the reporting period is then compared with the carrying amount of the liability as of that date prior to updating cash flow assumptions to determine the current period remeasurement gain or loss reflected in current period earnings. The revised net premiums are then applied as of the beginning of the quarter to calculate the benefit expense for the current reporting period.

The difference between the updated carrying amount of the liability for future policy benefits measured using the current discount rate assumption and the original discount rate assumption is recognized in OCI. The interest accretion rate remains the original discount rate used at contract issue date.

If the updating of cash flow assumptions results in the present value of future benefits and expenses exceeding the present value of future gross premiums, a charge to net income is recorded for the current reporting period such that net premiums are set equal to gross premiums. In subsequent periods, the liability for future policy benefits is accrued with net premiums set equal to gross premiums.

Contracts (except for life contingent payout annuities sold subsequent to December 31, 2020) are grouped into cohorts by contract type and issue year, as well as by legal entity and reportable segment. Life contingent payout annuities sold in periods beginning in 2021 are grouped into quarterly cohorts.

See Note 10 for information regarding the liabilities for traditional long-duration products.

Deferred Profit Liability

For limited-payment products, gross premiums received in excess of net premiums are deferred at initial recognition as a deferred profit liability (“DPL”). Gross premiums are measured using assumptions consistent with those used in the measurement of the liability for future policy benefits, including discount rate, mortality, lapses and expenses.

The DPL is amortized and recognized as premium revenue in proportion to expected future benefit payments from annuity contracts. Interest is accreted on the balance of the DPL using the discount rate determined at contract issuance. The Company reviews and updates its estimate of cash flows from the DPL at the same time as the estimates of cash flows for the liability for future policy benefits. When cash flows are updated, the updated estimates are used to recalculate the DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period, and any difference is recognized as either a charge or credit to premium revenue.

DPL is recorded in Policyholder account balances, future policy benefits and claims and included as a reconciling item within Note 10.

Unearned Revenue Liability

The Company’s UL and VUL policies require payment of fees or other policyholder assessments in advance for services to be provided in future periods. These charges are deferred as unearned revenue and amortized consistent with DAC amortization

 

 F-12


RiverSource Life Insurance Co. of New York

 

 

factors. The unearned revenue liability is recorded in Other liabilities and the amortization is recorded in Policy and contract charges.

Income Taxes

The Company qualifies as a life insurance company for federal income tax purposes. As such, the Company is subject to the Internal Revenue Code provisions applicable to life insurance companies.

The Company’s taxable income is included in the consolidated federal income tax return of Ameriprise Financial. The Company provides for income taxes on a separate return basis, except that, under an agreement between Ameriprise Financial and the Company, tax benefits are recognized for losses to the extent they can be used in the consolidated return. It is the policy of Ameriprise Financial that it will reimburse its subsidiaries for any tax benefits recorded. The controlled group for which the Company is a member is an applicable corporation with regard to the corporate alternative minimum tax (“CAMT”) and is therefore required to compute the CAMT. In accordance with the tax sharing agreement, Ameriprise Financial will be liable for any CAMT liability and expense.

The Company’s provision for income taxes represents the net amount of income taxes that the Company expects to pay or to receive from various taxing jurisdictions in connection with its operations. The Company provides for income taxes based on amounts that the Company believes it will ultimately owe taking into account the recognition and measurement for uncertain tax positions. Inherent in the provision for income taxes are estimates and judgments regarding the tax treatment of certain items.

In connection with the provision for income taxes, the financial statements reflect certain amounts related to deferred tax assets and liabilities, which result from temporary differences between the assets and liabilities measured for financial statement purposes versus the assets and liabilities measured for tax return purposes.

The Company is required to establish a valuation allowance for any portion of its deferred tax assets that management believes will not be realized. Significant judgment is required in determining if a valuation allowance should be established and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business. Consideration is given to, among other things in making this determination: (i) future taxable income exclusive of reversing temporary differences and carryforwards; (ii) future reversals of existing taxable temporary differences; (iii) taxable income in prior carryback years; and (iv) tax planning strategies. Management may need to identify and implement appropriate planning strategies to ensure its ability to realize deferred tax assets and reduce the likelihood of the establishment of a valuation allowance with respect to such assets. See Note 19 for additional information on the Company’s valuation allowance.

Changes in tax rates and tax law are accounted for in the period of enactment. Deferred tax assets and liabilities are adjusted for the effect of a change in tax laws or rates and the effect is included in net income.

Revenue Recognition

Premiums on traditional life, DI and LTC insurance products and life contingent payout annuities are net of reinsurance ceded and are recognized as revenue when due.

Interest income is accrued as earned using the effective interest method, which makes an adjustment of the yield for security premiums and discounts on all performing fixed maturity securities classified as Available-for-Sale so that the related security or loan recognizes a constant rate of return on the outstanding balance throughout its term. When actual prepayments differ significantly from originally anticipated prepayments, the retrospective effective yield is recalculated to reflect actual payments to date and updated future payment assumptions and a catch-up adjustment is recorded in the current period. In addition, the new effective yield, which reflects anticipated future payments, is used prospectively.

Mortality and expense risk fees are based on a percentage of the fair value of assets held in the Company’s separate accounts and recognized when assessed. Variable annuity guaranteed benefit rider charges, cost of insurance charges on UL and VUL insurance and contract charges (net of reinsurance premiums and cost of reinsurance for UL insurance products) and surrender charges on annuities and UL and VUL insurance are recognized as revenue when assessed.

Realized gains and losses on the sale of securities, other than equity method investments, are recognized using the specific identification method, on a trade date basis.

Fees received under marketing support and distribution services arrangements are recognized as revenue when earned.

See Note 4 for further discussion of accounting policies on revenue from contracts with customers.

3. RECENT ACCOUNTING PRONOUNCEMENTS

Adoption of New Accounting Standards

Financial Instruments — Credit Losses — Troubled Debt Restructurings and Vintage Disclosures

In March 2022, the Financial Accounting Standards Board (“FASB”) proposed amendments to ASU 2016-13, Financial Instruments — Credit Losses: Measurement of Credit Losses on Financial Instruments (“Topic 326”). The update removes the recognition and measurement guidance for Troubled Debt Restructurings (“TDRs”) by creditors in Subtopic 310-40,

 

F-13 


RiverSource Life Insurance Co. of New York

 

 

Receivables — Troubled Debt Restructurings by Creditors, and modifies the disclosure requirements for certain loan refinancing and restructuring by creditors when a borrower is experiencing financial difficulty. Rather than applying the recognition and measurement for TDRs, an entity must apply the loan refinancing and restructuring guidance to determine whether a modification results in a new loan or a continuation of an existing loan. The update also requires entities to disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments — Credit Losses — Measured at Amortized Cost. The amendments are to be applied prospectively, but entities may apply a modified retrospective transition for changes to the recognition and measurement of TDRs. For entities that have adopted Topic 326, the amendments are effective for interim and annual periods beginning after December 15, 2022. The Company adopted the standard on January 1, 2023. The adoption of this update did not have an impact on the Company’s financial condition and results of operations and modifications to disclosures are immaterial in the current period.

Financial Services — Insurance — Targeted Improvements to the Accounting for Long-Duration Contracts

In August 2018, the FASB updated the accounting standard related to long-duration insurance contracts (ASU 2018-12). The guidance changes elements of the measurement models and disclosure requirements for an insurer’s long-duration insurance contract benefits and acquisition costs by expanding the use of fair value accounting to certain contract benefits, requiring updates, if any, and at least annually, to assumptions used to measure liabilities for future policy benefits, changing the amortization pattern of deferred acquisition costs to a constant-level basis and removing certain shadow adjustments previously recorded in AOCI. Adoption of the accounting standard did not impact overall cash flows or regulatory capital requirements.

When the Company adopted the standard effective January 1, 2023 with a transition date of January 1, 2021 (the “transition date”), opening equity was adjusted for the adoption impacts to retained earnings and AOCI and prior periods presented (i.e. 2021 and 2022) were restated. The adoption impact as of January 1, 2021 was a reduction in total equity of $76 million, of which $23 million and $53 million were reflected in retained earnings and AOCI, respectively.

The following table presents the effects of the adoption of the above new accounting standard to the Company’s previously reported Balance Sheets:

 

(in thousands)    As Filed
December 31,
2022
     Adjustment      Post-adoption
December 31,
2022
     As Filed
December 31,
2021
     Adjustment      Post-adoption
December 31,
2021
 

Assets

                 

Market risk benefits

   $      $ 64,498      $ 64,498      $      $ 36,740      $ 36,740  

Reinsurance recoverables (allowance for credit losses: 2022, $3,500; 2021, $5,400)

     189,465        6,082        195,547        184,971        57,016        241,987  

Deferred acquisition costs

     214,324        (40,286      174,038        175,258        4,854        180,112  

Other assets

     198,981        (4,072      194,909        406,002        9,404        415,406  

Total assets

   $ 6,798,860      $ 26,222      $ 6,825,082      $ 8,644,453      $ 108,014      $ 8,752,467  

Liabilities and Shareholder’s Equity

                 

Liabilities:

                 

Policyholder account balances, future policy benefits and claims

   $ 1,997,633      $ (47,637    $ 1,949,996      $ 2,106,471      $ (2,928    $ 2,103,543  

Market risk benefits

            68,635        68,635               129,715        129,715  

Other liabilities

     182,723        (2,092      180,631        526,623        14,101        540,724  

Total liabilities

     6,411,246        18,906        6,430,152        8,065,355        140,888        8,206,243  

Shareholder’s Equity:

                 

Retained earnings

     386,646        21,918        408,564        420,377        6,768        427,145  

Accumulated other comprehensive income (loss), net of tax

     (107,958      (14,602      (122,560      49,795        (39,642      10,153  

Total shareholder’s equity

     387,614        7,316        394,930        579,098        (32,874      546,224  

Total liabilities and shareholder’s equity

   $ 6,798,860      $ 26,222      $ 6,825,082      $ 8,644,453      $ 108,014      $ 8,752,467  

 

 F-14


RiverSource Life Insurance Co. of New York

 

 

The following table presents the effects of the adoption of the above new accounting standard to the Company’s previously reported Statements of Income:

 

     Years Ended December 31,  
(in thousands)    As Filed 2022      Adjustment      Post-adoption
2022
     As Filed 2021      Adjustment      Post-adoption
2021
 

Revenues

 

Policy and contract charges

   $ 125,459      $ (163    $ 125,296      $ 139,659      $ (1,523    $ 138,136  

Total revenues

     234,526        (163      234,363        259,384        (1,523      257,861  

Benefits and Expenses

                 

Benefits, claims, losses and settlement expenses

     107,180        (69,186      37,994        84,589        (42,108      42,481  

Remeasurment (gains) losses of future policy benefit reserves

            2,225        2,225               55        55  

Change in fair value of market risk benefits

            40,393        40,393               (8,080      (8,080

Amortization of deferred acquisition costs

     8,919        6,610        15,529        6,296        9,678        15,974  

Other insurance and operating expenses

     34,217        618        34,835        35,838        801        36,639  

Total benefits and expenses

     201,904        (19,340      182,564        173,888        (39,654      134,234  

Pretax income (loss)

     32,622        19,177        51,799        85,496        38,131        123,627  

Income tax provision (benefit)

     3,353        4,027        7,380        15,392        8,007        23,399  

Net income

   $ 29,269      $ 15,150      $ 44,419      $ 70,104      $ 30,124      $ 100,228  

The adoption of the standard did not affect the previously reported totals for net cash flows provided by (used in) operating, investing, or financing activities.

Future Adoption of New Accounting Standards

Segment Reporting — Improvements to Reportable Segment Disclosures

In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures, updating reportable segment disclosure requirements in accordance with Topic 280, Segment Reporting (“Topic 280”), primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss and contain other disclosure requirements. The amendments also expand Topic 280 disclosures to public entities with one reportable segment. The amendments are effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted. The Company is assessing changes to the segment related disclosures resulting from the standard. The adoption of the standard will not have an impact on the Company’s financial condition and results of operations as the standard is disclosure-related only.

Income Taxes — Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, updating the accounting standards related to income tax disclosures, primarily focused on the disaggregation of income taxes paid and the rate reconciliation table. The standard is to be applied prospectively with an option for retrospective application and is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is assessing changes to the income tax related disclosures resulting from the standard. The adoption of the standard will not have an impact on the Company’s financial condition and results of operations as the standard is disclosure-related only.

 

F-15 


RiverSource Life Insurance Co. of New York

 

 

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Statements of Income:

 

     Years Ended December 31,  
(in thousands)    2023        2022        2021  

Policy and contract charges

            

Affiliated (from Columbia Management Investment Distributors, Inc.)

   $ 9,193        $ 9,762        $ 11,402  

Unaffiliated

     850          829          936  

Total

     10,043          10,591          12,338  

Other revenues

            

Administrative fees

            

Affiliated (from Columbia Management Investment Services, Corp.)

     2,317          2,474          2,908  

Unaffiliated

     1,029          1,019          1,127  
       3,346          3,493          4,035  

Other fees

            

Affiliated (from Columbia Management Investment Advisers, LLC (“CMIA”) and Columbia Wanger Asset Management, LLC)

     18,482          19,845          22,969  

Unaffiliated

     230          232          282  
       18,712          20,077          23,251  

Total

     22,058          23,570          27,286  

Total revenue from contracts with customers

     32,101          34,161          39,624  

Revenue from other sources(1)

     219,936          200,202          218,237  

Total revenues

   $ 252,037        $ 234,363        $ 257,861  

 

(1)

Amounts primarily consist of revenue associated with insurance and annuity products and investment income from financial instruments.

The following discussion describes the nature, timing, and uncertainty of revenues and cash flows arising from the Company’s contracts with customers.

Policy and Contract Charges

The Company earns revenue for providing distribution-related services to affiliated and unaffiliated mutual funds that are available as underlying investments in its variable annuity and variable life insurance products. The performance obligation is satisfied at the time the mutual fund is distributed. Revenue is recognized over the time the mutual fund is held in the variable product and is generally earned based on a fixed rate applied, as a percentage, to the net asset value of the fund. The revenue is not recognized at the time of sale because it is variably constrained due to factors outside the Company’s control, including market volatility and how long the fund(s) remain in the insurance policy or annuity contract. The revenue will not be recognized until it is probable that a significant reversal will not occur. These fees are accrued and collected on a monthly basis.

Other Revenues

Administrative Fees

The Company earns revenue for providing customer support, contract servicing and administrative services for affiliated and unaffiliated mutual funds that are available as underlying instruments in its variable annuity and variable life insurance products. The transfer agent and administration revenue is earned daily based on a fixed rate applied, as a percentage, to assets under management. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.

Other Fees

The Company earns revenue for providing affiliated and unaffiliated partners an opportunity to educate the financial advisors of its affiliate, AFS, that sell the Company’s products as well as product and marketing personnel to support the offer, sale and servicing of funds within the Company’s variable annuity and variable life insurance products. These payments allow the parties to train and support the advisors, explain the features of their products, and distribute marketing and educational materials. The affiliated revenue is earned based on a rate, updated at least annually, which is applied, as a percentage, to the market value of assets invested. The unaffiliated revenue is earned based on a fixed rate applied, as a percentage, to the market value of assets invested. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis.

Receivables

Receivables for revenue from contracts with customers are recognized when the performance obligation is satisfied and the Company has an unconditional right to the revenue. Receivables related to revenues from contracts with customers were $2.9 million as of both December 31, 2023 and 2022.

 

 F-16


RiverSource Life Insurance Co. of New York

 

 

5. VARIABLE INTEREST ENTITIES

The Company invests in structured investments which are considered variable interest entities (“VIEs”) for which it is not the sponsor. These structured investments typically invest in fixed income instruments and are managed by third parties and include asset backed securities and commercial and residential mortgage backed securities. The Company classifies these investments as Available-for-Sale securities. The Company has determined that it is not the primary beneficiary of these structures due to the size of the Company’s investment in the entities and position in the capital structure of these entities. The Company’s maximum exposure to loss as a result of its investment in these structured investments is limited to its amortized cost. The Company has no obligation to provide financial or other support to the structured investments beyond its investment nor has the Company provided any support to the structured investments. See Note 6 for additional information on these structured investments.

6. INVESTMENTS

Available-for-Sale securities distributed by type were as follows:

 

       December 31, 2023  
Description of Securities (in thousands)      Amortized
Cost
    

Gross

Unrealized

Gains

    

Gross

Unrealized

Losses

    

Allowance

for Credit

Losses

    

Fair

Value

 

Fixed maturities:

                

Corporate debt securities

     $ 951,360      $ 25,060      $ (54,874    $ (365    $ 921,181  

Residential mortgage backed securities

       290,104        187        (37,468             252,823  

Commercial mortgage backed securities

       322,845               (33,099             289,746  

State and municipal obligations

       83,146        7,417        (452             90,111  

Asset backed securities

       31,919        467        (1,648             30,738  

Foreign government bonds and obligations

       638        84                      722  

U.S. government and agency obligations

       220                             220  

Total

     $ 1,680,232      $ 33,215      $ (127,541    $ (365    $ 1,585,541  

 

       December 31, 2022  
Description of Securities (in thousands)      Amortized
Cost
    

Gross

Unrealized

Gains

    

Gross

Unrealized

Losses

    

Allowance

for Credit

Losses

    

Fair

Value

 

Fixed maturities:

                

Corporate debt securities

     $ 905,629      $ 13,188      $ (85,717    $ (572    $ 832,528  

Residential mortgage backed securities

       310,338        27        (41,976             268,389  

Commercial mortgage backed securities

       340,684               (39,053             301,631  

State and municipal obligations

       86,002        6,539        (781             91,760  

Asset backed securities

       34,959        1,033        (2,552             33,440  

Foreign government bonds and obligations

       747        68        (35             780  

U.S. government and agency obligations

       216               (1             215  

Total

     $ 1,678,575      $ 20,855      $ (170,115    $ (572    $ 1,528,743  

As of December 31, 2023 and 2022, accrued interest of $14.9 million and $14.2 million, respectively, is excluded from the amortized cost basis of Available-for-Sale securities in the tables above and is recorded in Accrued investment income.

As of December 31, 2023 and 2022, fixed maturity securities comprised approximately 89% and 88%, respectively, of the Company’s total investments. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations (“NRSROs”), including Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings Ltd. (“Fitch”). The Company uses the median of available ratings from Moody’s, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody’s, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. As of December 31, 2023 and 2022, $15.8 million and $21.9 million, respectively, of securities were internally rated by CMIA, an affiliate of the Company, using criteria similar to those used by NRSROs.

 

F-17 


RiverSource Life Insurance Co. of New York

 

 

A summary of fixed maturity securities by rating was as follows:

 

     December 31, 2023      December 31, 2022  
Ratings (in thousands, except percentages)    Amortized
Cost
      

Fair

Value

       Percent of
Total Fair
Value
     Amortized
Cost
      

Fair

Value

       Percent of
Total Fair
Value
 

AAA

   $ 355,286        $ 319,280          20    $ 681,243        $ 598,313          39

AA

     344,046          315,804          20        62,194          68,657          5  

A

     175,912          179,826          11        128,524          128,819          8  

BBB

     762,945          731,081          46        749,531          681,552          45  

Below investment grade

     42,043          39,550          3        57,083          51,402          3  

Total fixed maturities

   $ 1,680,232        $ 1,585,541          100    $ 1,678,575        $ 1,528,743          100

As of December 31, 2023, approximately 75% of securities rated AA were GNMA, FNMA and FHLMC mortgage backed securities. These issuers were downgraded in the third quarter of 2023 from AAA to AA due to the downgrade of the U.S. Government long-term credit rating. As of December 31, 2022, approximately 42% of securities rated AAA were GNMA, FNMA and FHLMC mortgage backed securities. No holdings of any issuer were greater than 10% of the Company’s total shareholder’s equity as of both December 31, 2023 and 2022.

The following tables summarize the fair value and gross unrealized losses on Available-for-Sale securities, aggregated by major investment type and the length of time that individual securities have been in a continuous unrealized loss position for which no allowance for credit losses has been recorded:

 

    December 31, 2023  
    Less than 12 months     12 months or more     Total  
Description of Securities
(in thousands, except number of securities)
  Number of
Securities
   

Fair

Value

    Unrealized
Losses
    Number of
Securities
   

Fair

Value

    Unrealized
Losses
    Number of
Securities
   

Fair

Value

    Unrealized
Losses
 

Corporate debt securities

    17     $ 75,331     $ (1,862     176     $ 518,163     $ (53,012     193     $ 593,494     $ (54,874

Residential mortgage backed securities

    5       3,800       (48     57       242,301       (37,420     62       246,101       (37,468

Commercial mortgage backed securities

    1       7,423       (216     97       282,323       (32,883     98       289,746       (33,099

State and municipal obligations

    3       2,700       (113     10       6,501       (339     13       9,201       (452

Asset backed securities

                      15       22,384       (1,648     15       22,384       (1,648

U.S. government and agency obligations

    1       220                               1       220        

Total

    27     $ 89,474     $ (2,239     355     $ 1,071,672     $ (125,302     382     $ 1,161,146     $ (127,541

 

    December 31, 2022  
    Less than 12 months     12 months or more     Total  
Description of Securities
(in thousands, except number of securities)
 

Number of

Securities

    Fair
Value
    Unrealized
Losses
    Number of
Securities
   

Fair

Value

    Unrealized
Losses
    Number of
Securities
   

Fair

Value

    Unrealized
Losses
 

Corporate debt securities

    190     $ 533,591     $ (39,382     49     $ 169,667     $ (46,335     239     $ 703,258     $ (85,717

Residential mortgage backed securities

    64       115,585       (9,029     6       151,248       (32,947     70       266,833       (41,976

Commercial mortgage backed securities

    94       245,420       (27,630     10       56,211       (11,423     104       301,631       (39,053

State and municipal obligations

    14       8,637       (738     1       207       (43     15       8,844       (781

Asset backed securities

    15       26,559       (2,552                       15       26,559       (2,552

U.S. government and agency obligations

    1       215       (1                       1       215       (1

Foreign government bonds and obligations

                      1       71       (35     1       71       (35

Total

    378     $ 930,007     $ (79,332     67     $ 377,404     $ (90,783     445     $ 1,307,411     $ (170,115

As part of the Company’s ongoing monitoring process, management determined that the decrease in gross unrealized losses on its Available-for-Sale securities for which an allowance for credit losses has not been recognized during the year ended December 31, 2023 is primarily attributable to the impact of lower interest rates and tighter credit spreads. The Company did not recognize these unrealized losses in earnings because it was determined that such losses were due to non-credit factors. The Company does not intend to sell these securities and does not believe that it is more likely than not that the Company will be required to sell these securities before the anticipated recovery of the remaining amortized cost basis. As of December 31, 2023 and 2022, approximately 91% and 89%, respectively, of the total of Available-for-Sale securities with gross unrealized losses were considered investment grade.

 

 F-18


RiverSource Life Insurance Co. of New York

 

 

The following table presents a rollforward of the allowance for credit losses on Available-for-Sale securities:

 

(in thousands)    Corporate Debt
Securities
 

Balance at January 1, 2021

   $ 739  

Additional increases (decreases) on securities that had an allowance recorded in a previous period

     (104

Charge-offs

     (635

Balance at December 31, 2021

      

Additions for which credit losses were not previously recorded

     572  

Balance at December 31, 2022

     572  

Additions for which credit losses were not previously recorded

     365  

Reductions for securities sold during the period (realized)

     (458

Additional increases (decreases) on securities that had an allowance recorded in a previous period

     (114

Balance at December 31, 2023

   $ 365  

Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in Net realized investment gains (losses) were as follows:

 

     Years Ended December 31,  
(in thousands)    2023        2022        2021  

Gross realized investment gains

   $ 93        $ 1,316        $ 11,923  

Gross realized investment losses

     (524        (3,234        (9

Credit reversals (losses)

     207          (572        104  

Other impairments

              (856        (1,641

Total

   $ (224      $ (3,346      $ 10,377  

For the year ended December 31, 2023, net credit reversals primarily related to the reversal of a previously recorded allowance for credit losses due to the sale of a corporate debt security in the communications industry partially offset by recording an allowance for credit losses of another corporate debt security in the communications industry. For the year ended December 31, 2022, credit losses primarily related to recording an allowance for credit losses on a corporate debt security in the communications industry. For the year ended December 31, 2021, net credit reversals primarily related to decreases in an allowance for credit losses. Other impairments for the years ended December 31, 2022 and 2021 related to Available-for-Sale securities which the Company intended to sell.

See Note 18 for a rollforward of net unrealized investment gains (losses) included in AOCI.

Available-for-Sale securities by contractual maturity as of December 31, 2023 were as follows:

 

(in thousands)   

Amortized

Cost

      

Fair

Value

 

Due within one year

   $ 34,289        $ 34,025  

Due after one year through five years

     174,445          169,312  

Due after five years through 10 years

     185,592          170,901  

Due after 10 years

     641,038          637,996  
     1,035,364          1,012,234  

Residential mortgage backed securities

     290,104          252,823  

Commercial mortgage backed securities

     322,845          289,746  

Asset backed securities

     31,919          30,738  

Total

   $ 1,680,232        $ 1,585,541  

Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities were not included in the maturities distribution.

 

F-19 


RiverSource Life Insurance Co. of New York

 

 

The following is a summary of Net investment income:

 

     Years Ended December 31,  
(in thousands)    2023        2022        2021  

Fixed maturities

   $ 66,737        $ 60,796        $ 57,644  

Mortgage loans

     6,080          6,419          7,223  

Other investments

     13,384          6,926          2,411  
     86,201          74,141          67,278  

Less: investment expenses

     1,616          1,932          1,909  

Total

   $ 84,585        $ 72,209        $ 65,369  

7. FINANCING RECEIVABLES

Financing receivables are comprised of mortgage loans and policy loans. See Note 2 for information regarding the Company’s accounting policies related to financing receivables and the allowance for credit losses.

Allowance for Credit Losses

The following table presents a rollforward of the allowance for credit losses:

 

(in thousands)    Mortgage
Loans
 

Balance at January 1, 2021

   $ 2,075  

Provisions

     (1,216

Balance at December 31, 2021

     859  

Provisions

     106  

Balance at December 31, 2022

     965  

Provisions

     (411

Balance at December 31, 2023

   $ 554  

As of December 31, 2023 and 2022, accrued interest on mortgage loans was $474 thousand and $516 thousand, respectively, and is recorded in Accrued investment income and excluded from the amortized cost basis of mortgage loans.

Credit Quality Information

There were no nonperforming loans as of both December 31, 2023 and 2022. All loans were considered to be performing.

Mortgage Loans

The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on mortgage loans. Loan-to-value ratio is the primary credit quality indicator included in this review.

Based on this review, the mortgage loans are assigned an internal risk rating, which management updates when credit risk changes. There were no mortgage loans which management has assigned its highest risk rating as of both December 31, 2023 and 2022. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months. There were no mortgage loans past due as of both December 31, 2023 and 2022.

The tables below present the amortized cost basis of mortgage loans by year of origination and loan-to-value ratio:

 

     December 31, 2023  
(in thousands)    2023        2022        2021        2020        2019        Prior        Total  

Loan-to-Value Ratio

  

>100%

   $        $        $        $        $        $        $  

80% – 100%

                                1,988                   2,118          4,106  

60% – 80%

              5,810                   3,671          2,481          7,027          18,989  

40% – 60%

              2,350          2,433          6,546          5,466          30,058          46,853  

<40%

     1,488                   2,981          8,651          10,287          52,109          75,516  

Total

   $ 1,488        $ 8,160        $ 5,414        $ 20,856        $ 18,234        $ 91,312        $ 145,464  

 

 F-20


RiverSource Life Insurance Co. of New York

 

 

     December 31, 2022  
(in thousands)    2022        2021        2020        2019        2018        Prior        Total  

Loan-to-Value Ratio

  

>100%

   $        $        $ 2,003        $        $        $ 1,082        $ 3,085  

80% – 100%

              2,480          1,751                   2,191          6,369          12,791  

60% – 80%

     7,205          1,741          5,950          6,430          1,691          2,739          25,756  

40% – 60%

     1,142          1,337          2,907          5,195          10,993          21,202          42,776  

<40%

                       8,970          7,280          8,903          48,472          73,625  

Total

   $ 8,347        $ 5,558        $ 21,581        $ 18,905        $ 23,778        $ 79,864        $ 158,033  

Loan-to-value ratio is based on income and expense data provided by borrowers at least annually and long-term capitalization rate assumptions based on property type. For the year ended December 31, 2023, the Company did not have any write-offs of mortgage loans.

In addition, the Company reviews the concentrations of credit risk by region and property type. Concentrations of credit risk of mortgage loans by U.S. region were as follows:

 

     Loans            Percentage  
     December 31,             December 31,  
(in thousands)    2023             2022             2023             2022  

Pacific

   $ 44,912        $ 47,107          31        30

South Atlantic

     25,135          30,528          17          19  

Mountain

     20,907          21,716          14          14  

Middle Atlantic

     17,055          16,994          12          11  

East North Central

     12,125          13,993          8          9  

West North Central

     10,224          11,651          7          7  

West South Central

     6,675          7,103          5          5  

East South Central

     4,904          5,274          3          3  

New England

     3,527                3,667                3                2  

Total

   $ 145,464              $ 158,033                100              100

Concentrations of credit risk of mortgage loans by property type were as follows:

 

     Loans            Percentage  
     December 31,             December 31,  
(in thousands)    2023             2022             2023             2022  

Apartments

   $ 45,692        $ 48,592          32        31

Retail

     39,748          45,513          27          29  

Industrial

     27,264          26,501          19          17  

Office

     17,849          18,953          12          12  

Mixed use

     5,882          7,444          4          4  

Other

     9,029                11,030                6                7  

Total

   $ 145,464              $ 158,033                100              100

Policy Loans

Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, there is no allowance for credit losses.

Modifications with Borrowers Experiencing Financial Difficulty

There were no modifications of financing receivables with borrowers experiencing financial difficulty by the Company during the year ended December 31, 2023.

 

F-21 


RiverSource Life Insurance Co. of New York

 

 

8. DEFERRED ACQUISITION COSTS AND DEFERRED SALES INDUCEMENT COSTS

The following tables summarize the balances of and changes in DAC, including the January 1, 2021 adoption of ASU 2018-12.

 

(in thousands)    Variable
Annuities
       Fixed
Annuities
       Universal
Life
Insurance
       Variable
Universal
Life
Insurance
       Indexed
Universal
Life
Insurance
 

Pre-adoption balance at December 31, 2020

   $ 112,335        $ 2,991        $ 5,204        $ 24,103        $ 10,521  

Effect of shadow reserve adjustments

     2,903          1,551          1,934          3,003          9,774  

Post-adoption balance at January 1, 2021

     115,238          4,542          7,138          27,106          20,295  

Capitalization of acquisition costs

     10,349                   154          2,648          783  

Amortization

     (10,306        (394        (529        (2,565        (1,410

Balance at December 31, 2021

   $ 115,281        $ 4,148        $ 6,763        $ 27,189        $ 19,668  

 

(in thousands)    Other Life
Insurance
       Life
Contingent
Payout
Annuities
       Term and
Whole
Life
Insurance
       Disability
Income
Insurance
       Total,
All
Products
 

Pre-adoption balance at December 31, 2020

   $ (59      $        $ 805        $ 6,662        $ 162,562  

Effect of shadow reserve adjustments

     168                                     19,333  

Post-adoption balance at January 1, 2021

     109                   805          6,662          181,895  

Capitalization of acquisition costs

              23          28          206          14,191  

Amortization

     (11        (5        (56        (698        (15,974

Balance at December 31, 2021

   $ 98        $ 18        $ 777        $ 6,170        $ 180,112  

 

(in thousands)    Variable
Annuities
       Fixed
Annuities
       Universal
Life
Insurance
       Variable
Universal
Life
Insurance
       Indexed
Universal
Life
Insurance
 

Balance at January 1, 2022

   $ 115,281        $ 4,148        $ 6,763        $ 27,189        $ 19,668  

Capitalization of acquisition costs

     5,287                   71          3,152          547  

Amortization

     (9,648        (798        (496        (2,470        (1,378

Balance at December 31, 2022

   $ 110,920        $ 3,350        $ 6,338        $ 27,871        $ 18,837  

 

(in thousands)    Other Life
Insurance
       Life
Contingent
Payout
Annuities
       Term and
Whole
Life
Insurance
       Disability
Income
Insurance
       Total,
All
Products
 

Balance at January 1, 2022

   $ 98        $ 18        $ 777        $ 6,170        $ 180,112  

Capitalization of acquisition costs

              87          97          214          9,455  

Amortization

     (10        (4        (60        (665        (15,529

Balance at December 31, 2022

   $ 88        $ 101        $ 814        $ 5,719        $ 174,038  

 

(in thousands)    Variable
Annuities
       Fixed
Annuities
       Universal
Life
Insurance
       Variable
Universal
Life
Insurance
       Indexed
Universal
Life
Insurance
 

Balance at January 1, 2023

   $ 110,920        $ 3,350        $ 6,338        $ 27,871        $ 18,837  

Capitalization of acquisition costs

     3,760                   21          3,117          383  

Amortization

     (9,121        (781        (462        (2,377        (1,362

Balance at December 31, 2023

   $ 105,559        $ 2,569        $ 5,897        $ 28,611        $ 17,858  

 

(in thousands)    Other Life
Insurance
       Life
Contingent
Payout
Annuities
       Term and
Whole
Life
Insurance
       Disability
Income
Insurance
       Total,
All
Products
 

Balance at January 1, 2023

   $ 88        $ 101        $ 814        $ 5,719        $ 174,038  

Capitalization of acquisition costs

              175          56          205          7,717  

Amortization

     (9        (12        (63        (635        (14,822

Balance at December 31, 2023

   $ 79        $ 264        $ 807        $ 5,289        $ 166,933  

 

 F-22


RiverSource Life Insurance Co. of New York

 

 

The following tables summarize the balances of and changes in DSIC, including the January 1, 2021 adoption of ASU 2018-12. DSIC are recorded in Other assets.

 

(in thousands)    Variable Annuities        Fixed Annuities        Total, All Products  

Pre-adoption balance at December 31, 2020

   $ 7,796        $ 800        $ 8,596  

Effect of shadow reserve adjustments

     272          552          824  

Post-adoption balance at January 1, 2021

     8,068          1,352          9,420  

Capitalization of sales inducement costs

     43          10          53  

Amortization

     (827        (154        (981

Balance at December 31, 2021

   $ 7,284        $ 1,208        $ 8,492  

 

(in thousands)    Variable Annuities        Fixed Annuities        Total, All Products  

Balance at January 1, 2022

   $ 7,284        $ 1,208        $ 8,492  

Capitalization of sales inducement costs

     30          7          37  

Amortization

     (725        (209        (934

Balance at December 31, 2022

   $ 6,589        $ 1,006        $ 7,595  

 

(in thousands)    Variable Annuities        Fixed Annuities        Total, All Products  

Balance at January 1, 2023

   $ 6,589        $ 1,006        $ 7,595  

Capitalization of sales inducement costs

                        

Amortization

     (639        (235        (874

Balance at December 31, 2023

   $ 5,950        $ 771        $ 6,721  

9. REINSURANCE

The Company reinsures a portion of its insurance risks through reinsurance agreements with unaffiliated reinsurance companies.

Reinsurance contracts do not relieve the Company from its primary obligation to policyholders.

The Company generally reinsures 90% of the death benefit liability for new term life insurance policies beginning in 2002 and new individual UL and VUL insurance policies beginning in 2003. Policies issued prior to these dates are not subject to these same reinsurance levels.

However, for IUL policies issued after September 1, 2013 and VUL policies issued after January 1, 2014, the Company generally reinsures 50% of the death benefit liability.

The maximum amount of life insurance risk the Company will retain is $10 million on a single life and $10 million on any flexible premium survivorship life policy; however, reinsurance agreements are in place such that retaining more than $1.5 million of insurance risk on a single life or a flexible premium survivorship life policy is very unusual. Risk on UL and VUL policies is reinsured on a yearly renewable term basis. Risk on most term life policies starting in 2002 is reinsured on a coinsurance basis, a type of reinsurance in which the reinsurer participates proportionally in all material risks and premiums associated with a policy.

The Company also has life insurance risk previously assumed under reinsurance arrangements with an unaffiliated insurance company.

As of December 31, 2002, the Company discontinued underwriting LTC insurance. For existing LTC policies, the Company has continued ceding 50% of the risk on a coinsurance basis to Genworth Life Insurance Company of New York (“Genworth”) and retains the remaining risk. This reinsurance arrangement applies for 1996 and later issues only, which are 89% of the Company’s total in force policies. Under these agreements, the Company has the right, but never the obligation, to recapture some, or all, of the risk ceded to Genworth.

Generally, the Company retains at most $5,000 per month of risk per life on DI policies sold on policy forms introduced in 2010 and reinsures the remainder of the risk on a coinsurance basis with unaffiliated reinsurance companies. The Company retains all risk for new claims on DI contracts sold on other policy forms introduced prior to 2010. The Company also retains all risk on accidental death benefit claims and substantially all risk associated with waiver of premium provisions.

As of December 31, 2023 and 2022, traditional life and UL insurance policies in force were $11.4 billion and $11.5 billion, respectively, of which $8.0 billion and $8.2 billion as of December 31, 2023 and 2022 were reinsured at the respective year ends.

The effect of reinsurance on premiums for traditional long-duration products was as follows:

 

     Years Ended December 31,  
(in thousands)    2023        2022        2021  

Direct premiums

   $ 32,254        $ 27,673        $ 26,456  

Reinsurance ceded

     (10,841        (10,980        (11,040

Net premiums

   $ 21,413        $ 16,693        $ 15,416  

 

F-23 


RiverSource Life Insurance Co. of New York

 

 

Policy and contract charges are presented on the Statements of Income net of $11.0 million, $10.3 million and $9.3 million of reinsurance ceded for non-traditional long-duration products for the years ended December 31, 2023, 2022 and 2021, respectively.

The amount of claims recovered through reinsurance on all contracts was $22.6 million, $20.4 million and $16.0 million for the years ended December 31, 2023, 2022 and 2021, respectively.

Reinsurance recoverables include approximately $156.7 million and $149.3 million related to LTC risk ceded to Genworth as of December 31, 2023 and 2022, respectively.

Policyholder account balances, future policy benefits and claims include $1.1 million and $1.2 million related to previously assumed reinsurance arrangements as of December 31, 2023 and 2022, respectively.

10. POLICYHOLDER ACCOUNT BALANCES, FUTURE POLICY BENEFITS AND CLAIMS

Policyholder account balances, future policy benefits and claims consisted of the following:

 

     December 31,  
(in thousands)    2023        2022  

Policyholder account balances

       

Policyholder account balances

   $ 1,322,686        $ 1,392,756  

Future policy benefits

       

Liability for future policy benefits

     480,237          461,095  

Deferred profit liability

     5,772          4,768  

Additional liabilities for insurance guarantees

     86,365          76,941  

Other insurance and annuity liabilities

     12,043          4,340  

Total future policy benefits

     584,417          547,144  

Policy claims and other policyholders’ funds

     9,896          10,096  

Total policyholder account balances, future policy benefits and claims

   $ 1,916,999        $ 1,949,996  

Variable Annuities

Purchasers of variable annuities can select from a variety of investment options and can elect to allocate a portion to a fixed account. A vast majority of the premiums received for variable annuity contracts are held in separate accounts where the assets are held for the exclusive benefit of those contractholders.

Most of the variable annuity contracts issued by the Company contain a GMDB. The Company previously offered contracts with GMAB, GMWB and GMIB provisions. See Note 2 and Note 12 for additional information regarding the Company’s variable annuity guarantees. See Note 13 and Note 17 for additional information regarding the Company’s derivative instruments used to hedge risks related to these guarantees.

Fixed Annuities

Fixed annuities include both deferred and payout contracts. In 2020, the Company discontinued sales of fixed deferred annuities.

Deferred contracts offer a guaranteed minimum rate of interest and security of the principal invested. Payout contracts guarantee a fixed income payment for life or the term of the contract. Liabilities for fixed annuities in a benefit or payout status are based on future estimated payments using established industry mortality tables and interest rates.

Insurance Liabilities

UL policies accumulate cash value that increases by a fixed interest rate. Purchasers of VUL can select from a variety of investment options and can elect to allocate a portion of their account balance to a fixed account or a separate account. A vast majority of the premiums received for VUL policies are held in separate accounts where the assets are held for the exclusive benefit of those policyholders.

IUL is a UL policy that includes an indexed account. The rate of credited interest for funds allocated by a contractholder to the indexed account is linked to the performance of the specific index for the indexed account (subject to stated account parameters, which include a cap and floor, or a spread). The policyholder may allocate all or a portion of the policy value to a fixed or any available indexed account. The amount allocated by a contractholder to the indexed account creates an embedded derivative which is measured at fair value. The Company hedges the interest credited rate including equity and interest rate risk related to the indexed account with freestanding derivative instruments. See Note 17 for additional information regarding the Company’s derivative instruments used to hedge the risk related to IUL.

The Company also offers term life insurance as well as DI products. The Company no longer offers standalone LTC products and whole life insurance but has in force policies from prior years.

Insurance liabilities include accumulation values, incurred but not reported claims, obligations for anticipated future claims, unpaid reported claims and claim adjustment expenses.

 

 F-24


RiverSource Life Insurance Co. of New York

 

 

The balances of and changes in policyholder account balances were as follows:

 

(in thousands, except percentages)    Variable Annuities        Fixed
Annuities
       Non-Life
Contingent
Payout
Annuities
       Universal Life
Insurance
 

Balance at January 1, 2023

   $ 267,080        $ 730,919        $ 27,698        $ 90,510  

Contract deposits

     9,736          8,023          4,254          9,224  

Policy charges

     (554        (45                 (12,393

Surrenders and other benefits

     (30,401        (88,051        (7,521        (3,147

Net transfer from (to) separate account liabilities

     (3,010                           

Interest credited

     8,205          26,789          621          3,014  

Balance at December 31, 2023

   $ 251,056        $ 677,635        $ 25,052        $ 87,208  

Weighted-average crediting rate

     3.2        3.9        N/A          3.4

Net amount at risk

     N/A          N/A          N/A        $ 592,770  

Cash surrender value(1)

   $ 247,881        $ 676,453          N/A        $ 76,809  

 

(in thousands, except percentages)    Variable Universal
Life Insurance
       Indexed
Universal
Life
Insurance
       Other Life
Insurance
       Total, All
Products
 

Balance at January 1, 2023

   $ 98,080        $ 152,485        $ 25,984        $ 1,392,756  

Contract deposits

     10,495          13,828                   55,560  

Policy charges

     (6,655        (8,081                 (27,728

Surrenders and other benefits

     (4,774        (3,765        (2,477        (140,136

Net transfer from (to) separate account liabilities

     (2,897                          (5,907

Interest credited

     3,728          4,810          974          48,141  

Balance at December 31, 2023

   $ 97,977        $ 159,277        $ 24,481        $ 1,322,686  

Weighted-average crediting rate

     4.0        2.0        4.0     

Net amount at risk

   $ 3,049,078        $ 951,825        $ 10,233       

Cash surrender value(1)

   $ 69,218        $ 135,122        $ 18,716       

 

(in thousands, except percentages)    Variable Annuities        Fixed
Annuities
       Non-Life
Contingent
Payout
Annuities
       Universal Life
Insurance
 

Balance at January 1, 2022

   $ 268,266        $ 751,081        $ 28,499        $ 94,662  

Contract deposits

     12,592          10,520          4,901          10,167  

Policy charges

     (551        (12                 (12,494

Surrenders and other benefits

     (19,469        (57,895        (7,018        (4,888

Net transfer from (to) separate account liabilities

     (2,028                           

Interest credited

     8,270          27,225          1,316          3,063  

Balance at December 31, 2022

   $ 267,080        $ 730,919        $ 27,698        $ 90,510  

Weighted-average crediting rate

     3.2        3.8        N/A          3.4

Net amount at risk

     N/A          N/A          N/A        $ 622,950  

Cash surrender value(1)

   $ 263,788        $ 729,330          N/A        $ 79,202  

 

(in thousands, except percentages)    Variable Universal
Life Insurance
       Indexed
Universal
Life
Insurance
       Other Life
Insurance
       Total, All
Products
 

Balance at January 1, 2022

   $ 98,292        $ 143,396        $ 28,265        $ 1,412,461  

Contract deposits

     8,185          14,582          (228        60,719  

Policy charges

     (6,606        (7,525                 (27,188

Surrenders and other benefits

     (4,352        (1,800        (3,092        (98,514

Net transfer from (to) separate account liabilities

     (1,247                          (3,275

Interest credited

     3,808          3,832          1,039          48,553  

Balance at December 31, 2022

   $ 98,080        $ 152,485        $ 25,984        $ 1,392,756  

Weighted-average crediting rate

     4.0        2.0        4.0     

Net amount at risk

   $ 3,068,303        $ 970,129        $ 10,697       

Cash surrender value(1)

   $ 70,324        $ 126,862        $ 20,209       

 

(1)

Cash surrender value represents the amount of the contractholder’s account balances distributable at the balance sheet date less certain surrender charges. For VA and VUL, the cash surrender value shown is the proportion of the total cash surrender value related to their fixed account liabilities.

 

F-25 


RiverSource Life Insurance Co. of New York

 

 

Refer to Note 12 for the net amount at risk for market risk benefits associated with variable annuities. Fixed and non-life contingent payout annuities do not have net amount at risk in excess of account value. Net amount at risk for insurance products is calculated as the death benefit amount in excess of applicable account values, host, embedded derivative and separate account liabilities.

The following tables present the account values of fixed deferred annuities, fixed insurance, and the fixed portion of variable annuities and variable insurance contracts by range of guaranteed minimum interest rates (“GMIRs”) and the range of the difference between rates credited to policyholders and contractholders as of December 31, 2023 and 2022 and the respective guaranteed minimums, as well as the percentage of account values subject to rate reset in the time period indicated. Rates are reset at management’s discretion, subject to guaranteed minimums.

 

    December 31, 2023  
        Account Values with Crediting Rates  
(in thousands, except percentages)   Range of Guaranteed
Minimum Crediting
Rates
  At
Guaranteed
Minimum
    1-49 bps above
Guaranteed
Minimum
    50-99 bps above
Guaranteed
Minimum
    100-150 bps
above
Guaranteed
Minimum
    Greater than
150 bps above
Guaranteed
Minimum
    Total  

Fixed accounts of variable annuities

  1% – 1.99%   $ 3,762     $ 12,487     $ 6,593     $ 3,836     $ 1,353     $ 28,031  
  2% – 2.99%     5,385                               5,385  
  3% – 3.99%     119,503                               119,503  
  4% – 5.00%     91,460                               91,460  
  Total    $ 220,110     $ 12,487     $ 6,593     $ 3,836     $ 1,353     $ 244,379  

Fixed annuities

  1% – 1.99%   $ 6,931     $ 26,004     $ 12,838     $ 8,108     $     $ 53,881  
  2% – 2.99%     893       269                         1,162  
  3% – 3.99%     300,328       86                         300,414  
  4% – 5.00%     321,863                               321,863  
  Total    $ 630,015     $ 26,359     $ 12,838     $ 8,108     $     $ 677,320  

Universal life insurance

  1% – 1.99%   $     $     $     $     $     $  
  2% – 2.99%     3,411       117       465       7       25       4,025  
  3% – 3.99%     47,337       46       259       420             48,062  
  4% – 5.00%     32,800       59       19                   32,878  
  Total    $ 83,548     $ 222     $ 743     $ 427     $ 25     $ 84,965  

Fixed accounts of variable universal life insurance

  1% – 1.99%   $     $ 264     $ 171     $     $ 1,068     $ 1,503  
  2% – 2.99%     920       640             41       412       2,013  
  3% – 3.99%     6,405       38       123       462             7,028  
  4% – 5.00%     45,045       144                         45,189  
  Total    $ 52,370     $ 1,086     $ 294     $ 503     $ 1,480     $ 55,733  

Non-indexed accounts of indexed universal life insurance

  1% – 1.99%   $     $     $ 184     $     $     $ 184  
  2% – 2.99%     9,091                               9,091  
  3% – 3.99%                                    
  4% – 5.00%                                    
  Total    $ 9,091     $     $ 184     $     $     $ 9,275  

Other life insurance

  1% – 1.99%   $     $     $     $     $     $  
  2% – 2.99%                                    
  3% – 3.99%                                    
  4% – 5.00%     18,649                               18,649  
  Total    $ 18,649     $     $     $     $     $ 18,649  

Total

  1% – 1.99%   $ 10,693     $ 38,755     $ 19,786     $ 11,944     $ 2,421     $ 83,599  
  2% – 2.99%     19,700       1,026       465       48       437       21,676  
  3% – 3.99%     473,573       170       382       882             475,007  
  4% – 5.00%     509,817       203       19                   510,039  
  Total    $ 1,013,783     $ 40,154     $ 20,652     $ 12,874     $ 2,858     $ 1,090,321  

Percentage of total account values that reset in:

 

Next 12 months

    100.0     99.7     99.0     100.0     100.0     100.0

>12 months to 24 months

          0.3       1.0                    

>24 months

                                   

Total

    100.0     100.0     100.0     100.0     100.0     100.0

 

 F-26


RiverSource Life Insurance Co. of New York

 

 

    December 31, 2022  
        Account Values with Crediting Rates  
(in thousands, except percentages)   Range of Guaranteed
Minimum Crediting
Rates
  At
Guaranteed
Minimum
    1-49 bps above
Guaranteed
Minimum
    50-99 bps above
Guaranteed
Minimum
    100-150 bps
above
Guaranteed
Minimum
    Greater than
150 bps above
Guaranteed
Minimum
    Total  

Fixed accounts of variable annuities

  1% – 1.99%   $ 17,394     $ 7,427     $ 1,612     $ 54     $ 44     $ 26,531  
  2% – 2.99%     6,233                               6,233  
  3% – 3.99%     132,527                               132,527  
  4% – 5.00%     95,654                               95,654  
  Total    $ 251,808     $ 7,427     $ 1,612     $ 54     $ 44     $ 260,945  

Fixed annuities

  1% – 1.99%   $ 27,163     $ 26,774     $ 12,274     $ 2,501     $ 1,683     $ 70,395  
  2% – 2.99%     1,415                               1,415  
  3% – 3.99%     341,318                               341,318  
  4% – 5.00%     317,477                               317,477  
  Total    $ 687,373     $ 26,774     $ 12,274     $ 2,501     $ 1,683     $ 730,605  

Universal life insurance

  1% – 1.99%   $     $     $     $     $     $  
  2% – 2.99%     3,562             75       4       6       3,647  
  3% – 3.99%     49,437       36       185       80             49,738  
  4% – 5.00%     35,024                               35,024  
  Total    $ 88,023     $ 36     $ 260     $ 84     $ 6     $ 88,409  

Fixed accounts of variable universal life insurance

  1% – 1.99%   $ 744     $ 22     $ 166     $     $ 536     $ 1,468  
  2% – 2.99%     1,626             56       59       291       2,032  
  3% – 3.99%     6,858       14       191       45             7,108  
  4% – 5.00%     48,372                               48,372  
  Total    $ 57,600     $ 36     $ 413     $ 104     $ 827     $ 58,980  

Non-indexed accounts of indexed universal life insurance

  1% – 1.99%   $     $     $ 440     $     $     $ 440  
  2% – 2.99%     8,622                               8,622  
  3% – 3.99%                                    
  4% – 5.00%                                    
  Total    $ 8,622     $     $ 440     $     $     $ 9,062  

Other life insurance

  1% – 1.99%   $     $     $     $     $     $  
  2% – 2.99%                                    
  3% – 3.99%                                    
  4% – 5.00%     20,154                               20,154  
  Total    $ 20,154     $     $     $     $     $ 20,154  

Total

  1% – 1.99%   $ 45,301     $ 34,223     $ 14,492     $ 2,555     $ 2,263     $ 98,834  
  2% – 2.99%     21,458             131       63       297       21,949  
  3% – 3.99%     530,140       50       376       125             530,691  
  4% – 5.00%     516,681                               516,681  
  Total    $ 1,113,580     $ 34,273     $ 14,999     $ 2,743     $ 2,560     $ 1,168,155  

Percentage of total account values that reset in:

           

Next 12 months

    99.9     83.0     89.7     100.0     100.0     99.3

>12 months to 24 months

    0.1       16.2       9.9                   0.7  

>24 months

          0.8       0.4                    

Total

    100.0     100.0     100.0     100.0     100.0     100.0

 

F-27 


RiverSource Life Insurance Co. of New York

 

 

The following tables summarize the balances of and changes in the liability for future policy benefits, including the January 1, 2021 adoption of ASU 2018-12:

 

(in thousands)   Life Contingent
Payout
Annuities
    Term and
Whole Life
Insurance
    Disability
Income
Insurance
    Long Term
Care
Insurance
    Total, All
Products
 

Pre-adoption balance at December 31, 2020

  $ 89,471     $ 37,489     $ 27,771     $ 359,311     $ 514,042  

Effect of shadow reserve adjustments

    (10,000                 (43,400     (53,400

Adjustments for loss contracts (with premiums in excess of gross premiums) under the modified retrospective approach

    200                   1,229       1,429  

Effect of change in deferred profit liability

    (2,755                       (2,755

Effect of remeasurement of the liability at the current single A discount rate

    12,644       15,220       12,083       128,049       167,996  

Post-adoption balance at January 1, 2021

    89,560       52,709       39,854       445,189       627,312  

Less: reinsurance recoverable

          35,085       702       199,963       235,750  

Post-adoption balance at January 1, 2021, after reinsurance recoverable

  $ 89,560     $ 17,624     $ 39,152     $ 245,226     $ 391,562  

(in thousands, except percentages)

         

Present Value of Expected Net Premiums:

         

Balance at January 1, 2021

  $     $ 37,950     $ 12,288     $ 77,495     $ 127,733  

Beginning balance at original discount rate

          29,946       9,404       62,785       102,135  

Effect of changes in cash flow assumptions

          24             (12     12  

Effect of actual variances from expected experience

          173       (1,957     (3,068     (4,852

Adjusted beginning of year balance

  $     $ 30,143     $ 7,447     $ 59,705     $ 97,295  

Issuances

    1,730       4,899       917             7,546  

Interest accrual

          1,540       467       3,040       5,047  

Net premiums collected

    (1,730     (3,502     (1,062     (7,848     (14,142

Derecognition (lapses)

                             

Ending balance at original discount rate

  $     $ 33,080     $ 7,769     $ 54,897     $ 95,746  

Effect of changes in discount rate assumptions

          5,881       1,694       10,204       17,779  

Balance at December 31, 2021

  $     $ 38,961     $ 9,463     $ 65,101     $ 113,525  

Present Value of Future Policy Benefits:

         

Balance at January 1, 2021

  $ 89,560     $ 90,660     $ 52,142     $ 522,684     $ 755,046  

Beginning balance at original discount rate

    76,916       67,434       37,175       379,926       561,451  

Effect of changes in cash flow assumptions

          24             62       86  

Effect of actual variances from expected experience

    (666     116       (2,203     (3,315     (6,068

Adjusted beginning of year balance

  $ 76,250     $ 67,574     $ 34,972     $ 376,673     $ 555,469  

Issuances

    1,927       4,897       917             7,741  

Interest accrual

    3,137       3,932       2,049       20,216       29,334  

Benefit payments

    (9,837     (6,488     (2,683     (19,157     (38,165

Derecognition (lapses)

                             

Ending balance at original discount rate

  $ 71,477     $ 69,915     $ 35,255     $ 377,732     $ 554,379  

Effect of changes in discount rate assumptions

    8,230       17,716       11,463       112,657       150,066  

Balance at December 31, 2021

  $ 79,707     $ 87,631     $ 46,718     $ 490,389     $ 704,445  

Adjustment due to reserve flooring

  $     $ 124     $     $     $ 124  

Net liability for future policy benefits

  $ 79,707     $ 48,794     $ 37,255     $ 425,288     $ 591,044  

Less: reinsurance recoverable

          33,344       780       191,576       225,700  

Net liability for future policy benefits, after reinsurance recoverable

  $ 79,707     $ 15,450     $ 36,475     $ 233,712     $ 365,344  

Discounted expected future gross premiums

  $     $ 95,686     $ 59,559     $ 68,855     $ 224,100  

Expected future gross premiums

  $     $ 126,793     $ 71,497     $ 80,456     $ 278,746  

Expected future benefit payments

  $ 98,474     $ 116,891     $ 61,301     $ 678,673     $ 955,339  

Weighted average interest accretion rate

    4.2     6.4     5.9     5.4  

Weighted average discount rate

    2.5     2.7     2.7     2.8  

Weighted average duration of liability (in years)

    7       7       8       10    

 

 F-28


RiverSource Life Insurance Co. of New York

 

 

(in thousands, except percentages)   Life Contingent
Payout
Annuities
    Term and
Whole Life
Insurance
    Disability
Income
Insurance
    Long Term
Care
Insurance
    Total, All
Products
 

Present Value of Expected Net Premiums:

         

Balance at January 1, 2022

  $     $ 38,961     $ 9,463     $ 65,101     $ 113,525  

Beginning balance at original discount rate

          33,080       7,769       54,897       95,746  

Effect of changes in cash flow assumptions

          2,253       41       (970     1,324  

Effect of actual variances from expected experience

          478       (612     (2,913     (3,047

Adjusted beginning of year balance

  $     $ 35,811     $ 7,198     $ 51,014     $ 94,023  

Issuances

    2,950       2,675       695             6,320  

Interest accrual

    8       1,631       390       2,654       4,683  

Net premiums collected

    (2,958     (3,439     (857     (7,255     (14,509

Derecognition (lapses)

                             

Ending balance at original discount rate

  $     $ 36,678     $ 7,426     $ 46,413     $ 90,517  

Effect of changes in discount rate assumptions

          (2,058     (100     226       (1,932

Balance at December 31, 2022

  $     $ 34,620     $ 7,326     $ 46,639     $ 88,585  

Present Value of Future Policy Benefits:

         

Balance at January 1, 2022

  $ 79,707     $ 87,631     $ 46,718     $ 490,389     $ 704,445  

Beginning balance at original discount rate

    71,477       69,915       35,255       377,732       554,379  

Effect of changes in cash flow assumptions

          1,989       53       1,932       3,974  

Effect of actual variances from expected experience

    (1,876     380       (943     (1,772     (4,211

Adjusted beginning of year balance

  $ 69,601     $ 72,284     $ 34,365     $ 377,892     $ 554,142  

Issuances

    2,950       2,676       698             6,324  

Interest accrual

    2,830       4,022       1,998       19,965       28,815  

Benefit payments

    (9,180     (4,744     (2,572     (20,943     (37,439

Derecognition (lapses)

                             

Ending balance at original discount rate

  $ 66,201     $ 74,238     $ 34,489     $ 376,914     $ 551,842  

Effect of changes in discount rate assumptions

    (4,814     (532     1,622       1,493       (2,231

Balance at December 31, 2022

  $ 61,387     $ 73,706     $ 36,111     $ 378,407     $ 549,611  

Adjustment due to reserve flooring

  $     $ 69     $     $     $ 69  

Net liability for future policy benefits

  $ 61,387     $ 39,155     $ 28,785     $ 331,768     $ 461,095  

Less: reinsurance recoverable

          27,134       669       148,609       176,412  

Net liability for future policy benefits, after reinsurance recoverable

  $ 61,387     $ 12,021     $ 28,116     $ 183,159     $ 284,683  

Discounted expected future gross premiums

  $     $ 93,084     $ 47,976     $ 51,373     $ 192,433  

Expected future gross premiums

  $     $ 149,730     $ 68,574     $ 69,925     $ 288,229  

Expected future benefit payments

  $ 90,675     $ 123,160     $ 59,626     $ 660,615     $ 934,076  

Weighted average interest accretion rate

    4.2     6.4     6.1     5.4  

Weighted average discount rate

    5.2     5.5     5.4     5.4  

Weighted average duration of liability (in years)

    5       6       8       9    

 

F-29 


RiverSource Life Insurance Co. of New York

 

 

(in thousands, except percentages)   Life Contingent
Payout
Annuities
    Term and
Whole Life
Insurance
    Disability
Income
Insurance
    Long Term
Care
Insurance
    Total, All
Products
 

Present Value of Expected Net Premiums:

         

Balance at January 1, 2023

  $     $ 34,620     $ 7,326     $ 46,639     $ 88,585  

Beginning balance at original discount rate

          36,678       7,426       46,413       90,517  

Effect of changes in cash flow assumptions

          (1,238     (788     3,562       1,536  

Effect of actual variances from expected experience

          (754     819       1,791       1,856  

Adjusted beginning of year balance

  $     $ 34,686     $ 7,457     $ 51,766     $ 93,909  

Issuances

    8,076       2,607       716             11,399  

Interest accrual

    39       1,747       390       2,473       4,649  

Net premiums collected

    (8,115     (3,391     (843     (6,842     (19,191

Derecognition (lapses)

                             

Ending balance at original discount rate

  $     $ 35,649     $ 7,720     $ 47,397     $ 90,766  

Effect of changes in discount rate assumptions

          (1,127     116       1,092       81  

Balance at December 31, 2023

  $     $ 34,522     $ 7,836     $ 48,489     $ 90,847  

Present Value of Future Policy Benefits:

         

Balance at January 1, 2023

  $ 61,387     $ 73,706     $ 36,111     $ 378,407     $ 549,611  

Beginning balance at original discount rate

    66,201       74,238       34,489       376,914       551,842  

Effect of changes in cash flow assumptions

          (1,241     (1,091     2,302       (30

Effect of actual variances from expected experience

    (1,074     (1,296     1,000       7,258       5,888  

Adjusted beginning of year balance

  $ 65,127     $ 71,701     $ 34,398     $ 386,474     $ 557,700  

Issuances

    8,076       2,607       714             11,397  

Interest accrual

    2,810       4,066       2,031       20,274       29,181  

Benefit payments

    (8,743     (5,215     (2,500     (23,464     (39,922

Derecognition (lapses)

                             

Ending balance at original discount rate

  $ 67,270     $ 73,159     $ 34,643     $ 383,284     $ 558,356  

Effect of changes in discount rate assumptions

    (3,009     1,079       2,470       12,102       12,642  

Balance at December 31, 2023

  $ 64,261     $ 74,238     $ 37,113     $ 395,386     $ 570,998  

Adjustment due to reserve flooring

  $     $ 86     $     $     $ 86  

Net liability for future policy benefits

  $ 64,261     $ 39,802     $ 29,277     $ 346,897     $ 480,237  

Less: reinsurance recoverable

          28,013       942       156,173       185,128  

Net liability for future policy benefits, after reinsurance recoverable

  $ 64,261     $ 11,789     $ 28,335     $ 190,724     $ 295,109  

Discounted expected future gross premiums

  $     $ 88,128     $ 47,156     $ 52,116     $ 187,400  

Expected future gross premiums

  $     $ 138,691     $ 65,922     $ 69,651     $ 274,264  

Expected future benefit payments

  $ 93,290     $ 120,813     $ 58,748     $ 653,735     $ 926,586  

Weighted average interest accretion rate

    4.2     6.2     6.1     5.3  

Weighted average discount rate

    4.9     5.1     5.1     5.1  

Weighted average duration of liability (in years)

    6       7       8       8    

Impacts of the annual review of policy benefit reserves assumptions are reflected within the effect of changes in cash flow assumptions in the disaggregated rollforwards above. The annual review of policy benefit reserves assumptions in the third quarter of 2023 resulted in a net decrease in future policy benefit reserves, primarily due to updates to LTC premium rate increase and benefit reduction assumptions. The annual review of policy benefit reserves assumptions in the third quarter of 2022 resulted in a net increase in future policy benefit reserves, primarily due to updates to LTC morbidity, premium rate increase and benefit reduction assumptions, and updates to term life lapse assumptions. The annual review of policy benefit reserves assumptions in the third quarter of 2021 resulted in a net decrease in future policy benefit reserves, primarily due to updates to LTC premium rate increase and benefit reduction assumptions.

 

 F-30


RiverSource Life Insurance Co. of New York

 

 

The balances of and changes in additional liabilities related to insurance guarantees were as follows:

 

(in thousands, except percentages)   Universal Life
Insurance
    Variable
Universal
Life
Insurance
    Other Life
Insurance
    Total, All
Products
 

Balance at January 1, 2023

  $ 72,524     $ 4,620     $ (203   $ 76,941  

Interest accrual

    2,317       344       28       2,689  

Benefit accrual

    9,474       405       218       10,097  

Benefit payments

    (4,890     (405     (309     (5,604

Effect of actual variances from expected experience

    (751     462       (140     (429

Impact of change in net unrealized (gains) losses on securities

    1,965       83       623       2,671  

Balance at December 31, 2023

  $ 80,639     $ 5,509     $ 217     $ 86,365  

Weighted average interest accretion rate

    2.9     6.7     4.0  

Weighted average discount rate

    3.2     7.0     4.1  

Weighted average duration of reserves (in years)

    10       8       7    

 

(in thousands, except percentages)   Universal Life
Insurance
    Variable
Universal
Life
Insurance
    Other Life
Insurance
    Total, All
Products
 

Balance at January 1, 2022

  $ 74,498     $ 4,328     $ 2,717     $ 81,543  

Interest accrual

    2,115       297       42       2,454  

Benefit accrual

    8,754       344       92       9,190  

Benefit payments

    (1,956           (426     (2,382

Effect of actual variances from expected experience

    (2,836     (6     (82     (2,924

Impact of change in net unrealized (gains) losses on securities

    (8,051     (343     (2,546     (10,940

Balance at December 31, 2022

  $ 72,524     $ 4,620     $ (203   $ 76,941  

Weighted average interest accretion rate

    2.9     6.7     4.2  

Weighted average discount rate

    3.2     7.1     4.0  

Weighted average duration of reserves (in years)

    10       7       7    

The amount of revenue and interest recognized in the Statements of Income was as follows:

 

    Years Ended December 31,  
    2023     2022     2021  
(in thousands)   Gross
Premiums
    Interest
Expense
    Gross
Premiums
    Interest
Expense
    Gross
Premiums
    Interest
Expense
 

Life contingent payout annuities

  $ 8,895     $ 2,771     $ 3,353     $ 2,822     $ 1,730     $ 3,137  

Term and whole life insurance

    9,177       2,319       9,534       2,391       9,235       2,392  

Disability income insurance

    6,609       1,641       6,765       1,608       6,928       1,582  

Long term care insurance

    7,573       17,801       8,021       17,311       8,563       17,176  

Total

  $ 32,254     $ 24,532     $ 27,673     $ 24,132     $ 26,456     $ 24,287  

The following table summarizes the balances of and changes in unearned revenue, including the January 1, 2021 adoption of ASU 2018-12:

 

(in thousands)   Universal Life
Insurance
    Variable
Universal
Life
Insurance
    Indexed
Universal
Life
Insurance
    Total, All
Products
 

Pre-adoption balance at December 31, 2020

  $ 28     $ 3,836     $ 450     $ 4,314  

Effect of shadow reserve adjustments

    63       449       11,632       12,144  

Post-adoption balance at January 1, 2021

    91       4,285       12,082       16,458  

Deferral of revenue

    19       1,386       3,970       5,375  

Amortization

    (13     (377     (1,007     (1,397

Balance at December 31, 2021

    97       5,294       15,045       20,436  

Deferral of revenue

    15       2,086       3,913       6,014  

Amortization

    (14     (468     (1,224     (1,706

Balance at December 31, 2022

    98       6,912       17,734       24,744  

Deferral of revenue

    14       2,714       3,877       6,605  

Amortization

    (14     (588     (1,457     (2,059

Balance at December 31, 2023

  $ 98     $ 9,038     $ 20,154     $ 29,290  

 

F-31 


RiverSource Life Insurance Co. of New York

 

 

11. SEPARATE ACCOUNT ASSETS AND LIABILITIES

The fair value of separate account assets is invested exclusively in mutual funds.

No gains or losses were recognized on assets transferred to separate accounts for the years ended December 31, 2023, 2022 and 2021.

The balances of and changes in separate account liabilities were as follows:

 

(in thousands)    Variable
Annuities
     Variable
Universal
Life
     Total  

Balance at January 1, 2023

   $ 3,793,152      $ 437,738      $ 4,230,890  

Premiums and deposits

     83,153        25,482        108,635  

Policy charges

     (77,945      (18,750      (96,695

Surrenders and other benefits

     (298,531      (20,075      (318,606

Investment return

     516,055        71,946        588,001  

Net transfer from (to) general account

     2,510        661        3,171  

Other charges

     (69      (3      (72

Balance at December 31, 2023

   $ 4,018,325      $ 496,999      $ 4,515,324  

Cash surrender value

   $ 3,912,313      $ 472,542      $ 4,384,855  

 

(in thousands)    Variable
Annuities
     Variable
Universal
Life
     Total  

Balance at January 1, 2022

   $ 4,897,176      $ 535,085      $ 5,432,261  

Premiums and deposits

     102,016        25,622        127,638  

Policy charges

     (80,319      (17,861      (98,180

Surrenders and other benefits

     (271,750      (13,816      (285,566

Investment return

     (856,480      (92,941      (949,421

Net transfer from (to) general account

     2,414        1,648        4,062  

Other charges

     95        1        96  

Balance at December 31, 2022

   $ 3,793,152      $ 437,738      $ 4,230,890  

Cash surrender value

   $ 3,676,735      $ 417,230      $ 4,093,965  

12. MARKET RISK BENEFITS

Market risk benefits are contracts or contract features that both provide protection to the contractholder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Most of the variable annuity contracts issued by the Company contain a GMDB provision. The Company previously offered contracts containing GMWB, GMAB, or GMIB provisions.

The GMDB provisions provide a specified minimum return upon death of the contractholder. The death benefit payable is the greater of (i) the contract value less any purchase payment credits subject to recapture less a pro-rata portion of any rider fees, or (ii) the GMDB provisions specified in the contract. The Company has the following primary GMDB provisions:

 

 

Return of premium — provides purchase payments minus adjusted partial surrenders.

 

 

Reset — provides that the value resets to the account value at specified contract anniversary intervals minus adjusted partial surrenders. This provision was often provided in combination with the return of premium provision and is no longer offered.

 

 

Ratchet — provides that the value ratchets up to the maximum account value at specified anniversary intervals, plus subsequent purchase payments less adjusted partial surrenders.

The variable annuity contracts with GMWB riders typically have account values that are based on an underlying portfolio of mutual funds, the values of which fluctuate based on fund performance. At contract issue, the guaranteed amount is equal to the amount deposited but the guarantee may be increased annually to the account value (a “step-up”) in the case of favorable market performance or by a benefit credit if the contract includes this provision.

The Company has GMWB riders in force, which contain one or more of the following provisions:

 

 

Withdrawals at a specified rate per year until the amount withdrawn is equal to the guaranteed amount.

 

 

Withdrawals at a specified rate per year for the life of the contractholder (“GMWB for life”).

 

 

Withdrawals at a specified rate per year for joint contractholders while either is alive.

 

 

Withdrawals based on performance of the contract.

 

 

Withdrawals based on the age withdrawals begin.

 

 

Credits are applied annually for a specified number of years to increase the guaranteed amount as long as withdrawals have not been taken.

 

 F-32


RiverSource Life Insurance Co. of New York

 

 

Variable annuity contractholders age 79 or younger at contract issue could obtain a principal-back guarantee by purchasing the optional GMAB rider for an additional charge. The GMAB rider guarantees that, regardless of market performance at the end of the 10-year waiting period, the contract value will be no less than the original investment or a specified percentage of the highest anniversary value, adjusted for withdrawals. If the contract value is less than the guarantee at the end of the 10-year period, a lump sum will be added to the contract value to make the contract value equal to the guarantee value.

Individual variable annuity contracts may have both a death benefit and a living benefit. Net amount at risk is quantified for each benefit and a composite net amount at risk is calculated using the greater of the death benefit or living benefit for each individual contract. The net amount at risk for GMDB and GMAB is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB is defined as the greater of the present value of the minimum guaranteed annuity payments less the current contract value or zero. The net amount at risk for GMWB is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero.

The following tables summarize the balances of and changes in market risk benefits, including the January 1, 2021 adoption of ASU 2018-12:

 

      (in thousands)  

Pre-adoption balance at December 31, 2020

   $ 137,943  

Effect of shadow reserve adjustments

     (396

Adjustments for the cumulative effect of the changes in instrument-specific credit risk on market risk benefits

between the original contract issuance date and the transition date

     28,704  

Adjustments for the remaining difference (exclusive of the instrument-specific credit risk change and host contract adjustments) between previous carrying amount and fair value measurements for the market risk benefits

     28,135  

Post-adoption balance at January 1, 2021

   $ 194,386  

 

     Years Ended December 31,  
(in thousands, except age)    2023      2022      2021  

Balance at beginning of period

   $ 4,137      $ 92,975      $ 194,386  

Issuances

     3        42        284  

Interest accrual and time decay

     (8,114      (16,308      (17,939

Reserve increase from attributed fees collected

     43,343        44,350        44,469  

Reserve release for benefit payments and derecognition

     (1,878      (1,391      (135

Effect of changes in interest rates and bond markets

     (19,266      (216,461      (55,587

Effect of changes in equity markets and subaccount performance

     (69,222      120,007        (77,231

Effect of changes in equity index volatility

     (4,254      11,723        3,204  

Actual policyholder behavior different from expected behavior

     (2,579      (1,594      (361

Effect of changes in other future expected assumptions

     6,621        (5,362      7,662  

Effect of changes in the instrument-specific credit risk on market risk benefits

     3,734        (23,844 )        (5,777

Balance at end of period

   $ (47,475    $ 4,137      $ 92,975  

Reconciliation of the gross balances in an asset or liability position:

        

Asset position

   $ 94,641      $ 64,498      $ 36,740  

Liability position

     (47,166      (68,635      (129,715

Net asset (liability) position

   $ 47,475      $ (4,137    $ (92,975

Guaranteed benefit amount in excess of current account balances (net amount at risk):

        

Death benefits

   $ 58,245      $ 180,279      $ 1,325  

Living benefits

   $ 54,321      $ 185,651      $ 427  

Composite (greater of)

   $ 107,200      $ 339,888      $ 1,750  

Weighted average attained age of contractholders

     67        67        67  

Changes in unrealized (gains) losses in net income relating to liabilities held at end of period

   $ (96,583    $ (106,928    $ (132,470

Changes in unrealized (gains) losses in other comprehensive income relating to liabilities held at end of period

   $ 3,742      $ (23,420    $ (4,551

The following tables provide a summary of the significant inputs and assumptions used in the fair value measurements developed by the Company or reasonably available to the Company of market risk benefits:

 

    December 31, 2023  
     Fair Value      Valuation Technique    Significant Inputs and
Assumptions
   Range      Weighted
Average
 
    (in thousands)                                    
Market risk benefits   $ (47,475    Discounted cash flow    Utilization of guaranteed withdrawals(1)      0.0       48.0      12.1
        Surrender rate(2)      0.3       55.7      3.9
        Market volatility(3)      0.0       25.2      10.6
        Nonperformance risk(4)      85 bps        85  bps 
        Mortality rate(5)      0.0%         35.4      1.7

 

F-33 


RiverSource Life Insurance Co. of New York

 

 

    December 31, 2022  
     Fair Value      Valuation Technique    Significant Inputs and
Assumptions
   Range      Weighted
Average
 
    (in thousands)                                    
Market risk benefits   $ 4,137      Discounted cash flow    Utilization of guaranteed withdrawals(1)      0.0       48.0      11.4
        Surrender rate(2)      0.2       45.6      3.9
        Market volatility(3)      5.0       17.4      11.7
        Nonperformance risk(4)      95 bps        95  bps 
        Mortality rate(5)      0.0%         33.2      1.6

 

(1)

The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any giver year. The weighted average utilization rate represents the average assumption, weighted based on the benefit base. The calculation excludes policies that have already started taking withdrawals.

(2) 

The weighted average surrender rate represents the average assumption weighted based on the account value of each contract.

(3) 

Market volatility represents the implied volatility of each contractholder’s mix of funds. The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit.

(4) 

The nonperformance risk is the spread added to the U.S. Treasury curve.

(5) 

The weighted average mortality rate represents the average assumption weighted based on the account value of each contract.

Changes to Significant Inputs and Assumptions:

During the years ended December 31, 2023 and 2022, the Company updated inputs and assumptions based on management’s review of experience studies. These updates resulted in the following notable changes in the fair value estimates of market risk benefits calculations:

Year ended December 31, 2023

 

 

Updates to utilization of guaranteed withdrawals assumptions resulted in a decrease to pre-tax income of $1.5 million.

 

 

Updates to surrender assumptions resulted in a decrease to pre-tax income of $5.0 million.

Year ended December 31, 2022

 

 

Updates to utilization of guaranteed withdrawals assumptions resulted in a decrease to pre-tax income of $1.9 million.

 

 

Updates to surrender assumptions resulted in a decrease to pre-tax income of $10.1 million.

 

 

Updates to mortality assumptions resulted in a decrease to pre-tax income of $2.1 million.

Refer to the rollforward of market risk benefits for the impacts of changes to interest rate, equity market, volatility and nonperformance risk assumptions.

Uncertainty of Fair Value Measurements

Significant increases (decreases) in utilization and volatility used in the fair value measurement of market risk benefits in isolation would have resulted in a significantly higher (lower) liability value.

Significant increases (decreases) in nonperformance risk and surrender assumptions used in the fair value measurement of market risk benefits in isolation would have resulted in a significantly lower (higher) liability value.

Significant increases (decreases) in mortality assumptions used in the fair value measurement of the death benefit portion of market risk benefits in isolation would have resulted in a significantly higher (lower) liability value whereas significant increases (decreases) in mortality rates used in the fair value measurement of the life contingent portion of market risk benefits in isolation would have resulted in a significantly lower (higher) liability value.

Surrender assumptions, utilization assumptions and mortality assumptions vary with the type of base product, type of rider, duration of the policy, age of the contractholder, calendar year of the projection, previous withdrawal history, and the relationship between the value of the guaranteed benefit and the contract accumulation value.

Determination of Fair Value

The Company values market risk benefits using internal valuation models. These models include observable capital market assumptions and significant unobservable inputs related to implied volatility as well as contractholder behavior assumptions that include margins for risk, all of which the Company believes a market participant would expect. The fair value also reflects a current estimate of the Company’s nonperformance risk. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3.

13. FAIR VALUES OF ASSETS AND LIABILITIES

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale.

 

 F-34


RiverSource Life Insurance Co. of New York

 

 

Valuation Hierarchy

The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety.

The three levels of the fair value hierarchy are defined as follows:

 

Level 1

Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.

 

Level 2

Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.

 

Level 3

Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

The following tables present the balances of assets and liabilities measured at fair value on a recurring basis:

 

       December 31, 2023  
(in thousands)      Level 1      Level 2      Level 3      Total  

Assets

             

Available-for-Sale securities:

             

Corporate debt securities

     $      $ 897,905      $ 23,276      $ 921,181  

Residential mortgage backed securities

              252,823               252,823  

Commercial mortgage backed securities

              289,746               289,746  

State and municipal obligations

              90,111               90,111  

Asset backed securities

              30,738               30,738  

Foreign government bonds and obligations

              722               722  

U.S. government and agency obligations

       220                      220  

Total Available-for-Sale securities

       220        1,562,045        23,276        1,585,541  

Cash equivalents

              79,967               79,967  

Market risk benefits

                     94,641        94,641 (1) 

Other assets:

             

Interest rate derivative contracts

       141        3,039               3,180  

Equity derivative contracts

       1,540        69,821               71,361  

Foreign exchange derivative contracts

       74        232               306  

Total other assets

       1,755        73,092               74,847  

Separate account assets at net asset value (“NAV”)

                                  4,515,324 (2) 

Total assets at fair value

     $ 1,975      $ 1,715,104      $ 117,917      $ 6,350,320  

Liabilities

             

Policyholder account balances, future policy benefits and claims:

             

IUL embedded derivatives

     $      $      $ 50,529      $ 50,529  

Total policyholder account balances, future policy benefits and claims

                     50,529        50,529 (3) 

Market risk benefits

                     47,166        47,166 (1) 

Other liabilities:

             

Interest rate derivative contracts

       2        2,806               2,808  

Equity derivative contracts

       165        35,344               35,509  

Foreign exchange derivative contracts

       104                      104  

Credit derivative contracts

              3,508               3,508  

Total other liabilities

       271        41,658               41,929  

Total liabilities at fair value

     $ 271      $ 41,658      $ 97,695      $ 139,624  

 

F-35 


RiverSource Life Insurance Co. of New York

 

 

       December 31, 2022  
(in thousands)      Level 1      Level 2      Level 3      Total  

Assets

             

Available-for-Sale securities:

             

Corporate debt securities

     $      $ 803,156      $ 29,372      $ 832,528  

Residential mortgage backed securities

              268,389               268,389  

Commercial mortgage backed securities

              301,631               301,631  

State and municipal obligations

              91,760               91,760  

Asset backed securities

              33,440               33,440  

Foreign government bonds and obligations

              780               780  

U.S. government and agency obligations

       215                      215  

Total Available-for-Sale securities

       215        1,499,156        29,372        1,528,743  

Cash equivalents

              204,645               204,645  

Market risk benefits

                     64,498        64,498 (1) 

Other assets:

             

Interest rate derivative contracts

       138        11,278               11,416  

Equity derivative contracts

       3,851        77,768               81,619  

Foreign exchange derivative contracts

       11        1,230               1,241  

Total other assets

       4,000        90,276               94,276  

Separate account assets at NAV

                                  4,230,890 (2) 

Total assets at fair value

     $ 4,215      $ 1,794,077      $ 93,870      $ 6,123,052  

Liabilities

             

Policyholder account balances, future policy benefits and claims:

             

IUL embedded derivatives

     $      $      $ 42,382      $ 42,382  

Total policyholder account balances, future policy benefits and claims

                     42,382        42,382 (4) 

Market risk benefits

                     68,635        68,635 (1) 

Other liabilities:

             

Interest rate derivative contracts

              7,625               7,625  

Equity derivative contracts

       53        50,834               50,887  

Foreign exchange derivative contracts

       272                      272  

Total other liabilities

       325        58,459               58,784  

Total liabilities at fair value

     $ 325      $ 58,459      $ 111,017      $ 169,801  

 

(1)

See Note 12 for additional information related to market risk benefits, including the balances of and changes in market risk benefits as well as the significant inputs and assumptions used in the fair value measurements of market risk benefits.

(2)

Amounts are comprised of financial instruments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy.

(3) 

The Company’s adjustment for nonperformance risk resulted in a $7.5 million cumulative decrease to the embedded derivatives as of December 31, 2023.

(4) 

The Company’s adjustment for nonperformance risk resulted in a $7.7 million cumulative decrease to the embedded derivatives as of December 31, 2022.

The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis:

 

    Available-for-
Sale Securities
  Policyholder Account Balances,
Future Policy Benefits and Claims
(in thousands)  

Corporate

Debt

Securities

 

IUL

Embedded

Derivatives

Balance at January 1, 2023

    $ 29,372     $ (42,382 )

Total gains (losses) included in:

       

Net income

      (68 )(1)       (13,670 )(2)

Other comprehensive income (loss)

      585      

Purchases

      419      

Issues

            (2,453 )

Settlements

      (7,032 )       7,976

Balance at December 31, 2023

    $ 23,276     $ (50,529 )

Changes in unrealized gains (losses) in net income relating to assets and liabilities held at December 31, 2023

    $ (68 )(1)     $ (13,670 )(2)

Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets and liabilities held at December 31, 2023

    $ 511     $

 

 F-36


RiverSource Life Insurance Co. of New York

 

 

     Available-for-Sale
Securities
   Policyholder Account Balances,
Future Policy Benefits and Claims
(in thousands)   

Corporate

Debt

Securities

  

IUL

Embedded

Derivatives

Balance at January 1, 2022

     $ 45,834      $ (51,617 )

Total gains (losses) included in:

         

Net income

       (69 )(1)        5,029 (2) 

Other comprehensive income (loss)

       (3,002 )       

Issues

              (2,483 )

Settlements

       (13,391 )        6,689

Balance at December 31, 2022

     $ 29,372      $ (42,382 )

Changes in unrealized gains (losses) in net income relating to assets and liabilities held at December 31, 2022

     $ (66 )(1)      $ 5,029 (2) 

Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets and liabilities held at December 31, 2022

     $ (2,829 )      $

 

    Available-for-Sale
Securities
  Policyholder Account Balances,
Future Policy Benefits and Claims
(in thousands)   Corporate
Debt
Securities
  IUL
Embedded
Derivatives

Balance at January 1, 2021

    $ 64,484     $ (52,327 )

Total gains (losses) included in:

       

Net income

      (66 )(1)       (4,136 )(2)

Other comprehensive income (loss)

      (1,237 )      

Issues

            (299 )

Settlements

      (9,341 )       5,145

Transfers into Level 3

      33,041      

Transfers out of Level 3

      (41,047 )      

Balance at December 31, 2021

    $ 45,834     $ (51,617 )

Changes in unrealized gains (losses) in net income relating to assets and liabilities held at December 31, 2021

    $ (61 )(1)     $ (4,136 )(2)

Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets and liabilities held at December 31, 2021

    $ (962 )     $

 

(1) 

Included in Net investment income.

(2) 

Included in Interest credited to fixed accounts.

The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $20 thousand, $1.7 million and $(390) thousand, net of the reinsurance accrual, for the years ended December 31, 2023, 2022 and 2021, respectively.

Securities transferred from Level 3 primarily represent securities with fair values that are now obtained from a third-party pricing service with observable inputs or fair values that were included in an observable transaction with a market participant. Securities transferred to Level 3 represent securities with fair values that are now based on a single non-binding broker quote.

The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:

 

    December 31, 2023  
     Fair Value      Valuation
Technique
   Unobservable Input    Range      Weighted
Average
 
    (in thousands)                                    
Corporate debt securities
(private placements)
  $ 23,253      Discounted cash flow    Yield/spread to U.S. Treasuries(1)      1.0       2.4      1.6
IUL embedded derivatives   $ 50,529      Discounted cash flow    Nonperformance risk(2)      85 bps        85  bps 

 

F-37 


RiverSource Life Insurance Co. of New York

 

 

    December 31, 2022  
     Fair Value      Valuation
Technique
   Unobservable Input    Range      Weighted
Average
 
    (in thousands)                                    
Corporate debt securities
(private placements)
  $ 29,351      Discounted cash flow    Yield/spread to U.S. Treasuries(1)      1.1       2.3      1.7
IUL embedded derivatives   $ 42,382      Discounted cash flow    Nonperformance risk(2)      95 bps        95  bps 

 

(1)

The weighted average for the yield/spread to U.S. Treasuries for corporate debt securities (private placements) is weighted based on the security’s market value as a percentage of the aggregate market value of the securities.

(2) 

The nonperformance risk is the spread added to the U.S. Treasury curve.

Level 3 measurements not included in the tables above are obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company.

Uncertainty of Fair Value Measurements

Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities in isolation would have resulted in a significantly lower (higher) fair value measurement.

Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would have resulted in a significantly lower (higher) fair value measurement.

Determination of Fair Value

The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company’s market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company’s income approach uses valuation techniques to convert future projected cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy.

Assets

Available-for-Sale Securities

When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third-party pricing services, non-binding broker quotes, or other model-based valuation techniques.

Level 1 securities primarily include U.S. Treasuries.

Level 2 securities primarily include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third-party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes. The fair value of securities included in an observable transaction with a market participant are also considered Level 2 when the market is not active.

Level 3 securities primarily include certain corporate bonds. The fair value of corporate bonds classified as Level 3 is typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company’s privately placed corporate bonds are typically based on a single non-binding broker quote.

Management is responsible for the fair values recorded on the financial statements. Prices received from third-party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third-party pricing services. The Company’s due diligence procedures include assessing the vendor’s valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise.

Cash Equivalents

Cash equivalents include time deposits and other highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less. The Company’s cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization.

 

 F-38


RiverSource Life Insurance Co. of New York

 

 

Other Assets

Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active over-the-counter (“OTC”) markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The counterparties’ nonperformance risk associated with uncollateralized derivative assets was immaterial as of both December 31, 2023 and 2022. See Note 16 and Note 17 for further information on the credit risk of derivative instruments and related collateral.

Separate Account Assets

The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV is used as a practical expedient for fair value and represents the exit price for the separate account. Separate account assets are excluded from classification in the fair value hierarchy.

Liabilities

Policyholder Account Balances, Future Policy Benefits and Claims

There is no active market for the transfer of the Company’s embedded derivatives attributable to the provisions of IUL products.

The Company uses discounted cash flow models to determine the fair value of the embedded derivatives associated with the provisions of its IUL products. The fair value of IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and the significant unobservable estimate of the Company’s nonperformance risk. Given the significance of the nonperformance risk assumption, the IUL embedded derivatives are classified as Level 3.

The embedded derivatives attributable to these provisions are recorded in Policyholder account balances, future policy benefits and claims.

Other Liabilities

Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active OTC markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The Company’s nonperformance risk associated with uncollateralized derivative liabilities was immaterial as of both December 31, 2023 and 2022. See Note 16 and Note 17 for further information on the credit risk of derivative instruments and related collateral.

Fair Value on a Nonrecurring Basis

During the years ended December 31, 2023 and 2022, there were no material assets or liabilities measured at fair value on a nonrecurring basis.

Assets and Liabilities Not Reported at Fair Value

The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value:

 

       December 31, 2023  
      

Carrying

Value

     Fair Value  
(in thousands)    Level 1      Level 2      Level 3      Total  

Financial Assets

                                              

Mortgage loans, net

     $ 144,910      $      $      $ 134,224      $ 134,224  

Policy loans

       53,615               53,615               53,615  

Financial Liabilities

                

Policyholder account balances, future policy benefits and claims

     $ 705,348      $      $      $ 684,945      $ 684,945  

Separate account liabilities – investment contracts

       3,412               3,412               3,412  

 

       December 31, 2022  
      

Carrying

Value

     Fair Value  
(in thousands)    Level 1      Level 2      Level 3      Total  

Financial Assets

                                              

Mortgage loans, net

     $ 157,068      $      $      $ 143,477      $ 143,477  

Policy loans

       50,791               50,791               50,791  

Financial Liabilities

                

Policyholder account balances, future policy benefits and claims

     $ 761,275      $      $      $ 728,833      $ 728,833  

Separate account liabilities – investment contracts

       3,048               3,048               3,048  

See Note 7 for additional information on mortgage loans and policy loans.

 

F-39 


RiverSource Life Insurance Co. of New York

 

 

Policyholder account balances, future policy benefits and claims include fixed annuities in deferral status, non-life contingent fixed annuities in payout status and the fixed portion of a small number of variable annuity contracts classified as investment contracts. See Note 10 for additional information on these liabilities. Separate account liabilities are related to certain annuity products that are classified as investment contracts.

14. RELATED PARTY TRANSACTIONS

Revenues

See Note 4 for information about revenues from contracts with customers earned by the Company from related party transactions with affiliates.

Expenses

Charges by Ameriprise Financial and affiliated companies to the Company for use of joint facilities, technology support, marketing services and other services aggregated $23.0 million, $22.9 million and $23.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. Certain of these costs are included in DAC. Expenses allocated to the Company may not be reflective of expenses that would have been incurred by the Company on a stand-alone basis.

Income Taxes

The Company’s taxable income is included in the consolidated federal income and various state tax returns of Ameriprise Financial. The net amount due to Ameriprise Financial for income taxes was $428 thousand and $3.8 million as of December 31, 2023 and 2022, respectively, which is reflected in Other liabilities.

Lines of Credit

The Company, as the borrower, has amended its revolving credit agreement with Ameriprise Financial as the lender. The aggregate amount outstanding under this line of credit may not exceed the lesser of $25 million or 3% of the Company’s statutory admitted assets (excluding separate accounts) as of the prior year end. Prior to July 1, 2023, the interest rate for any borrowing under the agreement was established by reference to London Interbank Offered Rate (“LIBOR”) for U.S. dollar deposits with maturities comparable to the relevant interest period. In July 2023, in anticipation of the end of the publication of U.S. dollar LIBOR, an amendment to the agreement changed the interest rate to Daily Simple Secured Overnight Financing Rate plus 0.1% and an applicable margin subject to adjustment based on debt ratings of the senior unsecured debt of Ameriprise Financial. Amounts borrowed may be repaid at any time with no prepayment penalty. The credit agreement is amended to extend the maturity on an annual basis with Ameriprise Financial, subject to the New York Department’s non-disapproval. There were no amounts outstanding on this line of credit as of both December 31, 2023 and 2022.

Dividends or Distributions

During the years ended December 31, 2023, 2022 and 2021, the Company paid cash dividends or distributions of $50 million, $63 million and nil, respectively, to RiverSource Life. For dividend or other distributions from the Company, advance notification was provided to the New York Department prior to payments. See Note 15 for additional information.

15. STATUTORY ACCOUNTING PRINCIPLES AND REQUIREMENTS

The National Association of Insurance Commissioners (“NAIC”) defines Risk-Based Capital (“RBC”) requirements for insurance companies. The RBC requirements are used by the NAIC and state insurance regulators to identify companies that merit regulatory actions designed to protect policyholders. These requirements apply to the Company. The Company has met its minimum RBC requirements.

Insurance companies are required to prepare statutory financial statements in accordance with the accounting practices prescribed or permitted by the insurance departments of their respective states of domicile, which vary materially from GAAP. Prescribed statutory accounting practices include publications of the NAIC, as well as state laws, regulations and general administrative rules. The State of New York has adopted the NAIC Accounting Practices and Procedures Manual as its prescribed basis of statutory accounting principles. In addition, New York has prescribed certain reserve requirements that differ from those required under NAIC statutory accounting principles. As of December 31, 2023 and 2022, application of these New York prescribed practices which deviate from the NAIC requirements resulted in an increase of $7.1 million and $66.0 million to the Company’s net income, respectively, and a decrease to the Company’s statutory surplus of $76.1 million and $83.2 million, respectively. The Company’s RBC would not have triggered a regulatory event without the application of these prescribed practices.

The more significant differences between NAIC statutory accounting principles and GAAP include charging policy acquisition costs to expense as incurred, establishing annuity and insurance reserves using different actuarial methods and assumptions, valuing investments on a different basis and excluding certain assets from the balance sheet by charging them directly to surplus, such as a portion of the net deferred income tax assets.

State insurance statutes generally require insurance companies to provide notice to state regulators prior to payment of dividends or distributions and those dividends or distributions exceeding prescribed limitations are subject to potential disapproval. For the Company, dividends or distributions in a calendar year which exceed the greater of: (i) 10% of statutory surplus as of the

 

 F-40


RiverSource Life Insurance Co. of New York

 

 

immediately preceding year end, or (ii) statutory net gain from operations for the immediately preceding calendar year, not to exceed 30% of statutory surplus as of the immediately preceding year end would require pre-notification to the New York Department and are subject to potential disapproval. Statutory net gain from operations was $66.6 million, $212.7 million and $63.6 million for the years ended December 31, 2023, 2022 and 2021, respectively.

Comparisons of net income and shareholder’s equity, as shown in the accompanying GAAP financial statements, to that determined using statutory accounting principles prescribed by the State of New York (“SAP”) were as follows:

 

     Years Ended December 31,  
(in thousands)    2023        2022        2021  

Net Income

            

Net income, per accompanying GAAP financial statements

   $ 46,567        $ 44,419        $ 100,228  

Net income, SAP basis(1)

     60,310          317,442          6,125  

Difference

   $ (13,743      $ (273,023      $ 94,103  
       December 31,  
(in thousands)      2023        2022  

Shareholder’s Equity

         

Shareholder’s equity, per accompanying GAAP financial statements

     $ 424,097        $ 394,930  

Capital and surplus, SAP basis(2)

       244,121          319,620  

Difference

     $ 179,976        $ 75,310  

 

(1) 

Results may be significantly impacted by changes in reserves for variable annuity guaranteed benefits, however, these impacts may be substantially offset by unrealized gains (losses) on derivatives which are not included in statutory income but are recorded directly to surplus.

(2) 

Includes unassigned surplus of $135.2 million and $210.7 million as of December 31, 2023 and 2022, respectively.

As of December 31, 2023 and 2022, bonds carried at $220 thousand and $215 thousand, respectively, were on deposit with the State of New York as required by law.

16. OFFSETTING ASSETS AND LIABILITIES

Certain financial instruments and derivative instruments are eligible for offset in the Balance Sheets. The Company’s derivative instruments are subject to master netting and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis in the Balance Sheets.

The following tables present the gross and net information about the Company’s assets subject to master netting arrangements:

 

    December 31, 2023  
    Gross
Amounts of
Recognized
Assets
    Gross Amounts
Offset in the
Balance Sheets
    Amounts of Assets
Presented in the
Balance Sheets
    Gross Amounts Not Offset
in the Balance Sheets
    Net
Amount
 
(in thousands)   Financial
Instruments(1)
    Cash
Collateral
    Securities
Collateral
 

Derivatives:

                                                       

OTC

  $ 72,768     $     $ 72,768     $ (29,626   $ (40,364   $ (2,249   $ 529  

OTC cleared

    323             323       (323                  

Exchange-traded

    1,756             1,756       (271                 1,485  

Total

  $ 74,847     $     $ 74,847     $ (30,220   $ (40,364   $ (2,249   $ 2,014  
    December 31, 2022  
    Gross
Amounts of
Recognized
Assets
    Gross Amounts
Offset in the
Balance Sheets
    Amounts of Assets
Presented in the
Balance Sheets
    Gross Amounts Not Offset
in the Balance Sheets
    Net
Amount
 
(in thousands)   Financial
Instruments(1)
    Cash
Collateral
    Securities
Collateral
 

Derivatives:

                                                       

OTC

  $ 89,575     $     $ 89,575     $ (13,173   $ (75,976   $     $ 426  

OTC cleared

    701             701       (442                 259  

Exchange-traded

    4,000             4,000       (325                 3,675  

Total

  $ 94,276     $     $ 94,276     $ (13,940   $ (75,976   $     $ 4,360  

 

(1)

Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets.

 

F-41 


RiverSource Life Insurance Co. of New York

 

 

The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements:

 

    December 31, 2023  
    Gross
Amounts of
Recognized
Liabilities
    Gross Amounts
Offset in the
Balance Sheets
    Amounts of Liabilities
Presented in the
Balance Sheets
    Gross Amounts Not Offset
in the Balance Sheets
    Net
Amount
 
(in thousands)   Financial
Instruments(1)
    Cash
Collateral
    Securities
Collateral
 

Derivatives:

                                                       

OTC

  $ 39,853     $     $ 39,853     $ (29,626   $ (7,007   $ (3,063   $ 157  

OTC cleared

    1,805             1,805       (323                 1,482  

Exchange-traded

    271             271       (271                  

Total

  $ 41,929     $     $ 41,929     $ (30,220   $ (7,007   $ (3,063   $ 1,639  

 

    December 31, 2022  
    Gross
Amounts of
Recognized
Liabilities
    Gross Amounts
Offset in the
Balance Sheets
    Amounts of Liabilities
Presented in the
Balance Sheets
    Gross Amounts Not Offset
in the Balance Sheets
    Net
Amount
 
(in thousands)   Financial
Instruments(1)
    Cash
Collateral
    Securities
Collateral
 

Derivatives:

                                                       

OTC

  $ 58,017     $     $ 58,017     $ (13,173   $ (13,227   $ (31,449   $ 168  

OTC cleared

    442             442       (442                  

Exchange-traded

    325             325       (325                  

Total

  $ 58,784     $     $ 58,784     $ (13,940   $ (13,227   $ (31,449   $ 168  

 

(1)

Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets.

In the tables above, the amount of assets or liabilities presented are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables.

When the fair value of collateral accepted by the Company is less than the amount due to the Company, there is a risk of loss if the counterparty fails to perform or provide additional collateral. To mitigate this risk, the Company monitors collateral values regularly and requires additional collateral when necessary. When the value of collateral pledged by the Company declines, it may be required to post additional collateral.

Freestanding derivative instruments are reflected in Other assets and Other liabilities. Cash collateral pledged by the Company is reflected in Other assets and cash collateral accepted by the Company is reflected in Other liabilities. See Note 17 for additional disclosures related to the Company’s derivative instruments.

17. DERIVATIVES AND HEDGING ACTIVITIES

Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations.

Certain of the Company’s freestanding derivative instruments are subject to master netting arrangements. The Company’s policy on the recognition of derivatives on the Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 16 for additional information regarding the estimated fair value of the Company’s freestanding derivatives after considering the effect of master netting arrangements and collateral.

 

 F-42


RiverSource Life Insurance Co. of New York

 

 

Generally, the Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives:

 

    December 31, 2023     December 31, 2022  
          Gross Fair Value           Gross Fair Value  
(in thousands)   Notional     Assets(1)     Liabilities(2)     Notional     Assets(1)     Liabilities(2)  

Derivatives not designated as hedging instruments

                                               

Interest rate contracts

  $ 1,883,300     $ 3,180     $ 2,808     $ 3,131,000     $ 11,416     $ 7,625  

Equity contracts

    1,401,329       71,361       35,509       1,291,022       81,619       50,887  

Foreign exchange contracts

    114,951       306       104       90,943       1,241       272  

Credit contracts

    104,115             3,508                    

Total non-designated hedges

    3,503,695       74,847       41,929       4,512,965       94,276       58,784  

Embedded derivatives

           

IUL

    N/A             50,529       N/A             42,382  

Total embedded derivatives

    N/A             50,529       N/A             42,382  

Total derivatives

  $ 3,503,695     $ 74,847     $ 92,458     $ 4,512,965     $ 94,276     $ 101,166  

N/A Not applicable

(1)

The fair value of freestanding derivative assets is included in Other assets.

(2) 

The fair value of freestanding derivative liabilities is included in Other liabilities. The fair value of IUL embedded derivatives is included in Policyholder account balances, future policy benefits and claims.

See Note 13 for additional information regarding the Company’s fair value measurement of derivative instruments.

As of December 31, 2023 and 2022, investment securities with a fair value of $93.9 million and $117.4 million, respectively, were pledged to meet contractual obligations under derivative contracts, of which $3.6 million and $32.5 million, respectively, may be sold, pledged or rehypothecated by the counterparty. As of December 31, 2023 and 2022, investment securities with a fair value of $2.6 million and nil, respectively, were received as collateral to meet contractual obligations under derivative contracts, of which nil may be sold, pledged or rehypothecated by the Company as of both December 31, 2023 and 2022. As of both December 31, 2023 and 2022, the Company had sold, pledged or rehypothecated none of these securities. In addition, as of both December 31, 2023 and 2022, non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Balance Sheets.

The following table presents a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Statements of Income:

 

(in thousands)    Interest
Credited to
Fixed Accounts
     Change in Fair
Value of
Market Risk
Benefits
 

Year Ended December 31, 2023

     

Interest rate contracts

   $      $ (23,725

Equity contracts

     4,569        (77,123

Foreign exchange contracts

            402  

Credit contracts

            (19

IUL embedded derivatives

     (5,694       

Total gain (loss)

   $ (1,125    $ (100,465

Year Ended December 31, 2022

     

Interest rate contracts

   $      $ (145,925

Equity contracts

     (6,797      35,340  

Foreign exchange contracts

            5,198  

IUL embedded derivatives

     11,718         

Total gain (loss)

   $ 4,921      $ (105,387

Year Ended December 31, 2021

     

Interest rate contracts

   $      $ (49,439

Equity contracts

     4,552        (38,592

Foreign exchange contracts

            477  

IUL embedded derivatives

     1,009         

Total gain (loss)

   $ 5,561      $ (87,554

The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company.

 

F-43 


RiverSource Life Insurance Co. of New York

 

 

The deferred premium associated with certain of the above options is paid or received semi-annually over the life of the contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options as of December 31, 2023:

 

(in thousands)    Premiums
Payable
       Premiums
Receivable
 

2024

   $ 260        $  

2025

     130           

2026

     23,701           

2027

               

2028

               

2029 – 2030

     35,700           

Total

   $ 59,791        $  

Actual timing and payment amounts may differ due to future settlements, modifications or exercises of the contracts prior to the full premium being paid or received.

IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to IUL products will positively or negatively impact earnings over the life of these products. The equity component of IUL product obligations is considered an embedded derivative, which is bifurcated from the host contract for valuation purposes and reported on the Balance Sheets at fair value with changes in fair value reported in earnings. As a means of economically hedging its obligations under the provisions of this product, the Company enters into interest rate swaps, index options and futures contracts.

As discussed in Note 12, the Company issues variable annuity contracts that provide protection to contractholders from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. The Company economically hedges its obligations under these market risk benefits using options, swaptions, swaps and futures.

Credit Risk

Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting and collateral arrangements whenever practical. See Note 16 for additional information on the Company’s credit exposure related to derivative assets.

Certain of the Company’s derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company’s financial strength rating (or based on the debt rating of RiverSource Life’s parent, Ameriprise Financial). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial’s debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company’s counterparty could require immediate settlement of any net liability position. As of December 31, 2023 and 2022, the aggregate fair value of derivative contracts in a net liability position containing such credit contingent provisions was $9.9 million and $42.9 million, respectively. The aggregate fair value of assets posted as collateral for such instruments as of December 31, 2023 and 2022 was $9.7 million and $42.7 million, respectively. If the credit contingent provisions of derivative contracts in a net liability position as of December 31, 2023 and 2022 were triggered, the aggregate fair value of additional assets that would be required to be posted as collateral or needed to settle the instruments immediately would have been $157 thousand and $168 thousand as of December 31, 2023 and 2022, respectively.

18. SHAREHOLDER’S EQUITY

The following tables present the amounts related to each component of OCI:

 

       Year Ended December 31, 2023  
(in thousands)      Pretax      Income Tax
Benefit
(Expense)
     Net of Tax  

Net unrealized gains (losses) on securities:

          

Net unrealized gains (losses) on securities arising during the period(1)

     $ 54,710      $ (11,489    $ 43,221  

Reclassification of net (gains) losses on securities included in net income(2)

       224        (47      177  

Impact of benefit reserves and reinsurance recoverables

       (2,181      458        (1,723

Net unrealized gains (losses) on securities

       52,753        (11,078      41,675  

Effect of changes in discount rate assumptions on certain long-duration contracts

       (7,753      1,628        (6,125

Effect of changes in instrument-specific credit risk on MRBs

       (3,734      784        (2,950

Total other comprehensive income (loss)

     $ 41,266      $ (8,666    $ 32,600  

 

 F-44


RiverSource Life Insurance Co. of New York

 

 

       Year Ended December 31, 2022  
(in thousands)      Pretax      Income Tax
Benefit
(Expense)
     Net of Tax  

Net unrealized gains (losses) on securities:

          

Net unrealized gains (losses) on securities arising during the period(1)

     $ (282,360    $ 59,296      $ (223,064

Reclassification of net (gains) losses on securities included in net income(2)

       3,346        (703      2,643  

Impact of benefit reserves and reinsurance recoverables

       8,809        (1,849      6,960  

Net unrealized gains (losses) on securities

       (270,205      56,744        (213,461

Effect of changes in discount rate assumptions on certain long-duration contracts

       78,368        (16,457      61,911  

Effect of changes in instrument-specific credit risk on MRBs

       23,844        (5,007      18,837  

Total other comprehensive income (loss)

     $ (167,993    $ 35,280      $ (132,713

 

       Year Ended December 31, 2021  
(in thousands)      Pretax      Income Tax
Benefit
(Expense)
     Net of Tax  

Net unrealized gains (losses) on securities:

          

Net unrealized gains (losses) on securities arising during the period(1)

     $ (53,907    $ 11,321      $ (42,586

Reclassification of net (gains) losses on securities included in net income(2)

       (10,377      2,179        (8,198

Impact of benefit reserves and reinsurance recoverables

       2,233        (469      1,764  

Net unrealized gains (losses) on securities

       (62,051      13,031        (49,020

Effect of changes in discount rate assumptions on certain long-duration contracts

       22,008        (4,622      17,386  

Effect of changes in instrument-specific credit risk on MRBs

       5,777        (1,213      4,564  

Total other comprehensive income (loss)

     $ (34,266    $ 7,196      $ (27,070

 

(1)

Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period.

(2)

Reclassification amounts are recorded in Net realized investment gains (losses).

Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.

The following table presents the changes in the balances of each component of AOCI, net of tax:

 

(in thousands)   Net Unrealized
Gains (Losses)
on Securities
    Effect of
Changes in
Discount
Rate
Assumptions
    Effect of
Changes in
Instrument-
Specific
Credit Risk
on MRBs
    Total  

Balance at January 1, 2021

  $ 90,117     $     $     $ 90,117  

Cumulative effect of adoption of long-duration contracts guidance

    48,935       (79,153     (22,676     (52,894

OCI before reclassifications

    (40,822     17,386       4,564       (18,872

Amounts reclassified from AOCI

    (8,198                 (8,198

Total OCI

    (49,020     17,386       4,564       (27,070

Balance at December 31, 2021

    90,032       (61,767     (18,112     10,153  

OCI before reclassifications

    (216,104     61,911       18,837       (135,356

Amounts reclassified from AOCI

    2,643                   2,643  

Total OCI

    (213,461     61,911       18,837       (132,713

Balance at December 31, 2022

    (123,429     144       725       (122,560

OCI before reclassifications

    41,498       (6,125     (2,950     32,423  

Amounts reclassified from AOCI

    177                   177  

Total OCI

    41,675       (6,125     (2,950     32,600  

Balance at December 31, 2023

  $ (81,754   $ (5,981   $ (2,225   $ (89,960

 

F-45 


RiverSource Life Insurance Co. of New York

 

 

19. INCOME TAXES

The components of income tax provision were as follows:

 

     Years Ended December 31,  
(in thousands)    2023        2022        2021  

Current income tax

            

Federal

   $ 9,247        $ 11,869        $ 22,663  

State and local

     (173        185          624  

Total current income tax

     9,074          12,054          23,287  

Deferred federal income tax

     (1,519        (4,674        112  

Total income tax provision

   $ 7,555        $ 7,380        $ 23,399  

The principal reasons that the aggregate income tax provision is different from that computed by using the U.S. statutory rate of 21% were as follows:

 

     Years Ended December 31,  
      2023        2022        2021  

Tax at U.S. statutory rate

     21.0        21.0        21.0

Changes in taxes resulting from:

            

Dividends received deduction

     (3.4        (3.9        (1.6

Foreign tax credit, net of addback

     (2.9        (2.9        (0.9

Other

     (0.7                 0.4  

Income tax provision

     14.0        14.2        18.9

The decrease in the Company’s effective tax rate for the year ended December 31, 2022 compared to 2021 is primarily due to lower pretax income relative to tax preferred items.

Deferred income tax assets and liabilities result from temporary differences between the assets and liabilities measured for GAAP reporting versus income tax return purposes. Deferred income tax assets and liabilities are measured at the statutory rate of 21% as of both December 31, 2023 and 2022. The significant components of the Company’s deferred income tax assets and liabilities, which are included net within Other assets or Other liabilities, were as follows:

 

     December 31,  
(in thousands)    2023        2022(1)  

Deferred income tax assets

       

Insurance and annuity benefits including corresponding hedges

   $ 66,330        $ 66,283  

Investments including net unrealized on Available-for-Sale securities

     22,092          31,247  

Other

     72          277  

Gross deferred income tax assets

     88,494          97,807  

Deferred income tax liabilities

       

Deferred acquisition costs

     23,492          25,486  

Other

     1,431          1,602  

Gross deferred income tax liabilities

     24,923          27,088  

Net deferred income tax assets

   $ 63,571        $ 70,719  

 

(1)

Prior period amounts have been reclassified to conform to current year presentation and relate to derivative activity being presented with the liabilities they are hedging and remaining investments being presented together inclusive of net unrealized on Available-for-Sale securities.

Based on analysis of the Company’s tax position, management believes it is more likely than not that the Company’s results of future operations and implementation of tax planning strategies will generate sufficient taxable income to enable the Company to utilize all of the deferred tax assets. Accordingly, no valuation allowance for deferred tax assets has been established as of both December 31, 2023 and 2022.

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits was as follows:

 

(in thousands)    2023        2022        2021  

Balance at January 1

   $ 320        $ 346        $ 372  

Additions for tax positions related to the current year

     6                    

Reductions for tax positions related to the current year

     (6        (26        (26

Additions for tax positions of prior years

     324                    

Reductions for tax positions of prior years

     (644                  

Balance at December 31

   $        $ 320        $ 346  

 

 F-46


RiverSource Life Insurance Co. of New York

 

 

If recognized, approximately nil, $218 thousand and $218 thousand, net of federal tax benefits, of unrecognized tax benefits as of December 31, 2023, 2022 and 2021, respectively, would affect the effective tax rate.

The Company is not aware of any tax positions for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly change in the next 12 months.

The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company recognized a net decrease of $90 thousand for the year ended December 31, 2023, and a net increase of $16 thousand and $11 thousand in interest and penalties for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2023 and 2022, the Company had a payable of nil and $90 thousand related to accrued interest and penalties, respectively.

The Company files income tax returns as part of its inclusion in the consolidated federal income tax return of Ameriprise Financial in the U.S. federal jurisdiction and various state jurisdictions. As of December 31, 2023, the federal statutes of limitations are closed on years through 2018. A previously open item for 2014 and 2015 was resolved in the second quarter of 2023. Also in the second quarter of 2023, the Internal Revenue Service (“IRS”) audit for tax years 2016 through 2018 was finalized. The IRS is currently auditing Ameriprise Financial’s U.S. income tax returns for 2019 and 2020. The state income tax returns of Ameriprise Financial and its subsidiaries, including the Company, are currently under examination by various jurisdictions for years ranging from 2017 through 2021.

20. COMMITMENTS AND CONTINGENCIES

Commitments

As of both December 31, 2023 and 2022, the Company had no funding commitments related to mortgage loans.

Contingencies

The Company and its affiliates are involved in the normal course of business in legal proceedings which include regulatory inquiries, arbitration and litigation, including class actions, concerning matters arising in connection with the conduct of its activities. These include proceedings specific to the Company as well as proceedings generally applicable to business practices in the industries in which it operates. The Company can also be subject to legal proceedings arising out of its general business activities, such as its investments, contracts and employment relationships. Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally.

As with other insurance companies, the level of regulatory activity and inquiry concerning the Company’s businesses remains elevated. From time to time, the Company and its affiliates, including AFS and RiverSource Distributors, Inc. receive requests for information from, and/or are subject to examination or claims by various state, federal and other domestic authorities. The Company and its affiliates typically have numerous pending matters, which include information requests, exams or inquiries regarding their business activities and practices and other subjects, including from time to time: sales and distribution of, and disclosure practices related to, various products, including the Company’s insurance and annuity products; supervision of associated persons, including AFS financial advisors and RiverSource Distributors, Inc.’s wholesalers; administration of insurance and annuity claims; security of client information; and transaction monitoring systems and controls. The Company and its affiliates are cooperating with the applicable regulators.

These pending matters are subject to uncertainties and, as such, it is inherently difficult to determine whether any loss is probable or even reasonably possible, or to reasonably estimate the amount of any loss that may result from such matters. The Company cannot predict with certainty if, how, or when any such proceedings will be initiated or resolved. Matters frequently need to be more developed before a potential loss or range of loss can be reasonably estimated for any matter. An adverse outcome in any matter could result in an adverse judgment, a settlement, fine, penalty, or other sanction, and may lead to further claims, examinations, or adverse publicity each of which could have a material adverse effect on the Company’s financial condition, results of operations, or liquidity.

In accordance with applicable accounting standards, the Company establishes an accrued liability for contingent litigation and regulatory matters when those matters present loss contingencies that are both probable and can be reasonably estimated. The Company discloses the nature of the contingency when management believes there is at least a reasonable possibility that the outcome may be material to the Company’s financial statements and, where feasible, an estimate of the possible loss. In such cases, there still may be an exposure to loss in excess of any amounts reasonably estimated and accrued. When a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability, but continues to monitor, in conjunction with any outside counsel handling a matter, further developments that would make such loss contingency both probable and reasonably estimable. Once the Company establishes an accrued liability with respect to a loss contingency, the Company continues to monitor the matter for further developments that could affect the amount of the accrued liability that has been previously established, and any appropriate adjustments are made each quarter.

 

F-47 


RiverSource Life Insurance Co. of New York

 

 

Guaranty Fund Assessments

The Company is required by law to be a member of the guaranty fund association in the State of New York. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund association. The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations and the amount of its premiums written relative to the industry-wide premium in the State of New York. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated.

As of both December 31, 2023 and 2022, the Company had no accrual established for estimated future guaranty fund assessments.

 

 F-48


LOGO

  

RiverSource Life Insurance Co. of New York

20 Madison Avenue Extension

Albany, NY 12203

1-800-541-2251

   RiverSource Distributors, Inc. (Distributor), Member FINRA. Issued by RiverSource Life Insurance Co. of New York, Albany, New York. Affiliated with Ameriprise Financial Services, LLC.
ANN9126_12_C01_(05/24)    © 2008-2024 RiverSource Life Insurance Company. All rights reserved.